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SUMMARY 
 
In this study, the interplay of flavivirus West Nile and different cellular 
components were investigated from the point of virus entry to egression.  Understanding 
these important issues of virus-host interaction will provide avenue for rational design of 
anti-viral strategies. 
The first part of this study attempts to isolate and characterize West Nile virus 
(WNV)-binding molecules on the plasma membrane of Vero cells that is responsible for 
virus entry. The virus overlay protein blot detected a 105-kDa molecule on the plasma 
membrane extract of Vero cells that bind to WN virus. Treatment of the 105-kDa 
molecules with β-mercaptoethanol resulted in the virus binding to a series of lower 
molecular weight bands ranging from 30 to 40 kDa. The disruption of disulfide-linked 
subunits did not affect virus binding. N-linked sugars with mannose residues on the 105-
kDa membrane proteins were found to be important in virus binding. Specific antibodies 
against the 105-kDa glycoprotein were highly effective in blocking virus entry. These 
results strongly supported that the 105-kDa protease-sensitive glycoprotein with complex 
N-linked sugars is the putative receptor for WN virus. 
Peptide sequencing of the 105-kDa plasma membrane-associated glycoprotein 
revealed its identity as a member of the integrin superfamily.  Infection of WNV was 
markedly inhibited in Vero cells pretreated with functional blocking antibodies against 
αVβ3 integrin and its subunits. Soluble αVβ3 integrin can also effectively blocked WNV 
infection in a dose-dependent manner. Similarly, gene silencing of β3 integrin subunit in 
Hela cells resulted in cells largely resistant to WNV infection. In contrast, expression of 
recombinant human αVβ3 integrin substantially increased the permissiveness of CS-1 
melanoma cells for WNV infection. However, virus entry was not affected by RGD 
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peptides, suggesting that the interaction between virus and αVβ3 integrin was not highly 
dependent of the classical RGD binding motif.  In addition, domain III of WNV envelope 
protein was shown to associate with αVβ3 integrin by immunoprecipitation and virus 
entry can be blocked by soluble recombinant domain III of envelope protein in a dosage-
dependent manner. 
The entry pathway of WNV was also mapped in detail. Overexpression of 
dominant-negative mutants of Eps15 strongly inhibited WNV internalization and 
pharmacological drugs that blocked clathrin pit formation also caused a marked reduction 
in virus entry.  This was not the case for caveolae-dependent endocytosis when the 
inhibitory agent, filipin was used. Double-labelling immunofluorescence assays and 
immunoelectron microscopy performed with anti-WNV envelope or capsid proteins and 
cellular markers (EEA1 and LAMP1) revealed the trafficking pathway of the internalized 
virus particles from early endosomes to lysosomes and finally the uncoating of the virus 
particles.  Protein kinase C was also shown to be involved in intracellular trafficking of 
the internalized virus particles.  Disruption of host cell cytoskeleton (actin filaments and 
microtubules) with cytochalasin D and nacodazole showed significant reduction in virus 
entry.  Actin filaments were shown to be essential during the initial penetration of the 
virus across the plasma membrane while microtubules were involved in the trafficking of 
the internalized virus from early endosomes to lysosomes for uncoating. Cells treated 
with lysosomotrophic agents were largely resistant to infection, indicating that a low pH - 
dependent step was required for WNV infection. In-situ hybridization with DNA probes 
specific for viral RNA demonstrated the trafficking of uncoated viral RNA genomes to 
the ER.  
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Previous studies have shown that WNV (Sarafend) matured by budding at the 
plasma membrane, which differed from the usual intracellular maturation of other 
flaviviruses. The present study further investigated the trafficking mechanism of the 
structural proteins as well as the maturation process of WNV (Sarafend).  Microtubules 
were required to serve as highway for the trafficking of virus structural proteins from site 
of synthesis to the plasma membrane for assembly.  Subsequent studies revealed that the 
transportation of virus E protein was also associated with the microtubules-based motor 
protein, kinesin.  Furthermore, actin filaments were required to serve as a driving force 
for the budding of virus particles across the plasma membrane.   
Lastly, the mechanism of WNV-induced cell death was shown to be dependent by 
the initial infectious dose. In Vero cells infected with WNV at an M.O.I. of ≥ 10, 
morphological changes characteristic of necrosis were observed as early as 8 hr post-
infection (p.i.). High extracellular lactate dehydrogenase (LDH) activity was observed 
together with leakage of the high mobility group 1 (HMGB1) protein into the 
extracellular space.  At high infectious doses, loss of cell plasma membrane integrity was 
due to the profuse budding of WN progeny virus particles during maturation. When this 
profuse budding process was disrupted using cytochalasin B, LDH activity was reduced 
dramatically. In contrast, WNV-induced cell killing occurred predominantly by apoptosis 
when cells were infected with an M.O.I. of ≤1; the process of apoptosis observed was 
much later after infection (32 hr p.i.). The WNV-induced apoptosis pathway was initiated 
by the release of cytochrome c from the mitochondria and accompanied by the formation 
of apoptosomes. In turn, this led to the activation of caspase-9 and -3, and to the cleavage 
of the poly (ADP-ribose) polymerase. 
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1.0 LITERATURE REVIEW 
1.1 FLAVIVIRUS CLASSIFICATION 
Flaviviruses consisting of approximately 50 antigenically related viruses are 
classified as one of three genera under the family Flaviviridae (Hase et al., 1989b; 
Chambers et al., 1990). Most members are arboviruses, transmitted by arthropod vectors 
(either ticks or mosquitoes) and a few viruses have no known vectors.  The most recent 
classification, as listed in the 7th Report of the International Committee on Taxonomy of 
Viruses (ICTV), has assigned members of the genus into species (Heinz et al., 2000; 
Mackenzie et al., 2002).  There are currently 27 mosquito - borne species, 12 tick - borne 
species and 14 species with no known vector.  The classification of the mosquito - borne 
flaviviruses, their major vectors and hosts, their geographic range, and their virulence for 
human is summarized in Table 1 [adapted from Mackenzie et al (2002)]. 
 
1.2 FLAVIVIRUS WEST NILE  
West Nile virus (WNV) is a mosquito-borne virus that was first isolated and 
identified as a distinct pathogen from a febrile adult woman in the West Nile region of 
Uganda in 1937 (Smithburn et al., 1940).  West Nile virus is taxonomically placed within 
the family of Flaviviridae, genus Flavivirus.  Based on cross-neutralisation tests, WNV 
was classified within the Japanese encephalitis sero-complex and is closely related to 
Japanese encephalitis virus, eastern Asia; Kunjin virus, Australia and Southeast Asia; and 
St. Louis encephalitis virus, North and South America (Calisher et al., 1989).  
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Table 1:  Classification of mosquito-borne flaviviruses. 
Groupa Speciesa Subtype/strain/serotypea Major vectorb Vertebrate hostsb Geographic rangeb Human diseaseb,c
Aroa virus group 
 Aroa virus  None known (Sentinel hamster)d Venezuela  -
     Bussuquara virus Culex sp. Rodents Brazil +
  Iguape virus Not known Rodents? Brazil - 
      Naranjal virus Culex species (Sentinel hamster)d ecuador -
       
Dengue virus group 
 Dengue virus      
  Dengue virus type 1 Aedes aegypti Humans All tropical/subtropical
regions 
 + + + / + + + +e
  Dengue virus type 2 Aedes  aegypti   Humans All tropical/subtropical
regions 
+ + + / + + + +e
  Dengue virus type 3 Aedes aegypti   Humans All tropical/subtropical
regions 
+ + + / + + + +e
  Dengue virus type 4 Aedes  aegypti   Humans All tropical/subtropical
regions 
+ + + / + + + +e
       
Japanese Encephalitis virus group 
 Cacipacore virus  None known Birds Brazil - 
   Koutango virus Culex sp.?, ticks Gerbils? Western and central 
Africa 
+ 




Birds and pigs Eastern and southern 
Africa 
+ + + + 
 Murray Valley encephalitis 
virus 
 Cx. annulirostris Birds  Australasia/eastern
Indonesia? 
+ + + +
       Alfuy virus Cx. annulirostris Birds Australia -
 St. Louis encephalitis virus  Cx. pipiens/Cx. 
tarsalis 
Birds   North and South
America 
+ + + +
   Usutu virus Culex sp. Birds Eastern, central, 
southern and western 
Africa 
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   West Nile virus Cx. species Birds Africa, southern and 
eastern Europe, Middle 
East, India, North 
America 
+ + + (+ + + +)f
       Kunjin virus Cx. annulirostris Birds Australasia/Malaysia + + +
  Yaounde virus  Culex sp. Birds?/rodents? Central and western 
Africa 
- 
       
Kokobera group 
 Kokobera virus     Cx. annulirostris Marsupials? Australasia +
      Stratford virus Ochlerotatus vigilax Marsupials? Australasia -
       
Ntaya virus group 
 Bagaza virus  Culex species Not known Central and western 
Africa 
- 
   Ilheus virus Psorophorra ferox Birds, bats? Southern and central 
America 
+ + 
   Rocio virus Psorophorra ferox birds South America + + + +




 Birds (turkeys) Israel, Southern Africa - 
  Ntaya virus Culex sp. Not known Eastern, central and 
western Africa 
- 
   Tembusu virus Culex gelidus Not known Malaysia/Thailand - 
       
Spondweni virus group 




   Spondweni virus Aedes sp. and 
various 
Not known Southern and western 
Africa 
+ 
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Yellow fever virus group 
 Banzi virus  Cx. rubinotus Not known Southern and eastern 
Africa 
+ 
     Edge Hill virus Oc. Vigilax Marsupials Australasia +
   Jugra virus Aedes species Not known Malaysia  - 
 Soboya virus  Not known Gerbils, rodents Western Africa - 
       Potiskum virus Not known Rodents? Western Africa -
  Sepik virus  Ficalbia sp., various Not known Australasia (New 
Guinea) 
+
    Uganda S Aedes sp. Birds, monkeys? Africa - 
   Wesselsbron virus Aedes sp. Domestic animals Africa + + 
 Yellow fever virus  Aedes aegypti, 
Hemagogus sp. 
Prmates, humans Western, central and 
eastern Africa, South 
America 
+ + + + 
 
aBased on Heinz et al (2000) 
bBased on Karabatsos (1985), with additional data from Figueiredo  (2000) and Russell (1995). 
cSeverity scored as -, no known diseases; +, possible diseases or mild very occasional disease; +, mild disease; + +, moderate disease; + + +, moderate disease with some cases of 
greater severity; + + +, severe disease, usually requiring hospitalization; + + + +, severe disease, with some fatalities; + + + +, severe disease with significant mortality. 
dIsolates only from sentinel animals. 
eDengue fever (DF): Dengue haemorrhagic fever (DHF). 
fSeverity score in parentheses relate to severity of recent strains in the elderly. 
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The WNV isolates have been recently grouped into two genetic lineages (1 and 2) 
on the basis of signature amino acid substitutions or deletions in their envelope protein 
(Berthet et al., 1997).  All WNV isolates that are associated with human diseases have 
been found in lineage 1 while lineage 2 viruses are mainly restricted to endemic enzootic 
infection in Africa (Jia et al., 1999; Lanciotti et al., 2002).  Due to the fact of antigenic 
cross - reactivity between different flaviviruses, techniques such as in situ hybridization 
and sequence analyses of real - time polymerase chain reaction (PCR) products are 
required to unequivocally identify of WNV as the causative agent (Briese et al., 2002; 
Lanciotti et al., 2002; Steele et al., 2000). 
West Nile virus is the causative agent of the disease syndrome named West Nile 
Fever.  The incubation period of WNV infection is typically 2 - 6 days and patients with 
West Nile fever develop a sudden onset of an acute non - specific flu - like illness, 
characterized by high fever, headache, anorexia, malaise and retro - orbital pain.  A 
maculopapula or pale roseolar rash was reported in about half the patients and is more 
common among the children (Petersen and Roehrig, 2001). Myocarditis, pancreatitis and 
hepatitis have also been occasionally described in patients with severe infection (Hayes, 
1988).  Neurological manifestation is a possible complication of WNV infection, as 
WNV is neuroinvasive and has caused many fatalities in the immunocompromised 
individual (George et al., 1984). Neurological manifestations of WNV are quite similar 
with other flaviviruses (Japanese encephalitis virus and Murray Valley encephalitis 
virus).  Damages are seen in the meninges contributing to meningitis, the brain 
parenchyma contributing to encephalitis and the spinal cord contributing to myelitis.  In 
the recent outbreak of WNV in North America, generalized muscle weakness and later 
described as poliovirus - like flaccid paralysis was recognized in most of the infected 
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patients (Sejvar et al., 2003).  Humans age 60 and older have an increase risk of 
developing fatal disease (Chowers et al., 2001). 
Being an old world flavivirus, WNV is one of the most widespread flaviviruses.  
West Nile virus is an endemic febrile illness in Africa, Europe, the Middle East, central 
Asia and Oceania (Brinton, 2002).  Occasionally, WNV has been the causative agent of 
brief epizootics in Romania, Russia, Algeria, Madagascar, France, Senegal and South 
Africa and of infrequent disease outbreaks in human.  During the 1950's, an estimated 
40% of the human population in Egypt's Nile Delta were seropositive for the virus 
(Smithburn et al., 1940).  The largest human epidemic occurred in Cape Province, South 
Africa, in 1974, when approximately 3,000 clinical cases of the virus were recorded 
(McIntosh et al., 1976).  Recently, the first known human case of WNV infection in the 
Western Hemisphere (New World) was reported in August 1999 (CDC, 1999).  Since 
1999, WNV has spread across the eastern and southern states and into central United 
States.  In 2002, 39 states reported 4156 human WNV illness cases (O’Leary et al., 
2004). 
The mode of introduction of WNV into North America is unclear but phylogenic 
analysis of the envelope gene of a WNV isolate from the New York outbreak suggested 
that the virus was very closely related to a goose isolate from Israel [(WN - Israel 1998) 
(Jia et al., 1999; Lanciotti et al., 2002)]. Therefore, it was speculated that the movement 
of WNV to the Western Hemisphere was caused by migratory birds that acted as 
introductory hosts, perhaps by infecting ornithophilic mosquitoes (Rappole et al., 2000).   
West Nile virus has been isolated from Culex, Aedes, Minomyia, Mansonia and 
Anopheles mosquitoes in Asia, United States, Africa, but Culex species are the most 
susceptible to infection (Ilkal et al., 1997).  High levels of viremia have been detected in 
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a number of wild birds.  The viremic levels of WNV were sustained at at least 105 
PFU/ml of serum (this amount of virus has been estimated to be required to infect feeding 
mosquitoes) for several days to weeks.  This allowed them to remain as the main 
reservoir host for maintaining the transmission of WNV infection (Bernard and Kramer 
2001). 
In addition, natural vertical transmission of WNV in Culex mosquitoes has been 
reported and was suggested to enhance virus maintenance in nature (Miller et al., 2000).  
Recently, ticks have been shown to be involved in mechanical transmission thus may 
have a possible role in maintenance (L’vov et al., 2002).  Since the virus travels with 
viremic migrating birds, many experts believe it might be expected to spread to new 
niches in the coming years. 
Human, mammals and amphibians are incidental hosts with low viremic levels 
and they do not play a role in the transmission cycle (Anderson et al., 1999; Hubalek, 
2000; Rappole et al., 2000).  However, alternative modes of transmission between human 
can occur through blood transfusions, organ transplantation and even ingestion of breast 
milk (Hayes and O’Leary, 2004). 
 
1.3 VIRAL MORPHOLOGY 
Mature virions are spherical and have a diameter of about 50 nm (Figure 1a).  
Their cores are about 25 - 30 nm in diameter.  Along the outer surface of the virion 
envelope are projections that are 5 - 10 nm long with terminal knobs of 2 nm in diameter 
(Murphy, 1980).  Mature virions of WNV are relatively simple particles consisting of 
three structural proteins: the large envelope glycoprotein (E), a single nucleocaspid 
protein (C) and a lipid membrane protein [(M) (Figure 1b)].  Within the virion is a single-
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stranded positive sense, infectious RNA genome.  The C proteins and genomic viral RNA 
form an isometric nucleocapsid (Figure 1c).  The M and E proteins together with the lipid 
bilayers surround the nucleocapsid.  
Virions contain about 17 % lipid by weight and the lipids are derived from host 
cell membranes (endoplasmic reticula or plasma membrane). Virions also contain about 9 
% carbohydrate by weight (glycolipids and glycoproteins), and their composition and 
structures are highly dependent on the host cell (vertebrate or arthropod).  Several N-
linked glycosylation sites are located in prM and E proteins.  The virion Mr has not been 
precisely determined but mature flavivirus particles sediment at approximately 200S and 
has a buoyant density of approximately 1.19 g/cm3 in sucrose.  Virus is stable at slightly 
alkaline pH 8 and can be readily inactivated at acidic pH ≤ 3, temperature above 40 °C, 







Figure 1.  Structure of mosquito - borne flavivirus. (A) 17 Å structure of WNV 
determined by cryo-EM. A surface shaded view of the virus with one asymmetric unit of 
the icosahedron shown by the triangle. The 5 - fold and 3 - fold icosahedral symmetry 
axes are labelled (Mukhopadhyay et al., 2003).  (B) Central cross-section showing the 
cryo-electron microscopy density.  The outermost layer in dark blue is the envelope 
protein, light blue region is the membrane protein, the green region is the lipid bilayer, 
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the yellow region is the nucleocapsid and the red shaded region is the viral RNA (Kuhn et 
al., 2002).  (C) Stereo diagram showing the less ordered nucleocapsid in yellow and the 
viral RNA genome in red (Kuhn et al., 2002).  
 
1.4 FLAVIVIRUS RNA GENOME ORGANISATION  
It has been established that the genome of WNV is single-stranded with molecular 
weight of about 4x106. It is approximately 11,029 bases in length and contains a single 
open reading frame (ORF) of 10,301 bases. The 5’ untranslatable region (UTR) of the 
viral genome RNA is 96 nucleotide in length, while the 3’ UTR is 631 nucleotides.  
Within the 3’ UTR, the RNA genome contains two to three conserved repeated sequences 
that formed a pseudo-knot structure necessary for RNA cyclization (Shi et al., 1996). The 
genomic RNA of WNV is infectious due to its mammalian messenger - like positive 
polarity (Ada and Anderson, 1959).  The genomic RNA has a type I cap at its 5' end 
(m7GpppAmp) and internal base-methylated adenine residues.  The 5' cap is followed by 
conserved dinucleotide sequence AG.  Genomic RNAs of mosquito - borne flaviviruses 
(WNV) appear to lack the 3'-terminal poly (A) tract (Brinton et al, 1986; Rice, 1996; 
Westaway, 1987) and instead terminate with the conserved dinucleotide CUOH.
The most notable feature of WNV genome is the presence of one ORF of over 
10,000 bases.  The order of the proteins encoded in the long ORF is 5'-C-prM/M-E-NS1-
NS2A-NS2B-NS3-NS4A-NS4B-NS5-3' (Figure 2).  The three structural proteins are C, 
prM and E which are encoded in the 5' quarter of the genome and the genes for the non-
structural proteins are located in the remainder.  The non - structural proteins include the 
large, highly conserved proteins NS1, NS3, and NS5, and four small hydrophobic 
proteins, NS2A, NS2B, NS4A and NS4B. 
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Figure 2. The genomic organisation of WNV (Heinz et al., 2000). 
 
1.5 FLAVIVIRUS STRUCTURAL PROTEINS 
The translation of viral proteins is initiated near the 5' end of the genome which is 
followed by proteolysis to produce individual viral proteins.  The individual proteins are 
thought to be formed by co- or post-translational cleavage of a large precursor protein 
(Rice, 1996).  Three structural proteins are generated during this process (Castle et al., 
1985; Wengler et al., 1985). 
 
1.5.1 Capsid (C) Protein 
The first structural protein found in the ORF is the nucleocapsid protein, C [(Mr 
of 12 - 14 kDa) (Boulton and Westaway, 1972; Naeve and Trent, 1978; Wengler et al.,
  10 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
 1978; Cleaves and Dubin, 1979)]. A precursor of C protein (anchored C) contains a 
hydrophobic region at its C - terminal and is cleaved to generate the mature virion C 
protein.  The sequences of C proteins are poorly conserved among flaviviruses but are 
highly basic and complex with the RNA genome to form the nucleocapsid.   
Cryo-electron microscopy analysis of the dengue virus indicated that the capsid 
protein is poorly ordered (Kuhn et al., 2002).  Ma and co-workers (2004) has recently 
resolved the solution structure of dengue virus capsid protein using NMR spectroscopy. 
A region designated as α4 - α4’ in the C protein that is rich in basic residues interacts 
with the viral RNA whereas the apolar α2 - α2’ region interacts with the viral lipid 
bilayer membrane (Figure 3).  However, the encapsidation signal on the flavivirus 
genome RNA that is recognized by the C protein has yet to be identified.   
Truncation studies have shown that removal of the central hydrophobic domain 
(28 to 43 amino acids) did not affect virus translation or replication. Such deletion is still 
capable of producing infectious virus particles (Kofler et al., 2002).  In flavivirus -
infected cells, C proteins can be visualized in the nucleus during late infection.  Wang 
and group (2002) have characterized a functional bipartite nuclear localization signal 
located at the C terminal of dengue virus capsid protein that is responsible for nuclear 
localization of the C protein.  The purpose of localizing flavivirus C protein in the cell 
nucleus during virus replication is currently not known.  Since the introduction of WNV 
C protein into the nuclei of host cells has been shown to induce apoptosis, it could 
contribute to the pathogenesis of flavivirus infection (Yang et al., 2002). 
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Figure 3. Model for molecular interactions between structural components of flavivirus. 
The viral membrane is shown on top near the hydrophobic cleft, and the viral RNA is 
shown on the bottom near the positively charged surface of capsid protein (Ma et al., 
2004). 
 
1.5.2 Precusor Membrane/Membrane (prM/M) Protein 
The second structural protein followed by the C protein is the prM (Mr of 18 – 
19-kDa), which is a glycoprotein precursor of the unglycoslated structural M protein (Mr 
of 8-kDa). Intracellular immature virion contains prM protein and the hydrophilic N-
terminal portion of prM protein is cleaved in the trans - Golgi network by cellular furin or 
a related protease to produce mature virions with M protein (Stadler et al., 1997). Virions 
with prM - E protein complexes are also reported to be less infectious than mature virions 
(Heinz and Allison, 2000).  It is suggested that the function of prM protein is to stabilize 
E protein from undergoing irreversible conformational changes in acidic compartments of 
the secretory pathway (Heinz and Allison, 2000). Catteau & colleagues (2003) has 
  12 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
reported the presence of a pro-apoptotic sequence (residues 32 to 40) in dengue virus M 
protein. Intracellular expression of recombinant M protein activates a mitochondrial 
apoptotic pathway in a number of cell lines thus, proposed as another contributor to the 
pathogenesis of flavivirus infection. 
 
1.5.3 Envelope (E) Protein 
The largest viral structural protein of the WNV is the envelope protein E (50 – 60- 
kDa) and is present on surfaces of the virus particles as short club - like projections 
(Westaway, 1987).  It is a typical type I integral membrane protein with a large N - 
terminal ectodomain anchored in the bilayer via a hydrophobic C - terminal domain 
(Chambers et al., 1990).  Cysteine residues in the E protein ectodomain are highly 
conserved and all of them form intracellular disulfide bonds (Nowak and Wengler, 1987).  
Recent cystallography data on the ectodomain of the E protein of tick borne encephalitis 
virus (Rey et al., 1995) revealed that the E protein forms homodimers arranged in a head 
– to - tail orientation and lies relatively flat on the virion surface (Figure 4a and b).  A 
series of three dimers is aligned back to back to give a herringbone structure arrangement 
that form a protein shell over the lipid bilayer [(Mukhopadhyay et al., 2003; Zhang et al., 
2003) (Figure 4c)]. 
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Figure 4. Structural arrangement of flavivirus envelope protein. (a) Diagrams of the 
flavivirus ectodomain and transmembrane domain proteins. The volume occupied by the 
ectodomain of an E monomer is pink (domain I), yellow (domain II) and lilac (domain 
III). (b) Homodimer arrangement of the E protein on the surface of the flavivirus particle 
(Zhang et al., 2003). (c) Structure of the whole WNV with the homodimer E proteins 
arranged in a herringbone conformation (Mukhopadhyay et al., 2003). 
 
Each monomer of the E protein is folded into three distinct domains: a central 
domain designated as domain I, an elongated dimerization region designated as domain II 
and domain III having an Ig - like modules (Rey et al., 1995).  The destruction of 
epitopes on domain II upon exposure to low pH suggested that this particular domain is 
responsible for fusion to the endocytic vesicle membrane during entry process 
(Guirakhoo et al., 1989; Mandl et al., 1989).  Furthermore, the presence of sequences 
corresponding to that of typical β - barrel type structures is proposed as the class II fusion 
peptide in domain II of E protein (Rey et al., 1995). 
Based on the structure of dengue virus, the E dimers are closely packed on the 
surface of the virus. This makes the fusion impossible at neutral pH.  However, Modis 
and co-worker (2004) proposed that conformational rearrangement of the E proteins 
occurred at reduced pH environment.  The reduced pH in endocytic vesicles causes E 
protein dimers on the virion surface to dissociate exposing their fusion peptide (domain 
II) and allowing domain I and II to flex relative to one another.  These movements allow 
domain II to turn outward, away from the virion surface, and to insert its fusion peptide 
into the target cell membrane (Figure 5).  Subsequent interactions of the viral E proteins 
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with the endocytic vesicle membrane form hemifusion pores allow for the release of viral 
nucleocapsids into the cytoplasm for uncoating and replication. 
 
Figure 5.  A model of the rearrangement of the E homodimers in flavivirus upon low pH 
exposure.  The E dimers in mature virus (A) are shown undergoing a rearrangement to 
the predicted T=3 fusogenic structure (C) with a possible intermediate (B).  Arrows in 
(B) indicate the direction of E proteins rotation.  The solid triangle in (C) indicates the 
position of a quasi-3 fold axis (Kuhn et al., 2002). 
 
Domain III is postulated to function as the receptor binding domain of the virus 
for the following reasons.  Analysis of domain III at the structural level showed that it has 
an Ig - like fold that is commonly associated with glycoprotein with an adhesion function.  
Domain III also extends perpendicularly to the surface of virus with a tip projecting 
further from the virion surface than any part of the E protein.  In mosquito - borne 
flaviviruses (except Dengue viruses), the common integrin molecular binding motif 
arginine-glycine-asparate (RGD) is incorporated in domain III (Rey et al., 1995).  
However, several recent studies have shown that this integrin binding motif is not 
required for virus binding to cell surface (Hurrelbrink and McMinn, 2001; van der Most 
et al., 1999).  Monoclonal antibodies generated against domain III of flavivirus E protein 
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are highly effective in neutralizing the viruses (Volk et al., 2004; Beasley and Barrett, 
2002; Crill and Roehrig, 2001).  Mutagenesis of flavivirus domain III of E protein also 
alters the entry process and virulence of viruses (Vlaycheva and Chambers, 2002; Lee 
and Lobigs, 2002).  In addition, a report from Ni and co-workers (2000) has noted that a 
region of domain II of E protein may also participate in binding of virus to cells in 
monkey brains. 
Generally, the E proteins of most flaviviruses are glycosylated.  However, 
unglycosylated E proteins have been reported for some isolates of Kunjin, WNV, yellow 
fever and St. Louis encephalitis viruses (Wright, 1982; Wengler et al., 1985; Vorndam et 
al., 1993).  The acquisition of a carbohydrate residue on WNV E protein after passage in 
mosquito cells was not linked to attenuation of the virus (Chambers et al., 1998).  The 
role of glycosylation of flavivirus E protein in contributing to the pathogenesis was 
extensively studied but no conclusive definition was drawn from these studies (Chambers 
et al., 1998; Lee et al., 1997; Beasley et al., 2004).   
Therefore, the E protein of flaviviruses has many important biological functions.  
It is the receptor - binding protein to host cells and also responsible for membrane fusion 
activity (Gollins and Porterfield, 1985).  The E protein is also the virus haemagglutinin, 
and induced a protective immune response (Chamber et al., 1990; Guirakhoo et al., 
1990).  It therefore contains components important in determining host range, tissue 
tropism, and virulence as well as eliciting protective immunity. 
 
1.6 FLAVIVIRUS NON - STRUCTURAL (NS) PROTEINS  
All seven NS proteins appear to be directly and indirectly involved in the 
intracellular viral RNA synthesis and replication of WNV.  Majority of the NS proteins 
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are multifunctional and interact with cellular proteins to facilitate the virus replication 
processes. 
 
1.6.1 Flavivirus NS1 Protein 
The NS1 is a glycoprotein with 2 conserved N - linked glycosylation sites and 12 
conserved cysteines that are essential for virus viability.  The translocation of NS1 
protein into the lumen of endoplasmic reticulum (ER) occurs after its cleavage from E 
protein by a cellular signalase (Chambers et al., 1990).  On the other hand, NS1 protein is 
cleaved from NS2A protein by a membrane bound host protease of the ER (Falgout and 
Markoff, 1995). The NS1 protein can be detected within as well as on the surface of 
infected cells and is secreted in mammalian cell but not mosquito cells (Smith and 
Wright, 1985).  It is thought to play crucial role in flavivirus RNA synthesis. Both 
immunofluorescence assay and cryo-immuno-electron microscopy of dengue virus-
infected cells have shown that NS1 protein associates with intracellular membranes.  Co-
localization of NS1 protein with double - stranded viral RNA was observed in association 
with vesicles packets of infected cells (Lindenbach and Rice, 1999).   
Trans complementation has been successfully achieved in yellow fever virus with 
a large in - frame deletion in NS1 protein by expressing wild type NS1 protein in Sindbis 
virus replicon (Lindenbach and Rice, 1997).  The absence of both positive - and negative 
- strands viral RNA accumulation in infected cells with mutated NS1 protein (unless it is 
supplied in trans), suggested the NS1 protein roles prior to or early in negative - strand 
RNA synthesis.  The interaction between NS1 and NS4A proteins is suggested to be 
necessary for viral RNA synthesis too (Lindenbach and Rice, 1999). In addition, Jacobs 
& colleagues (2000) have suggested an addition function of NS1 protein which was 
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involved in the cell activation of dengue virus - infected cells.  However, the role of 
flavivirus virus-induced cell activation is not yet known. 
 
1.6.2 Flavivirus NS2A, NS2B, NS4A & NS4B Proteins 
The NS2A, NS2B, NS4A and NS4B proteins are small, hydrophobic proteins that 
contain no conserved motifs characteristics of any currently known enzymes (Brinton, 
2002).  These proteins are believed to facilitate the assembly of viral replication complex 
and their localization on cytoplasmic membranes.  Mutation on the C - terminal of NS2A 
protein in yellow fever virus can cripple virus replication (Rice, 1996).  The NS2B 
protein has been shown to form a complex with NS3 protein and served as a cofactor for 
virus serine protease NS3 activity (Chamber et al., 1998; Falgout and Markoff, 1995).  
The function of NS4A and NS4B proteins are currently unknown but studies have shown 
that these proteins are likely to be membrane - spanning proteins and undergo post - 
translational modification (Lindenbach and Rice, 1999).  The NS4B proteins are 
predominantly localized to the perinuclear ER and can be observed within nucleoplasm at 
late infection (Westaway et al., 1997a).  So far attempts to complement the expression of 
NS2A, NS2B, NS4A and NS4B proteins in trans were not successful (Khromykh et al., 
2001).  Future works are required to decipher the actual function(s) of these proteins in 
flavivirus replication.  
 
1.6.3 Flavivirus NS3 Protein 
The NS3 protein (Figure 6) is a highly conserved protein that encodes a serine 
protease of the trypsin family (Bazan and Fletterick, 1989; Gorbalenya et al., 1989).  It is 
required to interact with its cofactor NS2B protein to form an active protease (Arias et 
  18 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
al., 1993).  The NS3 protease cleaves the anchor region from the C protein and also 
cleaves at multiple sites within the non - structural polyprotein.  The specific cleavage 
sites of NS3 protein consist of two basic amino acids followed by an amino acid with a 
short side chain (Lindenbach and Rice, 2001).  Analysis of the C - terminal portion of 
NS3 protein revealed region with high homology to the DEAD family of RNA helicases 
(Gorbalenya et al., 1989), to an RNA - stimulated nucleoside triphosphatase (NTPase) 
and to an RNA triphosphatase (Warrener et al., 1993; Wengler and Wengler, 1991).  The 
RNA triphosphatase is involved in the synthesis of viral type I cap at the 5’ terminal of 
the viral RNA genome (Wengler and Wengler, 1993).  Borowski and co-workers (2001) 
has managed to purify a C - terminal fragment of NS3 protein from WNV - infected cells 
and this fragment contained both helicase and NTPase acitivity.  A protein - protein 
interaction between NS3 and NS5 proteins has also been demonstrated (Kapoor et al., 
1995) thus, suggesting these interactions would be important for the coordination of the 
helicase, polymerase and capping activities. 
 
 





Figure 6. Overall structure of Dengue 2
virus protease. A Cα trace of the 
polypeptide chain (red and yellow) is 
shown with individual strands and helices 
labelled. The orientation has been chosen 
to show the catalytic triad and two water 
molecules, but the COOH-terminal β 
barrel can also be seen. Residues of the 
catalytic triad are shown as balls and 
sticks. Carbon atoms are coloured gray, 
nitrogen in cyan, and oxygen in magenta
(Murthy et al., 1999). 
1.6.4 Flavivirus NS5 Protein 
The NS5 is the largest and the most conserved of the flavivirus proteins 
(Lindenbach and Rice, 2001).  The C-terminal portion of NS5 protein contains motif 
  19 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
characteristics of an RNA - dependent RNA polymerase (RdRps), including the highly 
conserved GDD (Kamer and Argos, 1984; Koonin, 1991).  The N - terminal region of 
NS5 protein contains a methyltransferase domain and is responsible to function in the 
methylation of the type I cap (Koonin, 1993; Khromykh et al., 1998; Khromykh et al., 
1999).  Since flaviviruses replicate exclusively in the cytoplasm of infected cells, the 
synthesis of the type I cap must be accomplished by viral enzymes.  The flavivirus NS3 
protein serve as the RNA triphosphatase while NS5 protein functions as the 
methyltransferase, but the guanylytransferase has yet to be identified.  Both cytoplasmic 
and nuclear localization of NS5 protein in infected cells have been described (Buckle et 
al., 1992; Khromykh et al., 1999).   The hyper-phosphorylated form of NS5 protein is 
located predominantly in the nucleus while the hypo-phosphorylated form is only found 
in the cytoplasm (Kapoor et al., 1995).  Whether the nuclear localization of NS5 protein 
plays a role in the virus replication cycle is currently unknown. A number of cellular 
phosphoproteins as well as cellular kinases were observed to co-immunoprecipitate with 
NS5 protein, suggesting that cellular proteins may be required for polymerase activity or 
forming the viral replication complex (Reed et al., 1998). 
 
1.7 CELLULAR RECEPTOR MOLECULES AND VIRUS ENTRY 
PROCESSES 
1.7.1 Virus Receptors 
The first step in the initiation of a successful virus infection cycle requires animal 
viruses binding to specific molecules on the cellular surface, followed by penetration into 
the host cells for the release of viral genome for replication. The cell surface molecule(s) 
to which virus bind, constitute a diverse collection of cellular protein, carbohydrates and 
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lipids.  They differ from one virus to another and they range from abundant and 
ubiquitous to rare and cell specific.  Some of these molecules merely help to concentrate 
viruses on the cell surface while others served as true receptor(s) for binding and 
responsible for guiding the bound viruses into endocytic pathway. 
Some viruses may use multiple attachment factors and receptors in parallel or in 
succession.  For human immunodeficiency virus (HIV), the initial contacts often involved 
cell surface attachment factors such as mannose binding C - type lectin receptor family 
(DC - SIGN).  However, these initial interactions do not induce conformational changes 
in the glycoprotein (Pohlmann et al., 2001; Bashirova et al., 2001). The subsequent 
binding of gp120 of HIV virus to the outermost IgG domain of CD4, induced a 
conformational change that would allow the virus to interact with its co-receptor, CXCR4 
or CCR5 (Feng et al., 1996).  These interactions will then facilitate the internalization of 
the virus particles. 
Several attempts have been carried out to isolate and identify the receptor 
molecule(s) responsible for flavivirus entry.  Initial studies have characterized a number 
of different proteins as potential flavivirus receptors, but there is no direct evidence for 
the role of any of these molecules during host cell entry and some of the results are 
controversial (Lindenbach and Rice, 2001).  Flaviviruses can infect a wide range of 
different cell types and most flaviviruses circulate in nature between arthropod vectors 
(mosquitoes or ticks) and their vertebrate hosts.  Therefore, this suggests that the receptor 
molecules recognized by flaviviruses are ubiquitous or the flaviviruses can utilize a range 
of different receptors in different cell types.   
Heparan sulfate (glycosaminoglycan) was demonstrated for the attachment of 
flaviviruses (Chen et al., 1997; Germi et al., 2002; Hilgard and Stockert, 2000; Lee and 
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Lobigs, 2002; Mandl et al., 2001; Hung et al., 1999) but the role of heparan sulphate in 
flavivirus infection remained highly debatable.  In the case of dengue virus, some studies 
showed the involvement of heparan sulfate in the attachment and uptake of virus (Chen et 
al., 1997; Hilgard and Stockert, 2000; Hung et al., 1999) whereas another study by 
Bielefeldt-Ohmann and colleagues (2001) showed that the removal of heparan sulfate 
from cell surface results in increase uptake of dengue virus. The propagation of wild type 
flavivirus in cell lines may lead to the selection of heparan sulfate - dependent phenotype. 
This is attributed to mutation that occurred in the receptor binding domain (domain III) of 
envelope protein with newly formed heparan sulfate binding sites (Mandl et al., 2001).  
A recent study conducted by Kroschewski & group (2003), suggested that in 
addition to heparan sulfate serving as the receptor for tick borne encephalitis virus, there 
is existence of an alternative but specific receptor that is responsible for the virus entry.  
Therefore, it was suggested that heparan sulfate molecules might concentrate virus 
binding to the cell surface. This facilitates the subsequent binding of more specific 
receptor to mediate internalization.   
Recent studies have also shown that DC - SIGN instead of heparan sulfate is 
responsible for the uptake of dengue virus into human dendritic cells (Navarro-Sanchez et 
al., 2003; Tassaneetrithep et al., 2003).  Another study by Jindadamrongwech (2004) 
suggested the involvement of GRP78 (BiP) as the receptor element in liver cells.  
Therefore, it is highly plausible that different receptors are utilized by flaviviruses in 
different cell types.  So far, there are no known receptor molecule(s) for WNV. 
Characterization of the WNV receptor(s) is essential to understand the replication 
mechanism, tropism as well as pathogenesis of flavivirus infection. 
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1.7.2 Virus Entry Processes 
A number of different internalization and trafficking pathways are utilized by 
animal viruses to gain entry into host cells. These pathways include clathrin - mediated 
endocytosis, uptake via caveolae, macropinocytosis, phagocytosis and other pathways 
that presently are poorly characterized (Sieczkarski and Whittaker, 2002).  
Clathrin - mediated endocytosis is triggered by an internalization signal (di-
leucine or YXXΦ) in the cytoplasmic tail of the receptor.  Clathrin is assembled on the 
inside face of the plasma membrane to form electron dense coat known as clathrin -
coated pit.  Clathrin interacts with a number of accessory protein molecules (Eps15, 
ampiphysin and AP2 adapter protein) as well as the dynamin GTPase responsible for 
releasing the internalized vesicle from the plasma membrane (Marsh and McMahon, 
1999).   
Two principal post - internalization endocytic trafficking routes have been 
deciphered, which can be termed recycling and lysosomal targeted (Gruenberg, 2001).  
The trafficking of the internalized virus particles within the endocytic vesicles is 
determined by either the inherent signals of the receptor or by signaling events within the 
cell.  A set of crucial regulatory molecules are the Rab family of small GTPases and their 
accessory proteins as well as a specific set of protein kinases (Protein Kinase C) is 
important for correct endocytic trafficking (Collins and Brenwald, 2000; Somsel and 
Wandinger-Ness, 2000).  In the recycling pathway, internalized cargo within internalized 
vesicles termed early endosomes can be delivered back to the plasma membrane whereas, 
in the lysosomal targeted pathway, early endosomes can progress and mature to form late 
endosomes and eventually lysosomes (Hopkins et al., 1990).  The late endosomes have a 
significantly lower pH (approximately pH 5.5) as compared to the early endosomes [(pH 
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of 6.2-6.5) (Kornfeld and Mellman, 1989)].  The lowering of pH within the endosomes is 
essential for the uncoating process for a number of viruses (Smith and Helenius, 2004).   
The non - clathrin endocytic pathway is the caveolae - mediated endocytosis and 
is predominantly associated with lipid rafts [(detergent - resistant membrane domains) 
(Harder and Simons, 1997)].  After internalization of the virus particles, the caveolar 
vesicles deliver the viruses to membrane - bound cytoplasmic organelles, the caveosomes 
(Pelkmans and Helenius, 2003).  The caveosomes are neutral in pH and are multiple flask 
- shaped caveolar domains enriched in caveolin-1.  They are devoid of markers of the 
classical endocytic and biosynthetic organelles, including Rab GTPases.  Virus 
containing caveosomes are usually sorted to the ER for the release of virus genome for 
replication (Pelkmans and Helenius, 2003). Beyond the established roles of clathrin and 
caveolae, there are other less defined route of virus entry as defined by Sieczkarski and 
Whittaker (2002). 
Semliki Forest virus (Helenius et al., 1980), Vesicular stomatitis virus (Crimmins 
et al., 1983), influenza virus (Kielian and Jungerwirth, 1990), ecotropic murine leukemia 
virus (Andersen and Nexo, 1983; McClure et al., 1990; Nussbaum et al., 1993) and 
Hantaan virus (Jin et al., 2002) gained entry into cells through a pH - dependent 
endocytic pathway. The acidification of endocytic vesicles triggers a conformational 
change in the virus envelope protein and subsequent release of the virus genome at 
appropriate location of the cells for replication. In contrast, human immunodeficiency 
virus type 1 (McClure et al., 1988; McClure et al., 1990), Severe Acute Respiratory 
Syndrome (SARS) coronavirus (Ng et al., 2003), amphotrophic murine leukemia virus 
(McClure et al., 1990) are observed to fuse at the plasma membrane and the 
nucleocapsids are released into the cytoplasm. This process is a pH - independent 
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process. The entry event is often a major determinant of virus tropism and pathogenesis 
(Schneider-Schaulies, 2000). Understanding the early event of virus replication cycle will 
provide opportunities to develop strategies to block this initial but crucial interaction.  
The entry mechanism and pathway of flaviviruses into host cells is poorly 
defined.  Limited studies have suggested that flaviviruses are internalized into cells via 
endocytosis (Gollins and Porterfield, 1985; Nawa et al., 2003). A low pH - dependent 
step after internalized is required for successful infection (Nawa, 1998; Gollins and 
Porterfield, 1985). Alternatively, flaviviruses have been shown to enter into host cells by 
the means of direct fusion at the cell surface. However, it is not known if this alternative 
mode of virus entry is infectious. Currently, the exact internalization and trafficking 
pathways taken by flaviviruses to gain access into host cells is poorly documented.  
 
1.8 METHODS TO STUDY VIRUS RECEPTORS AND ENTRY 
MECHANISMS INTO CELLS  
1.8.1 Virus Overlay Protein Blot Assay (VOPBA) 
The use of protein blot analysis of virus receptor was first described by Gershoni 
and colleagues (1986).  They have managed to identify the receptors for Sendai virus by 
using VOPBA on human erythrocyte plasma membrane proteins. The VOPBA involved 
the separation of the extracted plasma membrane proteins by electrophoresis under either 
native or denaturation conditions, followed by transferring the proteins onto membranes.  
Non - radiolabelled or 125I-labelled Sendai virus was then added to the membrane and the 
detection of virus binding to the respective protein bands was carried out with either 
virus-specific antibodies or autoradiography.  Competitive inhibition of virus binding to 
specific receptors can also be assayed using VOPBA.  The establishment of VOPBA has 
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contributed significantly to the search of cellular receptors for viruses. So far, the cellular 
receptors for a number of viruses has been successfully characterized and identified by 
using VOPBA with the combination of peptide sequencing (Spiropoulou et al., 2002; 
Borrow and Oldstone, 1992; Jin et al., 1994; Crane et al., 1991; Ramos-Castaneda et al., 
1997; Salas-Benito and del Angel, 1997; Ohtsuka et al., 1996; Basak et al., 1994). 
 
1.8.2 Anti-Idotypic Antibodies as Probes for Cell Surface Receptors 
Anti-idiotypic antibodies have been shown to have unique applications as probes 
in both functional and biochemical analyse of cell surface receptors (Pan et al., 1995).  
Anti-idiotypic antibodies have been extensively utilized for isolation of specific 
membrane receptors for cellular ligands as well as viruses, for example, the neutrophil 
chemotactic receptor, retinol binding protein, B-1H globulin receptor and the mammalian 
reovirus receptor (Pan et al., 1995).  In this technology, the receptor binding domains of 
the ligand is expressed as the anti-idiotypic antibodies used for “fishing out” the specific 
receptors responsible for binding to the ligand.  In the TBE virus system, the anti-idotypic 
antibodies have been shown to mimic the physiological properties of ligand upon binding 
to the cellular receptor (Kopecky et al, 1999). 
 
1.8.3 Methods to Decipher Virus Entry Mechanism and Pathway  
Clathrin - mediated endocytosis has been shown to play important role in the 
internalization of many cellular biomolecules and viruses into cells.  One of the earlier 
methods to identify the uptake of viruses (influenza virus and vesicular stomatitis virus) 
via clathrin - mediated endocytosis was through the use of transmission electron 
microscopy where viruses were observed with electron dense coated pits (Marsh and 
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Helenius, 1980; Matlin et al., 1981, 1982). Subsequently, the microinjection of antibodies 
against clathrin was shown to arrest the entry of Semliki Forest virus (Doxsey et al., 
1987).  
Traditionally, the inhibition of clathrin function relied on three approaches – low 
pH shock treatment, potassium depletion and treatment of cells with brefeldin A [(BFA) 
(Brodsky et al., 2001)] and more recently the use of chlorpromazine (Wang et al., 1993).  
The main disadvantage of using these treatments is that their effects can be rather non -
specific, for example BFA targets ADP - ribosylation factor (ARF) and GTPase exchange 
factors in the secretory pathway and chlorpromazine targets many intracellular enzymes 
(Sieczkarski and Whittaker, 2002).  Nevertheless, chlorpromazine has been extensively 
employed for studies of virus entry pathway.  Clathrin - mediated endocytosis of 
influenza virus (Krizanova et al., 1982), polyomavirus (Pho et al., 2000) and 
parechovirus type 1 (Joki-Korpela et al., 2001) into cells have been convincingly shown 
by the action of chlorpromazine.  The alternative techniques (possibly more specific) are 
the use of potassium depletion and hypotonic shock to investigate the role of clathrin in 
mediating the entry of human rhinovirus (Bayer et al., 2001; Madshus et al., 1987).   
In the recent years, the use of dominant - negative mutants of cellular proteins 
seems to provide a more specific way to analyse the function of defined pathways within 
the cells.  In this technology, the overexpression of the dominant - negative mutant 
protein will act by overwhelming the wild type protein and preventing its function 
(Sieczkarski and Whittaker, 2002).  This approach has been used quite extensively in the 
study of GTPases function within the cell (Feig, 1999), where a dominant - negative 
protein led to sequestration of effectors and regulatory molecules thus, effectively 
inhibiting the function of the endogenous wild type protein.   
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The most commonly applied dominant negative mutant to study the entry of virus 
is dynamin, a GTPase required for the release of virus from clathrin - coated pits 
(Hinshaw, 2000; Schmid et al., 1998).  However, as the study of dynamin progressed, it 
became evident that dynamin functions in many different membrane - traffic events.  In 
addition to clathrin - mediated endocytosis, dynamin also plays a role in the formation of 
caveole (Henley et al., 1998), budding of Golgi-dervied vesicles (Jones et al., 1998; 
Nicoziani et al., 2000), phagocytosis (Gold et al., 1999) and non - clathrin endocytosis 
(Lamaze et al., 2001).  Due to the pleiotrophic effects of dynamin, investigators have 
searched for more specific molecular inhibitors of clathrin. 
One promising candidate is the Eps15 protein which binds to the AP-2 adapter for 
the internalization of biomolecules through clathrin-coated pits.  The deletion of the EH 
domain(s) of Eps15 produces a dominant negative mutant of the protein that prevents 
internalization of transferrin, a cellular marker of clathrin - mediated endocytosis 
(Benmerah et al., 1999).  Other molecular inhibitors of clathrin - mediated endocytosis 
include the overexpression of clathrin hub domain (prevent normal clathrin pit assembly) 
(Brodsky et al, 2001), expression of the µ2 subunit of AP-2 [specific inhibition of AP-
mediated endocytosis of receptors containing YXXΦ motifs (Nesterov et al., 1999)] and 
microinjection of purified Eps15 protein with EH domain deleted (Carbone et al., 1997). 
Recently, caveolae has emerged as a route of entry for a number of viruses 
(Sieczkarski and Whittaker, 2002).  To determine if viruses utilized the caveolae for 
internalization into host cells, a number of inhibitory drugs are used.  One of the most 
effective ways is to disrupt caveolar function with sterol - binding drugs that sequester 
cholesterol, a prominent component of the lipid rafts involved in caveolae formation.  
Such drugs include nystatin, filipin and methyl-β-cyclodextrin (Neufeld et al., 1996; 
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Orlandi and Fishman, 1998; Rothberg et al., 1992) and none of these drugs have shown 
to affect clathrin - mediated endocytosis.  Molecular inhibitor in the form of deletion of 
the N - terminus of caveolin-3 has been used to inhibit the entry of SV40 and echovirus-1 
(Roy et al., 1999; Marjomaki et al., 2002). 
Other non-clathrin and non-caveolae dependent endocytosis process 
(phagocytosis and pinocytosis) have also been implicated in the entry of viruses.  A 
number of drugs and molecular approaches in targeting these pathways have emerged 
over the years toward a common goal in understanding the internalization pathway of 
viruses and cellular ligands. 
Upon the penetration, viruses have to be transported to specific locations (either 
the nucleus or cytosolic membranes/organelles) within the cells for replication. Diffusion 
within the crowded and highly structured cytosol is not efficient and complicated. 
Viruses often exploit the trafficking/sorting mechanism of endocytic vesicles and 
cytoskeleton - mediated transportation.  A major class of molecule that regulates 
endosomal trafficking events is the Rab family of small GTPases (Collins and Brenwald, 
2000).  Dominant negative mutants of the Rab proteins such as Rab5 (prevents the 
formation of early endosomes), Rab7 (prevents the trafficking of early to late endosomes) 
and Rab 11 (prevents the recycling of endocytic pathway) were used to investigate the 
entry mechanism of viruses (Sieczkarski and Whittaker, 2002).   
As befits a role as a major signaling event in the cell, virus endocytic trafficking 
can be regulated by phosphorylation.  The main attention has focused on two kinase 
families, PI3K and protein kinase C (PKC).  For adenovirus, the initial activation of virus 
with the cell surface integrin receptor activates PI3K, which in turn modulates virus 
endocytosis.  The addition of PI3K inhibitors such as wortmannin or LY294002 
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significantly reduced adenovirus internalization (Li et al., 1998).  The entry of several 
enveloped viruses, including rhabdoviruse, alphaviruses, poxviruses and herpesviruses 
have been proposed to require PKC based on the action of protein kinase inhibitors, such 
as H7 and staurosporine (Constantinescu et al., 1991).  More recently, specific inhibitor 
of PKC, bisindolymaleimide I prevented the entry of influenza virus and subsequent 
infection (Root et al., 2000).  In addition, the overexpression dominant - negative mutant 
of PKC βII isotype arrested the entry of influenza virus at the level of the late endosomes 
(Sieczkarski et al., 2003). 
The latest advancement in the study of virus entry process into host cells is the 
development of real - time imaging of single virus particle (Seisenberger et al., 2001).  
Such experiments allow an extra level of sophistication to view the process in real time, 
together with subsequent trafficking pathway in cells.  Fluorescent probes and dyes for 
labelling of virus particles and cellular organelles are available hence facilitate the 
monitoring of each component of the virus - host interactions by multi-fluorescent 
labelling microscopy. 
 
1.9 FLAVIVIRUS RNA GENOME REPLICATION STRATEGY 
Westaway and colleagues (2002) proposed a model for the formation of the 
flavivirus replication complex (RC).  This model suggested that NS3 protein first binds to 
non - complementable regions of NS5 protein during translation in cis, and NS2A protein 
to the terminal stem loop of the 3’ UTR.  Hydrophobic NS4A protein provides a link 
between NS2A in the assembling RC.  The membrane site of replication where NS4A 
protein binds also interacts with the hydrophilic extensions with NS1 protein in the lumen 
of ER. Upon the completion of RC assembly and its attachment to the ER membrane, 
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cyclization of the positive - strand RNA template occurs thus facilitating the switch from 
translation to transcription.  
  Virus RNA synthesis beings with the synthesis of complementary negative 
strands by the viral RNA - dependent RNA polymerase, NS5 protein, in conjunction with 
other virus NS proteins and possibly other cellular proteins.  These negative - stranded 
molecules serve as templates to produce more copies of the genome positive - stranded 
molecules.  Flavivirus RNA are synthesized by a semi - conservative mechanism that 
involved replicative intermediates (containing double - stranded regions as well as 
nascent single - stranded molecules) and replicative forms (duplex RNA molecules).  The 
synthesis of viral genome RNA is approximately 10 times more efficient than the minus - 
strand RNA synthesis.  Chu and Westaway (1985) has documented that only a single, 
nascent negative - strand RNA is copied from a plus strand template at a time (replicative 
form), while the negative - strand template is efficiently reinitiated so that multiple copies 
of the nascent positive strands can be copied from a single negative strand molecule 
template (replicative intermediate).  The establishment of these processes would then 
allow the RNA synthesis (both positive and negative RNA) to take place in the absence 
of protein synthesis, hence indicating that transient viral polyprotein precursors are not 
necessary. Data from Westaway and co-workers (1999) with the Kunjin virus replicon 
system suggested that nascent genome RNA could function as templates for translation 
and transcription and as substrates for encapsidation. 
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1.10 MORPHOGENESIS OF FLAVIVIRUS 
Flavivirus infections have been associated with the rearrangement of intracellular 
membranes and the induction of a unique set of membranous structures, but their 
functions during infection mostly remained elusive (Westaway et al., 2002).  One of such 
generic flavivirus - induced features in both vertebrate and invertebrate cells is the 
formation of vesicles packets that contains bi-layered membrane vesicles of 50 - 100 nm 
in size. These vesicles enclosed distinctively single or double-stranded ‘thread-like’ 
structures were observed during early stages of infection. The other well - documented 
structures include the proliferation of both smooth and rough endoplasmic reticula upon 
infection (Ko et al., 1979; Murphy, 1980; Westaway and Ng, 1980), the formation of 
convoluted membrane and microtubule paracrystals (Ng, 1987; Ng and Hong, 1989).   
With the use of highly specific cryo-immuno-electron microscopy, Westaway and 
colleagues (1997a, b) and Mackenzie and co-workers (1998, 1999), showed that several 
virus-specific proteins were associated with these virus-induced structures.  Immunogold 
labelling of cryo-sections of kunjin virus-infected Vero cells with antibody to the double 
- stranded RNA showed a distribution confined exclusively to the induced - vesicle 
packets and not the bounding membrane (Westaway et al., 2002). The antibodies 
produced against kunjin virus NS1, NS2A, NS3 and NS4A proteins were also shown to 
label the vesicle packets.  In contrast, the convoluted membrane and paracrystals were 
decorated with antibodies against NS2B, NS3 and NS4A proteins.  The NS4B protein 
was localized on the proliferating ER adjacent to the convoluted membranes and 
paracrystals.  By using immunofluorescence assay, NS5 protein was observed to be 
distributed throughout the cytoplasm and the induced reticular membranes (Westaway et 
al., 2002).  
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From these immunolabelling experiments, it was proposed that the vesicle packets 
were the putative sites of viral RNA synthesis in late infection since most of the non-
structural proteins and double-stranded RNA were localized to these sites in the infected 
cell.  The co-localizations of viral proteases NS2B - NS3 with NS4A protein in the 
convoluted membranes and paracrystals implied that these membrane structures are the 
sites of NS2B-NS3 cleavages of virus polyprotein (Mackenzie et al., 1998). These studies 
have shown how the enzymatic events of flavivirus replication are compartmentalized 
within virus factories comprising several different sets of induced host membranes. 
Flavivirus - infected cells exhibit two modes of maturation, termed cis and trans 
by Hase & colleagues (1989b). These viruses have shown much diversity in the mode of 
maturation even though they are from the same family (Flaviviridae) and these may be 
the contributing factors that lead to the different outcome of diseases. 
The trans mode of flavivirus maturation has been extensively studied over the 
past 30 years.  In the trans mode of maturation, virus particles are assembled 
intracellularly in the rough endoplasmic reticulum and associated membranous structure. 
Mature virions are then transported by the host secretory channel to the plasma 
membrane and eventually released by exocytosis (Leary and Blair, 1980; Ng, 1987; Ng 
and Hong, 1989; Mackenzie et al., 1999; Mackenzie and Westaway, 2001).  
For the cis mode of maturation, flavivirus nucleocapsids are formed in the 
cytoplasm, and the virus particles are released into the extracellular by budding at the 
host plasma membrane. Thus far, the cis mode of maturation has been shown 
convincingly only in WNV [(strain Sarafend) (Ng et al., 1994, 2001; Ng and Chu, 2002)] 
and dengue-2, strain PR-159 (Hase et al., 1987). At the cell periphery, the C proteins 
assemble into physical nucleocapsid particles with the viral genome RNA and eventually 
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egress by budding at the plasma membrane. The budding process of WNV (strain 
Sarafend) virus begins with individual electron - dense nucleocapsids extruding from the 
plasma membrane and leading eventually to a bag - like protrusion.  Individual virus 
particles then pinch off from these bags (Ng et al., 1994, 2001). 
 
1.11 INVOLVEMENT OF CELLULAR CYTOSKELETON NETWORK IN 
VIRUS REPLICATION CYCLE 
1.11.1 Cellular Cytoskeleton Network  
The cytoskeleton is a cellular network containing three classes of filaments: the 
microfilaments (5 - 6 nm in diameter), the intermediate filaments (7 - 10 nm), and the 
microtubules (20 - 25 nm)] and a set of accessory proteins (Hartwig, 1992).  The three 
classes of filaments are assembled into a three - dimensional structure that defines the 
shape and structural organisation of the cell. They participate in cell motility, intracellular 
transport mechanism and chromosomal movement during mitosis. 
Indirect immunofluorescence and immuno-electron microscopy have played 
critical roles in the morphological interpretation of the cell cytoskeleton ultrastructure 
data (Henderson and Weber, 1982).  The structure that remained after detergent 
extraction is known as the skeletal framework (Lindroth et al., 1988). Critical point 
drying and carbon shadowing are then used to stabilize this network before visualization. 
 
1.11.1.1 Microtubule Network and its Associated Motor Proteins 
Microtubules, characterised by their tubular appearance, are universally present in 
the cytoplasm of eukaryotic cells.  From electron microscopic observations, microtubules 
are found to be uniform in diameter (largest diameter of all cytoskeletal fibrils), several 
  34 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
micrometers in length and they show no evidence of branching (Kessel, 1967; McIntosh 
et al., 1967). Microtubules are polar structures with unequal ends, called plus and minus 
ends.  They are often observed to be irradiating from the region containing the centrioles.  
These focal points from which the microtubules arise are called microtubule organizing 
centres (MTOC).  Cross-sections of microtubules from a variety of cells suggested that 
the wall of the microtubules consist of protofilaments or spiraling filamentous structures 
about 5 nm in diameter.  These individual structures are made up of protein subunits 
termed tubulin.  Each tubulin molecule is a heterodimer (110,000 to 120,000 daltons) 
consisting of one α- and one β-chain.  The heterodimers are arranged longitudinally to 
form the protofilament (Olmstead and Borisy, 1973). 
Several models were proposed for the microtubule assembly dynamics.  
Threadmilling or head – to - tail polymerisation driven by GTP was first proposed by 
Wegner (1976) and Hill & Carlier (1983). Recent dynamic instability model is believed 
to be the most accurate interpretation of the dynamic behavior of the microtubules 
assembly from pure tubulin in vitro (Mitchison & Kirschner, 1987). 
The study of polymerisation or assembly of the microtubulin, has led to the 
discovery of the microtubule-associated proteins (MAPs).  These proteins (70 - 200 kD) 
seem to facilitate the assembly process of microtubulins.  In the presence of MAPs, 
microtubules are formed more efficiently and require considerably lower tubulin 
concentration.  The MAPs also protect microtubules from disrupting agents (such as 
colchicine) and stress conditions (such as low temperature and high fluid pressure) that 
tend to dissociate them.  
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Microtubules in eurkaryotes cells are generally organised in a sterotypical pattern 
with respect to their structural polarity.  The minus ends of microtubules are anchored at 
centrosomes or spindle pores and the plus ends radiate centrifugally into the cytoplasm.  
This stereotypical organisation of the microtubules serve the basis for the defined 
directions of movement generated by each microtubule associated motor proteins. 
There are two main types of microtubule - associated molecular motor proteins.  
The kinesin family, which are mostly plus – end - directed microtubule motors, although 
a few family member power minus-end-directed movements along the microtubules.  The 
dyneins are predominantly minus-end-directed microtubule motor proteins (Kamal and 
Goldstein, 2002).  These microtubule-associated motor proteins serve as important 
carriers of cargo within cells. 
Native kinesin-1 is a heterotetramer composed of two kinesin heavy chain 
subunits (KHC) and two kinesin light chain subunits (KLC).  The motor activity is 
located in the KHC subunits. (Bloom and Endow, 1994, 1995; Yang et al., 1990).  
Detailed analysis of structure, sequence, and expression strongly suggested the region of 
KHC that generate force and movement (the motor domain) is composed of two units: (i) 
a 330 amino acids catalytic domain that hydrolyses ATP and interacts with microtubule 
track (Vale and Fletterick, 1997) and (ii) a short (40 amino acids) neck domain important 
for progressive movement and control of direction (Case et al., 1997; Romberg et al., 
1998).  The motor domain of KHC is attached to a helical coiled - coil stalk domain and a 
globular tail domain.  The motor domain is attached to a variety of divergent tail 
domains.  These tail domains are thought to provide cargo - binding and regulatory 
specificity to each motor.  Hence, the tail domains serve to generate functions in mitosis, 
meiosis, vesicle transport, organelle transport, and yet unknown processes.  
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1.11.1.2 Actin Filaments and its Associated Motor Proteins  
Actin is the most abundant cytosolic protein in eukaryotic cells and is encoded by 
a large, highly conserved gene family.  Actin exists in the cell as globular monomer of G-
actin and as a filamentous polymer called the F - actin. Each actin monomer contains a 
magnesium ion complex with either ATP or ADP.  Actin filaments exhibit two main 
types of organization, networks or bundles.  In bundles, the actin filaments are packed in 
parallel arrays, whereas in networks, the actin filaments crisscross and are loosely 
packed.  Bundling actin filaments are associated with the plasma membrane while the 
actin filament network provides the three dimensional of the cell.   
Polymerization of actin filaments proceeds in three distinct steps.  Firstly, G - 
actin forms short unstable polymers. Secondly, the short oligomers reach a length of 3-4 
subunits whereby they can act as stable seeds which rapidly elongate into filaments. As F 
- actin grows in amount, G - actin concentration decreases.  Finally, a steady state is 
reached where G - actin monomers exchange with subunits at the filament ends but there 
is no net change in the total mass of filaments.   
Myosins consist of a large superfamily of molecular motors that move along actin 
filaments. These motor proteins (myosin) are important in providing the mechanical 
energy for cell motility and cellular processes.  Analysis of myosin mutants in a wide 
variety of organisms suggested that myosin is involved in the transport of several cargo 
organelles [including melanosomes and synaptic vesicles (Kamal and Goldstein, 2002)].  
Recent studies on Myosin VI provide compelling evidence that the interaction between 
myosin and actin filaments is required in two distinct steps of endocytosis in higher 
eukaryotes: the formation of clathrin - coated vesicles and movement of uncoated 
vesicles from actin rich cell periphery to early endosomes.  In addition, interaction of 
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myosin and actin has been shown to provide the necessary energy for the budding process 
of human immunodeficiency virus type 1 at the plasma membrane (Sasaki et al., 1995).  
Therefore, the actin - based motor protein, myosin may play diverse cellular functions. 
 
1.11.2 Viruses Associate with the Cytoskeleton 
Currently, there is an emerging theme that all viruses must interact with the 
cytoskeleton, and probably at multiple stages throughout their infectious cycles (Smith & 
Enquist, 2002).  The entering virus must engage and regulate various components of the 
cytoskeleton network and its associated protein to mediate transport to interior of cell for 
replication.  For example, the endocytosis of adenovirus and adeno-associated virus is 
dependent on actin polymerization and the subsequent transportation to the nucleus relies 
on the intact microtubule network (Smith and Enquist, 2002).  Dynein, the microtubule - 
associated motor protein is required for the intracellular transportation of the virus from 
the cell peripheral to the nucleus for replication (Suomalainen et al., 1999).  Upon 
arriving at the replication site in the cytoplasm (viral factories), other cytoskeleton 
interactions may occur as these sites are often enriched with intermediate filaments 
(Smith and Enquist, 2002).  Components of the microtubule and actin cytoskeleton are 
also essential cofactor for replication and morphogenesis of some viruses. 
Respiratory syncytial virus (Burke et al., 2000), human parainfluenza virus (De & 
Banerjee, 1991; Gupta et al., 1998) and vesicular stomatitis virus (Hill & Summers, 
1990) utilizes the cytoskeleton network for the transcription of their genomes.  Viruses 
and their proteins can also induce the depolymerisation of cytoskeletal elements to 
compromise the integrity of the cell, facilitating virus egression.  The viruses can also 
engage cytoskeletal motor proteins to mediate their movement back to the cell periphery 
  38 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
or sites of viral release.  Examples of such viruses are the herpesvirus and vaccina virus 
(Smith and Enquist, 2002).  In the final steps of the virus life cycle of Frog virus 3 (Murti 
et al., 1985) and human respiratory syncytical virus (Ulloa et al., 1998), these viruses can 
utilize actin polymerization to propel viruses to adjacent cells.  Alternatively, 
cytoskeleton serves as highway for transporting virus across syncytial cells without 
exposure to the extracellular environments.  This mode of dissemination often allows the 
virus to escape from the host immune responses. 
Various experiments were carried out to study the interactions of different animal 
virus replication systems with the mammalian cell cytoskeletons (microtubules, 
intermediate filaments and actin filaments).  The employment of various methods which 
includes: the use of cytoskeleton disrupting drugs, immunological and microscopy 
techniques have allowed the study on the interaction of virus structural proteins with the 
cytoskeleton, role of cytoskeleton in transcription and transport of viral proteins, viral 
penetration and release from host cells were obtained (Dales and Chardonnet, 1973; 
Moyers et al., 1986; De et al., 1991; Hill and Summers, 1990; Heine et al., 1985; Norrild 
et al., 1986; Kaelin et al., 2000; Nejmeddine et al., 2000).  Based on these reports, it was 
concluded that for several virus systems, there were association of viruses or the virus 
sub - particles with one or more components of the cytoskeleton.  
Microtubules disrupting drugs (includes vinblastine sulphate, colchicine and 
nocodazole) were extensively utilized and their specific actions on the microtubules make 
them very useful as biological tools in the elucidation of the role of microtubules in virus 
replication.  Disruption of microtubules by these drugs has been demonstrated to interfere 
with the replication mechanism of herpesvirus (Wittels & Spears, 1991), simian virus 40 
(Shimura et al., 1987) and Junin virus replication (Candurra et al., 1999). 
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Several actin disrupting drugs have been utilized to decipher the interaction of the 
virus proteins with actin filaments.  Most of these drugs act by disrupting actin monomer 
– polymer equilibrium.  Cytochalasin, a fungal alkaloid that binds to the plus end of F -
actin where it blocks the addition of actin subunits to the growing ends of the filaments 
(Krucker et al., 2000).  Latrunculin, a toxin secreted by sponges that disrupt the 
physiological function of actin filaments by binding to G - actin and inhibits it from 
polymerizing into F - actin filaments (Braet et al., 1996).  Phalloidin is isolated from 
mushroom that locks adjacent subunits of actin filaments together and prevents them 
from depolymerization.  Perturbation of actin filaments with these drugs have shown to 
affect the replication as well as maturation of a number of viruses (Bohn et al., 1986; 
Murti et al., 1985; Perotti et al., 1996; Lanier and Volkman, 1998; Ravkov et al., 1998; 
Boulanger et al., 2000). 
 
1.11.3 Flavivirus Interaction with Cytoskeleton Network 
Hong and Ng (1987) first reported morphological changes in the uninfected and 
Kunjn virus-infected Vero cells when 10 µg/ml of vinblastine sulphate was used.  The 
virus yield was reduced by 10 - 15 folds.  The disruption of microtubules by vinblastine 
sulphate was suggested as the cause for the reduction of virus yield.  Furthermore, Ng 
and Hong (1989) reported that different time of exposure of vinblastine sulphate on the 
infected cells had drastic effects on Kunjin virus production.  The extracellular virus yield 
from infected cultures exposed to the drug during the latent period was reduced by 99 %.  
However, 25 % reduction of virus yield was noted when the drug was added at 24 hr 
post-infection.  Kunjin virus NS3 protein was also observed to associate with virus -
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induced tubulin paracrystal by immunogold labelling (Ng and Hong, 1989). These results 
suggested the dependence of Kunjin virus on the host cell microtubules during the early 
stages of virus replication process.  In addition, Chiou and co-workers (2003) have also 
reported that microtubule is required for the replication of Japanese encephalitis virus.  
The virus NS3 protein was found to associate with microtubule and TSG101.  The 
interaction of the virus NS3 protein with the microtubule and TSG101 in the proximity of 
virus-induced structure is proposed to be essential for virus replication. 
 
1.12 APPLICATION OF GENE SILENCING TECHNOLOGY (SMALL 
INTERFERING RNA, siRNA) TO STUDY VIRUS REPLICATION 
MECHANISM 
Endogenous short interfering RNAs or siRNAs are small RNA duplexes 
approximately 21 nucleotides long and they are first identified in plants and Drosophila 
(Hamilton and Baulcombe, 1999; Elbashir et al., 2001). Their presence was associated 
with sequence - specific inhibition of gene expression as a result of post-transcriptional 
gene silencing.  The initial triggers of the post-transcriptional gene silencing involve 
siRNA that serves as guides to bring the complementary binding RNA molecules to a 
ribonucleic acid - protein complex (termed the RNA - induced silencing complex or 
RISC).  The RISC interacts with the homologous sequence on the target mRNA through 
alignment with the anti-sense strand of the siRNA. The target mRNA is then cleaved at a 
site corresponding to approximately the middle of the siRNA sequence, leaving the 
transcript susceptible to RNA degradation (Hammond et al., 2000, 2001; Zamore et al., 
2000; Elbashir et al., 2001). 
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The inhibition of gene expression by siRNA has been rapidly exploited as a form 
of reverse genetics tool to facilitate the identification of gene function.  In addition, 
siRNA has also been applied as potential therapeutic agents for the down - regulation of 
cellular and viral proteins that modulate diseases initiation or progression, including 
cancer, infectious disease and dominant genetic disorders (Wall and Shi, 2003).   
The first generation of gene silencing technology involved the use of double 
stranded RNA (dsRNA) that was prepared in vitro and transfected into mammalian cells.  
More recent technologies have developed plasmids and retrovirus system that expressed 
functional siRNA in mammalian cells and they have the advantage of constitutive 
expression, therefore the expression of target genes can be reduced for weeks or even 
months (Sui et al., 2002; Lee et al., 2002; Paddison and Hannon, 2002; Brummelkamp et 
al., 2002).  The understanding of virus - host protein interaction can be better defined 
with the application of gene silencing technology. 
 
1.13 VIRUS – INDUCED CELL DEATH DURING LATE INFECTION 
Eukaryotic cell death in response to either physiological or non - physiological 
insults is classified under two main categories: necrosis and apoptosis (Figure 7). 
Morphological characteristics of necrosis include generalized swelling of cells, disruption 
and loss of plasma membrane integrity accompanied by extensive cytoplasmic 
vacuolation and DNA breaks down in a non-specific fashion (Goudie, 1985). A recent 
study by Scaffidi & co-workers (2002) also documented the exclusive release of high 
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Figure 7.  Morphological observation of the two distinct pathways of cell death. i.e. 
necrosis and apoptosis (Courageot et al., 2003).  The agarose gel showed the DNA 
degradation products from the two distinct forms of cell death. 
 
mobility group 1 (HMGB1) protein, a chromatin - binding factor, from necrotic cells, 
which was not observed in cells undergoing apoptosis. The release of HMGB1 protein 
triggers inflammatory reactions that result in extreme tissue damage.  
In contrast, apoptosis is an energy - dependent process of cell death that displays 
distinct hallmarks, including cytoplasmic shrinkage, chromatin condensation, 
  43 
                                                                                       CHAPTER 1 
                                                                                        LITERATURE REVIEW 
 
intranucleosomal cleavage, phosphatidylserine exposure, plasma membrane blebbing, 
activation of caspases and cell fragmentation into apoptotic bodies which are 
phagocytosed without provoking an inflammatory response (Vaux & Strasser, 1996; 
O'Brien, 1998; Hay & Kannourakis, 2002).  The apoptotic process can be divided into 
three distinct phases: (1) initiation (cell receives a stimulus that activates the apoptotic 
cascade), (2) execution and (3) degradation [(cell presents the biochemical and 
morphological hallmarks of the final stages of apoptosis) (Hengartner, 2000; Slee et al., 
1999)].  Figure 8 provides a detail summary of the apoptosis process in detail.  The 
modulation of the apoptotic pathways by viruses is essential for their survival.  A 
summary of how different viruses and their encoded proteins can either promote 
apoptosis or inhibit apoptosis is shown in Figure 9. 
Previous studies have documented that WNV could infect, and induce 
cytopathetic effects in a variety of cell cultures of human, primate, rodent and insect 
origin (Paul et al., 1969; Odelola & Fabiyi, 1977; Jordan et al., 2000).  In several human 
cases, as well as in experimental animal studies, fatal WNV infection, trigger both 
necrosis and apoptosis in infected cells and tissue (Sampson et al., 2000; Senne et al., 
2000; Shieh et al., 2000; Cantile et al., 2001; Xiao et al., 2001).  Using Mesocricetus 
auratus (golden hamster) as a model for WNV encephalitis, Xiao and colleagues (2001) 
noted the activation of perivascular inflammation and microgliosis in response to 
neuronal cell death.  The activation of an inflammatory response implied that there was a 
secondary response to WNV-induced cell death, which may contribute to the fatal 
outcome. 
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Figure 8.  Intracellular pathways involved in apoptosis. These pathways are mediated 
through the interferon system (a), the death receptor-dependent system (b), p53 (c), 
endoplasmic reticulum stress (d), nuclear transcription factor NF-kB (e), cytosolic 
phospholipase A2 (f), death-inducing factors converging onto mitochondria (g), and 












Figure 9.  The interaction of viruses and viral products with the apoptotic pathways of 
the host (Hay and Kannourakis, 2002).   
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In a recent study, the expression of WNV C protein in mouse brain or 
interskeletal muscle of the mouse model is capable of inducing cell death via apoptosis.  
Therefore, Yang and co-workers (2002) proposed that the C protein of WNV may be 
responsible for aspects of viral pathogenesis through the induction of apoptotic cascade. 
So far, the factors contributing to WNV-induced cell death as well as the cell death 
mechanism of WNV-infected is poorly defined.  Future detail analyses of WNV - 




Viruses are nano-machines built within cell factory and designed to invade 
neighboring cells upon release.  The entry and building process of these infectious nano -
particles within the cell factory relies on the timely and dynamic interaction of the virus 
proteins with the different cellular components.  To decipher the functional relationship 
of the viruses with different cellular components of the host cells requires the use of a 
combination of independent approaches, such as biochemical and molecular 
characterization, co-localization and biosynthesis studies, gene silencing; and bio-
imaging. 
In this study, the focus is on deciphering the interactions of various cellular 
components during the entry and morphogenesis of flavivirus, West Nile (Sarafend) 
virus.  This is a laboratory strain.  It is believed to be a human isolate from Israel from the 
1950’s (Scherret et al., 2002) and belongs to genetic lineage 2.  The WNV belonging to 
genetic lineage 2 are maintained as enzootic. 
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Hence, the specific objectives of this study are as follows: 
(a) To isolate specific molecules on cell surface of permissive cells which WNV 
bind. 
(b) To identify the specific and functional cellular receptor for WNV in Vero cells. 
(c) To identify the various cellular components involved in the entry process of WNV 
and map the detail pathway of WNV internalization. 
(d) To analyse the possible involvement of cytoskeleton network in the intracellular 
trafficking and morphogenesis of WNV. 
(e) To investigate the mechanism of cell death in WNV - infected cells 




                                                                                       CHAPTER 2 
                                                                                       MATERIALS & METHODS 
2.0 MATERIALS AND METHODS 
2.1 CELL CULTURE TECHNIQUES 
All solutions and media for cell culture were made using double glass distilled 
water [(dgd) (Megapure, Corning, USA)].  The chemicals used were also of ultrapure 
grades.  Glass bottles were used for storage of media and chemical solutions.  These have 
screwed capped lids and with non-toxic silicone rubber washers.  All cell cultures and 
media preparation works were performed under aseptic conditions in a laminar flow 
cupboard (Gelman Sciences, Australia) or biohazard hood (Nuaire, USA). 
Cells used in this study were grown in sterile plastic tissue culture flasks (25 cm2, 
75 cm2 or 175 cm2), 6 - well, 24 - well or 96 - well tissue culture plates from Falcon 
(USA).  Cells were either cultured in humidified incubator (Nuaire, USA) with carbon 
dioxide (5 %) or dry incubator at 37 °C. 
 
2.1.1 Cell Lines 
Cell lines that were used in this study were listed in the Table 2. The culture 
media, passage level and origin of the cell lines are indicated. 
 
2.1.2 Media and Solution for Cell Culture  
Cell culture media supplemented with 10 % foetal calf serum was used as the 
growth medium (Appendix 1) for the respective cell lines (Section 2.1.1).  The pH of the 
medium was adjusted to 7.2 - 7.4 with sodium bicarbonate (Appendix 1). 
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Table 2: Cell lines and related information. 








Adherence Medium 199 25-90 








Adherence RPMI 20-50 




























Suspension RPMI 20-50 









Adherence RPMI 20-50 









Adherence L15 35-60 






2.1.3 Cultivation and Propagation of the Cell Lines 
2.1.3.1 Adherence Cell Lines 
New flasks of cells were sub-cultured from confluent monolayer at a ratio of 1:8 
(for 25 cm2 flask) and 1:4 (for 75 cm2 and 175 cm2 flask).  The growth medium 
(Appendix 1) was first discarded.  The monolayer was then rinsed twice with about 5 ml 
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of phosphate-buffered saline (PBS - Appendix 1).  This was followed by rinsing with 
trypsin-versene (ATV - Appendix 1) before a further volume was added.  The flask was 
incubated for 3 min at 37 °C to detach the cell monolayer from the flask. The cells were 
immediately dislodged.  Appropriate amounts of the growth media (depending on the size 
of the flask), were added to the cell suspension to inactivate the enzymatic activity of the 
ATV. Cell aggregates were dispersed by pipetting to give a single cell suspension.  The 
suspended cells were then distributed into new tissue culture flasks. The cells were then 
incubated at 37 °C.  The monolayer would reach confluency in 3 to 4 days and was used 
for all the experiments. 
 
2.1.3.2 Suspension Cell Lines 
The cell culture is first swirled and aspirated with sterile Pasteur pipette to 
dislodge clumping cells to obtain a homogenous cell suspension. The cell suspension was 
centrifuged at 2000 x g for 10 min at 4 ºC.  The supernatant was removed and the cell 
pellet was resuspended in 1 ml of cell culture medium (Appendix 1). Aliquot of cell 
suspension (0.2 ml) was taken for determination of cell viability and density.  The cells 
were counted using a Neubauer haemocytometer (Weber, England) and the viability of 
cells were determined by Trypan blue exclusion (Appendix 1).  Approximately, 1 x 106 
cells/ml was placed into 5 ml of cell culture medium (Appendix 1) in 25 cm2 tissue 
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2.1.3.3 Polarized Cell Line 
Polarized Vero C1008 cells were grown on 0.4 µm porous support membrane 
inserts (Becton Dickson, USA) immersed in M199 (Appendix 1) containing 10 % 
inactivated foetal calf serum. A total of 1 x 104 cells per insert was seeded and allowed to 
grow to confluency within 3 to 4 days. The integrity of the cell monolayers was 
monitored by measuring the transepithelial electrical resistance with the Millicell - ERS 
apparatus (Millipore). The net resistance of the cell monolayers was calculated as 
described by Blau & Compans (1995). 
 
2.1.4 Cultivation of Cells in 6-Well, 24-Well and 96-Well Tissue Culture Tray 
A confluent cell monolayer in a 25 cm2 tissue culture flask was used to seed a 6 -, 
24 -, or 96 -well tray (Falcon, USA).  The cell monolayer was treated as previously 
described (Section 2.1.3).  The cell suspension was made up to a final volume of 30 ml 
using cell culture medium (Appendix 1).  Five ml, 1 ml and 300 µl aliquot of this 
suspension was transferred into each well of the 6 -, 24 - and 96 - well tray, respectively.  
The trays were then incubated at 37 °C in the humidified incubator (Nuaire, USA) with 
carbon dioxide (5 %).  The monolayers were confluent within 3 days and ready for use. 
 
2.1.5 Cultivation of Cells on Glass Coverslips 
Cells were grown on coverslip for indirect immunofluorescence assay (Section 
2.11.1) and cytoskeleton carbon shadowing microscopy (Section 2.11.5).  The following 
steps were taken to ensure successful cultivation of cells on coverslips. 
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2.1.5.1 Pretreatment of Coverslips for Cultivation of Cells 
Glass coverslips of 13 mm in diameter (ARH, UK) were washed in 95 % ethanol 
for 30 min and then boiled in dgd water for about 15 min.  The coverslips were then left 
to dry in the incubator at 37 °C overnight. Dry heat sterilisation was performed in the hot 
air oven at 160 °C for 2 hr. 
 
2.1.5.2 Culture of Cells on Coverslips 
The individual coverslip was aseptically placed in a 24 - well tissue culture tray.  
A confluent cell monolayer in a 25 cm2 flask was used to propagate the cells as described 
in Section 2.1.3.  The cells were subcultured into the wells at a ratio of 1:25 using cell 
culture medium (Appendix 1).  The trays were incubated at 37 °C in a humidified 
incubator supplemented with 5 % carbon dioxide until they were about 50 % confluent. 
 
2.1.6 Storage of Cells 
A confluent cell monolayer in 25 cm2 tissue culture flask was used.  The cell 
monolayer was treated as for propagation of cell line in Section 2.1.3.  The cell 
suspension was spun in a sterile 15 ml centrifuge tube at 800 x g for 10 min.  The cell 
pellet was resuspended in 2 ml of preserving medium (Appendix 1).  One ml aliquot of 
this suspension (about 1 x 107 viable cells) was dispensed into cryovials with screw caps 
(Iwaki, Canada).  These vials were placed in Cryo-freezing container [(1 °C/min) 
(Nalgene, USA)] in a -80 °C freezer (Forma Scientific, USA) overnight.  The vials were 
then stored in liquid nitrogen.  These cell lines were regenerated by fast thawing at 37 °C 
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in a water bath when required.  The cell suspension was then transferred into a sterile 10 
ml centrifuge tube that contained 4 ml of cell culture medium (Appendix 1) for the 
specific cell line.  This was to dilute the dimethyl sulphoxide (DMSO) in the preserving 
medium that would be toxic to the cells.  The cell suspension was then pelleted by 
centrifuging at 800 x g for 10 min. The supernatant (preserving medium) was discarded 
and the cell pellet was resuspended in 5 ml of fresh growth medium (Appendix 1) of the 
specific cell line.  This suspension was transferred into a 25 cm2 tissue culture flask and 
was incubated at their respective temperature (37 °C or 28 °C) overnight.  The following 
day, the growth medium was changed and the cells were allowed to grow to confluency. 
 
2.2  INFECTION OF CELLS 
2.2.1 Viruses 
The viruses used in this study are given in Table 3.  The viruses were propagated 
in either Vero cells or C6/36 cells throughout this study and would be herein referred by 
the abbreviations given below.  Viruses were harvested at the appropriate timing post-
infection (p.i.) from the infected cells as indicated in Table 3.   
 
2.2.2 Infection of Cell Monolayers 
A confluent cell monolayer (3 days old) was used for infection.  The cell culture 
medium was discarded and the monolayer was washed with 5 ml of virus diluent 
(Appendix 2).  Different volumes of virus suspension [Multiplicity Of Infection 
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Table 3:  Viruses and related information. 
Virus Family Virus Strain Abbreviation Source 
Timing p.i. of 
obvious CPE/ 
Cell type 
Flaviviridae West Nile Sarafend WNV 






16 hr (Vero 
cells) 
20 hr (C6/36 
cells) 
Flaviviridae West Nile Wengler WNV (W) 






48 hr (Vero 
cell) 
Flaviviridae Kunjin MRM 61c KUN 






24 hr (Vero 
cell) 
Flaviviridae Japanese encephalitis Nakayama JEV 






48 hr (Vero 
cell) 
Flaviviridae Dengue Serotype 2, New Guinea DV 






60 hr (Vero 
cell/ C6/36 
cell) 





10 hr (Vero 
cell) 
 
(M.O.I.) of 10] used were: a) 0.2 ml for a 25 cm2 flask, b) 0.6 ml for a 75 cm2 flask and c) 
1.5 ml for a 175 cm2 flask.  The flask was incubated at 37 °C for 1 hr and rocked every 
15 min to ensure even infection.  After 1 hr, unabsorbed virus were washed off with 5 ml 
of maintenance medium [(MEM) (Appendix 2)] and an appropriate volume of MEM was 
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added to the flask.  The infected Vero or C6/36 cells were then incubated at 37 °C or 28 
°C, respectively, until the appropriate harvest time (Table 3). 
Mock - infected controls used in this study were prepared as abovementioned 
except that an appropriate amount of virus diluent (Appendix 2) was used instead of the 
virus.  
 
2.2.3 Preparation of Virus Pool 
Virus pools were prepared in 25 cm2 flasks.  Infection was carried out as 
described in Section 2.2.2.  The virus was harvested when cytopathic effects were 
pronounced (Section 2.2.1, Table 3).  At the end of the incubation period, the infected 
supernatant was harvested and spun at 800 x g for 10 min to remove cellular debris.  
These supernatant contained the extracellular virus.  In order to obtain intracellular virus 
yield, the infected cells were pelleted at 800 x g for 10 min and followed by freeze-
thawed action for three times.  The cell debris was then removed by spinning at 800 x g 
for 15 min.  About 500 µl of the infected supernatant (extracellular virus) or clarified cell 
lysate (intracellular virus) was aliquoted into sterile glass ampoules, sealed and 
immediately snapped frozen in -80 °C liquid ethanol.  The frozen ampoules were stored 
at -80 °C. 
 
2.2.4 Concentration and Purification of Virus 
Supernatant containing virus was prepared as described in Section 2.2.3 and was 
harvested by centrifugation at 800 x g for 10 min. Virus was then concentrated and 
partially purified by using a centrifugal filter device (Millipore, Bedford) at 1500 x g for 
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2 hr. The partially purified viruses were loaded onto a discontinuous sucrose gradient.  A 
5 ml discontinuous sucrose gradient was prepared by layering different concentration of 
sucrose solution from 10 % to 40 % in Tris buffer, pH 7.4 (Appendix 2).  The loaded 
discontinuous gradient was spun at 35000 rpm (Beckman L8-ultracentrifuge, USA) for 
2.5 hr in a SW 55 rotor.  At the end of the spin, the virus containing fraction was layered 
onto a 25 % sucrose cushion and spun at 25000 rpm for 2.5 hr at 4 °C in the SW55 rotor. 
Finally, the purified virus pellet was resuspended in Tris buffer, pH 7.4 (Appendix 2). 
The resuspended virus was aliquoted, snapped frozen and stored at –80 °C. The titer of 
the purified virus preparation was determined by plaque assay (Section 2.2.5).  
 
2.2.5 Plaque Assay 
Ten - fold serial dilution of the virus sample was prepared in virus diluent 
(Appendix 2).  Aliquots of 0.1 ml from the appropriate dilutions were inoculated in 
triplicate onto confluent Vero or BHK cell monolayers grown in sterile 24 - well tray 
(Falcon, USA) and incubated for 1 hr at 37 °C with rocking every 15 min (to ensure even 
distribution of virus inocula).  After 1 hr of adsorption, the excess inocula were removed.  
Two ml of 2 % w/v carboxymethylcellulose in growth media for the specific cell line 
(overlay medium, Appendix 2) were layered onto the infected cell monolayers.  The trays 
were incubated at 37 °C in a humidified carbon dioxide (5 %) incubator for 4 - 5 days.  
Plaques were visualized by staining the monolayer with 0.5 % crystal violet / 25 % 
formaldehyde solution (Appendix 2) for 30 min at room temperature. 
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2.2.6 Plaque Neutralization Assay 
Fifty µl of the neutralizing antibodies in 2-fold serial dilutions (from 1:2 to 
1:8192) were prepared in microcentrifuge tubes.  Virus was adjusted to 500 PFU in 50 µl 
of virus diluent (Appendix 2) and added to the tube containing serially diluted antibodies.  
The antibody - virus was mixed by vortexing for 30 sec and then incubated at 37 oC for 
an hour.  A 24 - well plate with confluent monolayers of Vero cells (prepared as 
described in Section 2.1.4) was used for virus infection.  Before inoculation of the 
antibody - virus mixture, the cell monolayer was rinse once with virus diluent (Appendix 
2), after which 100 µl of the antibody-virus mixture was added to the appropriate well.  
The plates were left at 37 oC for another hour, and rocked at 15 min intervals.  After 
incubation, the inoculum was removed and the cell monolayer was rinsed once with virus 
diluent (Appendix 2).  Overlay medium (Appendix 2) were added to the cell monolayers 
and further incubated at 37 °C for 4 days. Virus plaques were stained with 0.5 % crystal 
violet / 25 % formaldehyde solution (Appendix 2) for 30 min at room temperature. 
 
2.2.7 Extraction of Virus RNA Molecules 
 Viral RNA extraction procedure was carried out using QIAmp® Viral RNA 
extraction kit from Qiagen, USA.  A 140 µl of virus supernatant (approximately 5 x 108 
PFU/ml) were added to 560 µl of Buffer AVL containing carrier RNA in a 1.5 ml 
microfuge tube.  The mixture was incubated at 25 ºC for 10 min, followed by the addition 
of 560 µl of absolute ethanol.  The solution was then transferred to the QIAmp spin 
column and spun at 6000 x g for 1 min.  The filtrate was discarded.  The spin column was 
spun again at 6000 x g for 1 min after adding 500 µl of Buffer AW1.  The above step was 
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repeated with the addition of Buffer AW2.  Viral RNA was eluted from the spin column 
by adding 60 µl of Buffer AVE and spun at 6000 x g for 1 min.  The viral RNA was 
stored at -80 ºC until use. 
 
2.3 PRODUCTION OF RADIOLABELLED-VIRUS 
Both extra- and intracellular radiolabelled-virus were prepared from Vero cells.  
The radioisotopes sulphur-35 [35S] is a weak emitter of β-radiation.  The virus was 
labelled using [35S]-methionine obtained from Du Pont, USA.  Nonetheless all the 
necessary precautions were taken when handling them.  Benchkote (Whatman, USA) and 
gloves were used whilst working with the radioisotope.  Solid wastes were allowed to 
decay in plastic container and liquid wastes were absorbed onto vermiculite before 
disposal as solid waste.  Extran solution (Merck, Germany) was used to soak glass 
pipettes to allow radioactive decay before washing and reuse. 
 
2.3.1 Production of [35S]-Methionine-Labelled Virus 
Vero cells were grown in 175 cm2 flasks until confluent. Infection and 
maintenance procedures were essentially the same as for unlabelled virus (Section 2.2.2).  
The additional steps involved starvation and labelling of the infected cells as described 
below.  
At 6 hr p.i., the MEM (Appendix 2) was replaced with 25 ml of starvation medium 
[with Actinomycin D (ACD) (Appendix 3)] for 2 hr at 37 °C.  At the end of the starvation 
period, the starvation medium was replaced with labelling medium [with ACD (Appendix 
3)], which contained 10 µCi/ml of radioisotope.  The cultures were further incubated for 
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another 4 hr. The labelling medium was then removed and the monolayer was washed 
twice with PBS (Appendix 1). Radiolabelled-virus was harvested at the respective timing 
p.i. after obvious cytopathic effects were observed and purified (as describe in Section 
2.2.4).  The purified virus was lysed with 0.2 % SDS (Appendix 3) and measured for 
radioactivity using multipurpose liquid scintillation counter, LS6500 (Beckman, USA). 
 
2.4 MOLECULAR CLONING TECHNIQUES 
2.4.1 Bacterial Strains 
TOP10 Escherichia coli (E.coli) cells (Invitrogen, USA) were used for the 
transformation and propagation of cloning vectors. Genotype of TOP10 E.coli competent 
cells is F- mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 recA1 ara 139 (ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG.  BL21 E.coli cell (Invitrogen, USA) were 
used for the expression of GST-fusion protein.  Genotype of BL21 E.coli cell is F- ompT 
hsdS B (rB-mB-) gal dcm rne131 (DE3). 
 
2.4.2 Cloning and Expression Vectors 
The following table (Table 4) shows the list of cloning, mammalian expression 
and constitutive gene silencing vectors that were used in this study.  The insertions of the 
interest gene fragments into the respective vectors were carried out accordingly to the 
manufacturer’s instructions. 
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Protein of interest 
cloned in frame to 
the C-terminal of 
GFP. 
Cloning procedure 






Protein of interest 
cloned in frame to 
the GST 
Cloning procedure 










specific gene of 
interest. 
Cloning procedure 







2.4.3 Agarose Gel Electrophoresis 
A 1.3 % agarose gel was cast by the following method. 1.3 g of agarose (Bio-Rad, 
USA) was mixed with 100 ml of 1x TBE buffer (Appendix 4) in a 250 ml conical flask 
and heated in a microwave to dissolve the agarose.  After cooling to about 45 ºC, 7 µl of 
ethidium bromide solution (Sigma, USA) was added and mixed. The fluid of agarose 
mixture was poured into a gel tray where air bubbles were removed using a pipette before 
the gel comb was inserted. The solidified gel was then submerged in the gel-
electrophoresis tank filled with 1x TBE buffer (Appendix 4).  Ten µl of DNA sample was 
mixed with 2 µl of 6x gel loading buffer (Promega, USA) before loading into a well. Ten 
µl of pGEM DNA marker (Promega, USA) was also loaded as a relative molecular size 
reference. The sample was then electrophorized at 120 Volts for 30 min. The DNA bands 
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were then visualized under UV light (UV transilluminator, Vilber Lourmat, UK) and a 
Polaroid photograph of the gel was taken.  
 
2.4.4 Complementary DNA (cDNA) Synthesis 
cDNA was synthesized from virus RNA sample isolated as described in Section 
2.2.7. The reaction mixture consisted of 2 µl of 10x Reaction Buffer (Invitrogen, USA), 4 
µl of 25 mM MgCl2, 2 µl of Deoxynucleotide Mix (Promega, USA), 1 µl of gene specific 
reverse primer, 1 µl RNAse inhibitor (Invitrogen, USA) 0.8 µl Superscript Reverse 
Transcriptase (Invitrogen, USA), and 8.2 µl of RNA sample.  The mixture was briefly 
vortexed and pulsed before being incubated at 25 oC for 10 min and then 42 oC for 60 
min. The cDNA was then stored at –20 oC. 
 
2.4.5 Amplification of Specific Genes 
2.4.5.1 Primers Sequences and Related Information 
All the primers used in this study are synthesized by Proligo Singapore Pty Ltd 
(Singapore).  The primers are partially purified through desalting procedures.  The 
sequence, size and Tm of the primers are listed in Table 5. 
 
2.4.5.2 Polymerase Chain Reaction (PCR) 
PCR was used to amplify specific gene sequence using the respective primers 
flanking the 5’ and 3’ end.  The reaction mixture consisted of 36 µl of dgd water, 5 µl of 
10x reaction buffer (Roche, USA), 5 µl of dNTPs (10x) (Promega, USA), 1 µl of forward 
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primer (30 pmol/µl), 1µl of reverse primer (30 pmol/µl), 0.5 µl of DNA Polymerase 
(Roche, USA) and 1 µl DNA template.  The reaction mixture was vortexed before it was 
amplified in a PCR machine (Hybaid PCR ExpressTM, Hybraid Ltd).  This mixture was 
heated to 94 oC for 5 min, and then amplified for 30 cycles, each consisted of 94 oC for 
40 sec, 49 oC for 40 sec and 72 oC for 1 min, which enabled repetitive DNA denaturation, 
primer hybridization and primer extension, respectively. An extra step of 72 oC for 5 min 
allowed final extension to occur and a holding step at 4 oC.  However, the temperature or 
timing of the reaction cycle can be adjusted for each of the primer pairs to ensure optimal 
amplification. 
 
Table 5:  Primers used in this study. 
Primer Sequence Size Tm Polarity
   5’                                                                   3’  (nts) (oC)   
For the amplification of full length envelope gene from WNV  
WNVE1F CTTCAACTGTTTAGGAATG 20 52 Forward
WNVE1R CATGGACGTTGACCGAAAGG 20 62 Forward
For the amplification of full length integrin β3 subunit from human brain cDNA library
INTB3F ATGCGAGCGCGGCCGCGGCCC 21 78 Forward
INTB3R AGGATGACTGCTTATCATTAA 21 56 Reverse
For the synthesis of DNA probe to detect WNV viral RNA 
PE1 AGCTTCAACTGTTTAGGAATGA 22 60 Forward
PE2 CACCTTCCTGCGACCCTAGAG 21 68 Reverse
PE3 GGAGTTATGCTGAACCTTCC 20 60 Forward
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Primer Sequence Size Tm Polarity
Sequencing Primers 
Sequencing primer for pSilencer-3.0H1 
P1 AATTAACCCTCACTAAAGGG 20 64 Forward
Sequencing primer for pcDNA3.1 
T7  TAATACGACTCACTATAGGG 20 56 Forward
 
2.4.6 DNA Purification from Agarose Gel  
DNA band of the correct size was extracted using QIAEX® II Gel Extraction Kit 
(150) (Qiagen, Germany).  The band of interest was excised from the gel using a clean 
scalpel.  The gel slice was placed into a sterile eppendorf tube where 10 µl of Capture 
Buffer was added for every 10 mg of gel slice.  The tube was vortexed vigorously and 
incubated at 60 oC until the gel was completely dissolved (~10 min).  The dissolved 
sample was transferred to the GFX Column placed in a collection tube, which was 
incubated at room temperature for 1 min.  After incubation, the sample was centrifuged at 
15000 x g for 30 sec.  The flow-through was discarded and 500 µl of Wash Buffer was 
added.  The column was then centrifuged at 15000 x g for 30 sec and the GFX Column 
was transferred to a sterile 1.5 ml eppendorf tube.  For the elution of DNA, 50 µl of 
nuclease free water was added directly to the top of the glass fiber matrix in the GFX 
Column, which was incubated at room temperature for 1 min.  The purified DNA was 
recovered by centrifugation at 15000 x g for 1 min. 
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2.4.7 Transformation of Competent E.coli Cells 
Competent TOP10 E.coli cells (Invitrogen, USA) were pre-thawed on ice for 5 
min prior to transformation.  Ten µl of the vector mixture was added to 100 µl of TOP10 
cells and incubated on ice for 30 min.  This was followed by heat shock at 42 °C for 2 
min, after which the cells were placed on ice for another 2 min.  One hundred µl of 
transformed cells was then plated out on pre-warmed LB plate (Appendix 4) containing 
appropriate concentration of antibiotic (Appendix 4) and incubated overnight at 37 °C for 
the selection of clones. 
 
2.4.8 Plasmid Isolation and Purification 
Well - defined colonies were picked from LB plate and inoculated into 4 ml of LB 
broth (Appendix 4) containing appropriate antibiotic in sterile 15 ml tubes. The tubes 
were incubated at 37 °C with shaking at 200 rpm overnight. Glycerol stocks of the 
bacterial culture were made by adding 0.5 ml of 40 % glycerol (Sigma, USA) to 0.5 ml of 
culture and stored at –80 °C. The plasmids were then isolated following the procedures of 
the Wizard® Plus SV Miniprep DNA Purification System (Promega, USA). 
Briefly, the cells were harvested and the pellet was resuspended in 250 µl of Cell 
Resuspension Solution and transferred to a sterile eppendorf tube.  The cells were lysed 
with 250 µl of Cell Lysis Solution.  To inactivate endonucleases and other proteins 
released by the lysed cells, 10 µl of Alkaline Protease Solution was added.  The reaction 
mixture was then neutralized with 350 µl of Wizard® Plus SV Neutralization Solution 
and was centrifuged at 8000 x g.  The cleared lysate was transferred to a Spin Column, 
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and was washed twice with 750 µl and 250 µl of Column Wash Solution previously 
diluted with 95 % ethanol (Merck, Germany).  The spin column was then transferred to a 
sterile 1.5 ml eppendorf tube and the plasmid DNA was eluted with 100 µl of nuclease 
free water.   
 
2.4.9 Verification of Vector Containing Insert 
To verify whether the plasmids isolated from Section 2.4.8 contain the 
appropriate insert, restriction digestion, PCR and DNA sequencing were carried out.  For 
restriction digestion, 5 µl of plasmid was digested with the appropriate restriction enzyme 
with manufacturer’s instructions.  All mixtures were vortexed being incubated at 37 oC 
for 1 - 2 hr.  The digested DNA was then electrophoresized in a 1.3 % agarose-EtBr gel at 
120 Volts for 30 min and the bands of interest were visualized and photographed. For 
PCR, gene specific primers were used and the procedures were carried out as essentially 
described in Section 2.4.5.2. 
For DNA sequencing, the specific forward or reverse primer that primed the 
appropriate vector backbone sequence was used.  DNA sequencing was used to verify if 
the respective inserts in the vector constructs was in the correct orientation. DNA 
sequencing was performed using the sequencing primers as described in Section 2.4.5.1 
(Table 5) and ABI PRISM BigDye™ Terminator Cycle Sequencing Ready Reaction Kit 
(Applied Biosystem, USA). The composition of the sequencing reaction, sequencing 
profiles and purification of the extension product was performed as recommended by the 
manufacturer’s protocol. The precipitated extension product was stored in -20 oC until 
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they were sent for electrophoresis at the National University Medical Institute (NUMI) 
sequencing laboratory. Both the sequencing chromatogram and the sequence data file 
were subsequently obtained from NUMI and the sequences were analysed using free 
access software provided by http://www.ncbi.nlm.nih.gov/BLAST. 
 
2.4.10 Isolation of Recombinant Plasmid Using QIAGEN Plasmid Midi Kit 
Glycerol stock of the bacterial culture with the desired gene construct was spread 
onto pre-warmed LB plate with appropriate antibiotic (Appendix 4) and incubated 
overnight at 37 °C.  A well-defined colony was then picked and inoculated into 4 ml of 
LB broth containing appropriate concentration of antibiotic (Appendix 4) in a sterile 15 
ml tube before incubating at 37 °C with shaking at 200 rpm for 8 hr.  After the incubation 
period, 80 µl of the culture was sub-cultured into a flask containing 40 ml of LB broth 
and antibiotic (Appendix 4). The plasmids were then isolated according to the 
instructions of the QIAGEN Plasmid midi kit. 
In brief, the bacterial cells were harvested and the cell pellet was resuspended in 4 
ml of Buffer P1.  The cells were then lysed with 4 ml of Lysis Buffer, and the released 
proteins were precipitated with 4 ml of chilled Buffer P3.  The precipitated proteins were 
removed by 2 rounds of centrifugation at 12000 rpm for 5 min.  The supernatant was then 
added to the column and washed twice with 10 ml of Buffer QC to remove contaminants 
present in the sample.  The DNA was eluted into a 30 ml centrifuge tube with 5 ml of 
Buffer QF and was precipitated with 3.5 ml of isopropanol and centrifuged at 12000 rpm 
for 3 min.  The supernatant was discarded carefully as the DNA pellet was loosely 
attached to the tube, after which the pellet was washed with 70 % absolute ethanol.  The 
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supernatant was discarded and the pellet was air - dried for 20 min before being dissolved 
in 100 µl of nuclease free water.  The plasmid was then quantitated at OD260 in a 
spectrophotometer (Perkin Elmer, MBA 2000).   
 
2.4.11 Expression of Recombinant kinesin - GST Fusion Protein 
2.4.11.1 Bacterial Strain and Plasmid. 
BL21 E. coli competent cells and pGEX-uKinesin were kind gifts from Dr Hanry 
Yu (Department of Physiology, NUS).  The genotype of BL21 E. coli is shown in Section 
2.4.1.  The pGEX vector (GST fusion expression plasmid - Amersham Biosciences, UK) 
contained the cargo loading sequence (1781 - 3689 base-pairs) of the ubiquitous kinesin 
heavy chain (ukinesin) ligated between the restriction sites of BamHI and NotI, at the 
multiple cloning site. 
 
2.4.11.2  Analysis of Isolated Plasmids and Agarose Gel Electrophoresis. 
Restriction digestion by BamHI and NotI were carried out to ensure that the 
isolated plasmids carried the cargo loading sequence of uKinesin.  Five µl of the isolated 
plasmids was digested with 1 µl of BamHI (Amersham, USA), 1 µl of NotI (New 
Englands Biolabs, UK), 3 µl of Buffer 2 and topped up to a final volume of 30 µl with 
sterile dgd water.  These were incubated at 37 °C for 2 hr.  The digested samples were 
separated as described in Section 2.4.3. The gel was then visualized and photographed. 
 
2.4.11.3  Expression of Recombinant Fusion Protein 
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Overnight culture of putative transformants were inoculated into 20 ml of LB 
broth containing 20 µl of ampicillin [(100 µg/ml) (Appendix 4)] and incubated at 30 °C 
for 2 hr with shaking at 200 rpm.  The fusion proteins were expressed by the addition of 
0.2 mM isopropyl-β-D-thiogalactoside (Sigma, USA) for 3 hr.  Intact bacterial cells 
containing the expressed fusion proteins were collected by centrifugation at 4000 x g for 
10 min.  Fusion protein were extracted by freezing and thawing of the cell pellet and re-
suspended in GST purification buffer (Appendix 4). The GST - fusion proteins were 
purified by binding to glutathione beads (Amersham, USA) through end-over-end mixing 
for overnight at 4 °C.  Any unbound beads were removed through 3 x 5 min washes with 
GST purification buffer (Appendix 4).  The purified fusion proteins were analyzed with 
12 % Sodium dodecyl sulfate - polyacrylamide gel electrophoresis [(SDS - PAGE) 
(Section 2.6)]. 
 
2.5 TRANSFECTION OF CELL LINES 
2.5.1 Transfection of Vector-Based DNA Molecules into Cells 
Transfections were performed using Lipofectamine PLUS reagents from 
Invitrogen (USA) as specified by the manufacturer. Vero cells were grown on coverslips 
in 24 - well tissue culture plate (Section 2.1.4) until 75 % confluency. Two and a half µg 
of the respective DNA constructs was complexed with 4 µl of PLUS reagent in 25 µl of 
OPTI-MEM medium (GIBCO) for 15 min at room temperature. The mixture was then 
added to 25 µl of OPTI-MEM containing 2 µl of lipofectamine. After incubation for 
another 15 min, the DNA - liposome complexes were added to the cells. Following 
incubation for 3 hr at 37 ºC, 1 ml of complete cell culture medium (Appendix 1) was 
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added.  The transfection efficiency was checked by immunofluorescence assay (Section 
2.11.1) or immunoblotting (Section 2.7). 
 
2.5.2 Transfection of Antibodies and Protein Molecules into Cells 
Transfections were performed using ProTrans reagent from MoBitec Gmbh 
(Germany) as specified by the manufacturer. Vero cells were first grown on coverslips in 
24-wells tissue culture plate (Section 2.1.4) until 75 % confluency.  Antibodies or 
peptides (50 to 100 µg/ml) were first prepared in PBS (Appendix 1) and 40 µl of the 
antibodies or peptides were added to hydrate one QuickEase tube containing the dried 
ProTrans reagent.  The mixture was allowed to stand at 25 ºC for 5 min and followed by 
the addition of 500 µl of serum-free cell culture medium.  The cell monolayer was 
washed thrice with PBS (Appendix 1) before adding the transfection complexes to the 
cells.  The cells were incubated for 4 hr at 37 ºC.  After incubation, the cells were 
replaced with fresh serum-containing culture medium. The transfection efficiency was 
checked by immunofluorescence assay (Section 2.11.1) and the transfected cells were 
used for subsequent experiments (Section 2.15.5). 
 
2.6 SODIUM-DODECYL SULFATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE) 
The electrophoresis technique for protein separation was the Laemmli 
discontinous gel system (Laemmli, 1970).  The electrophoresis apparatus used was from 
Bio-Rad, USA. 
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A 12 % separation gel (Appendix 5) was cast between two grease-free glass plates 
(18 mm by 16 mm by 1.5 mm thickness).  The gel mixture was poured to about 1.5 cm 
below the comb bottom.  Seventy percentage ethanol was layered over the gel mixture to 
ensure a straight meniscus and to exclude oxygen which inhibits gel polymerization 
reaction. The gel is allowed to polymerise for approximately 45 min before the ethanol 
was decanted and washed with running buffer (Appendix 5) to flush out the residual 
polyacrylamide.  Stacking gel (Appendix 5) was then layered over the separation gel with 
comb in position and allowed to polymerise for 30 min.  The comb was removed and the 
wells were flushed with running buffer (Appendix 5) before loading the samples. 
Between 25 to 50 µl of each sample per well (varied with experiments) was used.  
Prior to loading, each protein sample was boiled for 1 min with 5 µl of glycerol -
bromophenol blue dye and dithioerytritol mixture (Appendix 5).  Five µl of the molecular 
weight marker (Amersham, USA) was treated as mentioned before.  The loaded gel 
assembly was immersed into the lower electrophoresis chamber containing 4 litres of 
running buffer (Appendix 5).  The upper electrophoresis chamber was filled with 500 ml 
of running buffer (Appendix 5).  Electrophoresis was carried out using constant current of 
15 mA per gel for the stacking gel for approximately 2 hr.  The current was then adjusted 
to 7 mA per gel for the separating gel for 16 hr.  The electrophoresis process was carried 
out in the cold room.   
After electrophoresis, the gel was fixed in 250 ml of gel fixing solution (Appendix 
5) for 30 min before transferring into the amplifier Tm (Amersham, UK) for another 30 
min.  The gel was subsequently dried on the blotting paper using a slab gel drier (Hoeffer 
Scientific Instruments, USA) at 80 °C for 2 hr.   
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For the radioactive protein samples, the dried gel was exposed to X-ray film 
(Kodak, USA) and kept at -70 °C. The film was developed by immersing into X-ray film 
developer (Appendix 5) for about 4 min followed by another 5 min in X-ray film fixer 
(Appendix 5).  The film was washed in running water and hung dry. 
 
2.7 IMMUNOBLOTTING 
For the immunoblotting of proteins, the gel was removed from the electrophoresis 
set and transferred into a blotting cell.  The 0.45 µm nitrocellulose membrane (Bio-Rad, 
USA), filter paper and sponge for transblot sandwich were presoaked in transfer buffer 
(Appendix 6).  The separation gel was placed between a wet nitrocellulose membrane and 
a piece of pre-wet filter paper.  The set-up was sandwiched between two pieces of sponge 
in the transblot cell.  The cell was immersed into the transfer chamber (with transfer 
buffer - Appendix 6) with the nitrocellulose membrane side adjacent to the positive 
electrode.  The transfer was carried out at 100 mA, 200 volts for 3 hr.  Cooling system 
(Colora, USA) was used. 
After the blotting period, the marker lane was cut out from the membrane.  The 
remaining blot was blocked in PBS containing 5 % skim milk (Appendix 6) for one hour 
to saturate the protein binding sites on the nitrocellulose membrane.  The blot was then 
washed thrice with wash buffer (Genelabs Diagnostics, Singapore) for 10 min each.  
Primary antibodies were prepared in 0.1 % BSA/PBS (Appendix 6) and added to the blot. 
The blot was incubated overnight in the primary serum at 4 °C on an orbital shaker 
(Bellco, USA). 
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On the following day, the immunoblot was thoroughly washed with wash buffer 
(Genelabs Diagnostics, Singapore) thrice for 10 min each.  The blot was then incubated 
with the appropriate secondary antibodies conjugated with alkaline phosphatase 
(Chemicon International, USA).  The secondary antibody was diluted in 0.1 % BSA/PBS 
(Appendix 6). The incubation was carried at room temperature for 1 hr. 
After the incubation period, the blot was washed extensively thrice for 10 min 
each time.  The substrate (Genelabs Diagnostics, Singapore) was added and the 
chromogenic reaction was carried out in the dark for 10 min.  The reaction was stopped 
by washing the blot in large amount of dgd water.  The blot was then dried and 
photographed. 
 
2.8 IMMUNODOT BLOTTING 
Two µl of protein samples (approximately 10 µg) were dotted onto nitrocellulose 
membrane (Bio - Rad, USA) in a series of dilutions.  The dots were dried at 50 ºC for 10 
min before soaking the membrane in blocking buffer (Appendix 6) for 1 hr at 25 °C. The 
membrane was washed thrice with wash buffer (Genelabs Diagnostics, Singapore) and 
incubated with the appropriate primary antibodies against the protein sample at the 
appropriate dilution for 1 hr at 37 ºC.  The membrane was washed thrice for 5 min with 
wash buffer (Genelabs Diagnostics, Singapore).  The appropriate diluted specific 
secondary antibodies were then incubated with the membrane for 45 min at 25 °C.  The 
secondary antibody was diluted in 0.1 % BSA/PBS (Appendix 6). The washing step was 
repeated as before and followed by the addition of the substrate (Genelabs Diagnostics, 
Singapore). The chromogenic reaction was carried out in the dark for 10 min.  The 
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reaction was stopped by washing the blot in large amount of distilled water.  The blot was 
dried and photographed. 
 
2.9 IMMUNOPRECIPITATION ASSAY 
At the appropriate time period post-infection or transfection, the cells were 
washed with PBS (Appendix 1) and lysed in RIP buffer, pH 7.4 (Appendix 6). The cell 
lysate was spun at 2000 x g for 5 min to remove the nuclei and was dialyzed overnight in 
PBS (Appendix 1). The clarified cell lysate were mixed with specific diluted antibodies 
and was incubated for 1 hr at 4 °C. Antibody-antigen complexes were then allowed to 
bind to Protein A-Sepharose. The mixtures were then washed three times in PBS 
(Appendix 1) and solubilized by boiling for 3 min in SDS - PAGE sample buffer 
(Appendix 5). The proteins were subjected to SDS-PAGE (Section 2.6) and Western blot 
detection (Section 2.7).   
 
2.10 EXTRACTION OF CELLS 
Cell extraction procedure used was adopted from Webster and colleagues (1978).  
Cell extraction was carried out to obtain cytosolic free cytoskeleton structures.  Cell 
monolayers were washed twice with cold PBS (Appendix 1) and once with the 
stabilisation buffer, pH 6.9 (Appendix 7).  This was followed by extraction with 
stabilisation buffer containing 0.2 % Trition X - 100 (Appendix 7) for 3 min.  Finally, the 
monolayer was rinsed twice with the stabilisation buffer.  The entire extraction procedure 
was carried out at room temperature.  The extracted cell monolayers were then processed 
for either indirect immunofluorscence or electron microscopy techniques. 
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2.10.1 High Salt and Octyl-glucoside Cell Extraction Procedure 
A protocol similar to Section 2.10 was carried out.  In this procedure, the 
stabilisation buffer (Appendix 7) was supplemented with either 1 M of NaCl (Merck, 
Germany) or 60 mM of octyl glucoside (Merck, Germany) instead of Triton X - 100. 
 
2.11 BIO-IMAGING 
2.11.1 Indirect Immunofluorescence Microscopy 
The antisera used in this study and their sources are indicated in Table 6. 
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2.11.1.1    Purification of Polyclonal Antibodies 
 Confluent monolayers of Vero cells grown in 75 cm2 tissue culture flask was 
washed with a cold solution of ammonium chloride in PBS (Appendix 8) for 3 times.  
The cell monolayer was then fixed with cold absolute methanol (Merck, Germany) for 10 
min at -20 °C.  After fixation for 10 min, the monolayer was washed again with cold 
solution of ammonium chloride in PBS (Appendix 8) for 3 times. One ml of anti-
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envelope WNV mono-specific polyclonal antibody was added to the monolayer and 
incubated at 4 °C overnight.  After incubation, the mono-specific polyclonal antibody 
was harvested and spun at 800 x g for 5 minutes before filtering through a 0.22 µ 
microfilter (Millipore, Germany).  The purified anti-envelope WNV virus antibodies 
were then aliqouted into smaller volume for storage. 
 
2.11.1.2  Preparation of Samples for Immunofluorescence with Antisera Against 
Specific Proteins 
Cells were fixed with cold absolute methanol (Merck, Germany) for 10 min, 
followed by a wash in cold PBS (Appendix 1) for 15 min. The cells were further washed 
(3 x 10 min) in cold PBS containing 0.1 % bovine serum albumin [(BSA-PBS) 
(Appendix 6)]. 
The anti-sera of the appropriate dilutions (Table 6) were used.  The washed 
coverslips with cells were inverted over 50 µl of the primary antiserum placed on a piece 
of laboratory sealing film (Whatman, USA).  These cells were exposed to the primary 
antiserum for 1 hr in a humidified chamber at 37 °C.  After 1 hr of incubation, the 
coverslips were washed in cold 0.1 % of BSA-PBS (Appendix 6) for 10 min each (3 
times in total). 
The cells were then treated in a similar fashion as above for the secondary 
antibodies (anti-mouse conjugated with Texas Red and anti-rabbit conjugated with FITC, 
see Table 6 for dilutions).  At the end of this second incubation, the coverslips were 
washed in cold 0.1 % of BSA - PBS (Appendix 6) for 10 min each (3 times in total). The 
coverslips were mounted onto ethanol cleaned glass slides using 15 µl of Dabco 
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mountant (Appendix 8).  The excess mountant was blotted dry.  The specimens were 
stored at 4 °C until ready for viewing with conventional optical-fluorescence microscope 
(Olympus BX60, Japan) and Laser Scanning Confocal Microscope (Leica TCS SP2, 
USA) with excitation wavelengths (480 nm for FITC) and (543 nm for Texas Red) using 
oil immersion objectives.  
 
2.11.2 Real-Time Imaging Using Laser Scanning Confocal Microscopy 
2.11.2.1  Cy5 Mono-Reactive Dye Labelling of Virus 
To be label with amine - reactive Cy5 fluorescent dye (Amersham Biosciences, 
USA), purified virus (as described in Section 2.2.4) was incubated with the dye in 
carbonate buffer, pH 9.5 (Appendix 8) at 25 °C for 1 hr. The unbound dye was removed 
via buffer exchange into 50 mM Hepes buffer, pH 7.4 (Appendix 8) through dialysis with 
3 changes of the buffer over a period of 24 hr.  Immediately before experiments, virus 
aggregates were removed by passing the virus containing solution through a 0.2 µm pore 
size filters (Millipore, USA). 
 
2.11.2.2  Fluorescence Labelling of Cellular Organelles and Structures 
For fluorescence labelling of microtubule network, cells were transfected (Section 
2.5.1) with 1 µg of pEGFP-Tub from Clontech (BD Biosciences, USA).  To obtain cells 
that stably expressed tubulin - GFP, cells transfected with pEGFP - Tub were incubated 
with 200 µg/ml of G418 (Invitrogen, USA).  Cells were then passage to obtain a 
homogenous population of cells expressing GFP - tubulin.  Fluorescence labelling of 
microtubule network was visualized without fixation in a culture chamber under the laser 
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scanning confocal microscope (Leica TCS SP2, USA) with temperature maintained at 37 
°C. The excitation and emission wavelength was set at 480 nm and 520 nm, respectively.  
For fluorescence labelling of late endosomes and lysosomes, LysoTracker Red DND - 99 
from Molecular Probes (USA) was utilized.  Cell monolayers were cultured on coverslips 
in 24 - well tissue culture plate as described in Section 2.1.5.  Two µl of LysoTracker Red 
DND - 99 was added to 1 ml of culture medium without serum (Appendix 1) and this 
mixture was then added to the cell monolayers for 5 min.  Labelling of the acidic 
endocytic vesicles were visualized without fixation in a culture chamber under the laser 
scanning confocal microscope (Leica TCS SP2, USA) with temperature maintained at 37 
°C.  The excitation and emission wavelength was set at 577 nm and 590 nm, respectively. 
 
2.11.3 Atomic Force Microscopy 
Vero cells were grown on coverslips and infected with WNV at a M.O.I. of 10. 
Uninfected cells were also imaged as controls to compare with cells infected for 10 – 12 
hr post infection (p.i.). The cells were fixed with 2.5 % glutaraldehyde and 2 % 
paraformaldehyde (Appendix 8) for 4 hr before dehydration through a series of different 
percentages of ethanol (Section 2.11.4). The processed cells were then imaged under the 
atomic force microscope (Veeco, Nanoscope IV Multimode, USA). Imaging was 
performed in air with a force modulation etched silicon probe (FESP). 
 
2.11.4 Transmission Electron Microscopy 
Virus-infected or mock-infected cell monolayer from 25 cm2 was first washed 
thrice with cold PBS (Appendix 1) and once with 0.2 M sodium cacodylate buffer, pH 
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7.4 (Appendix 8).  The cell monolayer was fixed with a primary fixative (2.5 % 
glutaraldehyde and 2.0 % paraformaldehyde – Appendix 8) at 4 °C for 4 hr.  The cell 
monolayer was rinsed with 0.2 M cacodylate buffer and scraped off the plastic surface of 
the tissue culture flask with a cell scraper (Nunc, Denmark).  The cells were then spun at 
1000 x g for 10 min and the supernatant was removed.   
The cell pellet was then post-fixed with secondary fixative (1 % osmium 
tetroxide, Appendix 8) for 2 hr at 4 °C.  A few crystals of potassium ferricyanide (Merck, 
Germany) were added to the secondary fixative to further enhance the contrast of 
membraneous structures.  The cell pellet was washed twice with cacodylate buffer before 
proceeding to dehydration process through a series of concentrations of ethanol as 
follows: 
 
Ethanol Concentrations Dehydration Time 
50% 5 min 
70% 10 min 
95% 10 min 
100% 15 min (thrice) 
 
The dehydrated cell pellet was then infiltrated with a 3:1 ratio of absolute ethanol 
to LVER (Appendix 8) for 2 hr at room temperature.  This was followed by a 1:1 ratio for 
another 2 hr and then 1:3 ratio mixture overnight.  On the following day, absolute LVER 
was used to further infiltrate the specimen (thrice, each for 2 hr).  Embedding and 
polymerization were done at 60 ºC for about 24 hr in dry gelatin capsules. 
  80 
                                                                                       CHAPTER 2 
                                                                                       MATERIALS & METHODS 
The embedded specimens were then trimmed (Spencer trimmer, Germany) and 
sectioned (50-70 nm thickness) using the ultramicrotome (Ultracut E, Reichert-Jung, 
Germany).  The ultrathin sections were picked up onto 200 mesh uncoated copper grid 
(Taabs, UK) and stained with saturated aqueous uranyl acetate (Appendix 8) for 5 min.  
Excess stains were washed off using deionized water.  This was then followed by a 
secondary staining with Reynold’s lead citrate solution (Appendix 8).  The sections were 
allowed to dry on hot plate and viewed under the 208S transmission electron 
microsocope (Philips, Netherlands). 
 
2.11.5 Carbon-Platnium Shadowing of Cytoskeleton 
Cytoskeleton of cells was prepared from Vero cells grown on coverslips as in 
Section 2.1.5.  The cells were extracted as described in Section 2.10 and fixed with 
methanol (Merck, Germany) for 10 min at -20 °C.  The cytoskeleton network was critical 
point dried and shadowed with tungsten at a 45° angle to the specimen plane, while 
rotating at 25 rpm.  This was followed by shadowing with carbon at a 90° angle.  The 
shadowed cytoskeleton network (replica) were detached from the coverslips in 48 % 
hydrofluoric acid (Merck, Germany) followed by 5 x 5 min washes with PBS (Appendix 
1).  The replicas were mounted onto nickel grids and viewed under the 208S transmission 
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2.11.5.1  Immunogold-Labelling of the Cytoskeleton, its Associated Proteins and 
Specific Virus Proteins 
The cytoskeletons were prepared as described in Section 2.10.  The preparations 
were then treated with 100 µg/ml of bovine DNase (Sigma, USA) followed by 100 µg/ml 
RNase-A (Sigma, USA) for 20 min.  The coverslips with the cytoskeleton network was 
washed twice with stabilization buffer (Appendix 8) before incubating with 50 µl of the 
appropriate antibodies (Table 6) for 1 hr.  These coverslips were then rinsed with 
stabilization buffer (Appendix 7) before reacting with 50 µl (dilution 1:500) of protein A 
colloidal gold (10 nm - BioCell, UK) for a further 30 min.  After incubation, 3 x 5 min 
washes with stabilization buffer supplemented with 0.05 % Tween 20 (Appendix 7) were 
performed.  The above labelling procedure was repeated for the second primary 
antibodies (Table 6) and 50 µl (dilution 1:500) of protein A colloidal gold (15 nm - 
BioCell, UK).  The cytoskeleton was fixed in absolute methanol (Merck, Germany) and 
dehydrated through a series of ethanol concentrations (50%, 70%, 90%, 95% & 100%), 
critical point dried and carbon shadowed (Section 2.11.5). 
 
2.11.6 Cryo-Immuno-Electron Microscopy 
West Nile virus-infected Vero cells or mock-infected cells were processed for 
cryo-electron microscopy using the Tokuyasu method (Tokuyasu, 1984). The cells were 
fixed for 30 min in 4 % paraformaldehyde and 0.2 % glutaraldehyde (Appendix 8) before 
washing twice with PBS (Appendix 1). The cells were scraped and spun down. The cell 
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pellet was resuspended in 10 % gelatin (Merck, Germany) at room temperature and spun. 
The gelatin with the pelleted cells was solidified at 48 °C for 10 min. 
The harden block was post-fixed with the above fixative again for 20 min. The 
gelatin block was then cut into 1-mm cubes and immersed into cryo-protection buffer of 
2.3 M sucrose (Appendix 8) for about 2 hr. The block was frozen by plunging into liquid 
nitrogen before cyro-ultramicrotomy, using an ultracut microtome (UCT) with a cryo-
attachment (EM FCS Leica, Austria).  
Ultrathin sections of the cells were picked up onto Formvar-coated grids and 
immunolabelling was then carried out at room temperature. The sections were washed for 
10 min with PBS. This was followed by three washes (5 min each) with 0.05 M glycine 
in PBS (block the aldehyde groups, Appendix 8) before incubating for 30 min in PBS 
with 5 % BSA (protein block). After this, the sections were washed in 0.1 % BSA in PBS 
(Appendix 6) for 5 min and exposed to the primary antibody (diluted accordingly in 0.1 
% BSA in PBS, Appendix 6) for 1 hr. Six washes (5 min) in 1 % BSA in PBS (Appendix 
6) was done before exposing the sections to the Protein A colloidal gold [(Agar Aids, 
UK)] for 1 hr. The above steps were repeated with the second primary antibody for 
double-labelling experiments.  
The sections are post-fixed in 2 % glutaraldehyde in PBS (Appendix 8) for 5 min 
and washed (2 - 5 min each) with PBS (Appendix 1) and distilled water (4 - 5 min). 
Finally, the sections were embedded in a 2 % uranyl acetate and 1.8 % methylcellulose 
mixture (1:9 parts, Appendix 6) for 5 min and dried before viewing under the CM120 
BioTwin transmission electron microscope (Philips, The Netherlands).  
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2.11.7 Negative Staining of West Nile Virus 
For negative staining of WNV preparation, 10 µl of WNV was added to freshly 
glow - discharged, carbon-coated grids and stained with 2 % uranyl acetate (Appendix 8) 
for 1 min. The grids were then air-dried before viewing under the CM120 Biotwin 
transmission electron microscope (Philips, The Netherlands).  
 
2.11.8 Virus RNA Detection Using Digoxigenin-11-dUTP Incorporated DNA Probe 
Coupled with Immuno-Electron Microscopy 
The DNA probes used for in situ hybridization were prepared as previously 
described by Grief and colleagues (1997) and An and group (1992). The first round PCR 
was performed using oligonucleotide primers PE1 (5’- 
AGCTTCAACTGTTTAGGAATGA) and PE2 (5’ CACCTTCCTGCGACCCTAGAG) 
that amplified a region of the virus E protein gene (784 base pairs) from plasmid 
pWNVE. Plasmid pWNVE was constructed by ligating the full length E protein gene of 
WNV into plasmid pcDNA3.1. (Invitrogen, USA). The resulting amplified products were 
used for a second round and asymmetric PCR using primer PE3 (5’-
GGAGTTATGCTGAACCTTCC) to generate the complementary (negative) single-
stranded probes with the incorporation of digoxigenin-11-dUTP (Roche, UK). The 
incorporation of digoxigenin-11-dUTP was checked by immuno-spotting the probes onto 
nylon membrane as described in Section 2.8.  
To perform in situ hybridization on cryo-sections of cells, the DNA probes were 
first diluted (1:10) in hybridization buffer (Appendix 8) and boiled for 5 min before 
proceeding to hybridization experiment.  Copper grids containing sections were first 
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placed onto 10 µl droplets of hybridization buffer (Appendix 8) and incubated for 4 hr at 
37 °C.  The grids were then washed thrice by transferring onto droplets of 30 µl of wash 
buffer (Appendix 8).  The grids were then processed for immunogold-labelling using 
anti-digoxigenin antibody (dilution, 1:1000) as stated in Section 2.11.6. Finally, the 
sections were viewed using CM120 BioTwin transmission electron microscope (Philips, 
the Netherlands).  
 
2.12 PERCOLL SUB-CELLULAR FRACTIONATION OF CELL 
HOMOGENATE 
Vero cells or cells treated with drugs were infected with [35S]-methionine -
labelled WNV at a M.O.I. = 10 for 1 hr at 4 °C. Unbound virus was removed by washing 
twice with PBS. The cells were then allowed to internalize WNV for appropriate periods 
at 37 ºC. At the appropriate timings after internalization of virus particles, the cells were 
washed twice with cold PBS before detaching by gentle scraping. Following 
centrifugation for 10 min at 800 x g, the cell pellet was re-suspended in homogenization 
buffer, pH 7.4, (Appendix 9). The suspension was subjected to 20 strokes in tight fitting 
homogenizer (Jensons, England). The homogenate was centrifuged for 10 min at 500 x g 
(to remove the nuclei) and the post-nuclear supernatant was collected. For the separation 
of sub-cellular particles in the post-nuclear supernatant, an iso-osmotic solution of 20 % 
Percoll was prepared as previously described (Punnonen et al., 1994). Percoll is diluted in 
0.15 M NaCl to prepare a 20 % Percoll solution (Appendix 9). The post-nuclear 
supernatant samples were centrifuged at 32000 × g for 30 min in a Beckman 70.1 Ti 
rotor. Density marker beads (Pharmacia Biotech, USA) were used as external standard 
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for the density gradients in the Percoll solution. Fractions of 250 µl were collected and 
processed for liquid scintillation counting of radioactivity in a Beckman LS6500 liquid 
scintillation counter. 
 
2.13 FLOW CYTOMETRIC ANALYSES  
Suspension cell cultures and single cell suspensions of adherent cell cultures (5 x 
106) were washed and incubated with anti-integrin αVβ3 antibodies (Chemicon 
International, USA) against the respective cell surface proteins at 4 °C for 30 min.  Cells 
were washed and incubated with FITC-conjugated secondary antibodies (Amersham 
International, UK) at 4 °C for 30 min, washed and analyzed in a FACScan flow 
cytometer (Becton Dickinson, USA) with the appropriate gating parameter. Isotype 
control was included. Dead cells stained with propidium iodide (Sigma, USA) were 
excluded from the analyses. 
 
2.14  PEPTIDE SEQUENCING  
The coomassie blue-stained protein band with VOPBA (Section 2.16.3) binding 
activity was excised from the 12 % SDS-PAGE, processed for in - gel digestion with 
trypsin and purification before peptide sequencing.  In - gel trypsin digestion was first 
carried out by washing the sample thrice with 100 µl of 50 mM ammonium bicarbonate / 
50 % methanol (Appendix 10).  The sample was digested with 5 µl of 40 ng/µl of trypsin 
(Promega, USA) prepared in 50 mM of ammonium bicarbonate (Appendix 10).  The 
mixture was incubated for 180 min at 25 °C.  After trypsin digestion, the peptides were 
extracted thrice with 20 µl of 5 % trifluoroacetic acid (TFA) in 50 % acetonitrile 
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(Appendix 10).  The purified sample is then sent for peptide sequencing using the protein 
sequencing facilities provided by the Institute of Molecular and Cell Biology, Singapore. 
 
2.15 VIRUS ENTRY ASSAY 
2.15.1 Virus Binding and Penetration Inhibition Assay 
Vero cells growing on coverslips were infected with WNV at M.O.I. = 10 for 1 hr 
at 4 °C with gentle rocking. Unbound virus was washed three times in ice-cold PBS and 
shifted to 37 °C for 1 hr in growth medium to allow virus penetration. Extracellular virus 
that failed to enter into cells can be inactivated with sodium citrate buffer, pH 2.8 
(Appendix 11) by washing the cells with this buffer for 5 min. Infected monolayers were 
then washed twice with PBS (Appendix 1) and further incubated at 37 °C for 24 hr. At 1 
day p.i., cells were fixed in methanol and processed for immunofluorescence assay as 
described above (Section 2.11.1). The number of infected cells is scored in comparison to 
mock-infected cells. 
To determine the effects of the drugs used to inhibit the entry of WNV, Vero cells 
were either pretreated with drugs (as listed below) for 1 hr at 37 °C, followed by virus 
infection or the drugs were added after 10 min, 30 min, 1 hr and 2 hr p.i. Cells were 
infected as described (Section 2.2.2) and processed for immunofluorescence assay 
(Section 2.11.1). Three independent experiments were carried out for each set of the 
drugs used. The inhibition of virus entry was determined by the number of viral antigen 
positive cells in relation to the total number of cells (viral antigen - positive and negative) 
and expressed as a percentage of viral antigen-positive cells.  
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The drugs used in this study were as follows: Inhibitor of receptor-mediated 
endocytosis, monodansylcadervine (0.5 mM); Inhibitors of clathrin function, 
chlorpromazine (5 µg/ml) and sucrose (0.3 M); Inhibitor of caveolae-dependent 
endocytosis, filipin (1 µg/ml); Lysosomotropic drug, chloroquine (0.1 - 2 µM) and 
amantidine (0.05 - 1.5 µM); Vacuolar-ATPase inhibitor, bafilomycin A1 (10 - 30 µM); 
Inhibitor of the endocytic trafficking pathway, cytochalasin D (0.1 - 2 µg/ml) and 
nacodazole (5 - 40 µM). The number of viable cells was determined by trypan blue 
(Appendix 1) exclusion method.  Acridine orange (100 ng/ml) was used to stain acidic 
vesicles in cells. 
 
2.15.2  Protein Kinase C (PKC) Enzymatic Assay 
The enzymatic activities of PKC and its isoforms in mammalian cells were 
determined by using PKC assay kit from Upstate, USA.  The assay kit measured the 
phosphotransferase activity of PKC.  Ten µl each of the substrate cocktail, inhibitor 
cocktail, ADBII, lipid activator, 200 µg of cell lysate and [γ-32P] ATP mixture was 
aliquoted into a 1.5 ml microcentrifuge tube.  The mixture was incubated at 30 ºC for 10 
min.  A 25 µl aliquot of the mixture was dotted onto an assay square area of the P81 
paper.  The assay squares were washed with 0.75 % phosphoric acid for three times and 
once with acetone.  Radioactivity on the assay squares were then read in the multipurpose 
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2.15.3 Virus Entry Inhibition Assay (Using PKC Specific Inhibitor, 
Bisindolymaleimide) 
Confluent monolayer of Vero cells grown in 6-well plate were either pretreated (1 
hr & 2 hr) or post-treated (0.5 hr to 5 hr) with 40 µm of bisindolymaleimide I.  The cells 
were then infected with WNV at a M.O.I. = 10.  Virus supernatants were harvested at 12 
hr p.i. and the productive virus yields were determined by plaque assays (Section 2.2.5).  
 
2.15.4 Effect of Bisindolymaleimide on Virus Entry of Transfected Infectious 
Viral RNA Molecules into Cells 
Vero cells were first grown on 24-well tissue culture plate (Section 2.1.4) until 75 
% confluency.  Vero cells were first pretreated with bisindolymaleimide (10 – 60 µM) for 
1 hr before carrying out transfection with infectious WNV RNA.  Transfections were 
performed using TransMessengerTM transfection reagent from Qiagen (USA) as specified 
by the manufacturer.  
Approximately 2 µg of viral RNA was mixed with 4 µl of Enhancer R in buffer 
EC-R for 5 min at 25 °C. The mixture was added to 8 µl of TransMessenger transfection 
reagent and incubated for 10 min at 25 °C.  At the mean time, the cell monolayer was 
washed thrice with PBS (Appendix 1) and 900 µl of growth medium without serum was 
added to the cells.  The transfection complex mixture was then added drop-wise onto the 
cell monolayer.  The plate was swirled gently to allow uniform distribution of the 
transfection complexes.  The cells were incubated for another 3 hr at 37 ºC.  These cells 
were then washed with PBS to remove the transfection complexes and fresh cell culture 
medium (Appendix 1) containing serum was added. Virus supernatants were harvested at 
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12 hr p.i. and the productive virus yields were determined by plaque assays (Section 
2.2.5).  
 
2.15.5 Virus Entry Inhibtion Assay (Using Cells Transfected with Antibodies  
Against PKC and its Isoforms) 
Cell monolayers grown on 6-well plates (Section 2.1.4) were obtained by seeding 
approximately 5 x 104 cells per well.  The cell monolayers were transfected with 50 
µg/ml of antibodies against PKC and its isoforms (PKCβ1, PKCβ2, PKCα, PKCγ) as 
described previously in Section 2.5.2.  Immediately after 3 hr post-transfection, the 
transfected cells were washed thrice with PBS (Appendix 1) and subjected to virus 
infection at a M.O.I. = 10 (Section 2.2.2).  Virus supernatants were harvested at 12 hr p.i. 
and the productive virus yields were determined by plaque assays (Section 2.2.5).  The 
cell monolayers on the glass coverslips were also processed for virus protein detection by 
immunofluorescence assay (Section 2.11.1). 
 
2.16 BIOCHEMICAL ANALYSES OF RECEPTOR MOLECULES 
2.16.1 Proteases, Phospholipases, Glycosidases & Lectin Treatment 
To determine the biochemical nature of the cellular receptor molecule to which 
WNV binds, cell monolayers of approximately 5 × 106 cells were washed twice with PBS 
(Appendix 1) before enzyme treatment. Cell monolayers were incubated with the 
proteases, phospholipases, glycosidases, and lectins (as listed below) in PBS (Appendix 
1) at pH 7.0 for 45 min at 25 °C. After treatment, cell monolayers were washed twice 
with PBS supplemented with 2 % FCS to remove the enzymes. Cell monolayers were 
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then incubated with WNV (M.O.I. = 10) at 37 °C for 1 hr. Excess virus particles were 
inactivated with sodium citrate buffer, pH 2.8 (Appendix 11) for 10 min and the cell 
monolayer was washed twice with PBS (Appendix 1). Vero cells were then incubated at 
37 °C for 12 hr. At 12 hr p.i., virus titers from the treated samples were determined by 
plaque assays (Section 2.2.5).  
The enzymes used in this study were as follows: Proteases: Proteinase K (EC 
3.4.21.64) from Tritirachium album (Sigma, USA), concentration of 10, 1, and 0.1 
µg/ml; α-chymotrypsin (EC 3.4.21.1) from bovine pancreas (Sigma, USA), concentration 
of 10 and 1 µg/ml; trypsin (EC 3.4.21.4) from bovine pancreas (Sigma,USA), 
concentration of 10, 1, and 0.1 µg/ml; Bromelain (EC 3.4.22.32) from pineapple stem 
(Sigma, USA), concentration of 20, 2, and 0.2 mU/ml; papain (EC 3.4.22.2) from Carica 
papaya (Roche, USA), concentration of 50 and 10 mU/ml; phospholipases: 
phospholipase A2 (EC 3.1.1.4) from bovine pancreas (Sigma, USA), concentration of 1 
and 0.1 U/ml; phospholipase C (EC 3.1.1.4.3) from Clostridium perfringes (Sigma, 
USA), concentration of 10 and 1 U/ml; phospholipase D (EC 3.1.4.4) from peanut 
(Sigma, USA), concentration of 100 and 10 U/ml; glycosidases: endoglycosidase H (EC 
3.2.1.96) from Streptomyces plicatus (Roche, USA), concentration of 100 and 10 mU/ml; 
O-glycosidase (EC 3.2.1.97) from Diploccus pneumoniae (Roche, USA), concentration 
of 1 and 0.1 mU/ml; α-mannosidase (EC 3.2.1.24) from almonds (Sigma, USA), 
concentration of 1000, 100, and 10 µg/ml; α-fucosidase (EC 3.2.1.11) from almond meal 
(Sigma, USA), concentration of 100 and 10 mU/ml; heparinase I (EC 4.2.2.7) and 
heparinase III (EC 4.2.2.2.8) from Flavobacterium heparinum (Sigma, USA), 
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concentration of 1 and 0.1 U/ml; lectins: concanavalin-A from Jack bean (Sigma, USA), 
wheat germ agglutinin from Triticum vulgaris (Sigma, USA), phytohemagglutinin from 
Phaseolus spp. (Wellcome Diagnostic, UK), concentration of 1000 and 100 µg/ml. 
Sodium periodate was obtained from Sigma and the working concentrations are 1 and 0.1 
mM. Cell viability after enzyme treatment was assessed by Trypan blue staining 
(Appendix 1) and by observation under phase-contrast microscope BX 60 (Olympus, 
Japan).  
 
2.16.2 Plasma Membrane Protein Preparation 
The plasma membrane proteins were prepared as previously described by Salas-
Benito and del Angel (1997). Monolayers of Vero cells or N2A cells were detached with 
PBS - 5 mM EDTA [Appendix 2, (5 ml / 75-cm2 flask)] for 10 min at room temperature. 
Afterwards, cells were resuspended in ice - cold buffer M (Appendix 12) and lysed by 5 
to 10 strokes in a tight fitting Dounce homogenizer. Nuclei and debris were removed by 
centrifugation at 500 x g for 10 min at 4 °C in a Sorvall centrifuge. Membrane proteins 
were pelleted from the supernatant by centrifugation at 18000 rpm for 30 min at 4 °C in a 
Beckman JA20 rotor and re-suspended in buffer M without β-mercaptoethanol (Appendix 
12). The integrity of extracted membrane proteins was determined as described by 
Atkinson and Summers (1971). The concentration of the protein was determined by 
Bradford assay with bovine serum albumin [(BSA) (CSL, Australia)] as the standard. 
Approximately 800 µg of proteins was obtained. The membrane protein preparation was 
aliquoted and stored at -20 °C.  
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2.16.3 Virus Overlay Protein Blot Assay (VOPBA) 
To identify the WNV binding molecules in Vero cell plasma membrane extract, 
VOPBAs were performed. Membrane proteins (80 µg) from Vero cells were separated by 
10 % SDS – PAGE as described in Section 2.6.  Proteins separated by SDS – PAGE were 
electrophoretically transferred onto nitrocellulose membrane (Bio-Rad, USA) as 
described in Section 2.7. The nitrocellulose membrane was soaked overnight in a 
blocking buffer (Appendix 6) to block non-specific-binding sites and to allow 
renaturation of the separated proteins. The membrane was rinsed with PBS (Appendix 1) 
for three times and incubated sequentially with (a) the purified WNV (prepared as in 
Section 2.2.4) for 6 hr at 4°C, (b) mono-specific polyclonal antibodies against WNV 
envelope protein for 1 hr at 37 °C, (c) secondary antibody (anti-rabbit IgG) conjugated 
with alkaline phosphatase (Chemicon International, USA) for 45 min at 37 °C. All 
incubations were carried out on a rocking platform and membranes were washed three 
times with high salt wash buffer (Appendix 12). Non-specific binding of the virus 
particles was reduced with a high-salt buffer wash.  
The presence of virus binding was detected by the addition of substrate, nitroblue 
tetrazolium (Genelabs Diagnostics, Singapore). Finally, the membranes were washed 
with dgd water and dried.  Alternatively, the membrane can be incubated with 35[S]-
methionine - radiolabelled WNV for 6 hr at 4 ºC, followed by exposing the membrane to 
storage phosphor screen (Amersham Biosciences, USA) for 12 hr before scanning for the 
radioactive bands by Typhoon 9410 variable mode imager unit (Amersham Biosciences, 
USA). 
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2.16.4 Enzymatic and Chemical Treatment of Plasma Membrane Protein 
Vero cells (approximately 5 × 106 cells) were treated with protease (papain), 
glycosidases (α-mannosidase, endoglycosidase H, and O-glycosidase), lectins 
(concanavalin-A and phytohemagglutinin), sodium periodate, and β-mercaptoethanol. 
The concentrations used (Section 2.16.1) were as before and the cells were prepared 
accordingly for cell - membrane protein preparation (Section 2.16.2) and VOPBA 
(Section 2.16.3).  
 
2.16.5 Kinetic Study on the Recovery of Receptor Molecules after Papain Digestion 
Vero cells (approximately 5 × 106 cells) were treated with papain at 50 mU/ml in 
PBS or PBS (untreated, Appendix 1) for 45 min at 25 °C. Another set of Vero cells was 
incubated with 100 µg/ml of cycloheximide (blockage of new protein synthesis) 2 hr 
prior to papain treatments.  Treated cells were washed twice with PBS supplemented with 
2 % FCS to inactivate the enzyme. Fresh M199 plus 10 % FCS (Appendix 1) with or 
without cycloheximide (100 µg/ml) were added to the cells. The cells were then 
incubated at 37 °C in 5 % CO2.  At specific times after incubation (0, 2, and 4 hr), plasma 
membrane proteins were extracted as described before (Section 2.16.2) and VOPBA was 
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2.16.6 Generation of Murine Polyclonal Antibodies Against 105-kDa Membrane 
Protein. 
The 105-kDa plasma membrane protein (from Vero cells) was excised from the 
10 % SDS – PAGE gels, homogenized, and incubated with ImmunEasy mouse adjuvant 
(Qiagen, USA) at a concentration recommended by the manufacturer.  The antigen – 
adjuvant mixture was used to immunize BALB/c mice (Animal Holding Unit, National 
University of Singapore) five times subcutaneously at 14 - day intervals. Mouse sera 
were collected 12 days after the last booster. Mouse sera were purified using Econo-Pac 
serum IgG purification kits (Bio-Rad, USA) and dialyzed overnight with PBS (Appendix 
1). The purified immunoglobulins were stored at -20°C. Sera were tested by Western 
blotting detection (Section 2.7) for the presence and specificity of antibody against the 
105-kDa membrane protein.  
 
2.16.7 Inhibition of Virus Infection by Murine Polyclonal Antibodies 
Confluent monolayers of Vero cells were first washed twice with PBS (Appendix 
1) and incubated with pre-immune serum or the anti-105-kDa polyclonal antibodies (1:10 
to 1:1000 dilutions) for 1 hr at 37 °C. After incubation, cells were washed thrice with 
PBS and infected with WNV or KUN virus (M.O.I. = 10). At appropriate p.i. time 
periods, supernatants from the virus-infected cells were processed for plaque assays 
(Section 2.2.5). For control, the above procedures were repeated with an unrelated 
poliovirus infection. 
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2.17 VIRUS BINDING AND PENETRATION INHIBITION ASSAY USING 
FUNCTIONAL BLOCKING INTEGRIN ANTIBODIES AND LIGANDS  
Cells were incubated with 0.25 to 25 µg/ml of functional blocking integrin 
antibodies (α1- FB12, α2 – P1E6, α3 – P1b5, α4 – P1H4, α5 – P1D6, α6 – NKI-GoH3, 
αV – P3G8, β1 – P4G11, β2 – P4H9, β3 – 25E11, β4 – ASC-9, β5 - , αVβ3 – LM609 , 
αVβ5 – P1F6 were purchased from Chemicon International and αVβ3 were purchased 
from Santa Cruz Biotechnology), 50 to 100 µg/ml of integrin ligands (fibronectin, 
vitronectin, heparin, chrondriotin sulphate, laminin, collagen type 1 were purchased from 
Sigma Aldrich, USA), BSA (Life Technologies, USA) and RGD peptides (Sigma 
Aldrich) in M199 (Appendix 1) for 30 min at 4 °C and follow by the addition of [35S] -
methionine-labelled flaviviruses (prepared accordingly as in Section 2.3) at a M.O.I. = 
10.  To assay for virus binding to cell surface, virus was incubated for 1 hr at 4 °C while 
to assess virus penetration, virus was incubated for 1 hr at 37 °C.  Excess or unbound 
virus were inactivated with acid citrate buffer, pH 2.6 (Appendix 11) and removed by 
extensive washing with PBS (Appendix 1).  The cells were then lysed with 1 % SDS 
(Appendix 1) and the specific radioactivity was determined by multipurpose liquid 
scintillation counter, LS6500 (Beckman, USA).   
 
2.17.1 Inhibition of Virus Entry with Soluble Integrin  
Virus (approximately 500 plaque forming unit) was first incubated with soluble 
integrin αVβ3 and αVβ5 (Chemicon International) at 1 to 10 µg/ml for 1 hr at 4 °C. The 
complex was then added to target cell monolayer for 1 hr at 37 °C.  The cell monolayers 
were washed with PBS (Appendix 1) thrice and overlay with overlay medium (Appendix 
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2) for 4 days and virus plaques were stained with 0.5 % crystal violet/25 % formaldehyde 
solution (Appendix 2) for 30 min at room temperature. 
 
2.17.2 Gene Silencing of Integrin β3 
Human integrin β3 gene was first obtained by PCR (Section 2.4.5.2) using gene 
specific primers (Section 2.4.5.1) to amplify from Gene Pool cDNA of human adult 
normal brain (Invitrogen, USA). Human integrin β3 sequence (5’- 
AAACATCAATTTGATCTTTGC-3’) was then cloned into small interfering RNA 
expression vector, pSilencer 3.0-H1 (Ambion, USA) according to manufacture’s 
instructions.  In brief, sense and anti-sense of the selected human integrin β3 siRNA 
sequence was designed by oligonucleotide program 
(http://WWW.ambion.com/techlib/tb/tb_506html).  The selected oligonucleotide was 
then synthesized, annealed and ligated with pSilencer 3.0-H1 (Ambion, USA) as 
specified by manufacturer’s instructions.  The recombinant pSilencer was transformed 
into E.coli cells and selected based on ampicillin maker and sequencing was performed.  
pSilencer containing integrin β3 and GADPH (internal control) genes and pSilencer 
(negative control) were transfected into Hela cells using Lipofectamine PLUS reagents 
from Invitrogen (USA) as per discussed in Section 2.5.1.  Down-regulation of cell surface 
integrin β3 was determined by flow cytometric analyses.  Cell clones with down-
regulated expression of integrin β3 were selected by flow cytometry (Section 2.13) for 
virus entry assay (Section 2.17).  
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2.17.3 Inhibition of West Nile Virus Entry by Soluble WNV Envelope DIII Protein. 
Soluble WNV E DIII or bovine serum albumin (in the concentration range of 5 to 
100 µg/ml) was incubated with Vero, C6/36 cells (1 x 106 cells) and CS-1β3 (1 x 106 
cells) in cell culture medium at 4 °C for 1 hr.  Unbound protein molecules were removed 
by washing the cells thrice with PBS (Appendix 1).  This was followed by incubating 
with 1 x 104 PFU/ml of [35S] - methionine-radiolabelled WNV or Dengue virus for 1 hr at 
37 °C.  After the incubation period, excess or unbound virus were inactivated with 
sodium citrate buffer, pH 2.8 (Appendix 11) and removed by washing thrice with PBS 
(Appendix 1).  The cells were then lysed with 1 % SDS and the specific radioactivity was 
determined. 
 
2.17.4 Generation of Murine Polyclonal Antibodies Against Soluble West Nile Virus 
Envelope DIII Protein  
Soluble WNV E DIII protein was incubated with ImmunEasy mouse adjuvant 
(Qiagen, USA) at a concentration recommended by the manufacturer. The antigen – 
adjuvant mixture was used to immunize BALB/c mice five times subcutaneously at 14 -
day intervals. Mouse sera were collected 12 days after the last booster. Mouse sera were 
purified using Econo-Pac serum IgG purification kits (Bio-Rad, USA) and dialyzed 
overnight with PBS (Appendix 1). The purified immunoglobulins were stored at -20°C.  
Antibody generated against WNV E DIII was used for plaque neutralization assay 
described in Section 2.2.6. 
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2.18 ANALYSES OF VIRUS MATURATION PATHWAY 
2.18.1 Time-Course Study on the Transport Mechanism of Virus Structural 
Proteins 
Vero cells were first grown on glass coverslips (Section 2.1.5) till 80 % 
confluency.  The cell monolayers were infected at a M.O.I. = 10.  After adsorption for an 
hour, 2 ml of MEM (Appendix 2) was added to the cultures and incubated for 4, 6, 8, 10, 
12 hr p.i.  After the incubation, the infected cultures were harvested and titred using 
plaque assay (Section 2.2.5) for both intracellular and extracellular virus yields (Section 
2.2.3).  Another set of the infected cells was also processed for indirect 
immunofluorescence [Section 2.11.1 - with or without Triton X-100 extraction procedure 
(Section 2.10)]. 
 
2.18.2 Time-Course Study on the Effect of Microtubules-Disrupting Drugs on Virus 
Infection. 
Vero cells monolayers were grown on glass coverslips (Section 2.1.5).  The cell 
monolayers were infected at a M.O.I. = 10.  After adsorption for an hour, 2 ml of MEM 
(Appendix 2) supplemented with 10 µg/ml of vinblastine sulphate (Sigma, USA) was 
added to the cultures.  The infected cultures were harvested and titred by method of 
plaque assay (Section 2.2.5) for both intracellular and extracellular virus yields (Section 
2.2.3) at 4, 6, 8, 10 and 12 hr p.i.  The infected cells were processed for indirect 
immunofluorescence (Section 2.11.1).  In addition, viability cell count by trypan blue 
(Appendix 1) exclusion method was also carried out at the various p.i. timings. 
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An alternative procedure was carried out with the removal of microtubule- 
disrupting drug after 4 and 6 hr p.i. The infected cells were washed twice with MEM 
(Appendix 2) and further incubated to 12 hr p.i. with fresh MEM (Appendix 2). The 
infected cultures were harvested and titred by plaque assay (Section 2.2.5) for both 
intracellular and extracellular virus yields (Section 2.2.3).  The infected cells were also 
processed for indirect immunofluorescence (Section 2.11.1). 
 
2.18.3 Microtubule-Disrupting Drug Treatment for Polarized Cells.  
Polarized Vero C1008 cells grown on cell culture inserts (Section 2.1.3.3) were 
infected apically with WNV or KUN virus at an M.O.I. = 10 (Section 2.2.2). At 6 (WNV) 
and 12 (KUN virus) hr p.i., culture media from both apical and basolateral chambers 
were supplemented with 10 µg/ml vinblastine sulphate (Sigma, USA). The supernatants 
from both apical and basolateral chambers were then harvested at 12 hr p.i. for WNV and 
24 hr p.i. for KUN virus. Titres of productive virus were determined by plaque assays 
(Section 2.2.5) and the infected cells on the culture inserts were also fixed and processed 
for immunofluorescence assays (Section 2.11.1). 
 
2.18.4 Time-Course Study on the Effect of Actin-Disrupting Drugs on Virus 
Infection. 
Vero cell monolayers were grown on glass coverslips and infected at an M.O.I. = 
10.  After adsorption for 1 hr, 2 ml of MEM (Appendix 2) supplemented with 10 µg/ml 
of cytochalasin B was added to the cultures. At different time intervals (p.i.), infected 
culture fluids were harvested, and the infectious titers were determined by plaque assays 
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(Section 2.2.5). Cytochalasin B-treated WNV - infected cells were also processed for 
indirect immunofluorescence (Section 2.11.1) and cryo-immunoelectron microscopy 
(Section 2.11.6).  
In a separate experiment, cytochalasin B was removed from the WNV - infected 
cells at 12 hr p.i., and fresh medium was added. Cell culture medium was then collected 
at 1, 2, and 3 hr after the removal of cyotchalasin B for plaque assays (Section 2.2.5). In 
addition, cell viability was determined by Trypan blue exclusion method (Appendix 1). 
Vero cells grown in a 25 cm2 tissue culture flask (Falcon, USA) were washed twice with 
PBS (Appendix 1) and were trypsinized. The number of viable cells was determined by 
the Trypan blue exclusion method. 
 
2.19 ASSESSING VIRUS-INDUCED CYTOPATHOLOGY 
2.19.1 Lactate Dehydrogenase (LDH) Assay  
The release of LDH was detected using CytoTox 96 (Promega, USA) in 
accordance with manufacturer’s procedure (Moravec, 1994). At different time points 
after virus infection at different M.O.I., supernatants were collected and centrifuged to 
obtain cell - free supernatants. For each sample, 50 µl per well was transferred to 96 - 
well plates. The LDH activity was detected by addition of freshly prepared reagents 
(Appendix 13) followed by incubation for 30 min in the dark at room temperature. The 
concentration of LDH was determined using an ELISA plate reader at an absorbance of 
490 nm. The concentration of LDH was expressed as the fold - increase in LDH activity 
from WNV - infected cells with respect to that of mock-infected cells. 
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2.19.2 Fluorometric Assay for Caspase Activity 
Vero cells were infected with WNV at either an M.O.I. = 1 or an M.O.I. = 10. At 
selected time intervals p.i., WNV - infected cells were harvested and processed in 
accordance with manufacturer’s instructions (Clontech, USA) to determine caspase-3, -8 
or -9 activities. In brief, the total number of cells was first adjusted to 2 X 105 cells per 
well of the 96 - well microtitre plate and lysed. The clarified cell lysate was incubated 
with the appropriate reactants for each caspase (Appendix 13). Samples were analysed in 
a fluorescent plate reader with an excitation wavelength of 380 nm and an emission 
wavelength of 460 nm. The activity of each caspase was expressed as the fold - increase 
in WNV-infected cells with respect to that of mock-infected cells. 
 
2.19.3 Chromosomal DNA Fragmentation Assay 
At appropriate time intervals after infection, mock - and WNV - infected cells 
were scraped and sedimented by centrifugation at 800 x g. Ice - cold PBS was used to 
wash the cell pellets before lysis in TNT buffer (Appendix 13) supplemented with a 
commercial protease inhibitor mixture (Roche, USA) at 4 °C for 30 min. The cell lysate 
was centrifuged for 10 min at 10,000 x g and the supernatant containing the fragmented 
DNA was incubated with 50 µg/ml RNase (Roche, Germany) for 2 hr at 37 °C. The 
mixture was extracted using phenol/chloroform (Roche, Germany).  DNA was 
precipitated in 70 % isopropanol (Sigma, USA) and 20 µg/ml glycogen (Roche, 
Germany) for 3 hr at -70 °C. The DNA pellet was dissolved in TE buffer (Appendix 13) 
and the DNA samples were analysed by 2 % agarose gel electrophoresis (Section 2.4.3). 
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The gel was stained with 1 µg/ml ethidium bromide (Sigma, USA) and viewed under UV 
lighting. 
2.19.4 Cytosolic Cytochrome C Assay 
Cytosolic cytochrome C from mock- and WNV-infected cells was prepared as 
described by Carrascosa and group (2002).  In brief, cells were resuspended in lysis 
buffer (Appendix 13) for 30 min at 4 °C. The cell lysate was then centrifuged at 20000 x 
g for 30 min and the supernatant was subjected to SDS - PAGE (Section 2.6) followed by 
Western blotting (Section 2.7) to detect cytosolic cytochrome C. 
 
2.19.5 Terminal Deoxynucleotidyl Transferase - Mediated dUTP Nick-End 
Labelling (TUNEL) Assay 
West Nile virus-infected cells grown on coverslips were processed for TUNEL 
assays at the appropriate times p.i. Cells were washed with PBS once before fixation with 
1 % paraformaldehyde for 10 min at room temperature. Cells were then permeabilized 
with 70 % ethanol at -20 °C. Apoptotic cells were stained using the ApoAlert DNA 
Fragmentation kit (Clontech, USA), according to the manufacturer's instructions. Cells 
were first washed twice with PBS (Appendix 1) and incubated with 50 µl of equilibration 
buffer for 10 min.  The cells were then incubated with 50 µl of TdT buffer provided for 
60 min at 37 °C in the dark.  Processed coverslips were washed thrice with PBS 
(Appendix 1) and mounted before viewing with a laser scanning confocal microscope 
(Leica TCS SP2, USA) at an excitation wavelength of 480 nm for FITC using a 63 x oil 
immersion objective. 
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2.19.6 Poly (ADP-ribose) Polymerase (PARP) Cleavage 
At appropriate time intervals after infection, mock- and WNV-infected cells were 
scraped and sediment by centrifugation at 800 x g for 10 min. Cell pellets were washed 
twice in ice - cold PBS and lysed in TNT buffer (Appendix 13) containing protease 
inhibitors at 4 °C for 30 min. Cell nuclei were removed from the cell lysate with a 
centrifugation step of 800 x g. The remaining supernatant was subjected to SDS-PAGE 
(Section 2.6) and cleavage of PARP into truncated forms was assessed by Western blot 
analysis (Section 2.7) with antibodies against PARP. 
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3.0 THE SEARCH FOR WEST NILE VIRUS CELLULAR RECEPTOR IN 
VERTEBRATE CELLS 
3.1 INTRODUCTION 
The present work started with the search of the unknown receptor molecule for 
WNV in vertebrate cells.  The search for virus receptor is a challenging and tedious task. 
The study began with preliminary studies on the biochemical characterization of putative 
receptors from WNV permissive Vero cells.  The effects of WNV binding to cells 
pretreated with phospholipases, proteases, glycosidases and lectins were analysed. Next, 
the plasma membrane proteins of permissive cells were extracted and purified for Virus 
Overlay Protein Blot Assay (VOPBA).  From VOPBA, a putative receptor for WNV was 
isolated and a series of experiments were carried out to confirm its interaction with 
WNV. 
3.2 BIOCHEMICAL ANALYSES OF WEST NILE VIRUS PUTATIVE 
RECEPTOR MOLECULES ON INTACT CELLS 
To determine the biochemical components (e.g., lipids, proteins, or 
carbohydrates) of WNV putative receptor molecules on the surface of Vero cells, cells 
were pre-treated with a panel of enzymes or chemicals that would destroy the individual 
membrane components (Section 2.16.1). The ability of treated cells to bind and allow 
entry of WNV was assessed by plaque assays of virus production after 12 hr p.i.  Figure 
10 (Appendix 14a) shows the effects of phospholipases, proteases, glycosidases, sodium 
periodate, and lectins treatment on Vero cells and the subsequent ability to allow 
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Figure 10.  
Effect of enzymes, sodium periodate, and lectins treatment on WNV - binding 
molecules present on the surface of intact Vero cells. (a) Cells treated phospholipases do 
not significantly reduce the entry of WNV. In contrast, protease-treated cells exhibit a 
dosage - dependent inhibition on the entry of WNV. (b) Vero cells that were pretreated 
with endoglycosidase H, α-mannosidase, and sodium periodate strongly inhibit WNV 
entry. The binding of concanavalin-A to mannose residues on the surface of Vero cells 
also exhibits a significant inhibition on the entry of WN virus. PLA = phospholipase A2; 
PLC = phospholipase C; PLD = phospholipase D; EH = endoglycosidase H; OG = O-
glycosidase; MA = α-mannosidase; FU = α-fucosidase; HepI = heparinase I; HepIII = 
heparinase III; SP = sodium periodate; WGA = wheat germ agglutinin; PHA = 
phytohemagglutinin; ConA = concanavalin-A. 
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WNV infection. Three independent experiments were carried out for each concentration 
of the enzymes or chemicals used. The enzymes or chemicals were used at a 
concentration known to be effective in reducing the entry of other known viruses 
(Borrow and Oldstone, 1992; Ramos-Castaneda et al., 1997; Salas-Benito and del Angel, 
1997). Results shown in Figure 10 were expressed as log unit inhibition with respect to 
the untreated samples. At the same time, cell viabilities after treatments were also 
assessed by Trypan blue exclusion method. The number of viable cells after treatments 
was not significantly different from the untreated.  
As shown in Figure 10a, treatment of Vero cells with the three phospholipases 
[phospholipase A (PLA), phospholipase C (PLC) & phospholipase D (PLD)] did not 
cause any reduction in the productive yields of WNV. Vero cells were also treated with a 
panel of proteases which included both serine and thiol proteases.  Pretreatment of Vero 
cells with proteases exhibited a dosage - dependent inhibition of WNV entry. Papain, a 
cysteine endopeptidase that solubilized integral membrane protein, showed the highest 
inhibition (over 5-log unit inhibition at 50 mU/ml concentration) on WNV infection. 
Therefore, these results suggested that the cellular receptor molecule responsible for 
WNV entry is of proteineous nature.  
Having shown that the cellular receptor molecule for WNV is a membrane 
protein, the possible involvement of the carbohydrate moieties on the plasma membrane 
for WNV binding and entry was investigated. Vero cells were treated with several 
glycosidases, sodium periodate, and lectins. 
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As shown in Figure 10b, both endoglycosidase H (EH - 100 mU/ml) and α-
mannosidase [(MA) (1000 mg/ml which hydrolyzes N-linked oligossacharides with 
mannose structures and α-mannose residues, respectively)] had a significant inhibition on 
WNV binding and entry into Vero cells. In agreement with this result, pre-treatment of 
cells with sodium periodate (SP) also substantially reduced the binding ability of the cells 
for WNV. Sodium periodate works by oxidizing cell - surface carbohydrate residues but 
without altering protein or lipid epitopes. As for O-glycosidase (OG), α-fucosidase (FU), 
and heparinase I (HepI) and III (HepIII) treatments, these enzymes had minimal effect on 
WNV infection. In this series of glycosidases treatment, protease inhibitor cocktails were 
included to prevent possible contamination by proteases.  
Lectins (highly specific carbohydrate binding molecules) are widely used to 
determine the nature of the carbohydrate involved in ligand – receptor interaction (Liener 
et al., 1986). In this part of the study, Vero cells were incubated with lectins such as 
wheat germ agglutinin [(WGA) (which binds to GlcNacβ1–4 on N-linked glycans)], 
concanavalin A [(ConA) (which binds to α-linked terminal mannose residues on N-linked 
glycans)], and phytohemagglutinin [(PHA) (which binds oligosaccharides)] to assess 
their effects on WNV entry. Again, blocking of the mannose residues on N-linked 
glycans with concanavalin-A on the cell surfaces prevented the entry of WNV into Vero 
cells (Figure 10b).  Therefore, these preliminary results suggested that the WNV cellular 
receptor molecule(s) on Vero cells is a glycoprotein with complex N-linked sugars with 
mannose residues. 
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3.3 ISOLATION AND CHARACTERIZATION OF WEST NILE VIRUS 
PUTATIVE BINDING RECEPTOR MOLECULES ON VERO CELLS 
To determine the specific receptor molecule(s) on the plasma membrane of cells 
that bind to WNV, virus overlay protein binding assay (VOPBA) was used (Section 
2.16.3). This technique has been successfully used to isolate and characterize receptor 
molecules for a number of viruses (Adlish et al., 1990; Taylor and Cooper, 1990; Choi et 
al., 1990; Borrow and Oldstone, 1992; Salas-Benito and del Angel, 1997; Cao et al., 
1998; Bruett et al., 2000; Martinez-Barragan and del Angel, 2001). In this experiment, 
plasma membrane proteins were isolated and the purity was checked under the 
transmitted light microscope (Figure 11). The purity of the plasma membrane extract was 
considered acceptable with reference to Atkinson and Summers (1971). Equal quantities 
of the membrane proteins were loaded into different lanes and separated by SDS – PAGE 
and transferred onto nitrocellulose membrane. The nitrocellulose membranes were 
incubated sequentially with purified WNV, rabbit polyclonal mono-specific antibody 
against the virus envelope protein, and detection by secondary anti-rabbit antibody - 
conjugated with alkaline phosphatase. 
Using VOPBA, WNV was observed to bind to a 105-kDa band in the membrane 
preparations of Vero cells (Figure 12, Lane 1). No bands were observed when 
supernatants of uninfected cells (prepared as according to the supernatants of WNV -
infected cells) were incubated under the same conditions (Figure 12, Lane 2). 
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Quality of plasma membrane proteins extracted from Vero cells. Intact (a) Vero 
cells were detached from cell surface by cell scraper.  The nuclei of the cells are indicated 
by arrows.  Plasma membranes of (b) Vero cells obtained after extraction and purification 
procedure as described in Section 2.16.2. The extracted plasma membranes are devoid of 
nuclei. The quality of the purified plasma membrane protein obtained is acceptable based 
on receptor isolation procedure. 
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Figure 12.  
WNV binds to a 105-kDa membrane protein from Vero cells using VOPBA.  
Plasma membrane proteins from Vero cell (Lanes 1 and 2) were extracted before 
purification under non-denaturing conditions. The proteins were then separated by SDS –
PAGE. After separation, the proteins were transferred onto nitrocellulose membrane and 
(i) purified WNV, (ii) anti-WNV envelope serum were added successively. Detection of 
virus binding was by secondary antibody - conjugated with alkaline phosphatase.  WNV 
binds to a 105-kDa membrane protein from Vero cells (Lane 1) and no band is observed 
from proteins purified from the supernatants of uninfected cells [(background control) 
(Lane 2)]. Molecular size markers are indicated on the left. 
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To affirm the observations based on enzymes and chemical treatments of intact 
Vero cells, VOPBAs were also performed on plasma membrane protein extracts that 
were treated with protease (papain), glycosidases (endoglycosidase H, α-mannosidase, 
and O-glycosidase), sodium periodate, and lectins.  In Figure 13, WNV binding to the 
membrane proteins of Vero cells after papain treatment at a concentration of 50 mU/ml 
was abolished (Lane 2) as compared to that of the untreated (Lane 1).  
In addition, the kinetics of WNV - binding molecules recycled to the cell surface 
after removal with papain was also examined (Section 2.16.5). In this part of the study, 
Vero cells were first treated with papain (50 mU/ml) for 45 min at room temperature and 
after protease (papain) removal for 0, 2, and 4 hr, virus binding was determined by 
VOPBA. No virus binding was observed at 0 hr following the removal of the protease 
[Figure 14, Lane 2 (without cycloheximide) and Lane 5 (with cycloheximide)] when 
compared to the membrane protein that is not treated with papain (Lane 1). WNV binding 
to the 105-kDa protein was observed after 2 hr with the removal of the protease and it 
reached its original level within 4 hr (Figure 14, Lane 3 and Lane 4, respectively). 
Despite the blockage of new protein synthesis by cycloheximide, virus binding 
was also observed at 2 and 4 hr after removal of papain (Figure 14, Lane 6 and Lane 7, 
respectively). Therefore, these could indicate the presence of abundant pre-existing 
internal pools of the 105-kDa proteins that were rapidly trafficked to the cell surface after 
its removal without the need for new protein synthesis to occur.
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Figure 13.  
VOPBA of Vero plasma membrane proteins treated with 50 mU/ml of papain.  
WNV binding is abolished (Lane 2), while virus binding to the untreated samples are not 
affected (Lane 1). Molecular size markers are indicated on the left. 
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Figure 14. 
Kinetics of the 105-kDa membrane protein recycling to the cell surface after 
removal with papain (protease) and cycloheximide treatments. Vero cells were first 
treated with 50 mU/ml of papain for 45 min at 25 °C (Lanes 2 to 7) or without treatment 
(Lane 1) and then fresh M199 medium with 10 % FCS was added.  At 0, 2, and 4 hr after 
the removal of the protease (Lane 2, Lane 3 and Lane 4, respectively, without 
cycloheximide), the plasma membrane proteins were extracted and process for VOPBA. 
The other set was carried out under the same conditions (Lane 5, Lane 6 and Lane 7, 
respectively) except that the cells were treated with 100 µg/ml of cycloheximide for 2 hr 
prior to and throughout the experiment. Despite the blocking of new protein synthesis by 
cycloheximide, virus binding is observed after 2 hr with the removal of papain (Lane 6) 
similar to the cells that are not treated with cycloheximide (Lane 3). Molecular size 
markers are indicated on the left. 
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As for the glycosidase treatments (Section 2.16.4) of membrane proteins (Figure 
15a), no binding of WNV was observed after treatment with α-mannosidase and 
endoglycosidase H in Vero cell (Lane 2 and Lane 3, respectively) plasma membrane 
protein extracts when compared with the untreated membrane proteins (Vero cells, Lane 
1). In contrast, O-glycosidase treatment of the membrane proteins (Vero cells, Lane 4) 
did not affect the binding of WNV to 105-kDa protein band.  It could be deduced that 
virus binding to the 105-kDa protein is neither mediated by O-linked sugars nor contain 
O-linked glycoslation.  The nature of carbohydrates present in the 105-kDa proteins 
necessary for WNV binding was further assessed after lectin treatments using VOPBA. 
In Figure 15b, concanavalin-A was observed to block the binding of WNV to the 105-
kDa membrane proteins in a dosage - dependent manner [Lane 1 (untreated), Lane 2 (10 
µg/ml), and Lane 3 (100 µg/ml)], whereas phytohemagglutinin had no effect in blocking 
virus binding to the membrane proteins [equal intensities: Lane 4 (untreated), Lane 5 (10 
µg/ml), and Lane 6 (100 µg/ml)].  
Similarly, binding of WNV to the sodium periodate - treated membrane proteins 
was reduced in a dosage - dependent manner (Figure 15c, Lane 1, untreated, Lane 2, 0.1 
mM, Lane 3, 1 mM, and Lane 4, 10 mM). These results have provided more evidence 
that the 105-kDa membrane protein contained carbohydrate groups with high - mannose 
residues that are important for virus binding.  The plasma membrane extracts were also 
treated with 5 mM of β-mercaptoethanol (Section 2.16.4), a reducing agent that is useful 
in determining whether the 105-kDa protein contains disulfide - linked subunits.
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Figure 15.  
Characterization of the carbohydrate entities involved in binding WNV using 
VOPBA. (a) Plasma membrane proteins extracted from Vero cells (Lanes 1 to 4) were 
either left untreated (Lane 1) or subjected to α-mannosidase (Lane 2), endoglycosidase H 
(Lane 3), and O-glycosidase treatment (Lane 4). No virus binding is observed after α-
mannosidase and endoglycosidase H treatments. However, O-glycosidase treatment does 
not seem to have an effect on virus binding when compared to the untreated sample. 
Molecular size marker is indicated on the right. (b) Plasma membrane proteins obtained 
from Vero cells were first pretreated with lectins, concanavalin-A [Lane 1 (untreated), 
Lane 2 (10 µg/ml), and Lane 3 (100 µg/ml)] and phytohemagglutinin binding [Lane 4 
(untreated), Lane 5 (10 µg/ml), and Lane 6 (100 µg/ml)] and virus binding was assessed. 
The WNV binding is significantly reduced in a dose - dependent manner for 
concanavalin-A, but not for phytohemagglutinin (equal intensities). Molecular size 
marker is indicated on the right. (c) Plasma membrane proteins obtained from Vero cells 
were either left untreated (Lane 1) or treated with 0.1 mM (Lane 2), 1 mM (Lane 3), and 
10 mM (Lane 4) of sodium periodate. A dosage - dependent inhibition of WNV binding 
to the treated membrane proteins is noted. Molecular size markers are indicated on the 
left. 
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Interestingly, a faint 105-kDa band and a series of protein bands ranging from 30 to 40-
kDa were observed after treatment with β-mercaptoethanol followed by VOPBA [Figure 
16, Lane 2 (Vero cells)]. Lane 1 was untreated samples from Vero cells. These results 
indicated that treatment with β-mercaptoethanol did not disrupt virus binding and virus 
binding occurs mainly through the interaction with the carbohydrate moieties instead of 
the peptide portion of the glycoprotein.  
 
3.4 LOCALIZATION STUDY OF THE 105-KDA MEMBRANE PROTEIN ON 
CELLS 
The murine polyclonal antibody generated against the 105-kDa protein (Section 
2.16.6) was shown to be specific for the 105-kDa protein (from Vero cells) by Western 
blot assay (Figure 17, Lane 2).  No bands were observed after incubation with pre-
immune serum (Figure 17, Lane 1). To determine the localization of the 105-kDa 
proteins on Vero cells, immunofluorescence assay and cryo-immunolabeling electron 
microscopy were carried out. Figure 18a shows that the 105-kDa proteins were localized 
on the plasma membrane of the cells by confocal microscopy. This is a typical 
localization pattern for cell-surface molecules. Despite methanol fixation and 
permeabilization, the murine polyclonal antibody against the 105-kDa protein still binds 
specifically to the plasma membrane (arrows). Localization of the 105-kDa protein was 
further confirmed by immunogold labelling of cryo-sections. At the ultrastructural level, 
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Figure 16.  
Effect of β-mercaptoethanol treatment on the 105-kDa membrane protein. 
Membrane proteins from Vero cells (Lane 2) were treated with 5 mM of β-
mercaptoethanol. For the untreated control, a 105-kDa band was observed (Lane 1, Vero 
cells). Through VOPBA, a faint distinct band of molecular weight 105-kDa and a series 
of protein bands ranging from 30- to 40-kDa (Lane 2) are observed in Vero cells. WNV 
binding is observed to be the strongest on a 30-kDa protein band.  Molecular size markers 
are indicated on the left. 
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   Detection of the 105-kDa membrane protein from plasma membrane extracts of 
Vero cells. Incubation of separated membrane proteins with the pre-immune serum (Lane 
1) and the anti-105-kDa protein polyclonal antibody at a dilution of 1:500 (Lane 2) was 
performed. Goat anti-mouse IgG - conjugated with alkaline phosphatase was used at a 
dilution of 1:2000. The anti-105-kDa protein murine polyclonal antibody generated is 
highly specific for 105-kDa membrane protein from Vero cells (Lane 2). Molecular size 
markers are indicated on the left. 
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Figure 18.  
Localization study of the 105-kDa membrane protein. (a) Vero cells grown on 
coverslip were fixed and permeabilized with absolute methanol before being processed 
for immunofluorescence and confocal microscopy. The 105-kDa proteins are distributed 
along the plasma membrane (arrows) as shown by the red staining. Intracellular pool of 
the 105-kDa protein is also observed within the cytoplasm.  (b) Immunogold - labelling 
of the 105-kDa proteins on cryo-sections reveals the binding of WNV (arrowhead) to the 
105-kDa membrane protein (arrows) at the site of virus attachment. The bar represents 50 
nm. 
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WNV (arrowhead) was observed to bind to the 105-kDa membrane proteins (as defined 
by the 10 nm gold particles, arrows) at the plasma membrane (Figure 18b).  
To determine whether the 105-kDa membrane protein is differentially expressed 
in polarized cells, immunofluorescence assay coupled with optical sectioning using laser 
scanning confocal microscopy was carried out with Vero C1008 cells (Section 2.11.1.2). 
Vero C1008 cell is a polarized cell line derived from Vero cells. These epithelial cells 
have distinct apical and basolateral domains of the plasma membrane. A distinct set of 
plasma membrane proteins were expressed on either the apical or basolateral surfaces of 
polarized cells.  These proteins were sorted to these distinct cell surfaces by either 
specific targeting signals or cytoskeleton-mediated targeting. Figure 19a shows a cross - 
section of the polarized Vero C1008 cell taken as a Z dimension using laser scanning 
confocal microscope (Leica, TCS SP2, USA),  revealed the apical localization of the 105-
kDa membrane proteins (stained with Texas red, arrows).  In addition, optical sectioning 
using the laser scanning confocal microscope also showed a preferential distribution of 
the 105-kDa membrane proteins at the apical surface of the polarized Vero C1008 cells 
and not on the basolateral surface (Figure 19b).  
 
3.5 WEST NILE VIRUS ENTRY INTO POLARIZED VERO C1008 CELLS 
OCCURS PREFERENTIALLY AT THE APICAL SURFACE 
Previous studies have shown that several viruses exhibited polarized entry into 
Vero C1008 cells. Simian virus 40 (Clayson & Compans, 1988), measles virus (Blau & 
Compans, 1995) and Black Creek Canal virus (Ravkov et al., 1997) entered Vero C1008  
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Figure 19. 
Apical localization of the 105-kDa membrane proteins on polarized Vero C1008 
epithelial cells.  (a) Cross - section of the Vero C1008 cells where the 105-kDa 
membrane proteins (arrows) are observed at the apical surface of the cells.  (b) Optical 
slicing of the fluorescent - labelled Vero C1008 cell reveals apical expression of the 105-
kDa membrane protein.  Images are taken from the apical surface (top slice) of the cell to 
the basolateral surface (bottom slice). 
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cells at the apical surface whereas entry of vesicular stomatitis virus was restricted to the 
basolateral surface of the cell's plasma membrane (Bergmann & Fusco, 1988). The entry 
of poliovirus occurred bidirectionally (Tucker et al., 1993).  
Polarized entry of these viruses into Vero C1008 cells has indicated that there 
could be differential expression of the virus cellular receptors at different domains (apical 
or basolateral) of the polarized cells. Since, the WNV putative cellular receptor (105-kDa 
glycoprotein) is localized predominantly at the apical surface of polarized Vero C1008 
cells, an attempt was carried out to determine whether WNV exhibits polarized entry into 
polarized cells. The WNV (M.O.I. of 10) were used to infect either the apical or the 
basolateral domains of confluent Vero C1008 cells grown on 0.4 µm porous cell culture 
inserts (Section 2.2.2).  Total extracellular WNV production at different times p.i. was 
determined by plaque assay (Section 2.2.5).  Higher yield of WNV was observed when 
the viruses were inoculated at the apical surface of Vero C1008 cells compared to 
inoculation of the viruses at the basolateral surface (Figure 20, Appendix 14b).  
The levels of WNV virus antigens and virus production after inoculation from 
either the apical or the basolateral surface of Vero C1008 cell monolayers were also 
assessed by immunofluorescence detection. Anti-WNV E protein serum was used as 
markers to detect the presence of expressed virus proteins and virus particles. By using 
immunofluorescence staining, it was noted that Vero C1008 cells were more susceptible 
to WNV infection when the virus was inoculated at the apical surface. From three 
independent experiments it was observed that higher proportions of Vero C1008 cells 
were infected when the WNV was inoculated at the apical surface (Figures 21a - c). In 
contrast, a much lower number of cells were infected following basolateral inoculation  
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Polarize entry of WNV into Vero C1008 cells.  At 12 hr p.i., supernatants of cells 
that were infected at the apical or basolateral were harvested for plaque assays.  Higher 
extracellular virus yields are observed upon apical inoculation of WNV than basolateral 
inoculation. 
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Figure 21.  
Indirect immunofluorescence detection of WNV antigen in virus - infected Vero 
C1008 cells.  Nuclei are stained with (b & e) 0.1 µg/ml propidium iodide and the virus E 
protein (a & d) is detected with anti-WNV E protein-specific serum and FITC - 
conjugated secondary antibody. WNV was inoculated (M.O.I. of 10) to either the (a - c) 
apical or the (d - f) basolateral chambers. High levels of virus antigen expression are 
observed when the viruses are inoculated to the apical surface of Vero C1008 cells. (c & 
f) Superimposed images of Figures (a & b) and (d & e), respectively. 
   125  
                                                                         CHAPTER 3 
                                                                                        RESULTS 
 
(Figures 21d - f). Hence, these results have provided strong evidence that entry WNV 
was restricted to the apical surface of polarized Vero C1008 cells.  This part of the 
experiment provided the confirmation that the putative receptor molecule for WNV was 
highly expressed at the apical domain of polarized epithelial cells.  
 
3.6 ANTI-105-KDA MEMBRANE PROTEINS POLYCLONAL ANTIBODY 
BLOCKED WEST NILE VIRUS ENTRY INTO VERO CELLS 
The final set of experiments was carried out to determine if the antibody against 
the 105-kDa protein (Section 2.16.7) recognized the same receptor molecule for WNV 
entry. Blockage of WNV cellular receptors with specific antibodies against the receptor 
would prevent virus entry. The anti-105-kDa protein serum (1:10 to 1:1000 dilutions) 
were first incubated with Vero cells before virus infection [WNV, KUN virus (a subtype 
of WNV) and poliovirus (non-related virus)].  Table 7 shows that the entry of WNV and 
KUN viruses was strongly inhibited up to the dilution of 1:100. The pre-immune serum 
from mouse obtained before inoculation of 105-kDa membrane protein, did not cause any 
inhibition. In contrast, the entry of poliovirus was not affected in the presence of the anti-
105-kDa protein serum.  The pre-incubation of the murine polyclonal anti-105-kDa 
antibody (1:10 dilution) on the separated membrane proteins through VOPBA also 
prevented the binding of WNV to the 105-kDa membrane protein (Figure 22, Lane 1). 
Virus binding occurred in the absence of the anti-105-kDa antibody (Figure 22, Lane 2).  
Hence, these results have provided strong evidence that the 105-kDa membrane protein is 
a possible cellular receptor for WNV and other closely related flaviviruses. 
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Table 7:  Inhibition of virus entry using anti-105-kDa protein polyclonal antibody. 
Log unit inhibition of infectivity by pre-immune sera at the 
following dilutions: Viruses 
1:10 1:100 1:1000 
WNV 0.25 ± 0.56 0.15 ± 0.85 0.20 ± 0.50 
Kunjin 0.35 ± 0.22 0.28 ± 0.60 0.32 ± 0.68 
Polio 0.95 ± 0.25 0.89 ± 0.87 0.88 ± 0.75 
Log unit inhibition of infectivity by anti-105-kDa membrane 
protein at the following dilutions: Viruses 
1:10 1:100 1:1000 
WNV 6.5 ± 0.80 4.5 ± 0.45 0.60 ± 0.50 
Kunjin 4.0 ± 0.35 2.8 ± 0.60 0.35 ± 0.20 
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Figure 22.  
VOPBA of Vero plasma membrane protein pre-incubated with anti-105-kDa 
murine antibody. WNV binding to the 105-kDa membrane protein was abolished (Lane 
1), while in the absence of the anti-105-kDa antibody, WNV binds to the 105-kDa 
membrane protein (Lane 2). 
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4.0 αVβ3 INTEGRIN, THE GATE MASTER OF WEST NILE VIRUS ENTRY 
INTO VERTEBRATE CELLS 
4.1 INTRODUCTION 
In the previous chapter (Chapter 3), a 105-kDa glycoprotein from the plasma 
membrane of Vero cells was identified as the putative receptor molecule for WNV 
infection.  This chapter further pursues to verify the identity of the 105-kDa glycoprotein 
by peptide sequencing.  Detail functional analyses of the receptor involving in WNV 
entry was confirmed with a combination of virus entry blocking studies (with functional 
blocking antibodies, ligands, and soluble proteins) and gene silencing technology.  
Receptor expressional studies were also carried out to mediate virus entry into less-
permissive cells.  The downstream activation of signals after the engagement of WNV 
with receptor was also investigated.  The receptor binding domain of WNV envelope 
protein was determined too. 
4.2 PEPTIDE SEQUENCING OF THE 105-KDA PLASMA MEMBRANE 
ASSOCIATED GLYCOPROTEIN 
Trypsin digestion and mass spectrometry was first carried out to determine the 
identity of the 105-kDa plasma membrane - associated glycoprotein from Vero cells.  The 
peptide sequencing data suggested a list of putative proteins 
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shown in Table 8.  Polyclonal antibodies against these proteins were used as a 
preliminary screen for the blocking of WNV entry into Vero cells.  Figure 23 (Appendix 
15a) showed that polyclonal antibody against β3 integrin subunits significantly blocked 
the entry of [35S] – methionine - radiolabelled virus.  Antibodies against the rest of the 
proteins have minimal effect on WNV entry into Vero cells. 
 
4.3 FUNCTIONAL BLOCKING ANTIBODIES AGAINST αVβ3 INTEGRIN 
INHIBIT WEST NILE VIRUS BINDING AND PENETRATION INTO 
CELLS. 
Given this finding, attempts were made to further determine the specific integrin 
molecule or its subunits that mediate binding and entry of WNV. Vero cells were pre-
incubated with a panel of functional blocking antibodies (a range of concentration 0.25 – 
25 µg/ml) against the integrins subunits (α1, α2, α3, α4, α5, α6, αV, β1, β2, β3, β4, β5 – 
Chemicon, USA), and WNV binding and penetration into Vero cells were assessed.   
Radioactive [35S] – methionine - labelled WNV (M.O.I.) = 10 were added to anti-
integrin antibodies pretreated cells and further incubated for 1 hr at 4 °C (to assay for 
virus binding to cells, Section 2.17) or 1 hr at 37 °C (to assay for virus penetration into 
cells, Section 2.17).  Excess and unbound virus particles were inactivated and cells were 
washed before radioactivity determination assay.  Obvious dose - dependent inhibition of 
WNV binding and entry was observed for Vero cells pre-treated with functional 
antibodies against β3 and αV integrin subunits. (Figure 24, Appendix 15b).  
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Table 8: Peptide sequencing of the 105-kDa membrane protein. 
A number of putative proteins were revealed with matching identities using the 
MS-Fit search program.  
Protein Identity Species MW (kDa) NCBI Accession No. 
Vascular Adhesion 
Protein-1 Homo Sapiens 84.62 4502119 
MPTPdelta Homo Sapiens 145.42 452199 
Spectrin beta chain Homo Sapiens 288.98 17368942 
Protocadherin Homo Sapiens 90.33 18105061 
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Virus entry blockage by using antibodies against putative receptor molecules. The 
percentage of inhibitory of WNV entry is plotted against concentrations of antibodies 
used. Vero cells treated with polyclonal antibody against β3 integrin subunit showed the 
highest inhibition of WNV infection while the rest of the polyclonal antibodies against 
vascular adhesion protein-1 (VAP), MPTPdelta (MPTP), spectrin β1 and protocadherin 
(PC) have minimal effect on WNV infection. 
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Figure 24. 
Antibodies to αVβ3 integrin and its subunits inhibit WNV binding and 
penetration.  Functional blocking antibody against β3 integrin subunits drastically inhibit 
WNV binding to (a) cell surface as well as (b) virus penetration. Similarly, anti-αV 
integrin antibody effectively inhibits WNV binding (c) and virus penentration (d) into 
Vero cells.  The remaining antibodies against integrins and their subunits did not affect 
both binding and penetration of WNV (a to d). INTA1 = α1 integrin, INTA2 = α2 
integrin, INTA3 = α3 integrin, INTA4 = α4 integrin, INTA5 = α5 integrin, INTA6 = α6 
integrin, INTAV = αV integrin, INTB1 = β1 integrin, INTB2 = β2 integrin, INTB3 = β3 
integrin, INTB4 = β4 integrin, INTB5 = β5 integrin. 
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Functional blocking antibody against β3 integrin exhibited the most significant 
inhibition of WNV binding (>60 %) and penetration (>75 %) into cells (Figure 24a and b, 
respectively).  As shown in Figure 24c and d, the antibody against αV integrin subunit 
reduced WNV binding by 50 % and penetration was inhibited by more than 60 % 
respectively.  Therefore, the data suggested the involvement of both αV and β3 integrin 
subunits in both binding and penetration of the virus.  Similar isotype - specific 
antibodies against integrin subunits (α1, α2, α3, α4, α5, α6, β1, β2, β4, β5) did not show 
any marked inhibition (<10 %) of WNV binding and penetration (Figure 24). This 
confirms the involvement of αV and β3 integrin subunits in WNV entry into cells.   
To further define if αVβ3 integrin in their heterodimeric entity is responsible for 
WNV entry into cells, blockage studies on VOPBA was performed with antibodies 
[(against αVβ3 integrin and αVβ5 integrin) (Section 2.17)]. As shown in Figure 25a, 
incubation of anti-αVβ3 integrin antibody (25µg/ml) totally blocked the binding of WNV 
to the 105-kDa plasma membrane glycoprotein (Lane 1) and to a much lesser extends for 
anti-αVβ5 integrin antibody (Lane 3).  Lane 2 represents WNV binding to the 
glycoprotein in the absence of antibody treatment.  
In addition, cells pre-incubated with anti-αVβ3 integrin antibody showed a drastic 
reduction (>70 % at 25 µg/ml) in WNV entry into cells whereas anti-αVβ5 integrin 
antibody pre-treated cells showed partial inhibition (28 % at 25 µg/ml) of WNV entry 
[(Figure 25b) (Appendix 15c)].  We have also repeated this set of experiment with 
closely related flaviviruses, the Japanese encephalitis virus (JEV) and dengue virus 
[(DEN2V) (Figure 25b, Appendix 15c)].  The inhibition pattern for JEV was similar to 
WNV.  
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Figure 25.  
Antibody to αVβ3 integrin and its subunits inhibit WNV binding and penetration. 
(a) VOPBA was performed and binding of WNV to the 105-kDa membrane protein band 
is detected (Lane 2).  Antibody to αVβ3 integrin (Lane 1) block the binding of WNV to 
the 105-kDa membrane protein band and antibody to αVβ5 integrin is not as effective in 
blocking virus binding (Lane 3).  (b) WNV and JEV entries are significantly inhibited by 
functional blocking antibody against αVβ3 integrin but not DV. No cytotoxicity was 
detected for the concentrations spectra of antibodies used. INTAVB3 = αVβ3 integrin 
and INTAVB5 = αVβ5 integrin. 
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Interestingly, the entry of DV into Vero cells was not significantly blocked (about 20 %) 
by anti-αVβ3 integrin antibody (Figure 25b).   
 
4.4 EFFECTS OF INTEGRIN LIGANDS ON WEST NILE VIRUS ENTRY 
INTO CELLS 
At the same time, assays were performed to investigate the effect of physiological 
integrin ligands (fibronectin, vitronectin, heparin, chrondriotin sulphate, laminin, 
collagen type 1) and glycoprotein (bovine serum albumin – BSA) on WNV entry into 
Vero cell (Section 2.17).  Results showed that the binding of fibronectin and vitronectin 
(both are known to interact with αVβ3 integrin by RGD - dependent motif) to the cell 
surface has resulted in partial inhibition of WNV entry by 38 % and 33 % at 100 µg/ml, 
respectively (Figure 26, Appendix 15d). The rest of the ligands (heparin, chrondriotin 
sulphate and laminin) and glycoprotein (BSA) when incubated with Vero cells before 
virus inoculation had minimal effect in preventing WNV entry into cells (Figure 26).   
Since the E protein of mosquito - borne flaviviruses (except DV) contain a RGD 
or RGE motif in the proposed receptor binding domain III (van der Most et al., 1999), 
evaluation was performed to observe whether these motifs are responsible for binding to 
αVβ3 integrin. Vero cells were incubated with synthetic RGD peptides (Gly-Arg-Gly-
Asp-Ser or Gly-Arg-Gly-Glu-Ser) before the inoculation of WNV.  The RGD peptides 
were not highly capable of blocking the entry of WNV into Vero cells (less than 30 %) 
when high but non-cytotoxic concentrations were used (Figure 26). The partial inhibition 
of virus entry by fibronectin, vitronectin and RGD peptides could probably due to steric 
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Figure 26.  
RGD - independent WNV interactions with host cells.  Entry of WNV is not 
drastically blocked by the binding of physiological ligands to integrins on cell surface. 
Blue shaded and red shaded bars represents 50µg/ml and 100µg/ml of ligands used, 
respectively.  FN = fibronectin, VN = vitronectin, LM = laminin, CS = chondroitin 
sulfate, HP = heparin, CL = collagen type 1, BSA = bovine serum albumin, RGE = Gly-
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hindrance rather than blocking of the RGD binding region on αVβ3 integrin. Therefore, 
these results suggested that the virus binding region on the αVβ3 integrin occurs through 
an alternative region independent of RGD-binding site. The binding of physiological 
ligands to integrin often required the presence of divalent cations.  The requirement of 
diavalent cations for WNV binding to αVβ3 integrin was also investigated by pre-treating 
cells with EDTA (divalent cations chelators) before virus infection.  Vero cells treated 
with EDTA (concentration - 3 to 12 mM) did not block the binding and subsequent entry 
of WNV and JEV (Figure 27, Appendix 15e). 
 
4.5 GENE SILENCING OF HUMAN β3 INTEGRIN SUBUNITS INHIBITS 
WEST NILE VIRUS ENTRY 
Next, we investigated the ability of cells with down-regulated expression of 
human β3 integrin to mediate WNV infection was investigated.  Gene knockout by the 
means of small interfering RNA (siRNA) technology was carried out to down-regulate 
the expression of human β3 integrin (Section 2.17.2).  Selected human gene sequences 
from β3 integrin were cloned into vector-based siRNA expression system - pSilencer 3.0-
H1 (Ambion, USA) and sequenced (Figure 28).  Since, the siRNA is designed to target 
only sequence of human β3 integrin, the recombinant plasmids were transfected into Hela 
cells instead of Vero cells for this part of the study.  
Transfected cells were screened for the down - regulation of cell surface and 
endogenous β3 integrin expression. Figures 29a and c show the down - regulated 
expression of β3 integrin in Hela cells while Figures 29b and d show the 
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The effects of EDTA on WNV and JEV binding to Vero cells.  The removal of 
divalent cations from the cell culture environment did not affect the binding of WNV and 
JEV to the cell surface of Vero cells. 
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Sequencing result of pSilencer-INTB3 showing the presence of human β3 integrin 
siRNA sequence (in red and underlined) inserted in the correct framework with the 
vector, pSilencer 3.0-H1 (in black).   
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Figure 29. 
Gene silencing of human β3 integrin reduced WNV entry. Hela cells were 
incubated with anti-β3 integrin antibody (transparent profiles) or mouse IgG2a control 
antibody (solid profiles), followed by staining with FITC - labelled anti-mouse IgG. 
Down-regulated expression of β3 integrin in Hela cells transiently - transfected with 
pSilencer-INTB3 was observed (a) when compared with the cells transfected with 
pSilencer (empty vector).  (b) using flow cytometry analysis. Similarly, (c) down-
regulated expression of human β3 integrin in Hela cells can also be observed by 
immunofluorescence assay as compared to (d) cells with pSilencer (empty vector).  (e) 
Drastic reduction of WNV entry into Hela cells expressing siRNA against β3 integrin can 
be observed.  In contrast, entry of WNV into Hela cells expressing siRNA against 
GADPH or transfected with pSilencer (empty vector, negative control) is not affected.   
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expression of β3 integrin in Hela cells transfected with pSilencer (empty vector only).  
Hela cells with more than 80 % of down-regulated expression of β3 integrin expression 
were selected by FACS for WNV entry assay.  The abolishment of β3 integrin expression 
exhibited significant reduction of more than 50 % of virus entry when compared with 
Hela cells transfected with pSilencer [(empty vector) (Figure 29e, Appendix 15f)].  
Furthermore, there was no abolishment of virus entry for cells with down - regulated 
expression of GADPH, used as an internal control. 
 
4.6 SOLUBLE INTEGRIN αVβ3 INHIBITS WEST NILE VIRUS ENTRY 
To further confirm the specificity of αVβ3 integrin in mediating the entry of 
WNV into cells, soluble αVβ3 and αVβ5 integrin were incubated with WNV before 
overlaying this complex onto Vero cell monolayer (Section 2.17.1).  Soluble αVβ3 
integrin can effectively blocked WNV infection in a dose - dependent manner (at 10 
µg/ml, there was more than 80 % inhibition of virus infectivity) while soluble αVβ5 
integrin showed minimal blockage of WNV infection (at 10 µg/ml, there was only less 
than 28 % inhibition of virus infectivity) as shown in Figure 30, Appendix 15g. 
 
4.7 EXPRESSION OF INTEGRIN αVβ3 INCREASES THE SUSCEPTIBILITY 
OF MELANOMA CELL (CS-1) TO WEST NILE VIRUS INFECTION 
To affirm that αVβ3 integrin is the functional receptor for WNV, virus was 
inoculated onto melanoma cells, CS-1 (do not synthesize endogenous β3 integrin subunit) 
and CS-1β3 (capable of expressing recombinant β3 integrin and 
  142 
                                                                                       CHAPTER 4 















































Specific interactions between soluble αVβ3 integrin and WNV prevent virus 
infection. Dose-dependent inhibition of WNV infectivity by soluble αVβ3 integrin 
(INTAVB3). Soluble αVβ5 integrin (INTAVB5) has minimal effect in blocking the 
infectivity of WNV. 
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formed functional αVβ3 integrin on cell surface (Filardo et al., 1996) and quantitated for 
WNV entry (Section 2.17). The levels of αVβ3 integrin cell surface expression in CS-1 
(Figure 31a) and CS-1β3 (Figure 31b) cells were confirmed using the FACS (Section 
2.13).  Entry of WNV into CS-1 cells was approximately 2000-fold lower than that of 
CS-1β3 cells (Figure 31c, Appendix 15h).  Furthermore, only a low virus titre of 5x102 
PFU/ml was obtained at 4 days p.i. for CS-1 infected cells with minimal cytopathic 
effects (Figure31d). For the CS-1β3 cells, advance cytopathic effect (CPE) was observed 
within 22 hr p.i. (Figure 31d) and a virus yield of 8 x 107 PFU/ml of virus was obtained.  
Therefore, the expression of αVβ3 integrin has significantly promoted the susceptibility 
of CS-1 cells to WNV infection.   
 
4.8 αVβ3 INTEGRIN EXPRESSION AND SUSCEPTIBILITY OF CELLS TO 
WEST NILE VIRUS INFECTION 
A correlation analysis of the relative abundance of αVβ3 integrin expression on 
the surface of various target cells and its susceptibility to WNV infection was assessed. 
Various cells were first incubated with monoclonal antibody against αVβ3 integrin, 
followed by incubation with FITC anti-mouse antibody and examined by FACS (Section 
2.13).  The percentage of fluorescent cells with fluorescence intensity higher than that of 
the negative control was noted.  Different target cells (5 x 106 cells) were also infected 
with WNV at a M.O.I. of 10 and the productive virus yields were determined by plaque 
assays (Section 2.2.5).  High level expression of αVβ3 integrin in Vero, BHK, chick 
embryo fibroblastic cells (CEF), HepG2 and N2a were noted and these cells were more 
  144 
                                                                                       CHAPTER 4 
                                                                                 RESULTS 
 
Figure 31.  
Expression of αVβ3 integrin in CS-1 cells increased its permissiveness for WNV. 
Expression of αVβ3 integrin on cell surface of (a) CS-1 and (b) CS-1β3 cells were 
detected with anti-αVβ3 integrin antibody (transparent profiles) or mouse IgG1 control 
antibody (solid profiles), followed by staining with FITC - labelled anti-mouse IgG.  
FACS was used to detect integrin expression.  Cell surface expression of αVβ3 integrin is 
observed in CS-1β3 cells but not CS-1 cells.  (c)  Entry of WNV is significantly enhanced 
in CS-1β3 cells (compared to CS-1 cells) for the expression of αVβ3 integrin on the cell 
surface. (d) Obvious cytopathic effects are observed in WNV - infected CS-1β3 cells 
within 22 hr p.i. but not in virus-infected CS-1 cells. 
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Table 9:  Correlation of integrin αVβ3 expression and WNV entry into different target 
cell lines. 
 
% distribution of integrin αVβ3 on target cells and  
WNV productive yields (PFU/ml) Integrin 
Vero BHK Cef HepG2 N2a U937 
% of αVβ3 95 92 98 71 84 11 
PFU/ml 5 x109 3 x 109 4 x 109 2 x 107 2 x 109 7 x 102
susceptible to WNV as compared to U937 [(a monocytic cell line that do not expressed 
cell surface αVβ3 integrin) (Table 9)].  Indeed, the expression of αVβ3 integrin in many 
different target cells supported WNV infection.   
 
4.9 ACTIVATION OF INTEGRIN - ASSOCIATED SIGNALLING PATHWAY 
BY WEST NILE VIRUS 
The interaction of ligands, integrins, numerous of signaling molecules including 
focal adhesion kinse (FAK), C-Src, p130cas and cytoskeletal proteins (talin, paxillin, 
vinculin and α-actinin) assemble into aggregate patches on the plasma membrane.  These 
patches are called focal adhesion (Giancotti and Ruoslahti, 1999).  Focal adhesion kinase 
is a non - receptor protein - tyrosine kinase that localizes with vinculin at the focal 
adhesion and most importantly, the activation of FAK is the first step necessary for the 
outside - in signaling by integrins (Sastry and Burridge, 2000).  The activation of integrin 
- dependent focal adhesion kinase (FAK) in cells, following the binding of WNV to αVβ3 
integrin was first determined. 
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The distribution of vinculin and FAK in serum - starved (negative control), 
lysophosphatidic acid (LPA) activated cells (positive control) and WNV infected cells 
were analysed by immunofluorescence assay.  Both FAK and vinculin were observed to 
be more diffused and did not co-localise in serum-starved cells (Figure 32a).  In contrast, 
distinct patchy pattern of vinculin and FAK (yellow staining revealed co-localisation of 
the two proteins) was observed in WNV-infected cell (within 5 min of infection, Figure 
32b) and cells treated with 30 ng/ml of LPA [(positive control) (Figure 32c)].  These 
results demonstrated the activation of FAK, presumably upon the binding of WNV to 
αVβ3 integrin. 
A recent study conducted by McLean and co-workers (2000) have shown that the 
residue Tyr397 of FAK specifically undergo auto-phosphorylation in response to the 
interaction of ligands and integrin at the focal adhesion sites.  The auto-phosphorylation 
of FAK is also responsible for the endocytosis signaling process.  As such, the auto-
phosphorylation of FAK at Tyr397 during WNV interaction with αVβ3 integrin was also 
investigated.  Phosphorylation of FAK was detected with antibody specific for the 
phosphorylated form of FAK.  Phosphorylated FAK was not detected in serum-starved 
cell lysate (Figure 33a, Lane 1).  [Induction of Vero cells with 200 ng/ml of LPA 
(positive control) resulted in FAK phosphorylation within 5 min (Figure 33a, Lane 7) and 
is sustained over a period of 30 min (Figure 33a, Lane 8)].  Phosphorylation of FAK in 
WNV-infected cells can be detected within 5 min after adding the virus to cells (Figure 
33a, Lane 2) and is sustained till 10 min after virus infection (Figure 33a, Lane 3).  
Dephosphorylation of FAK is observed as infection progressed from 20 to 45 min p.i.
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 West Nile virus activates the integrin-dependent FAK.  (a)  FAK (green speckles) 
and vinculin (stained red) is not observed to co-localize in serum-starved Vero cells.  (b)  
Co-localization (yellow staining) of FAK and vinculin is observed in Vero cells infected 
with WNV for a period of 5 min.  (c)  Co-localization (yellow staining) of FAK and 
vinculin is also observed in Vero cells after treatment with 200 ng/ml of LPA (positive 
control). 
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 Activation of FAK auto-phosphorylation via the engagement of WNV with αVβ3 
integrin.  (a)  West Nile virus induces phosphorylation of FAK.  Lane 1, serum-starved 
Vero cells were uninduced (negative control), Lane 2, Vero cells were infected with 
WNV for 5 min, Lane 3, Vero cells were infected with WNV for 10 min, Lane 4, Vero 
cells were infected with WNV for 20 min, Lane 5, Vero cells were infected with WNV 
for 30 min, Lane 6, Vero cells were infected with WNV for 45 min, Lane 7, Vero cells 
were induced with 200 ng/ml of LPA (positive control) for 5 min and Lane 8, Vero cells 
were induced with 200 ng/ml of LPA (positive control) for 30 min.  Auto-
phosphorylation of FAK is observed within 5 min of WNV infection and undergoes 
dephosphorylation after 30 min of WNV infection.  (b) The membrane is stripped and re-
probed with antibody against actin to ensure equal amount of cell lysate was loaded in 
each of the wells. 
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with WNV (Figure 33a, Lanes 4 to 6).  To ensure equal amount of proteins were loaded 
to each of the wells, the membrane was stripped and re-probed with antibody against 
actin.  Equal quantity of actin was observed throughout the lanes (Figure 33b).  Hence, 
these results affirmed the activation of FAK during the early interaction of WNV with 
αVβ3 integrins. 
 
4.10 SOLUBLE RECOMBINANT ENVELOPE PROTEIN DOMAIN III (E DIII) 
RECOGNIZED BY MONO-SPECIFIC ENVELOPE ANTIBODY  
To have a complete understanding of initial virus-host interaction, this part of the 
study further explored the possible attachment domain(s) on WNV particles with the host 
cellular receptor.  The E proteins of flavivirus arranged in a herringbone structure lie 
relatively flat on the surface of the virus particles and has been shown to be responsible 
for binding to cells (Hung et al., 2004, Mukhopadhyay et al., 2003; Zhang et al., 2003; 
Gollins and Porterfield, 1985). Based on the crystallography data of the tick-borne 
encephalitis flavivirus E protein, (Rey et al., 1995) it was noted that each E protein 
monomer is folded into three distinct domains. The domain III (DIII) of E protein is 
postulated to form the receptor-binding site of the protein and it contained an integrin-
binding motif [Arg-Gly-Asp (RGD)] in mosquito-borne flaviviruses except dengue virus 
(van der Most et al., 1999).  
For this reason, WNV E DIII (299 to 401 a.a) was cloned and expressed in 
prokaryotic system as a His - tagged fusion protein.  Soluble WNV E DIII protein was 
further purified using affinity chromatography with Ni-NTA column.  Recombinant 
soluble WNV E DIII is provided by fellow co-worker (R. Rajamanomani, Nanyang 
Technological University, Singapore) at a concentration of 5 to 10 mg/ml. Firstly, the 
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expressed soluble WNV E DIII protein was separated by 12 % SDS-PAGE (Section 2.6) 
and Western blot was performed (Section 2.7) to see if the monoclonal antibody 
(Microbix, Canada) against the WNV E protein can recognized this fragment (Figure 34).  
The DV (serotype 2) - infected cell lysate was used as negative controls.  The monoclonal 
antibody did not recognize the envelope protein of DV (Figure 34, Lane 1). Both the 
purified WNV E DIII (Figure 34, Lane 2 - arrow) and E protein (Figure 34, Lane 3) from 
the WNV - infected cell lysate were detected by the monoclonal antibody.  The WNV E 
DIII protein was also detected by the anti-His antibody (Figure 34, Lane 4).  
 
4.11 COMPETITIVE INHIBITION OF WEST NILE VIRUS ENTRY WITH 
SOLUBLE RECOMBINANT WNV E DIII PROTEIN 
Since WNV E DIII has been proposed to be the receptor binding domain, the 
ability of recombinant WNV E DIII protein binding to cellular receptor and blocked the 
entry of WNV infection was investigated (Section 2.17.3). Vero cells were first incubated 
with a range of concentrations (5 to 100 µg/ml) of soluble recombinant WNV E DIII 
protein or BSA (control) for 1 hr at 4 °C. Radiolabelled - WNV or DV was added to the 
pre-treated cells and quantitated for virus entry into Vero or C6/36 cells (Figure 35, 
Appendix 15i).  Figure 35a showed that exposure of Vero cells to 100 µg/ml of soluble 
WNV E DIII protein resulted in more than 60 % inhibition in WNV entry. The inhibition 
was dose - dependent, decreasing to 20 % when the Vero cells were pre-treated with low 
concentration (5 µg/ml) of WNV E DIII protein.  Although the inhibition of WNV entry 
was not complete, it was still very significant when compared to cells that were 
pretreated with BSA, at high concentration of 100 µg/ml. There was a baseline 5 to 10 %
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Detection of recombinant WNV E DIII protein expressed as a His-tagged fusion 
protein.  Recombinant WNV E DIII sequence from the envelope protein was expressed as 
a soluble protein.  Recombinant WNV E DIII protein was separated by 12 % SDS-PAGE 
and followed by transferring to nitrocellulose membrane.  Monoclonal antibody against 
WNV E protein is used for detection. Lane 1: DV-infected cell lysate, Lane 2: WNV E 
DIII protein (arrow) and Lane 3: WNV - infected cell lysate. The protein band indicates 
WNV E protein.  Lane 4:  WNV E DIII is also detected by anti-Penta His antibody. 
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Figure 35. 
Competitive inhibition of WNV entry with soluble recombinant WNV E DIII 
protein. (a)Vero and (b) C6/36 cells were first incubated with different concentrations of 
soluble WNV E DIII protein or BSA (negative control).  Radiolabelled - WNV or DV 
was added and assayed for virus entry.  Entry of WNV is significantly blocked in the 
presence of WNV E DIII protein in (a) Vero and (b) C6/36 cells.  Recombinant WNV E 
DIII protein is able to partially block the entry of dengue virus (30 % inhibition) when 
high concentration is used (>50 µg/ml) into (a) Vero cells and drastically inhibit DV 
entry into (b) C6/36 cells.  There is no effect of BSA on the entry of WNV and DV into 
(a) Vero and (b) C6/36 cells.  
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non - specific inhibition of WNV entry.  The solubilized WNV E DIII protein was only 
able to partially inhibit DV entry (30 % inhibition) into the pretreated Vero cells. Again, 
the inhibition was dose dependent, decreasing to about 1 % inhibition in cells that were 
pretreated with WNV-DIII protein concentrations ranging from 5 to 10 µg/ml.   
Similar experimental procedures were also carried out to determine if WNV E 
DIII protein is responsible for binding to the cell surface of mosquito cells, C6/36. Entry 
of WNV can be effectively blocked by the recombinant WNV E DIII (70 %) and, 
interestingly, the entry of dengue virus into C6/36 cells was also significantly inhibited 
[(>60 %) (Figure 35b)]. Again, BSA has minimal effect in blocking entry of WNV and 
DV into C6/36 cells.  Therefore, these results suggested that WNV E DIII is responsible 
for binding to the cell surface of both vertebrate and invertebrate cells and the plausibility 
of WNV and DV sharing the same receptor molecule(s) in C6/36 cells. 
 
4.12 MURINE POLYCLONAL ANTIBODY TO RECOMBINANT WEST NILE 
VIRUS E DIII NEUTRALIZED WNV 
To further affirm that WNV E DIII is indeed the receptor binding domain, murine 
polyclonal antibody against recombinant WNV E DIII protein was produced (Section 
2.17.4) and use for plaque neutralization assay (Section 2.2.6) of WNV.  The murine 
polyclonal was specific in detecting WNV E DIII proteins in a Western blot (Figure 36 - 
Lane 1, arrowhead). No protein bands were detected when pre-immune murine serum 
was used as probe (Figure 36, Lane 2).  Plaque neutralization assays were then carried 
out for both WNV and DV with a dilution series of antibody against WNV E DIII 
protein. At dilution of 1/64, there was at least 90 % neutralization of the WNV 
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Production of murine polyclonal antibody against recombinant WNV E DIII 
protein.  Lane 1 - A single 13 kDa protein band (WNV E DIII protein - arrowhead) is 
detected by the murine polyclonal serum.  Lane 2 - The WNV E DIII protein is probed 
with pre-immunized murine serum. No bands are detected. This shows the specificity of 




  155 
                                                                                       CHAPTER 4 
                                                                                 RESULTS 
 
(Figure 37a, Appendix 15j). High neutralization (80 %) of the WNV was maintained until 
the murine polyclonal antibody was diluted to 1/256. At higher dilutions, there was an 
exponential decrease in the degree of neutralization reaching 0 % when the dilution factor 
was 1/8192. When the WNV was reacted with the pre-immunized sera, no neutralization 
effect was observed.  In contrast, DV was only partially inhibited (maximum inhibition at 
50 %) at low dilution (<1/64) of the antibody (Figure 37b) and minimal neutralization 
effect was observed with higher dilution of the antibody (>1/256).   
 
4.13 RECOMBINANT WEST NILE VIRUS E DIII BINDS TO αVβ3 INTEGRIN 
AND PREVENTS WNV ENTRY 
 In the previous sections (Sections 4.10 to 4.12), WNV E DIII has demonstrated to 
bind to surface of cells and prevent WNV infection substantially.  The binding of WNV E 
DIII to WNV cellular receptor, αVβ3 integrin was further investigated.  αVβ3 integrin 
expressing CS-1 cell line (CS-1β3) and non-αVβ3 integrin expressing cell line (CS-1) 
were used for this part of the study.  In order to prove that WNV E DIII binds to αVβ3 
integrin on CS-1β3 cells, immunoprecipitation was carried out (Section 2.9).  WNV E 
DIII was detected after immunoprecipitation with antibody to αVβ3 integrin in the cell 
lysate of CS-1β3 after reacting with WNV E DIII (Figure 38a, Lane 1).  In contrast, 
WNV E DIII was not detected after immunoprecipitation with antibody to αVβ3 integrin 
in the cell lysate of CS-1 after reacting with WNV E DIII (Figure 38a, Lane 2).  The 
specificity of the antibody for immunoprecipitation was assessed by reacting with either 
CS-1β3 (Figure 38a, Lane 3) or CS-1 (Figure 38a, Lane 4) cell lysate that were not 
reacted with WNV E DIII.  The band for WNV E DIII was not detected in these lanes.
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Figure 37. 
Plaque neutralization of WNV with murine polyclonal antibody against WNV E 
DIII protein.  The polyclonal antibody produced against WNV E DIII proteins were 
diluted in a 2-fold series. Equal volume (50 µl) of anti-WNV E DIII protein antibody and 
(a) WNV (500 PFU) or (b) DV (500 PFU) were incubated for 1 hr before this mixture is 
overlaid onto Vero cells monolayer.  Plaques were stained with crystal violet.  Pre-
immune serum was used as a negative control instead of anti-WNV E DIII protein 
antibody. (a) Greater than 90 % of the WNV is neutralized when the anti-serum used is at 
a dilution of >1/64. The neutralization capacity is maintained at 80 % with the anti-serum 
dilution up to 1/256. The neutralization percentages decrease exponentially after that to 0 
% at the anti-serum dilution of 1/8192. (b) Partial neutralization of DV (only 50 % 
inhibition) with polyclonal anti-WNV E DIII protein is observed only at low dilution 
(1/4). 
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Figure 38. 
Specific binding of WNV E DIII protein to αVβ3 integrin.  (a) 
Immunoprecipitation was carried out with antibody to αVβ3 integrin from cell lysates of 
CS-1 and CS-1β3 cells.  WNV E DIII protein was detected using antibody against anti-
Penta His.  Lane 1, WNV E DIII protein band was detected from cell lysate of CS-1β3 
pre-reacted with WNV E DIII protein.  WNV E DIII protein was not detected in Lanes 2 
- 4.  Lane 2, cell lysate of CS-1 cells pre-reacted with WNV E DIII protein.  Lane 3, cell 
lysates of CS-1β3 cells without reacting with WNV E DIII protein.  Lane 4, cell lysates 
of CS-1 cells without reacting with WNV E DIII protein.  (b) Binding of WNV E DIII 
protein to αVβ3 integrin on CS-1β3 cells blocks the entry of WNV.  Pretreatment of CS-
1β3 cells with different concentrations of WNV E DIII proteins inhibits the entry of 
WNV in a dosage-dependent manner.  Negative control is the CS-1β3 cells incubated 
with BSA. 
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Having shown that WNV E DIII protein binds to αVβ3 integrin, experiments were 
further performed to affirm the specificity of WNV E DIII protein binding to αVβ3 
integrin.  A competitive inhibition study was carried out (Section 2.17.5) with WNV E 
DIII.  The binding of WNV E DIII proteins to αVβ3 integrin on CS-1β3 cells 
significantly inhibit the entry of WNV in a dosage manner.  At high concentration (100 
µg/ml) of WNV E DIII proteins, the entry of WNV can be inhibited by more than 75 % 
(Figure 38b, Appendix 15k).  Incubation of cells with BSA has minimal effect on the 
entry of WNV (Figure 38b).  Therefore, these results have showed that WNV E DIII 
protein binds specifically to αVβ3 integrin. 
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5.0 THE GRAND ENTRANCE OF WEST NILE VIRUS 
5.1 INTRODUCTION 
 Beside searching for the functional cellular receptor for WNV (presented in 
Chapters 3 and 4), the mapping of WNV entry pathway into vertebrate cells was carried 
out concurrently in this study.  A combination of bio-imaging techniques (for example, 
cryo-immuno-electron microscopy and real - time imaging with laser scanning confocal 
microscopy), molecular inhibitors and pharmacological drugs targeting the endocytic 
pathways were used to decipher the elusive entry process of WNV into host cells.  
Interestingly, the entry process of WNV is highly dependent on its interactions with a 
number of cellular components. 
 
5.2 ENTRY ROUTE OF WEST NILE VIRUS AND CELLULAR 
COMPONENTS INVOLVED IN THE ENTRY PROCESS 
The entry route as well as the cellular components involved during the entry 
process of WNV was investigated with double - labelled immunofluorescence using 
confocal laser scanning microscopy and cryo-immuno-electron microscopy.  Antibodies 
specific for endosomes (EEA1), lysosomes (LAMP1), RER (Bip) and Lysotracker 
(Molecular Probes, USA) were used in this part of the study.   
West Nile virus was first prepared by a combination of concentration and 
purification procedures (Section 2.2.4).  As revealed by negative staining of the virus 
preparation, a homogenous population of WNV particles with uniform size of 50 nm in 
diameter (Figure 39a) was obtained.  The purified virus was subsequently used in the 
  160 
                                                                                       CHAPTER 5 
                                                                                RESULTS 
 
Figure 39. 
Ultrastructural analyses of WNV internalization process using cryo-immuno-
electron microscopy.  (a) Homogenous population of negatively - stained WNV particles. 
Spherical particles with a diameter of 50 nm were noted.  (b)  Binding of WNV particle at 
the plasma membrane of Vero cells at 0 min after shifting from 4 °C to 37 °C.  (c) Uptake 
of WNV particle (arrow) by coated pit.  (d) WNV particle (arrow) is internalized within a 
clathrin - coated pit as indicated by the 10 nm gold particles (arrowheads). Bars represent 
100 nm (a-d). 
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ultrastructural analyses of the virus entry process.  To better define the entry route of 
WNV into cells, cryo-fixation coupled with immuno-electron microscopy was used to 
visualize the entry process at the ultrastructural level (Section 2.11.6).  Tokuyasu (1984) 
have clearly illustrated that cryo-fixation can preserve cellular structure much better than 
conventional chemical fixation.  Immunolabelling can also be performed without 
compromising the antigencity. 
In order to visualize synchronized entry of WNV, Vero cells were first incubated 
with WNV (at a M.O.I. = 25) at 4 °C for 1 hr.  Low temperature treatment allows binding 
of WNV to the cell surface receptors but prevents the internalization of virus particles 
into the cells.  Subsequently, the cells were warmed to 37 °C and the virus-infected cells 
were processed for cryo-sectioning (Section 2.11.6) at appropriate timings after warming.  
At 0 min upon warming to 37 °C, attachment of WNV particles along the cell surfaces of 
Vero cells were observed (Figure 39b).  At 3 min after shifting to 37 °C, WNV particle 
(arrow) was found within invaginations of the plasma membrane.  These invaginations 
resembled those of clathrin - coated pits (Figure 39c).   
To determine whether clathrin was involved in the initial internalization of WNV, 
cryo-sections were immunolabelled with anti-clathrin and conjugated to gold particles.  
Figure 39d shows the uptake of WNV (arrow) via a clathrin-coated pit as indicated by the 
10 nm gold particles (arrowheads) binding to anti-clathrin antibody. 
At 5 min p.i., double-labelled immunofluorescence assay with anti-WNV E 
protein and anti-EEA1 antibodies showed co-localization, suggesting that the virus 
particles were translocated to the endosomes after endocytosis.  At these timings, most of 
the endosomes containing WNV are distributed closer to the cell periphery (Figure 40a).  
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Figure 40.   
Localization of WNV within early endosomes.  (a) Anti-EEA1 is used to stain the early 
endosomes at 5 min p.i.  Red staining (TR) represents EEA1 marker and green staining 
(FITC) indicates WNV; Yellow staining shows co-localization.  (b) Localization of single 
WNV particle (arrow) in early endosomes as revealed by cryo-sectioning of infected cells 
at 5 min p.i. 
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At the ultrastructural level, single virus particle is observed within the early endosomes 
(Figure 40b).  By 10 min after shifting up to 37 oC, WNV were found mainly in vesicles 
(Figure 41a) that were stained with Lysotracker (Molecular Probes, USA).  This 
suggested that WNV were localized to the late endosomes and lysosomes by this timing.  
The fluorescent staining was more intense at the perinuclear region.  At the ultrastructural 
level, early endosomes containing single virus particle (Figure 41b - arrow) were seen 
fusing with one another (white arrows) resulting in the formation of late endosomes and 
lysosomes (approximately 500 nm in diameter) contain several virus particles 
(arrowheads).  These vesicles contained several virus particles and were predominantly 
localized to the perinuclear region in close association with the endoplasmic recticula 
(ER).  A unique accumulation of a large number of virus-containing late endosomes and 
lysosomes were observed at the perinuclear region by 15 min (Figure 41c – white arrow 
and Figure 41d) and these structures remained until 30 min p.i.  
Immunogold labelling electron microscopy further confirmed the identity of the 
virus-containing vesicles as lysosomes (Figure 41d).  Gold particles (arrowheads – 15 nm 
in diameter) were bound to antibodies against LAMP1 localized around the lysosomal 
membrane. The E proteins of the WNV (arrows) were also labelled with the 10 nm gold 
particles bound to antibody against WNV E protein.  Several virus particles with loosen 
envelope can be observed (Figure 41d).   
It has been a challenge to visualize the uncoating process of flaviviruses in 
endocytic vesicles. It is believed that the acidification of the late endosomes and 
lysosomes would cause the fusion of the virus envelope protein with the late endosomal 
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Figure 41. 
Localization of WNV within cell late endosomes and lysosomes.  (a) Lysotracker 
is used to stain late endosomes and lysosomes.  Red staining represents lysotracker and 
green staining indicates WNV; Yellow staining shows co-localization.  Majority of the 
virus containing late endosomes and lysosomes are found around the perinuclear region.  
NU denotes nucleus.  (b) Fusion of individual early endosomes (white arrows) containing 
WNV (black arrow) to form multi-virus (arrowheads) containing late endosomes and 
lysosomes. Bar represents 100 nm.  (c) Localization of WNV within cell after 15 min p.i.  
Antibody against LAMP1 is used to stain lysosomes.  Red staining represents LAMP1 
and green staining indicates WNV; Yellow staining shows co-localization.  
Accumulation of LAMP1 positive vesicles containing virus particles at the perinuclear 
region (white arrow) is observed.  NU denotes nucleus.  (d) LAMP1 positive lysosome 
(15 nm gold particles - arrowheads) containing large number of WNV particles (arrows) 
is seen in close vicinity with the ER.  The virus particles are decorated with 10 nm gold 
particles conjugated to the anti-WNV E protein.  Bar represents 50 nm.  ER denotes 
endoplasmic reticulum. 
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and lysosomal vesicle membrane and triggered the release of the flavivirus nucleocapsids 
into the cytoplasm (Brinton, 2002).  Figure 42a and 42b show the fusion process of WNV 
envelope with the endosomal or lysosomal membrane to expel the virus RNA-containing 
nucleocapsids into the cytosol.  In Figure 42a, the virus envelope was observed to have 
loosened and fused with the endosomal or lysosomal membrane. Figure 42b showed the 
release of the virus nucleocapsid (arrow) after fusion with the membrane of the late 
endosomes or lysosomes. With the superiority of cryo-fixation procedure, virus 
nucleocapsids in the cytoplasm were visualized in this study.  Nucleocapsids (arrows - 
labelled with anti-WNV capsid antibody conjugated to 10 nm gold particles) were 
observed in proximity with the lysosomes and the endoplasmic reticula (ER) region 
(Figure 42c).  Inset showed higher magnification of the boxed area. 
By 30 min p.i., the nucleocapsid particles were predominantly localized to the 
perinuclear region of the cells as shown in Figure 42c. Virus capsid proteins were 
observed to co-localize strongly (yellow staining) with the cellular marker (BiP) for ER 
(Figure 43a) but not the golgi complex in double - labelled immunofluorescence assay 
(Figure 43b). 
To investigate the location of the virus RNA genome upon release from the 
nucleocapsid, in-situ hybridization with digoxigenin-11-dUTP (DGdUTP) incorporated 
DNA probes coupled with cryo-immuno-electron microscopy were used (Section 2.11.6). 
The incorporation of DGdUTP into the specific DNA probe was assessed by immunodot 
blotting and detection of DG by anti-DG antibody (Figure 44a).  Antibody against 
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Figure 42. 
Utrastructural analyses of WNV uncoating process in late endosomes and lysosomes.  
(a) Fusion of WNV envelope (arrows) with the endosomal and lysosomal membrane.  (b) 
Expelling of the nucleocapsid of WNV (arrows) after fusion of the viral envelope with the 
endocytic membrane.  (c) Immuno-detection of WNV nucleocapsid particles in the cytoplasm 
with gold particles conjugated to anti-capsid serum.  Bars represent 100 nm (a) and 50 nm (b 
& c).  ER denotes for endoplasmic recticulum. 
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Figure 43.  
Co-localization of WNV nucleocapsids with ER marker.  Anti-BiP and anti-
capsid sera are used to stain the ER and nucleocapsids, respectively. (a) WNV 
nucleocapsids are localized to the ER.  Texas Red - BiP marker; FITC - capsid proteins; 
Yellow – co-localization. (b)  WNV nucleocapsids do not co-localize with golgi marker.  
(Texas Red - Golgi marker; FITC - C proteins).   
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Figure 44. 
Detection of WNV RNA with immunolabelling of DNA probes. (a) Immunodot blot 
of DGdUTP DNA probe.  The presence of DG in the DNA probe is detected by antibody 
against DG.  Spot 1, DNA probe without DGdUTP incorporation; Spot 2, WNV - specific 
DGdUTP incorporated DNA probe (1:50 dilution); Spot 3, WNV - specific DGdUTP 
incorporated DNA probe (1: 250 dilution); Spot 4, positive control (DG). No hybridization 
signal is noted in cryo-sections of (b) mock-infected Vero cells as well as (c) RNase-treated 
cryo-sections of WNV - infected Vero cells using immunogold labelling against DGdUTP 
that are incorporated into the WNV - specific DNA probes.  This indicates the specificity of 
the DNA probes. In contrast, (d) the uncoated WNV RNA genome is associated with the ER.  
The WNV RNA genome is detected using immunogold labelling against DGdUTP (arrows) 
that is incorporated into the WNV - specific DNA probes.  Bars represent 50 nm.  ER denotes 
endoplasmic reticulum and Nu denotes nucleus. 
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DGdUTP failed to detect any signal in the absence WNV - specific DGdUTP DNA probe 
(Figure 44a, spot 1).  Higher signal was detected in spots 2 and 4 that were spotted with 
1:50 dilution of WNV - specific DGdUTP DNA probe and DG (positive control), 
respectively.  Spot 3 is spotted with a much lower dilution (1:250) of WNV - specific 
DGdUTP DNA probe hence a much weaker signal was detected as compared to spot 2. 
Hybridization of the synthesized DNA probe to the viral RNA at the ultrastructural level 
was detected using anti-digoxigenin which was further conjugated with 10 nm gold 
particles. 
The specificity of the synthesized DNA probes binding to the virus RNA was 
assessed. No hybridization signal (absent of gold particles decoration) was detected when 
cryo-sections of uninfected Vero cells were incubated with the synthesized DNA probes 
(Figure 44b).  In addition, hybridization signals were not detected for RNAse - treated 
cryo-sections of WNV - infected cells (Figure 44c).  For WNV-infected cells, viral RNA 
(as indicated by the 10 nm gold particles) was found in close proximity with the ER after 
20 min at 37 oC (Figure 44d).  This observation is consistent with previous studies that 
have documented that the ER is the site of flavivirus replication (Ng, 1987 and Westaway 
et al., 2002). 
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 5.3 ENTRY OF WEST NILE VIRUS OCCUR THROUGH A CLATHRIN -
MEDIATED ENDOCYTIC PATHWAY 
The results presented in Figure 39d suggested the involvement of a clathrin - 
mediated endocytic pathway in WNV entry into Vero cells.  To affirm these results, Vero 
cells were treated with drugs that selectively inhibit receptor - mediated endocytosis 
(mondanslycadervine), clathrin - dependent endocytosis (chlorpromazine and sucrose) 
and caveolae - dependent endocytosis (filipin – disrupt the cholesterol enrich caveola-
containing membrane microdomain).   
Vero cells were pre-treated with mondanslycadervine, chlorpromazine and 
sucrose either for 1 hr before WNV infection or the drugs were added at 10 min p.i. 
(Section 2.15.1). The number of infected cells was reduced significantly by 
approximately 80 % (Figures 45a to c, Appendix 16a). However, mondanslycadervine, 
chlorpromazine and sucrose did not exert any inhibitory effect on WNV infection when 
these drugs were added at 1 hr and 2 hr p.i.. This suggested that these drugs selectively 
blocked early steps in the entry process of WNV.  In contrast, filipin had no significant 
effect on WNV infection regardless of the timing when the drug was added to the cells 
(Figure 45d, Appendix 16a).  In addition, the association of clathrin with WNV is also 
detected by double - labelling immunfluorescence with antibodies against WNV E 
protein and clathrin (Figures 46a - d).  In contrast, caveolin was not observed to co-
localize with WNV (Figures 46e - g).  
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Figure 45. 
Effects of clathrin - mediated endocytosis - disrupting drugs on WNV entry into 
Vero cells.  Percentage of viral antigen positive cells is plotted against time.  Cells treated 
with (a) monodanslycadervine, (b) chlorpromazine and (c) sucrose show marked 
reduction in WNV entry at early timings whereas filipin (d) does not significantly inhibit 
virus entry.  The average of three independent experiments is shown.  
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Figure 46. 
Double - immunofluorescence localization analyses of WNV with clathrin or 
caveolin. (c) Co-localization of (a) WNV E protein (stained green with FITC) and (b) 
clathrin (stained red with Texas Red).  (d) Enlargement of inset shows the strong 
association (yellow speckles - arrows) of WNV and clathrin in the entry process. (g) No 
co-localization signal was observed between (e) WNV (E protein was stained green with 
FITC) and (f) caveolin (stained red with Texas Red - conjugated to antibody specific for 
caveolin). 
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Molecular inhibitors in the form of dominant - negative mutants were also used to 
further confirm the role of clathrin - mediated endocytosis in the entry of WNV.  The use 
of dominant - negative mutants may provide alternative way to analyze the specific 
function of defined pathways within the cells.  Previous study by Benmerah and group 
(1998) has shown that Eps15, a protein that binds to the AP-2 adapter is required for 
internalization through clathrin coated pits.  However, the deletion of the EH domain of 
Eps15 produced a dominant - negative mutant of the protein that arrests clathrin - coated 
pits formation (Benmerah et al., 1999) and inhibit the uptake of transferrin (cellular 
marker of clathrin - mediated endocytosis). 
In this part of the study, Vero cells were first transfected (Section 2.5.1) with 
either GFP - E∆95/295 plasmid (dominant-negative mutant) or pEGFP plasmid (coding 
for GFP – internal control).  Transfected cells were then assayed for their capacity to 
internalize Texas Red (TR) - conjugated transferrin and WNV.  The internalization of TR 
-transferrin was impaired in cells expressing GFP - E∆95/295 (Figure 47a) but not in 
cells that are expressing GFP (Figure 47b), when visualized under the confocal scanning 
laser microscope after 30 min of addition of TR - transferrin.  This observation is 
consistent with the data documented by Benmerah and co-worker (1999). 
As shown in Figure 47c (Appendix 16b), the uptake of WNV was drastically 
reduced in cells transfected with GFP - E∆95/295 plasmid when compared to those that 
were either transfected with GFP plasmid alone or mock-transfected Vero cells.  GFP -
E∆95/295 - expressing cells were also incubated with WNV at 37 °C for 30 min and 
processed for immunofluorescence staining and confocal microscopy.  WNV particles 
(stained red by anti-WNV E protein antibody conjugated to TR - arrows) were observed 
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Figure 47.   
Inhibition of WNV entry into Vero cells expressing Eps15 - dominant negative 
mutant protein. (a) Abolishment of TR - conjugated transferring internalization into Vero 
cells transfected with vector expressing GFP - E∆95/295. (b) Internalization of TR -
conjugated transferrin into Vero cells expressing GFP (vector without Eps15 gene) only. 
(c) The entry of WNV is significantly inhibited in Vero cells transfected with GFP - 
E∆95/295. The number of virus E antigen-positive cells in relation to the total cell 
population is expressed as percentage of virus antigen-positive cells.  (d) Binding of 
WNV (stained Texas Red - arrows) on the plasma membrane of the GFP - E∆95/295 
expressing cell is observed but no internalization of the virus particles occur. (e) 
Internalized WNV particles (arrows) are observed within cells expressing the negative 
control plasmid expressing only GFP. 
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to attach and accumulate exclusively on the plasma membrane but failed to enter the cells 
(Figure 47d - arrows). In contrast, Figure 47e showed the internalization of WNV (arrows 
– yellow speckled staining) within the cytoplasm of cells expressing GFP (vector without 
Eps15 gene). These results provide further evidence that WNV entry into cells takes 
place through clathrin - mediated endocytosis. 
 
5.4 PROTEIN KINASE C (PKC) AND ITS ISOFORMS ARE INVOLVED IN 
WEST NILE VIRUS ENTRY PATHWAY 
Protein kinase C is a large superfamily of related proteins which carry out diverse 
regulatory roles in many key cellular processes (Mellor and Parker, 1998; Toker, 1998).  
Based on the action of certain protein kinase inhibitors, such as H7 and staurosporine, the 
replication mechanisms of several enveloped virus, including alphaviruses, poxviruses 
and herpesviruses, have been proposed to require cellular PKC activities (Constantinescu 
et al., 1991). Protein kinase C has been reported to mediate the process of endocytosis 
(Le et al., 2002) but the activity of specific PKC isoform, in general, has not been 
assigned to specific endocytic pathway.  Recently, Root and workers (2000) reported the 
inhibition of influenza virus entry into cells using a new generation of highly specific 
PKC inhibitor, bisindolymaleimides.  The bisindolymaleimides are thought to block the 
ATP - binding site on the catalytic domain of PKC and appear to inhibit all PKC 
isozymes with similar potency (Toullec et al., 1991). 
In the present study, the possible involvement of cellular PKC in the entry process 
of WNV was also analyzed.  Vero cells were first subjected to treatment with 
bisindolymaleimide (BIS) I either before virus infection (pre-treatment, to assess the 
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effect on virus entry) or after virus inoculation [(post-treatment, to assess the effect on 
subsequent virus replication events) (Section 2.15.3)].  The virus productive yields were 
assessed at 24 hr p.i.. Cells were treated with 40 µm of BIS I and this concentration of 
drug used has been shown to be effective in inhibiting functional activities of PKC and its 
isoforms (Le et al., 2002).  Figure 48 (Appendix 16c) shows that the pretreatment of Vero 
cells with BIS I significantly reduced (5 log units) the virus yield as compared to cells 
with BIS I added after 3 hr p.i.. An obvious inhibition of WNV replication (reduction by 
approximately 4 log units) also observed for cells with BIS I added within 1 hr p.i.. 
Therefore, these results provided first line evidence that PKC inhibition by BIS I have a 
direct effect on the early event (entry process) of WNV replication cycle. 
To further confirm the requirement of the PKC in the entry of WNV, Vero cells 
were pre-treated with BIS I and transfected with infectious WNV RNA (Section 2.15.4).  
The transfection of infectious virus RNA into cells employed a different strategy 
compared to wild-type virus infection (through the receptor-mediated endocytic 
pathway). The productive virus yields of the virus RNA - transfected cells were not 
affected with BIS I treatment (Figure 49, Appendix 16d).  Hence, these results further 
indicated the involvement of PKC in the entry process of WNV. 
 
5.4.1 Inhibition of PKC Does Not Affect West Nile Virus Binding to Cell Surface 
Next, experiments were carried out to dissect the particular phase of WNV entry 
process that was affected by PKC was investigated.  The first approach was to determine 
if BIS I can inhibit infection by imparing the binding of WNV to cell surface.  Vero cells 
were pre-treated with 40 µm of BIS I for 2 hr and inoculated with [35S] - methionine-
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Effects of PKC inhibitor (BIS I) on WNV entry into Vero cells.  Productive virus 
yield (PFU/ml) is plotted against time.  Cells that were pre-treated with BIS I show marked 
reduction in WNV infection as compared to post-infection treatment with BIS I.  There is 
approximately 5 log unit reduction of virus infection for cells pre-treated with BIS I for 1 hr 
and 2 hr.  Reduction in virus production (4 log unit) was also observed for cells treated with 
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Effect of BIS I on WNV infectivity for cells - transfected with virus RNA.  There 
was no significant inhibition of WNV infection in cells pre-treated with BIS I (in a series 
of concentrations) before transfection with infectious WNV RNA.  The infectious titre 
remained at around 106 PFU/ml up to 50 µM of BIS I.   
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radiolabelled WNV (M.O.I. = 10) at 4 ºC for 1 hr.  Excess and unbound viruses were 
inactivated with acid citrate buffer (pH 2.8) and extensively washed with PBS.  Cell-
associated radioactivity counts were then determined. No marked difference in virus 
binding to Vero cells were detected in the presence or absence of BIS I (Figure 50, 
Appendix 16e).  These data show that BIS I has no effect on virus binding to cells, hence 
suggesting that BIS I acts after the binding step of WNV entry pathway. 
 
5.4.2 PKC is Required for Trafficking Endosomes to Lysosomes Containing Virus 
Particles 
The specific location(s) that BIS I exert its effect on the internalization pathway 
of WNV was further investigated.  Sub-cellular fractionation in 20 % self - generated 
Percoll gradient was carried out as previously described in Section 2.12.  Density marker 
beads (Amersham Pharmacia, USA) were used as external markers to facilitate the 
density measurement of the separated sub-cellular particles in the gradient.  The densities 
of the endosomes, lysosomes, plasma membrane and endoplasmic recticulum were pre-
determined and were noted to be 1.034 g/ml, 1.075 g/ml, 1.045 g/ml and 1.058 g/ml, 
respectively (Evans, 1987). 
Vero cells that were pre-treated with 40 µm of BIS I for 3 hr or non-treated cells 
were processed for sub-cellular fractionation after 20 min of infection with [35S] -
methionine - labelled WNV (Figure 51, Appendix 16f).  The radioactivity of the 24 
fractions collected was determined.  For the untreated Vero cells, 2 peaks of radioactivity 
were detected (Figure 51b).  The densities of the peaks were correlated with density bead 
makers (Figure 51a). 
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Effect of BIS I on WNV binding to cell surface of Vero cells. Pre-treatment of 
Vero cells with BIS I did not significantly affect virus binding to cell surface when 
compared to the non-treated cells.  
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Figure 51. 
Sub-cellular fractionations of cellular homogenates from WNV-infected cells in 
20 % Percoll gradients.  (a)  Standard plot of density distribution determined by density 
marker beads in the 20 % Percoll gradient.  (b) Vero cells are allowed to internalize 
radiolabelled - WNV at an M.O.I. = 10 for 30 min and subjected to cellular fractionation. 
Two distinct peaks (fraction 9 and 17) correspond to the endosomal and lysosomal 
fractions, respectively, when compared to the density marker (a). (c) Similar procedure is 
carried out as in (b) except that the Vero cells were pre-treated with 40 µM of BIS I for 3 
hr before virus infection.  A single distinct peak of radioactivity was detected in fraction 
9 that corresponded to the endosomal fraction. (d)  Sub-cellular fractionation of WNV-
infected cells after BIS I washout for 3 hr.  With the removal of BIS I, the peak that 
corresponded to the lysosomal fraction was obvious as compared to BIS I - treated cells 
(c).   
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The density of the first peak was approximately 1.034 g/ml which corresponded 
to endosomal fraction while the second peak was 1.075 g/ml and corresponded to the 
lysosomal fraction.  For the BIS I - treated cells, the radioactive WNV particles are 
observed in a single density fraction of 1.034 g/ml that corresponded to the endosomes 
(Figure 51c).  However, when BIS I was removed from Vero cell for 3 hr, a shift in the 
radioactivity counts towards the lysosomal fraction can be detected Figure 51d).  This 
suggested a resumption of PKC activity in endo-lysosomal trafficking.  Hence, PKC is 
indeed necessary for the trafficking of the internalized WNV from the endosomes to the 
lysosomes. 
 
5.4.3 PKC Isoforms are Responsible for West Nile Virus Entry 
The roles of PKC isoforms (PKCα, PKCβI, PKCβII, and PKCζ) in the endocytic 
pathway are poorly characterized.  By using Pro Trans protein delivery agent (MoBiTec 
GmbH, Germany), antibodies against different PKC isoforms can be delivered into cells 
and caused arrestment of specific PKC isoform activities.  The abolishment of PKC 
activities in Vero cells were determined by PKC assay kit (Upstate, USA) after the 
delivery of specific anti-PKC antibodies for 3 hr (Section 2.15.2).  Figure 52 (Appendix 
16g) shows the drastic reduction of various PKC isoforms’ activities in Vero cells after 
the introduction of antibodies against these PKC isoforms when compared to cells 
delivered in the absence of antibodies or cells delivered with a non- related antibody (IgG 
conjugated with FITC).  Since, the deliveries of antibodies against the different PKC 
isoforms are highly specific and effective in the perturbation of PKC activity, the specific 
PKC isoform or a combination of these kinases that might be involved in the entry of 
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Enzymatic activities of PKC and its isoforms.  The enzymatic activities of PKC 
and its isoforms (α, βI, βII and ζ) in cells transfected with specific antibodies were 
assayed.  The radioactivity counts (CPM) of the cell lysate was plotted against the 
concentration of each PKC or isoform used.  Vero cells transfected with specific 
antibodies against PKC and its isoforms strongly inhibit its enzymatic activities 
especially at the concentration of 10 µg.  
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WNV is determined.  After 3 hr of PKC isoforms antibodies delivery into Vero cells, the 
cells were infected with WNV at a M.O.I. = 10 and virus were harvested at 24 hr p.i. for 
plaque assays (Section 2.2.5).  Figure 53 (Appendix 16h) shows those specific antibodies 
against PKC and its isoforms (the antibodies are specific to the hinge domain and 
antibodies binding to this domain inhibiting its enzymatic activities) and its effect on 
virus infectivity.  Antibodies against PKC and PKCα exhibited the highest inhibition of 
WNV infection while antibodies against FITC (negative control) have minimal effect on 
WNV infection.  
 
5.5 LOW pH-DEPENDENT ENTRY OF WEST NILE VIRUS 
Assays to examine pH - dependent entry of WNV in the presence of lysomotropic 
weak bases (chloroquine and amantidine) and vacuolar H+-ATPase (VATPase) inhibitor 
(Bafilomycin A) were also carried out.  Lysosomotropic weak bases act by raising the pH 
within acidic vesicles thus, function as a proton sink.  Bafilomycin is a potent and 
specific inhibitor of VATPase that inhibit endosomes and lysosomes acidification 
(Yoshimori et al., 1991).  To ensure that the concentrations of the drugs used in this 
experiment can inhibit the acidification of the endocytic vesicles, intracellular acidic 
vesicles were stained with acridine orange (Section 2.15.1) and observed under a 
fluorescence microscope.  
For untreated Vero cells, granular orange fluorescence was observed (Figure 54a) 
and this is consistent with the descriptions reported by Nawa (1998) and Umata and 
group (1990).  The granular orange fluorescence in the cytoplasm was totally abolished in 
cells that were treated with 1.5 µM of chloroquine (Figure 54b), 1 µM of amantidine 
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Inhibition of WNV infectivity in cells transfected with antibodies against PKC 
and its isoforms.  Vero cells transfected with antibodies against PKC and its isoforms 
significantly inhibited WNV infection. Antibodies against PKC and PKCα mediate the 
most significant inhibition (approximately 3 log unit compared to the positive control) of 
WNV infection among the PKC isoforms. 
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Acridine orange staining of lysomotrophic and VATPase inihibitor - treated Vero 
cells.  Untreated Vero cells (a) and cells after incubation with chloroquine (b) are stained 
with acridine orange.  Acridine orange staining of acidic vesicles in chloroquine (b), 
amantidine (c) and bafilomycin (d) - treated cells are abolished when compared to the 
untreated cells (a).   
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(Figure 54c) and 25 µM of bafilomycin A (Figure 54d).  To analyze the effect of 
chloroquine, amantidine and bafilomycin A on the infectious entry mechanism of WNV, 
Vero cells were pretreated with increasing non-cytotoxic concentrations of each drugs 
and followed by WNV infection (Section 2.15.1).  Cells were assayed for infectious entry 
of WNV by counting the number of virus E protein - expressing cells.  All the three drugs 
(Figure 55a - bafilomycin A, Figure 55b – chloroquine and Figure 55c – amantidine, 
Appendix 16i) caused a marked reduction of WNV infection at 12 hr p.i. in a dose 
dependent manner.  Bafilomycin has the highest inhibitory effect on WNV infection of 
more than 80 % at 30 µM (Figure 55a).  Possible cytotoxic effects of the drugs were 
assessed by Trypan blue exclusion procedure and the observation of morphological 
changes.  Minimal cell toxicity was observed in the drug-treated cells throughout the 
spectra of concentrations used in this experiment. 
 
5.6 INVOLVEMENT OF ACTIN FILAMENTS AND MICROTUBULES 
NETWORK IN WEST NILE VIRUS ENTRY PATHWAY 
Clathrin - mediated entry pathway can be inhibited at different stages by specific 
drugs such as cytochalsin D and nacodazole. Cytochalasin D and nacodazole induced 
depolymerization of actin filaments and microtubules, respectively.  Durrbach and co-
workers (1996) have documented the sequential involvement of both actin filaments and 
the microtubules network in the trafficking pathway of ligands via clathrin - mediated 
endocytosis. Pretreatment of Vero cells with increasing concentration of either 
cytochalasin D or nacodazole exhibited a dosage - dependent inhibition of WNV 
infection.  Non-cytotoxic concentrations of cytochalasin D (0.1 to 2 µg/ml) and 
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Figure 55. 
Low pH - dependent entry of WNV into Vero cells.  Inhibitory effect on the entry 
of WNV into pre-treated Vero cells with (a) bafilomycin A, (b) chloroquine and (c) 
amantidine.  A dose-response inhibition of WNV entry is observed for all the three drugs 
used. (a) Bafilomycin A has the highest inhibition of virus infection (85 %) at the 
concentration of 30 µm while (b) chloroquine and (c) amantidine exhibited more than 70 
% and 80 % inhibition of virus infection at concentration of 2 µM and 1.5 µM, 
respectively.  The average of three independent experiments is shown. 
  189 
                                                                                       CHAPTER 5 
                                                                                RESULTS 
 
nacodazole (5 to 40 µM) prevented WNV infection.  (Figure 56a & b, respectively, 
Appendix 16j).  To investigate the specific locations that these drugs exert the effects on 
the entry process of WNV, sub-cellular fractionation of homogenized WNV-infected 
cells in 20 % Percoll gradients were performed (Section 2.12). Cellular fractionation in 
20 % self - generated Percoll gradient allowed the separation of sub-cellular particles 
based on buoyant density.  Density marker beads (Amersham Pharmacia, USA) were 
used as external markers to facilitate the density measurement of the separated sub-
cellular particles in the gradient (Figure 57a, Appendix 16k).  The densities of the 
endosomes, lysosomes, plasma membrane, endoplasmic recticulum were pre-determined 
and were noted to be 1.034 g/ml, 1.075 g/ml, 1.045 g/ml and 1.058 g/ml, respectively 
(Evans, 1987).   
  In this experiment, Vero cells that were either pre-treated with cytochalasin D (2 
µg/ml) or nacodazole (40 µM) for 1 hr before incubation with [35S] - methionine-
radiolabelled WNV at a M.O.I = 10.  At 15 min p.i., the WNV - infected cells were 
subjected to homogenization and follow by fractionation in Percoll gradient.  A total of 
24 fractions were analyzed for radioactivity.  For the untreated Vero cells, 2 peaks of 
radioactivity were detected (Figure 57b).  The density of the peaks was determined 
relative to the density bead makers shown in Figure 57a.  The density of the first peak 
was approximately 1.034 g/ml which corresponded to endosomal fraction while the 
second peak was 1.075 g/ml corresponding to the lysosomal fraction.  For the nacodazole 
- treated cells, the radioactive WNV particles were observed in a single density fraction 
of 1.034 g/ml that corresponded to the early endosomes (Figure 57c).  Hence, 
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Figure 56.   
Cytochalasin D and nacodazole pre-treated Vero cells inhibit entry of WNV.  
Percentage of viral antigen-positive cells is plotted against time. A dosage dependent 
inhibition of WNV internalization into (a) cytochalasin D (more than 90 % inhibition at a 
concentration of 2 µg/ml) and (b) nacodazole – (more than 80 % inhibition at a 
concentration of 40 µM) treated Vero cells is observed.  The average of three independent 
experiments is shown.  
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Figure 57.   
Sub-cellular fractionations of cellular homogenates from WNV - infected cells in 20 % 
Percoll gradients.  (a) Standard plot of density distribution determined by density marker 
beads in the 20 % Percoll gradient.  (b) Vero cells are allowed to internalize radiolabelled 
WNV at an M.O.I. = 10 for 30 min and subjected to cellular fractionation.  Radioactive 
viruses are detected in two distinct peaks (fraction 9 and fraction 18). Fraction 9 
corresponds to the endosomes while fraction 18 corresponds to the lysosomes. (c) and (d) 
similar procedure is carried out as in (b) except that the Vero cells were pretreated (1 hr) 
with nacodazole and cytochalsin D, respectively.  The peak observed in (c) corresponds 
to the endosomes and the peak observed in (d) corresponds to the plasma membrane. 
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intact microtubules network is indeed necessary for the trafficking of the internalized 
WNV from the early to late endosomes.  As for the cytochalasin D - treated cells, a single  
radioactive peak at the density of 1.045 g/ml was detected and this corresponded to the 
plasma membrane fraction (Figure 57d) therefore suggesting that the perturbation of actin 
filaments might have prevented the internalization of the attached virus particles on the 
plasma membrane. 
 
5.7 REAL - TIME IMAGING OF THE ENDOCYTIC PATHWAY OF WEST 
NILE VIRUS USING LASER SCANNING CONFOCAL MICROSCOPY 
Tracking individual virus in real-time allows one to reveal unambiguously the 
dynamics of virus transport in cells.  In the first part of the experiment, the optimal 
concentration (not affecting virus infectivity) of amine reactive FluoroLink Cy5 mono-
function dye (Amersham Pharmacia, USA) for WNV labelling was assessed. West Nile 
virus was concentrated and purified as describe in Section 2.2.4. Approximately 5 x 108 
PFU/ml of WNV was labelled with different concentrations of the amine reactive Cy5 
dye in carbonate buffer (pH 9.5) at 25 ºC for 1 hr (Figure 58a to d).  Effective coupling of 
Cy5 dye into WNV (arrows) was observed throughout the concentration of dye used. 
Figure 58e (Appendix 16l) shows that the amine-reactive Cy5 dye used in the D/P ratio 
provide optimal labelling of virus particles without compromising the virus infectivity. 
Cy5-labelled WNV (M.O.I. = 50) were first inoculated onto Vero cells placed in 
an enclosed chamber with the temperature maintained at 37 ºC and visualized under the 
laser scanning confocal microscope [(Leica, TCS SP2, USA) (Figure 59)].  After 5 min 
of inoculation of Cy5-labelled WNV, blue fluoresencence of Cy5-labelled virus particles 
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Figure 58.  
Infectivity of WNV with Cy5 labelling at different D/P ratio.  WNV (arrows) was 
stained with Cy5 amine reactive dye in the following (D/P) ratio of (a) 0.5, (b) 1.5, (c) 2, 
(d) 3. These concentrations of the dyes are highly effective in labelling of the WNV 
particles.  (e) The infectivity of WNV was plotted against the D/P ratio of Cy5 labelling.  
The infectivity of WNV is not significantly affected with Cy5 labeling. 
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Figure 59. 
Localization of Cy5-labelled virus particles within endocytic vesicles. (a) 
Transmitted light image of Vero cell showing the distribution of endocytic vesicles and 
(b) fluorescent image of Cy5-labelled virus particles are superimposed as shown in (c).  
Cy5-labelled virus particles are contained within some of the endocytic vesicles found in 
the cytoplasm of Vero cell. 
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(Figure 59b) were obvious within endocytic vesicles (Figure 59a & c).  Live tracking of 
late endosomes and lysosomes in cells can be achieved by labelling these organelles with 
Lysotracker Red DND - 99 probe (Molecular Probes).  The lysotracker probe is a 
fluorescent acidtrophic probe that selectively labelled acidic organelles in live cell 
without compromising their physiological functions.  Vero cells were incubated with 50 
nM (as suggested by the manufacturer) of lysotracker probes at 37 °C for 30 min and 
cells were extensively washed with PBS before viewing under the confocal microscope 
(Section 2.11.2.2). Live imaging of lysotracker - labelled late endosomes and lysosomes 
were captured for a period of 5 min at 10 frames per min as shown in Movie 1 (see 
enclosed CD).   
In order to visualize the trafficking of WNV-containing endocytic vesicles 
containing WNV along the microtubules network, Vero cells were transfected with 
mammalian expression vector (pEGFP-Tub, Clonetech, USA) that expresses GFP -
tagged tubulin monomers. This will polymerise to form intact green fluorescence 
microtubule network.  The GFP - labelled microtubule network can be visualized within 
24 hr post-transfection (Figure 60).  Vero cells expressing GFP - tagged tubulin were 
selected by G418 (antibiotic that selects for cells containing pEGFP - Tub) and these cells 
were then used for the real - time imaging of WNV entry process (Section 2.11.2.2). 
From the biochemical and microscopic analyses of the entry process of WVN as 
shown in Sections 5.2 – 5.8, WNV entry process can be categorized into three distinct 
phases; Phase I, receptor-mediated endocytosis of virus particles by clathrin pit formation 
and with the involvement of actin filaments at the plasma membrane for internalization; 
Phase II, Trafficking and maturation of endocytic vesicles containing the virus particles 
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Vero cells expressing GFP - labelled microtubule network. Vero cells were first 
transfected with pEGFP - Tub (Clontech, USA) mammalian expression vector that is 
capable of expressing GFP - tubulin and these molecules were then polymerized to 
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along microtubule network from the plasma membrane to the perinuclear region; Phase 
III, Uncoating of virus particles in low pH environment and the release of virus genome 
close proximity to the ER for virus replication.  For this part of the study, the phase II of 
the entry process was imaged on real-time starting from 5 min p.i. 
Vero cells expressing GFP - tubulin were first incubated with lysotracker probe 
and followed by WNV (Cy5 - labelled) infection at an M.O.I. = 50.  Real - time imaging 
of the trafficking process of endocytic vesicles containing WNV were traced for a period 
of 8 min and images were captured at 5 frames per min (Movie 2, see CD enclosed).  The 
endocytic vesicles that contained the Cy5 - labelled virus particles appeared pink 
(endocytic vesicles were labelled red, virus particles were labelled blue) and can be 
differentiated from those (red fluorescence only) that did not contain any virus particles 
(Figure 61).  It can be observed that the endocytic vesicles with the WNV were 
transported along the microtubule network from the cell periphery towards the 
perinuclear region of the cell.   
The track taken by one of the endocytic vesicles with WNV was traced over a 
period of 120 sec (Figure 62). The distance travelled by this particular vesicle was 
measured to be approximately 12 µm and the speed of its movement was determined to 
be 0.1µm/sec.  The average speed of moving along the microtubule network derived from 
a total of 50 endocytic vesicles with WNV moving along the microtubules network was 
determined to be approximately 0.3 µm/sec.  This recorded speed is typical of endosomal 
- lysosomal trafficking along microtubules network (Lakadamyali et al., 2003).   
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Triple fluorescence labelling of the cellular organelles and virus particles. (a) GFP 
- labelled intact microtubule network. (b) Lysotracker red labels the acidtrophic late 
endosomes and lysosomes. (c) Cy5 - labelled WNV particles are shown. (d) The 
superimposed image of the three fluorescent images of (a) to (c). 
  199 
                                                                                       CHAPTER 5 
                                                                                RESULTS 
 
Figure 62. 
Time lapse study on the trafficking of endocytic vesicles with WNV along the 
microtubule network. A single endocytic vesicle with WNV is traced for a period of 120 
sec.  The pink dot represents the Cy5 - labelled WNV (blue) in an endocytic vesicle (red) 
while the black lines represent the microtubules.  The endocytic vesicle with WNV is 
noted to travel along the microtubule from the cell peripheral towards the interior of the 
cell at an average speed of 0.3 µm/sec. Bar represents 4 µm.  
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6.0 HOST CYTOSKELETON, THE FACILITATOR OF WEST NILE VIRUS 
MORPHOGENESIS 
6.1 INTRODUCTION 
 In the previous chapter (Chapter 5), the endocytosis process of WNV was shown 
to have heavy reliance on the cytoskeleton network to target the internalized WNV to site 
of replication.  This chapter further investigates the possible roles of the cytoskeleton 
network in the morphogenesis of WNV. 
 
6.2 TRAFFICKING OF NEWLY SYNTHESIZED VIRUS STRUCTURAL 
PROTEINS ALONG MICROTUBULE NETWORK 
Ng and co-workers (1994) has previously documented that WNV distinctly egress 
at the plasma membrane rather than the conventional intracellular maturation of other 
flaviviruses.  Using cryo-immuno-electron microscopy, the C and E proteins were 
observed to associate closely and co-transported to the plasma membrane for WNV 
maturation (Ng et al., 2001).  However, these previous studies did not define the actual 
trafficking mechanism of WNV E and C proteins from the site of synthesis to the plasma 
membrane for morphogenesis.  An attempt was made to investigate whether the 
cytoskeleton network is involved in mediating the trafficking of these virus proteins.  
Triton X-100 extraction procedure (remove cytoplasmic proteins except proteins that 
associate strongly with microtubules) coupled with time - based indirect 
immunofluorescence microscopy were performed to trace the interactions between the 
virus structural proteins and the microtubules at various timings (4, 8, and 12 hr p.i., 
Section 2.11.1.2). In this part of the study, both E and C proteins antibodies were used as 
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markers to follow the movement of these structural proteins. In addition, the E protein 
antibodies would also reflect the locations of the matured virus particles at late infection. 
At early infection (4 hr p.i.), yellow speckles of fluorescence [arrows - E (Figure 
63a) proteins or C (Figure 63d) proteins] were observed at the perinuclear region. The 
yellow staining indicated the co-localization of the microtubules (stained with TR) and 
the virus proteins (stained with FITC). As the infection progressed to 8 hr p.i., individual 
yellow dots [arrows - E proteins (Figure 63b) or C (Figure 63e) proteins] were visualized 
to be radiating away from the perinuclear region. By late infection (12 hr p.i.), the viral 
structural proteins and virus particles were seen accumulating at the plasma membrane 
[arrows – E proteins (Figure 63c) or C (Figure 63f) proteins]. Despite Triton X-100 
extraction, both E and C proteins were still observed to be strongly associated with the 
microtubules throughout this study period. 
To further confirm the immunofluorescence results, Triton X-100 extraction 
procedure was coupled with critical point drying, carbon-shadowing and immunogold - 
labelling of the samples (Section 2.11.5). Two sizes of Protein A-gold particles were used 
in this double immunogold-labelling procedure. The 15 nm Protein A - gold particles 
were tagged to the tubulin antibody and the 10 nm gold particles were tagged to the virus 
E or C protein antibodies. The concentration of the primary antibodies and Protein A - 
gold particles were optimized. 
The cytoskeleton of virus-infected cells at 8 hr p.i. was double immunogold-
labelled with anti-tubulin and E or C protein anti-sera. The E (Figure 64a – arrows, 10 nm 
gold particles) and C (Figure 64b – arrows, 10 nm gold particles) proteins were 
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Figure 63. 
Distributions of E and C proteins in WNV-infected Vero cells extracted with 
Triton X-100. The E or C protein antibodies were conjugated to FITC and the 
microtubules were labelled with TR. At 4 hr p.i., the distribution of E [(a) - arrows] and C 
[(d) - arrows] proteins appear as yellow speckles (co-localization of the newly 
synthesized virus structural proteins and the microtubule network) around the perinuclear 
region. As the infection progress to 8 hr p.i., the E [(b) - arrows] and C [(e) - arrows] 
proteins are observed to radiate from the perinuclear region towards the plasma 
membrane. By 12 hr p.i., large clusters of yellow fluorescence of E [(c) - arrows] and C 
[(f) - arrows] are seen at the plasma membrane. Co-localization of E or C protein and the 
microtubules are observed throughout these series of timings. 
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Double immunogold-labelling of WNV-infected Vero cells extracted with Triton 
X-100. The anti-tubulin antibodies are tagged with 15 nm gold particles and the E or C 
protein antibodies are tagged with 10 nm gold particles. Both E [(a) - arrows] and C [(b) 
– arrows] proteins are observed to co-localize with tubulin (arrowheads). 
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associated with the microtubule network (Figures 64a and b – arrowheads, 15 nm gold 
particles). These data from Triton X-100 extraction procedure coupled with 
immunofluorescence microscopy or immunogold-labelling revealed strong association of 
WNV virus structural proteins with the microtubules. 
6.2.1 Type of Association of Virus E Proteins with Microtubules 
In the above, it was shown the strong association of WNV E and C proteins with 
the microtubules. Further investigation was made to determine the type of association 
that the virus E proteins have with the microtubules. The underlying mechanism for the 
virus proteins to be resistant to Triton X-100 extraction could be due to either their 
associations with the cytoskeletal networks via protein-protein interaction or with Triton 
X-100 insoluble lipids. Two different approaches were used: (i) Triton X-100 insoluble 
lipids are soluble in octyl-glucoside (OG), and (ii) protein-protein interactions with 
cytoskeletal proteins are likely to be disrupted by high salt concentrations. Such proteins 
should be solubilised by Triton X-100 extraction in high salt, unlike proteins interacting 
with lipids (Brown & Rose, 1992; Candurra el al., 1999). The C protein was not studied 
in this part of the study due to the limited quantity of anti-serum available. 
Vero cells infected with WNV were extracted with 60 mM of OG or 1M of NaCl 
as described in Section 2.10.1. In preliminary experiments to optimize the extraction 
procedure, the extraction periods and temperatures of incubation were varied. After each 
extraction, the virus E proteins were analyzed by Western blotting. Figure 65 showed that 
after extraction with high salt, E protein became much more soluble [a thicker intense 
band of E protein was observed in the high-salt soluble fraction, (Figure 65, Lane 2)]
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Solubility of WNV E protein with Triton X-100 (high salt) and OG extraction. 
WNV-infected Vero cells (at 8 hr p.i.) were extracted with either (i) Triton X-100 in 1 M 
NaCl or (ii) 60 mM OG. The detergent insoluble cytoskeletal fraction (IS) and soluble 
fraction (S) were then subjected to SDS-PAGE and Western blotting. The distribution of 
virus E proteins was detected with mono-specific polyclonal antibodies. Lane 1 (IS) and 
Lane 2 (S) E proteins extracted with Triton X- 100 in 1 M NaCl.  Lane 3 (IS) and Lane 4 
(S) E proteins extracted with 60 mM OG.  High amount of WNV E protein (Lane 2) is 
noted in the soluble fraction of high salt extraction procedure.  In comparison, equal 
quantity of WNV E protein is detected in both the [(IS) – Lane 3] and [(S) – Lane 4] 
fractions of OG extraction procedure.  
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while a much lower amount of E protein is found in the insoluble cytoskeleton fraction 
(Figure 65, Lane 1). In contrast, with OG extraction, approximately equal amount of E 
protein were present in both the OG - insoluble fraction and the OG - soluble fraction 
(Figure 65, Lanes 3 & 4). As such, it could be concluded that the WNV E proteins 
association with the microtubules was via protein-protein interaction. 
 
6.2.2 Effect of Microtubule-Disrupting Drug on the Trafficking Mechanism of E 
and C Proteins of West Nile Virus 
Vinblastine sulphate, a microtubules disrupting drug has been widely used in the 
study of the transport mechanism of both cellular and virus proteins that were dependent 
on the microtubules. Thus, disruption of the microtubules by vinblastine sulphate was 
employed as an alternative approach to further confirm the role of microtubules in the 
trafficking of the newly synthesized WNV structural proteins. Possible cytotoxicity 
effects at the concentration of 10 µg/ml were examined by assessing the effect on cell 
viability and morphological changes. The use of Trypan blue exclusion procedure 
revealed no significant variations in number of viable cells. Despite the formation of drug 
- induced microtubulin paracrystals, there were minimal cell rounding as well as 
detachment. Furthermore, the drug-induced microtubulin paracrystals were reversible 
when normal culture medium was added onto the treated cells. Therefore, vinblastine 
sulphate treatment does not result in permanent toxic effects on Vero cells during the 
period of study at a concentration of 10 µg/ml. 
Infected Vero cells treated with vinblastine sulphate (10 µg/ml) were processed 
for indirect immunofluorescence analyses after 4, 8 and 12 hr p.i. (Section 2.18.2).  The 
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vinblastine sulphate - induced microtubulin paracrystals were stained with TR 
(arrowheads) and the virus E (arrows - Figures 66a to c) and C (arrows - Figures 66d to e) 
proteins were stained with FITC. 
Many similarities were observed in the distribution patterns of both E and C 
proteins during the time - based study. At early infection (4 hr p.i.), the E (arrows - 
Figure 66a) and C (arrows - Figure 66d) proteins were observed as faint yellow speckles 
(co-localization) associating with the vinblastine sulphate - induced microtubulin 
paracrystals (arrowheads). By 8 hr after infection, the intensity and quantity of the yellow 
speckles [E (Figure 66b) or C (Figure 66e) protein - arrows] increased drastically. At late 
infection (12 hr p.i.), the vinblastine sulphate - induced microtubulin paracrystals were 
observed to fluoresce intensively. This intense yellow fluorescence was due to the 
accumulation of large quantity of the virus E (arrows - Figure 66c) or C (arrows - Figure 
66f) proteins that were strongly associated and retained within the drug - induced 
microtubulin paracrystals. Throughout these timings, minimal E or C proteins staining 
were observed in the cytoplasm or the plasma membrane. 
Morphologically that vinblastine sulphate did have an effect in the blocking of the 
trafficking of the virus structural proteins. The next step was to determine whether 
vinblastine sulphate could affect the overall virus production, further confirming the 
morphological observations. It was found that when the WNV - infected Vero cells were 
treated with vinblastine sulphate at 10 µg/ml, the extracellular virus yield was 
approximately 1000-fold lower than that of the untreated, infected cells at 12 hr p.i.
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Figure 66. 
Immmunofluorescence of WNV E and C proteins in infected Vero cells treated 
with vinblastine sulphate. The E or C protein was labelled with FITC and the vinblastine 
sulphate - induced microtubulin paracrystals were labelled with TR. At early infection, (4 
hr p.i., the E [(a) - arrows] and C [(d) - arrows] are observed as faint yellow speckles that 
are associated with the vinblastine sulphate-induced microtubulin paracrystals (stained 
with TR - arrowheads). By 8 hr p.i., E [(b) - arrows] and C [(e) - arrows] proteins 
appeared as bright yellow spots associated with the red fluorescent microtubulin 
paracrystals (arrowheads). As the infection progress to 12 hr p.i., E [(c) -arrows] and C 
[(f) - arrows] proteins are observed to be accumulated within the microtubulin 
paracrystals (arrowheads). 
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(Figure 67, Appendix 17a).  It was also noted that the reduction in the extracellular virus 
titer was not due to the drastic decrease in the viability of the infected cells (Figure 67). 
  
6.3 KINESIN, A PUTATIVE MICROTUBULE - BASED MOTOR PROTEIN 
RESPONSIBLE FOR VIRUS ENVELOPE PROTEIN TRAFFICKING 
ALONG THE MICROTUBULES 
A number of microtubule - associated motor proteins has been identified and are 
involved in cargo transport along the microtubule network.  Kinesin is a plus – end - 
directed microtubule associated protein that mediates cargo transport toward the cell 
surface (Bloom and Endow, 1994, 1995).  Since, WNV E proteins were observed to 
transport along the microtubule towards the cell periphery for assembly, the involvement 
of kinesin in transporting WNV E protein was investigated. Both indirect 
immunofluorescence microscopy (Section 2.11.1.2) and affinity immunoprecipitation 
assay (Section 2.9) were carried out to examine kinesin in the trafficking of virus E 
protein towards the plasma membrane.  Co-localisation study of the WNV - infected cells 
at 8 hr p.i. has shown that the distribution of the virus E protein appeared to be similar to 
that of the kinesin (Figures 68a to c). Subsequent experiment was carried out to 
determine whether the C terminal (cargo loading domain) of kinesin interacts with virus 
E protein. 
The GST-kinesin (C terminus) fusion protein or GST bound to glutathione beads 
(negative control) were reacted with lysates of infected cells as described in Section 2.9. 
The bound proteins were rinsed and solubilised, electrophoretically separated and 
immunoblotted. Prominent E protein band (55-kDa) was observed after affinity 
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Extracellular virus production of WNV - infected Vero cells treated with 10 
µg/ml of vinblastine sulphate. Graphs of extracellular virus production or cell viability 
plotted against time (p.i.) are shown. The number of extracellular virus production upon 
vinblastine sulphate treatment (diamonds) was strongly inhibited as compared to that of 
the untreated (squares). The number of viable cells throughout this study was determined 
by Trypan blue exclusion method (circles). Results of three independent experiments are 
shown. 
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Figure 68. 
Co-localisation of virus E protein and kinesin. Vero cell were infected with WNV, 
maintained for 8 hr and stained with antibodies to kinesin and virus E protein. The 
kinesin (a) is stained with TR and the virus E protein (b) is stained with FITC. Obvious 
co-localisation of the virus E protein and kinesin (c) is observed when (a) and (b) are 
superimposed (d). Immunoblot of E protein bound to GST - kinesin (cargo loading 
domain) fusion proteins. Lane 1, Lysate of mock-infected Vero cells reacted with GST-
kinesin. Lane 2, Lysate of infected Vero cells reacted with GST - kinesin. Lane 3, Lysate 
of infected Vero cells reacted with GST (negative control). The cargo loading domain of 
kinesin interacts specifically with virus E protein (arrowhead) as shown in Lane 2. 
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precipitation with GST - kinesin (C terminus) fusion protein as shown in Figure 68d 
(Lane 2).  The E protein band was not detected in negative control (Figure 68d, Lane 1) 
and infected cell lysate reacted with GST only (Figure 68d, Lane 3).  This affinity 
precipitation assay further affirms the interaction of virus E protein with kinesin along 
with the microtubules. 
 
6.4 APICAL RELEASE OF WEST NILE VIRUS IS DEPENDENT ON 
PROTEIN SORTING ALONG MICROTUBULE NETWORK  
In the previous sections (6.2 – 6.3), microtubule network has been shown to be 
essential for the trafficking of WNV structural proteins in non-polarized cells. This part 
of the study continues to explore if microtubule network is involved in the directional 
trafficking of the virus structural proteins in polarized epithelial cells (Vero C1008). 
Several mechanisms have been proposed for the directional (either apical or basolateral) 
sorting of cellular proteins in polarized cells (Wandinger-Ness and Simons, 1991). 
 
6.4.1 Apical Egression of West Nile Virus from Polarized C1008 Cells 
The first part of the study is to determine if WNV (relies on microtubule for 
protein trafficking) or KUN virus (does not relies on microtubule for protein trafficking) 
are released at distinct (apical or basolateral) surfaces of polarized cells.  WNV or KUN 
virus was inoculated as described in Section 2.2. At different time - points (p.i.), the 
infected supernatants from either the apical or the basolateral chambers were assessed for 
the yield of progeny virus by plaque assays (Section 2.2.5, Figure 69, Appendix 17b). 
The WNV was found to be released predominantly from the apical surface of Vero 
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C1008 cells (Figure 69a). At 12 hr p.i., virus titres of WNV from the apical surface were 
more than 4 log units higher than those at the basolateral surface. In contrast, bi-
directional release of KUN virus was observed (Figure 69b). The titres of KUN virus 
released from the apical domain were approximately equivalent to those from the 
basolateral domain throughout the time sequence study. As a positive control, the release 
of poliovirus from Vero C1008 cells was determined. Figure 69c shows the bi-directional 
release of poliovirus from Vero C1008 cells. This was consistent to the previous study 
conducted by Tucker et al. (1993). In comparison, non - polarized Vero cells were also 
infected with WNV or KUN virus. Not surprisingly, bidirectional release of WNV virus 
from non - polarized cells was observed (Figure 69d). This was in contrast to that from 
polarized Vero C1008 cells.  The release of KUN virus from non - polarized Vero cells 
remained bi-directional (Figure 69e).  
To confirm the above results further, localization of virus E proteins and virus 
particles was determined during virus release in infected Vero C1008 cells using 
immunofluorescence coupled with confocal microscopy and transmission electron 
microscopy (Sections 2.11.1.2 and 2.11.4, respectively). The WNV virus E protein and 
maturing virus particles were observed as yellowish speckles of fluorescence localized 
exclusively at the apical surface of the infected cells (Figure 70a). In contrast, KUN virus 
was localized at both domains of the infected cell monolayer (Figure 70b).  
At the ultrastructural level, cross-sections of the flavivirus - infected cell 
monolayers grown on porous membranes revealed budding of WNV virus at the apical 
surface of the plasma membrane (Figure 71a & b, arrows). In contrast, exocytosis of 
intracellular mature KUN virus was noted at both apical and basolateral domains of 
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Figure 69. 
Release of WNV occurs predominantly at the apical domain, while KUN virus 
release occurs bi-directionally in Vero C1008 cells. Vero C1008 cells (a, b) and non-
polarized Vero cells (d, e) were inoculated apically with either WNV or KUN virus. (c) 
Positive control is the poliovirus-infected Vero C1008 cells. Productive virus titres from 
supernatants collected from the apical and basolateral chambers are determined by plaque 
assay at 4, 8, 12 and 14 hr p.i. for WNV and 6, 12, 18 and 24 hr p.i. for KUN viruses, 
respectively. (a) Apical release of WNV from Vero C1008 cells. (b) Bi-directional 
release of KUN virus from Vero C1008 cells is shown. (c) Bi-directional release of 
poliovirus is seen from Vero C1008 cells (positive control). (d, e) Bi-directional release 
of WNV and KUN viruses are observed from non-polarized Vero C1008 cells.
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Cross - sections of flavivirus-infected Vero C1008 cells late in infection. WNV - 
or KUN virus - infected Vero C1008 cells grown on porous membranes were processed 
for immunofluorescence staining of virus E proteins or maturing virus at 12 and 24 hr p.i., 
respectively. (a) Apical localization of WNV E protein on the plasma membrane of Vero 
C1008 cells (arrows) is observed. Some of the larger dot fluorescence could be due to 
clumping of extracellular virus particles on the plasma membrane during virus egress. (b) 
KUN virus are observed at both surfaces of the Vero C1008 cells (arrows). Nuclei are 
stained with propidium iodide (red) and the virus E proteins are stained with FITC. 
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Figure 71.  
Ultrastructural studies of WNV and KUN virus release from Vero C1008 cells. WNV - 
and KUN virus - infected Vero C1008 cells are processed for transmission electron 
microscopy, as described in Section 2.11.4. (a) Cross sections of the infected cells 
revealed distinct budding of WNV (arrows) from the apical surface of Vero C1008 cells. 
(b) A higher magnification [boxed area in (a)] of WNV virus budding from the apical 
surface. (c) Bi-directional release of KUN virus by exocytosis (arrowheads) was observed. 
(d, e) Higher magnification of the boxed area from (c) showing the apical (A) and 
basolateral (B) release of KUN virus, respectively. Bars represent (a) 300 nm, (b) 500 nm, 
(c) 300 nm, (d) 300 and (e) 300 nm. The apical (A) and basolateral (B) surfaces of Vero 
C1008 cells are indicated. 
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polarized epithelial Vero C1008 cells (Figures 71c to e, arrowheads).  Figure 71 (d & e) 
are the higher magnification of boxed area in (c). These results strongly indicated that the 
release of WNV is polarized and occurs predominantly at the apical domain of Vero 
C1008 cells, but this is not so for KUN virus. Throughout this study, the integrity and 
polarity of flavivirus - infected Vero C1008 cells were also monitored by measuring the 
electrical resistance across the cell monolayers. The electrical resistance of the flavivirus 
- infected cell monolayers was 50-70 Ω/cm2. In addition, the integrity of the cell 
monolayers was also monitored by visualizing under the optical microscope. It was 
observed that flavivirus - infected Vero C1008 cells formed tight epithelial cell 
monolayers until late infection. Cell rounding was only observed after 14 and 24 hr p.i. 
for WNV and KUN virus, respectively. Late in infection, the electrical resistance of 
flavivirus - infected cell monolayers was less than 20 Ω/cm2. 
 
6.4.2 Polarized Sorting of West Nile Virus E Protein to the Apical Domain of Vero 
C1008 Cells Is Dependent on Intact Microtubule Network 
  In the current study (Section 6.2), the E and C proteins of WNV were observed 
being transported along cellular microtubules in non-polarized Vero cells from the site of 
synthesis (i.e. endoplasmic recticulum and Golgi apparatus) to the cell periphery for 
assemby. However, it is not known whether microtubules are involved in the polarized 
sorting of WNV egression in Vero C1008 cell.   
In these series of experiments, the possible involvement of microtubules in the 
polarized sorting of the E proteins of WNV and KUN viruses was investigated. The 
WNV or KUN virus-infected Vero C1008 cells were treated with a microtubule 
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drug, vinblastine sulphate, at a concentration of 10 µg/ml (Section 2.18.3). Minimal 
cytotoxic effects on Vero C1008 cells was noted. Despite the formation of vinblastine 
sulphate-induced microtubulin paracrystals, minimal cell rounding and cell death was 
observed. As shown in Figure 72 (Appendix 17c, disruption of the microtubule network 
led to a drastic inhibition of the apical release of WNV but not KUN virus. However, the 
basolateral release of WNV (Figure 72) was not affected (see Figure 69a for similarity). 
Furthermore, WNV and KUN virus-infected Vero C1008 cells treated with 
vinblastine sulphate were also processed for indirect immunofluorescence assay at 12 and 
24 hr p.i., respectively. In Figure 73a, entrapment of WNV E protein (arrows) with the 
drug-induced microtubulin paracrystals (arrowheads) was observed. Yellow staining 
indicated co-localization of the E protein (FITC) with the microtubulin paracrystals (TR). 
Staining of WNV E proteins was not observed in the cytoplasm and cell plasma 
membrane. In contrast, KUN virus E proteins/virus particles were localized to the cell 
cytoplasm and plasma membrane (extracellular virus) but not the drug-induced 
microtubulin paracrystals (Figure 73b). Together these results strongly suggested that the 
intracellular sorting of WNV E protein to the apical surface is dependent on the 
microtubule network, whereas KUN virus is not. 
 
6.5 VIRUS STRUCTURAL PROTEINS ASSOCIATE WITH ACTIN 
FILAMENTS AT CELL PLASMA MEMBRANE 
An obvious increase in the concentration of filaments just beneath the infected 
cell plasma membrane was clearly shown using the atomic force microscopy (Figure 74). 
Figure 74a shows the height image of an uninfected cell periphery.  The presence of some 
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Figure 72.  
Role of microtubules in the polarize release of WNV and KUN virus in polarized 
epithelial cells. The disruption of microtubules by vinblastine sulphate strongly inhibits 
the apical release of WNV but not KUN virus. 
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 Localization of WNV E protein in infected Vero C1008 cells treated with 
vinblastine sulphate. (a) WNV E proteins (labelled with FITC, arrows) are observed as 
yellow speckles that were strongly associated with vinblastine sulphate - induced 
microtubulin paracrystals (labelled with TR, arrowheads).  (b) In contrast KUN virus 
particles (green fluorescence) are observed predominantly at the plasma membrane. 
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Figure 74.  
Atomic force microscopy of uninfected and WNV - infected Vero cells. The cells were 
fixed and dehydrated through a series of ethanol before imaging with a force modulation-
etched silicon probe (FESP). A hard tapping mode was used. (a) Some filamentous 
structures (arrows) are seen at the uninfected cell periphery. The height image is shown at 
scan size of 7.84 mm. (b) After 12 hr p.i., the filamentous network is enhanced. The 
filaments seen are thickened and lengthened (arrows) along the plasma membrane region. 
Interconnecting filaments are also observed between parallel filaments. The height image 
is shown at a scan size of 7.16 mm.  The bars represent 1 µm. 
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filamentous structures (arrows) was detected adjacent to the plasma membrane. However, 
with the progression of infection, the filaments (arrows) became thickened and 
lengthened parallel to the plasma membrane for both 10 and 12 hr p.i. (Figure 74b). The 
increased complexity of this filamentous network was evident. Interconnecting filaments 
are also observed to be forming between the parallel filaments. 
To identify these filaments, as well as their involvement with the virus maturation 
process at the cell periphery, immunolabelling on Triton X-100 - extracted cytoskeleton 
was performed. Immunogold labelling was used to identify the virus structural proteins 
and actin filaments on the cytoskeleton network (Section 2.11.5.1).  Two sizes of Protein 
A-gold particles were used: the 15 nm Protein A-gold particles were conjugated to WNV 
E protein antibodies, and the 10 nm gold particles were conjugated to actin antibodies.  
For WNV - infected cells, actin filaments at the cell peripheral (Figure 75a, arrows) were 
thickened extensively by 10 hr p.i. 
The thickening of the actin filaments at the cell peripheral (10 nm gold particles; 
Figure 75b, arrowheads) could indicate actin filament enhancement at late infection.  At 
this stage, the presence of virus envelope proteins (15 nm gold particles; Figure 75b, 
arrows) was evident and associated with the thickened filaments. 
To confirm the results obtained in Figure 75, immunoprecipitation of 
radiolabelled virus structural proteins with antibodies against actin was performed 
(Section 2.9). Using a time - based study (6, 8, and 10 hr p.i), WNV-infected and 
uninfected cells were lysed, clarified, and mixed with antibodies against actin protein. No 
virus proteins were detected when immunoprecipitation was carried out with mock-
infected cells (Figure 76a, Lane 1) or with Protein A - Sepharose beads, in the absence 
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Figure 75.  
The association of WNV E proteins with actin filaments at the cell periphery. 
Cytoskeletal filaments of WNV-infected Vero cells were prepared by Triton X-100 
extraction coupled with platinum and carbon shadowing. (a) The thickened filamentous 
network at the infected cell periphery is indicated by arrows. (b) Higher magnification of 
the thickened filamentous region is shown. The actin filaments are indicated by the 10 
nm gold particles (arrowheads), while the virus envelope proteins are indicated by the 15 
nm gold particles (arrows). Virus envelope proteins are observed to associate with the 
thickened actin filaments. Scale bar represents 500 nm in (a) and 100 nm in (b). 
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Immunoprecipitation of WNV structural proteins with anti-actin antibody. (a) Cell lysate 
from mock-infected and West Nile virus-infected were immunoprecipitated with anti-
actin antibody. Immunoprecipitated proteins were separated by polyacrylamide gel 
electrophoresis (SDS–PAGE). Lane 1, profile from cell lysate from mock-infected cells 
reacted with anti-actin antibody; Lane 2, profile from lysate of West Nile virus-infected 
cell reacted with Protein A - Sepharose beads, but without anti-actin antibody. No virus 
protein bands are detected in both Lanes 1 and 2. Lysate of West Nile virus-infected cells 
at 4 hr p.i. (Lane 3), 6 hr p.i. (Lane 4), 8 hr p.i. (Lane 5), and 10 hr p.i. (Lane 6) were 
reacted with anti-actin antibody. Two protein bands at 55-kDa and 15-kDa are seen in 
Lanes 5 and 6. (b) Western blotting detection of virus structural proteins. 
Immunoprecipitated virus proteins were reacted with anti-WNV C protein (Lane 1) and 
anti-WNV E protein (Lane 2). This confirms that the 15-kDa protein band is the C 
protein, while the 55-kDa protein band is the E protein. 
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of anti-actin antibodies (Figure 76a, Lane 2). This was to ensure that the Protein A-
Sepharose beads did not interact non-specifically with the virus proteins. Viral proteins 
were not observed at early infection (4 and 6 hr p.i.; Figure 76a, Lanes 3 and 4). 
However, two faint but distinct bands of 55-kDa and 15-kDa were obtained at 8 hr p.i. 
(Figure 76a, Lane 5). The bands increased in intensity by 10 hr p.i. (Figure 76a, Lane 6), 
indicating an elevation in the amount of viral proteins associating with the actin filaments 
at late infection. The 15-kDa band was the C protein, while the 55-kDa band was the E 
protein as identified by Western blotting with antibodies against the respective virus 
proteins (Figure 76b, Lanes 1 and 2, respectively). The results strongly suggested the 
close association of virus structural proteins with the actin filaments at the plasma 
membrane during the late infection stage.  
 
6.5.1 Budding of West Nile Virus at the Plasma Membrane is Associated with 
Actin Filaments. 
As illustrated earlier by Ng and colleagues (2001), cryo-fixation of virus-infected 
samples are capable of preserving virus and cellular structures better compared with 
conventional chemical fixation.  Furthermore, immunolabelling can be carried out 
without compromising the antigenicity. For this part of the study, WNV - infected cells 
were processed for cryo-immuno-electron microscopy (Section 2.11.6) during the 
maturation stage (at 8–10 hr p.i.). Actin filaments were labelled with anti-actin 
monoclonal antibodies and conjugated with Protein A-10 nm gold particles.  At 8 hr p.i., 
the plasma membrane was slightly raised to form the initial curvature of the egressing 
nucleocapsid particles (arrows) and actin filaments (thread-like structures, as indicated by 
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the 10 nm gold particles; arrowheads) were found in close proximity to the budding virus 
particles (Figure 77a). As the virus emerged through the plasma membrane, spherical 
virus particles enclosed in the lipid bilayer envelope were formed (Figure 77b, arrows). 
Throughout the process, the actin filaments were in close association with the budding 
surface (10 nm gold particles; Figure 77b). 
 
6.5.2 Disruption of Actin Filaments Inhibits West Nile Virus Budding at the 
Plasma Membrane 
Cytochalasin B, widely used to study the involvement of actin cytoskeleton in 
cellular processes (Cooper, 1987) was used to disrupt the actin filaments in Vero cells. 
The effect on WNV budding at the plasma membrane was assessed. The concentration of 
cytochalasin B used was first optimized to minimize its cytotoxic effect on Vero cells.  
Cytochalasin B, 10 mg/ml, was used, since it caused minimal cell rounding and lifting of 
cells from the growing substratum, when examined under the optical microscope. Trypan 
blue staining also indicated that the viability of cytochalasin B (10 mg/ml) - treated cells 
was not significantly different from those of the untreated cells as determined under the 
microscope.  
To investigate the effect of the disrupted actin filaments on virus budding at the 
plasma membrane, WNV-infected cells were treated with cytochalasin B at 4 – 12 hr p.i 
(Section 2.18.4). The yield of released extracellular virus particles was determined using 
plaque assays. Figure 78a (Appendix 17d) shows a 5-log unit reduction in the 
extracellular virus titer at 12 hr p.i. compared with that of the untreated cells.  Unlike 
most members of the flaviviruses, the latent period of WNV is very short; advanced 
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Cryo-immuno-electron microscopy of WNV budding at the plasma membrane. (a) 
Actin filaments are observed as thread - like structures (labelled by anti-actin antibodies 
conjugated with 10 nm gold particles) beneath the budding particles (arrows). (b) By 10 
hr p.i., advance budding process of WNV from the plasma membrane is observed. Actin 
filaments (10 nm gold particles) are localized at the site of the plasma membrane where 
there is prolific budding of WNV. Bar represents 50 nm in (a) & (b). 
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Figure 78. 
Effects of cytochalasin B on WNV egression from Vero cells.  (a) Extracellular 
virus production of WNV - infected cells treated with 10 mg/ml of cytochalasin B. 
Extracellular virus production is plotted against time (p.i.). The number of extracellular 
virus produced upon cytochalasin B treatment was strongly inhibited compared with the 
untreated cells (especially at late infection). The average of three independent 
experiments is shown. (b) Resumption of extracellular virus production with the removal 
of cytochalasin B. There is a drastic increase in the release of WNV within 3 hr after the 
removal of cytochalasin B from the WNV - infected cells. 
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cytopathic effects are often observed at 12 to 14 hr p.i.  In another experiment, 
cytochalasin B was removed from the virus-infected cells and replaced with fresh cell 
culture medium. Production of extracellular virus was then determined at 1, 2, and 3 hr 
after the removal of cytochalasin B. As shown in Figure 78b, the release of extracellular 
virus was observed to recover within 3 hr of removal of cytochalasin B. These results 
further led to the conclusion that intact actin filaments are essential during the budding 
process of WNV at the plasma membrane.  
In addition, the effect of cytochalasin B on the virus budding process was 
visualized using immunofluorescence and immuno-electron microscopy. At 10 hr p.i., 
WNV-infected cells treated with cytochalasin B were processed for immunofluorescence 
staining. The virus structural envelope proteins were observed to accumulate into large 
clusters at the infected cells periphery (Figure 79a, arrows). Disrupted actin filaments 
(stained with Texas Red; Figure 79b) were also noted to co-localize in a similar pattern 
with the virus E proteins (stained green; Figure 79a). When Figures 79a and b were 
superimposed, a strong correlation of localization was seen (stained yellow; Figure 79c, 
arrowheads). The clustering of the actin filaments seen in Figure 79b was not seen in the 
control untreated cells (Figure 79d). Ultrastructural analysis of the drug - treated cells in 
cryo-sections showed nucleocapsid-like particles accumulating in large numbers near the 
periphery of the virus - infected cells. The identity of the nucleocapsid - like particles was 
further confirmed using the anti-C antibody (conjugated to the 10 nm gold particles, 
Figure 79d, arrowheads). Actin filaments (indicated by the 5 nm gold particles, arrows)  
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Figure 79. 
Distribution of WNV structural proteins in cytochalasin B - treated Vero cells. 
The infected cells were treated with cytochalasin B from 4 to 12 hr p.i. (a) The E proteins 
are observed to accumulate in large clusters (arrows) at the cytoplasmic side of the 
infected cell plasma membrane. (b) Disrupted actin filaments are also observed to have 
similar distribution pattern as the E proteins in (a).  (c) Co-localization of both envelope 
proteins and the disrupted actin is seen (arrowheads). (d) No clustering of the actin 
filament is seen in the untreated cells. The filaments are well - dispersed throughout the 
cytoplasm and around the cell boundary. (e) Ultrastructural analyses by cryo-immuno-
electron microscopy of WNV - infected cells (treated with cytochalasin B). Disrupted 
actins (5 nm gold particles; arrows) are observed to co-localize with the accumulating 
nucleocapsid particles (10 nm gold particles; arrowheads). Scale for (a) to (d) is 1000 x 
magnification (e) The bar represents 50 nm.   
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were again detected intercalating with the accumulating nucleocapsids. Hence, 
perturbation of actin filaments held back the virus precursors (envelope proteins and 
nucleocapsids) from maturing into infectious virus particles.  
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7.0 INTERPLAY OF VIRUS AND CELLULAR COMPONENTS DURING 
WEST NILE VIRUS – INDUCED CELL DEATH 
 
7.1 INTRODUCTION 
 In this chapter, the contributing factors to the types and mechanisms of cell death 
were investigated.  In addition, the involvement of cellular components resulting in virus-
induced cell death was defined. 
 
7.2 WEST NILE VIRUS - INDUCED CYTOPATHOLOGY AT DIFFERENT 
M.O.I. 
The egression of maturing virus from the cell surface of infected cells is often 
accompanied by cell death.  During WNV infection, extensive cytopathic effects (CPE) 
are observed in both in-vivo and in-vitro systems (Paul et al., 1969; Odelola & Fabiyi, 
1977; Jordan et al., 2000; Sampson et al., 2000; Senne et al., 2000; Shieh et al., 2000; 
Cantile et al., 2001; Xiao et al., 2001).  However, the actual mechanism and factors 
contributing to cell death during WNV infection is poorly documented. 
Firstly, to determine the effect of the WNV infectious dose on the process of cell 
death, Vero cells were infected with WNV at an M.O.I. = 0·1, 1, 10 and 100. Productive 
virus yields and cell viability were determined at selected time intervals (Figure 80, 
Appendix 18a).   In WNV-infected cells with M.O.I. = 0·1 or 1, there was a delay in the 
onset of cell death, as revealed by the Trypan blue - exclusion assay. 
At 16 hr p.i., there were approximately 95 % viable cells, which decreased to 50 
% at 32 hr p.i. (Figures 80a and b, respectively). In relation to the slower virus - induced 
CPE, there were approximately 107 PFU/ml of virus obtained at 32 hr p.i. For cells that 
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Figure 80.  
The effects of different infectious doses of WNV-infected Vero cells. 
Extracellular virus production (■) and cell viability (•) plotted against time (p.i.). Vero 
cells were infected with WNV at an M.O.I. of (a) 0.1, (b) 1, (c) 10 and (d) 100.  At the 
indicated time, cell supernatants were harvested and plaque assays were performed. The 
trypan blue exclusion method was used to determine cell viability throughout the study.  
At M.O.I. = 0.1 and 1, the peak of virus production (107 PFU/ml) was observed by 32 hr 
p.i. while at M.O.I. = 10 and 100, the peak of virus production was observed within 14 hr 
p.i.  Results from three independent experiments are plotted. 
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were infected with WNV at high M.O.I. (10 or 100), by 14 hr p.i., there was less than 35 
% viable cells (Figure 80c and d, respectively). Approximately 109 PFU/ml of WNV was 
obtained from 14 hr p.i. For mock-infected cells, the number of viable cells remained 
relatively constant throughout the experiment.
Morphological characteristics of cell death induced by WNV at different M.O.I. 
were examined microscopically. Mock-infected cells had the epithelial cell appearance 
(Figure 81a). At the ultrastructural level (Figure 81b), the cells had a healthy number of 
mitochondria (M) and a well - defined nucleus (Nu).  At 12 hr p.i., WNV-infected 
(M.O.I. = 10 or 100) Vero cells showed generalized cell swelling (Figure 81c, 
arrowheads) and lysis (arrows) when compared to mock - infected cells (Figure 81a). At 
the ultrastructural level, extensive cytoplasmic vacuolation (V) and loss of plasma 
membrane integrity were noted (Figure 81d, arrows). These morphological characteristics 
of cell death are consistent with necrosis (Leist & Nicotera, 1997; Koyama et al., 2001). 
7.2.1 Necrosis Observed in Cells Infected with West Nile Virus at M.O.I. ≥ 10 
To confirm that infection of Vero cells with WNV at high infectious doses M.O.I. 
≥ 10) induced cell death by necrosis, lactate dehydrogenase (LDH) activity and 
extracellular release of high mobility group 1 (HMGB1) protein (a specific marker for 
necrosis) were assessed. The loss of plasma membrane integrity was determined by 
measuring LDH activity in supernatants of WNV - infected cells.  The LDH is a stable 
cytosolic enzyme that is released into the extracellular matrix upon cell lysis.  Figure 82a 
(Appendix 18b) shows that there was a remarkable increase in the level of LDH activity 
(approximately an 8-fold increase from 6 to 12 hr p.i.). This leakage suggested 
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Figure 81.  
Induction of morphological changes in Vero cells infected with WNV at high 
infectious doses (M.O.I. ≥ 10). Mock - infected cells (12 hr) viewed under an optical 
microscope (a) and transmission electron microscope (b). Normal cell morphology is 
seen. (c) Extensive swellings (arrowheads) of WNV-infected cells are observed at 12 hr 
p.i. under the optical microscope. Cell lysis is noted (arrows). (d) At the ultrastructural 
level, extensive vacuolation of WNV-infected cells is observed at 12 hr p.i. Arrows 
indicate the loss of plasma membrane integrity leading to cell lysis. Bars represent 1.0µm 
in (b) and 1.0 µm in (d).  In (b) and (d), Nu denotes nucleus, M denotes mitochondria, V 
denotes vacuoles, Cy denotes cytoplasm. 
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Figure 82.  
Measurement of LDH activity in WNV - infected Vero cell supernatants. (a) Vero 
cells infected with WNV at an M.O.I ≥ 10 exhibits a marked increase in LDH activity (6-
fold increase within 8 hr p.i.). The level of activity peaks to over an 8-fold increment 
after 12 hr p.i. (b) Measurement of LDH activity in WNV - infected cells treated with 
cytochalasin B. Inhibition of WNV budding at the plasma membrane through disruption 
of actin filaments by cytochalasin B has resulted in a drastic decrease in LDH release. (c) 
In contrast, Vero cells that were infected with WNV at an M.O.I. ≤ 1 only show a slow 
increase in LDH activity. Only basal levels of activity are seen at 24 hr p.i..  The LDH 
activity increased by 6-fold after 32 hr p.i. Results of three independent experiments are 
plotted.
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membrane integrity and the loss of plasma was consistent with the morphological data 
shown in Figure 81d. 
It was previously documented (Ng et al., 2001) that by 12 hr p.i., massive 
budding of progeny WNV particles at the plasma membrane was observed when Vero 
cells were infected at an M.O.I. = 10. Therefore, the loss of membrane integrity observed 
in necrotic cells in this study could be due to extensive budding. To address this issue, 
WNV-infected (M.O.I. = 10) Vero cells were treated with cytochalasin B (an actin-
disrupting drug) and extracellular LDH activities at selected time intervals were assayed 
(Section 2.19.1).  The disruption of actin filaments with cytochalasin B was able to inhibit 
the budding of WNV at the plasma membrane (Section 6.5.2). 
There was a drastic reduction in LDH activity (approximately a 6-fold reduction) 
in WNV - infected cells with cytochalasin B treatment (Figure 82b, Appendix 18b) when 
compared to the untreated sample (Figure 82a). These results suggested that the loss of 
membrane integrity was due to the profuse budding of virus particles at the plasma 
membrane, eventually contributing to necrosis. 
For WNV - infected cells (M.O.I. ≤ 1), there was only a slight increase in released 
LDH activity (1·8-fold) by 24 hr p.i. (Figure 82c, Appendix 18b) and, subsequently, 
almost a 6-fold increase was observed after 32 hr p.i. This level was still lower than 
infection with high M.O.I. and it took 20 hr longer compared to data shown in Figure 82a. 
 The late release of LDH from these infected cells suggested a delay of cell death due to 
lower virus egression activity prior to 32 hr p.i. 
Previous studies have suggested that HMGB1 protein is a specific marker for 
necrotic cells.  This protein leaks out rapidly into the extracellular space when 
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membrane integrity is lost during necrosis (Falciola et al., 1997; Degryse et al., 2001; 
Muller et al., 2001; Scaffidi et al., 2002). Figure 83a shows the release of HMGB1 
proteins into the extracellular medium of WNV-infected (M.O.I. = 10) cells by 12 hr p.i. 
Minimal HMGB1 protein was observed to associate with the nuclear fraction. Although 
some HMGB1 protein was observed in the extracellular medium of mock-infected cells, 
the protein was retained mostly within nuclei (Figure 83a). This contrasted with the lack 
of nuclei retention of the HMGB1 protein in WNV - infected cells (Figure 83a).  
This result was confirmed further using immunofluorescence staining for HMGB1 
protein (Figure 83b and Figure 83c). Clear nuclear staining was seen in mock-infected 
cells (Figure 83b), whereas there was minimal nuclear fluorescent staining in infected 
cells (Figure 83c). The majority of staining was present in the infected cell cytoplasm due 
to the leaking of HMGB1 from the nucleus. So far, the data suggested that necrosis was 
predominant mode of cell death induced by WNV infection at high infectious doses 
(M.O.I. ≥ 10). 
7.2.2 Apoptosis Observed in Cells Infected with West Nile Virus at an M.O.I. ≤ 1 
In contrast, Vero cells infected with WNV at M.O.I. = 1 exhibited cytopathic 
changes similar to apoptosis, which were notably different from that of WNV-infected 
cells at high infectious doses (M.O.I. ≥ 10). Cytopathic changes occurred only by 24 hr 
p.i. Membrane blebbing, cell shrinkage (Figure 84a, arrows) and detachment from 
substrum (cell rounding, arrowheads) were observed under optical microscopy. Using 
electron microscopy, further apoptotic characteristics such as chromatin condensation at 
the nuclear membrane (Figure 84b, arrows) and nuclear membrane blebbing were 
revealed. 
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Figure 83.  
Release of HMGB1 protein in WNV - infected cells at high infectious doses 
(M.O.I. ≥ 10). (a) HMGB1 protein is confined predominantly to the nuclear fraction of 
mock-infected cells. However, HMGB1 protein is detected in the extracellular fraction of 
Vero cells infected with WNV at a high infectious dose by 12 hr p.i. (b) Nuclear 
localization of HMGB1 protein in mock-infected cells is demonstrated by 
immunofluorescence assay. (c) Strong perinuclear staining of HMGB1 protein is 
observed in the cytoplasm of WNV - infected cells. HMGB1 protein staining is absent in 
the nuclei of virus - infected cells. 
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Figure 84.  
Morphology of WNV-infected Vero cells at a low infectious dose (M.O.I. ≤ 1). 
(a) Cell shrinkage (arrows), cytoplasmic blebbing and cell rounding (arrowheads) are 
typical morphological characteristics of cells undergoing apoptosis. (b) Ultrastructural 
observations show chromatin condensation (arrows) as well as nuclear membrane 
blebbing in WNV - infected cells at low infectious doses. (c) Formation of large numbers 
of apoptotic bodies (arrows) in close association with WNV - infected cells undergoing 
apoptosis. (b, c) Bars represent 1.0 µm.  In (b) and (c), Nu denotes nucleus, Cy denotes 
cytoplasm. 
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The formation of many membrane - bound apoptotic bodies (Figure 84c, arrows) was also 
observed at late times of infection (36 hr p.i.).  
Biochemical assays were also performed to ascertain whether the morphological 
changes observed in WNV - infected cells (M.O.I. = 1) were due to apoptosis. 
Fragmentation of chromosomal DNA into nucleosomal oligomers is commonly observed 
in cells undergoing the final stages of apoptosis (Nagata et al., 2003). Thus, WNV-
infected Vero cells were examined for the presence of DNA fragmentation by extracting 
genomic DNA and subjecting it to agarose gel electrophoresis. As shown in Figure 85a, a 
single intact chromosomal DNA band (minimal smearing) was observed in mock-infected 
cells (Figure 85a, Lane 2). Vero cells that were infected with WNV at an M.O.I. = 10 
(Figure 85a, Lane 3) and 100 (Lane 4) did not show any obvious DNA ladder formation, 
instead only a smear of DNA was observed by 14 hr p.i. The smear of DNA indicated 
products of non-specific degradation of chromosomal DNA and this is typical of cells 
undergoing necrosis (Koyama et al., 2001). In comparison, a ladder of DNA fragments 
was noted in cells infected with WNV at an M.O.I. = 0·1 (Lane 5) and 1 (Lane 6), 
respectively, by 36 hr p.i. (late in infection). Consistent with the above results, TUNEL 
staining of WNV - infected cells (M.O.I. = 1) also revealed extensive condensation and 
fragmentation of nuclei (Figure 85c, arrows) when compared to that of the intact and 
rounded nuclei of mock-infected cells (Figure 85b). The inset in Figure 85c shows a 
higher magnification of the condensed DNA within the nucleus (arrowhead). 
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Figure 85.  
Induction of chromosomal DNA fragmentation by WNV infection. (a) DNA from 
mock - or WNV - infected cells was obtained after infection with different infectious 
doses before subjecting them to electrophoresis on a 12 % agarose gel. Lane 1, Lambda 
DNA marker [(bp) (Promega)]; Lane 2, mock-infected cells (intact DNA band); Lane 3 
and Lane 4 (smearing of DNA), Vero cells infected with WNV at an M.O.I. = 10 and 
100, respectively; Lane 5 and Lane 6 (DNA laddering), Vero cells infected with WNV at 
an M.O.I. = 0.1 and 1, respectively. (b, c) TUNEL staining assay performed for mock - 
and WNV-infected cells, respectively. (c) At 36 hr p.i., cells infected with WNV at low 
infectious doses were processed using TUNEL assay. Incorporation of fluorescein – 
dUTP at the free 3’ hydroxyl ends of fragmented DNA by TUNEL is observed as green 
speckles in the nuclei of cells undergoing apoptosis (arrows). Arrowhead showing 
condensed chromatin in cell (inset). 
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7.3 Characterization of West Nile Virus – Induced Apoptotic Pathway 
7.3.1 Release of Holocytochrome C 
The subsequent series of experiments was carried out to define the relevant 
apoptosis signal transduction pathway in WNV - infected cells (M.O.I. = 1). Release of 
cytochrome c from mitochondria is conserved in all mammalian cells undergoing 
apoptosis (Liu et al., 1996; Kluck et al., 1997; Leist & Nicotera 1997; Scorrano & 
Korsmeyer, 2003). Cytochrome c is a small, 13-kDa protein which is attached loosely to 
the outer surface of the inner mitochondrial membrane. 
Release of cytochrome c from the mitochondria into the cytosol of WNV - 
infected cells was determined at different time periods after virus infection (Section 
2.19.4). Cytochrome c was detected as early as 14 hr p.i. in the cytosolic fraction of 
WNV-infected cells (Figure 86a). By 18 hr p.i., there was a remarkable increase in the 
presence of cytochrome c in the cytosolic fraction. Release of cytochrome c from the 
mitochondria is required for the formation of the apoptosome, which, in turn, is necessary 
for activation of pro-caspase-9. 
7.3.2 Activation of Caspases 
Activation of caspases plays important roles in the mediation of apoptosis of 
mammalian cells. Caspase-8 and -9 are upstream caspases. Caspase-8 is activated by 
signalling pathways for CD95/Fas as well as tissue necrosis factor (Nicholson & 
Thornberry, 1997); caspase-9 is activated by the mitochondrial release of cytochrome c 
into the cytosol (Zou et al., 1999). Both active caspase-8 and -9 can be involved in the 
initiation of downstream effector caspases, such as caspase-3 (Fernandes-Alnemri et al.,
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Figure 86.  
Characterization of WNV-induced apoptotic pathway. (a) Western blot detection 
of cytochrome c in the cytosolic fraction of WNV-infected cells using anti-cytochrome c 
antibody. By 18 hr p.i., there is a significant increase in the concentration of cytochrome 
c in the cytosolic fraction. (b) caspase-8, (c) caspase-9 and (d) caspase-3 activities of 
WNV-infected cells are detected over a time period from 12 to 26 hr p.i. At selected time 
intervals, cell lysates from mock- and WNV-infected Vero cells are analysed for caspase 
activity in fluorogenic assays with specific substrates. The data are normalized and are 
expressed as fold increase compared to the corresponding values of caspase activity in 
lysates of mock-infected cells. (e) The cleavage of PARP observed in WNV-infected 
cells at late times of infection. Western blotting was used to detect PARP in cell lysates 
of mock- and WNV - infected cells using anti-PARP antibody. Intact PARP (116-kDa) is 
detected in mock-infected cells. Cleavage of PARP into its truncated fragment of 85-kDa 
is first observed at 28 hr p.i. As infection proceeds from 28 to 36 hr p.i., the 85-kDa 
fragment is the band seen predominantly. 
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1994; Zou et al., 1999). Caspase-3 is involved in the execution phase of apoptosis and 
induces cells to undergo characteristic morphological changes (Porter & Janicke, 1999; 
Zou et al., 1999). 
The cascade of caspases activation was investigated in WNV - infected cells. Vero 
cells were infected with WNV at an M.O.I. = 1 and cell lysates were processed for 
caspase-8, -9 and -3 activity determination assays (Section 2.19.2). At selected time 
periods, cell lysates from both infected and mock-infected cells were subjected to 
caspases fluorometric assays (Figure 86b - d, Appendix 18c). There was a slight increase 
in caspase-8 activity (Figure 86b) but activation of both caspase-9 and -3 was 
significantly induced by WNV infection (Figures 86c and d, respectively). Activation of 
caspase-9 activity was also observed to occur much earlier and at higher levels [(20 hr 
p.i.) (Figure 86c)] than caspase-3 [(26 hr p.i.) (Figure 86d)].  This time sequence of 
caspase-3 and -9 activations correlated well with the fact that caspase-9 is required for 
activation of downstream effector, caspase-3.  
7.3.3 Cleavage of Poly (ADP - ribose) Polymerase 
Cleavage of PARP in WNV - infected cells was determined using Western 
blotting. PARP is an abundant nuclear enzyme and is one of the earliest proteins targeted 
by caspase-3, -7 and -9 during apoptosis of mammalian cells (Casciola-Rosen et al., 
1996). During apoptosis, caspase-3 cleaves the 116-kDa PARP into a stable 85-kDa 
fragment containing the C terminus. Intact, full-length PARP (116-kDa) was detected in 
the cell lysate harvested from mock-infected cells (Figure 86e). Cleavage of PARP into 
the 85-kDa fragment was observed by 28 hr p.i. in WNV - infected cells.  As infection 
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progressed from 32 to 36 hr p.i., the 85-kDa cleavage product of PARP became the 
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8.0 DISCUSSION AND CONCLUSIONS 
 The infectious cycle of viruses in the cells can be divided into three essential 
phases: entry into a host cell, replication, and egress to infect another cell.  This cycle is 
the crux of virus existence, and evolution has produced an amazing array of mechanisms 
to enable virus survival.  The limited coding ability of viruses makes them highly 
dependent on the cellular components to achieve each of the phases.  The importance of 
the interplay between WNV and cellular components during entry, morphogenesis and 
cell death is illustrated in this study. 
The initial events in the replication cycle of most viruses involved the interaction 
of the virus attachment protein (VAP) to specific receptors. This was followed by 
penetration into the host cells. The entry event is often a major determinant of virus 
tropism in pathogenesis (Schneider-Schaulies 2000). In flaviviruses, the E protein (major 
structural protein), which is exposed on the surface of the virus, has been identified as the 
VAP (Hasegawa et al., 1992; Heinz et al., 1994; Rey et al., 1995; Thullier et al., 2001). 
However, the cellular counterpart for the flavivirus VAP is highly debatable.  
The early interaction between flavivirus dengue (DV) and its cell surface 
attachment molecules are better studied amongst the flaviviruses. Studies have shown 
that the initial binding of DV-2 to the cell surface was mediated by heparan sulfate and 
subsequent entry was postulated to occur through a high-affinity receptor and co-
receptors (Chen et al., 1997; Putnak et al., 1997). In contrast, Bielefeldt-Ohmann and co-
workers (2001) reported that heparan sulfate played no role in the binding and entry of 
DV into human leukocyte cell lines. Alternatively, DC - SIGN expressed on the surface 
of dendritic cells have recently been shown to mediate entry of DV (Navarro-Sanchez et 
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al., 2003; Tassaneetrithep et al., 2003) but not WNV and yellow fever virus (Navarro-
Sanchez et al., 2003).  Studies have also suggested the involvement of less abundant 
receptors, other than that of heparan sulfate in binding or penetration of flaviviruses into 
host cells (Bielefeldt-Ohmann et al., 2001; Kroschewski et al., 2003).  Other reports on 
tick-borne encephalitis, Japanese encephalitis, and hepatitis C viruses noted the 
involvement of glycoprotein - and lipoprotein - like cellular receptor on various cell types 
for virus entry (Agnello et al., 1999; Kimura et al., 1999; Kopecky et al., 1999). These 
studies suggested that the flavivirus cellular receptors for virus entry might differ from 
one flavivirus to another.   
The first approach in this study involved the usage of VOPBA to screen for 
plasma membrane - associated proteins that bind to WNV. Virus overlay protein blot 
assays have been widely used to characterize putative receptors for a number of viruses, 
including visna virus (Crane et al., 1991; Bruett et al., 2000), reovirus (Verdin et al., 
1989; Choi et al., 1990), human cytomegalovirus (Adlish et al.,1990; Taylor and Cooper, 
1990), lymphocytic choriomeningitis virus (Borrow and Oldstone, 1992; Cao et al., 
1998), and dengue virus (Salas-Benito and del Angel, 1997; Ramos-Castaneda et al., 
1997). Through VOPBA, WNV was observed to bind to a 105-kDa protein band from the 
plasma membrane of Vero cells (Figure 12).  In addition, murine polyclonal antibodies 
raised against the 105-kDa membrane proteins also strongly inhibited the entry of WNV 
but not the unrelated poliovirus (Table 7), therefore supporting the data that the 105-kDa 
glycoprotein is the putative receptor for WNV (Chu and Ng, 2003a). 
Carbohydrate residues on cell surfaces have been shown to be important for the 
initial binding of viruses, which would then mediate the subsequent entry of the virus 
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through its high-affinity receptor. The nature and roles of the carbohydrate residues 
present on the 105-kDa protein for WNV binding was further assessed by VOPBA. 
Treatment of membrane proteins with endoglycosidase H (cleaves N high-mannose 
residues of N-linked oligosaccharides on glycoprotein) or α-mannosidase (cleaves 
mannose residues) abolished virus binding (Figure 15).  This further emphasized the 
importance of N-linked sugars with mannose residues on the 105-kDa membrane protein 
for WNV binding.  
Upon treatment of the membrane proteins with β-mecaptoethanol, WNV was 
observed to bind to a series of protein bands ranging from 30- to 40-kDa (Figure 16). 
This not only indicated that the 105-kDa membrane protein is made up of disulfide-
linked subunits but suggested that either WNV binding did not require a folding 
dependent disulfide bridge or WNV bind to the carbohydrates residues on the protein that 
was not affected by the action of β-mecaptoethanol. The latter seemed consistent with the 
above observations that the carbohydrate residues on the membrane proteins are 
necessary for virus binding.  
In polarized epithelial cells (Vero C1008), there was a high level of expression of 
the 105-kDa proteins at the apical surface when compared to the basolateral surface 
(Figure 19).  Consistent with the preferential expression of the 105-kDa protein on the 
apical surface of Vero C1008 cells, it was also observed that both WNV and KUN virus 
infections occurred with much higher efficiency when the viruses were inoculated at the 
apical surface of Vero C1008 cells (Figure 20). This type of restriction in the entry of 
viruses has also been documented for simian virus 40 (Clayson & Compans, 1998), 
measles virus (Blau & Compans, 1995), Black Creek Canal virus (Chodosh et al., 2000), 
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and hepatitis A virus (Blank et al., 2000).  For these viruses, polarized entry was also 
aided by the apical localization of their cellular receptors in Vero C1008 cells. Since 
polarized epithelial cells express distinct sets of receptors and cellular proteins at either 
the apical or the basolateral domain, the preferential entry of WNV and KUN viruses 
provided further evidence of the apical localization of their cellular receptor (105-kDa 
glycoprotein) in Vero C1008 cells (Chu and Ng, 2002b).  
The detail biochemical characterization of the 105-kDa glycoprotein purified 
from WNV - permissive cells provided a crucial step towards the identification of the 
receptor responsible for WNV entry.  The strategy taken to identify the actual identity of 
the 105-kDa glycoprotein was to perform a peptide sequencing of the molecule.  Peptide 
sequencing of the 105-kDa glycoprotein implicated that αVβ3 integrin could be the 
specific cellular receptor for WNV binding and entry into cells. A series of experiments 
(Sections 4.3 to 4.8) were carried out and confirmed this claim.  
It was however, noted that antibodies against αVβ3 integrin did not completely 
block (up to 75 %) WNV entry into Vero cells despite the presence of high concentration 
of antibodies used.  It is plausible then to postulate that additional cell surface molecules 
can be involved.  Nevertheless, the binding of WNV to αVβ3 integrin is highly specific 
and was demonstrated by the reduction of virus infectivity (up to 85 %) after incubating 
with soluble αVβ3 integrin (Figure 30). 
Attachment of WNV to αVβ3 integrin most probably occurs through the DIII of 
the E protein since strong interaction between WNV DIII protein and αVβ3 integrin was 
observed by co-immunoprecipitation (Figure 38).  In addition, binding of soluble WNV E 
DIII protein to αVβ3 integrin blocked virus entry in a dosage dependent manner.  
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However, we cannot exclude the possibility that other domains of the E protein may also 
participate in binding to αVβ3 integrin.  In most mosquito - borne flaviviruses, DIII of E 
protein contains an RGD motif or a very similar sequence (van der Most et al., 1999).  
The RGD motifs play essential roles in integrin - ligand interactions (Ruoslahti, 1997).   
Several viruses, including foot–and-mouth disease virus (Rieder et al., 1994), 
coxsackievirus (Roivainen et al., 1991), adenovirus (Bai et al., 1993) were shown to bind 
to integrins in an RGD - dependent fashion.  However, the binding of WNV to αVβ3 
integrin does not occur on the RGD binding site as illustrated with integrin’s ligands and 
RGD peptides blockage studies (Figure 26).  This result is also consistent with several 
reports that the RGD/RGE motif on the E protein of some flaviviruses is not essential in 
binding to RGD motif binding site on integrins (Hurrelbrink and McMinn, 2001; van der 
Most et al., 1999).  Mutagenesis of the RGD/RGE motif of yellow fever virus and 
Murray Valley encephalitis virus did not affect the absorption, penetration and growth of 
the viruses (van der Most et al., 1999; Hurrelbrink & McMinn, 2001). 
Since the entry of JEV can also be effectively blocked by antibodies to αVβ3 
integrin (Figure 25), this suggested that both WNV and JEV utilized αVβ3 integrin as a 
common receptor molecule in vertebrate cells.  This is further supported by a recent study 
conducted by Volk and co-worker (2004) showing the high structural similarity of the 
receptor binding region (domain III) on the E protein of both WNV and JEV.  However, 
it is currently not known whether WNV also utilized αVβ3 integrin or related molecules 
as the receptor for entry into mosquito cells.  Future work is required to address this 
issue. 
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The identification of αVβ3 integrin as the cellular receptor for WNV will be of 
importance in understanding virus replication, pathogenesis and tissue tropism in host.  
The relatively high sequence conservation in the gene encoding for αV or β3 integrin 
subunits may support the broad host range of WNV infection (Burke, 1999). In polarized 
Vero (C1008) cells, there is a high level of expression of the putative WNV receptor at 
the apical surface and facilitate the preferential entry of WNV through the apical surface 
[(Figure 20) (Chu and Ng, 2002b)].  This parallels a similar apical localization of αV and 
β3 integrin subunits expression in polarized cells (Aplin et al., 1996).  The αVβ3 integrin 
is expressed in a wide variety of cells (Table 9) and tissues and is highly expressed in 
endothelial cells, monocytes and macrophages [(hematogenous population) (Shattil, 
1995)] therefore mediating the susceptibility of these cells to WNV and facilitating the 
spread of WNV throughout the body.  
  Human become infected with WNV during the bite of an infected mosquito, upon 
inoculation, endothelial cells are readily infected and these cells serve as the primary sites 
of virus replication (Solomon and Vaugh, 2002).  It is proposed that the localization of 
WNV to the brain causing encephalitis occurred mainly through the hematogenous entry 
route (by infected inflammatory cells that enter the brain parenchyma) after peripheral 
virus replication (Solomon and Vaugh, 2002). Hepatitis, pancreatitis and myocarditis 
have also been reported in WNV infection (Hayes, 1998).  The presence of αVβ3 integrin 
in a wide variety of cells is consistent with the pathology of WNV infection.   
With the identification of αVβ3 integrin as the functional receptor molecule for 
WNV, further characterization of molecular and structural basis of the interacting 
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domains of αVβ3 integrin and WNV E protein is necessary.  These valuable data will 
provide the basis for anti-viral strategies. 
Upon attachment of the virus to cellular receptor molecules on the plasma 
membrane of host cells, this is followed by internalization, uncoating and subsequent 
viral gene transcription at specific location in cells.  Previous studies (Sieczkarski and 
Whittaker, 2002) have clearly demonstrated that animal viruses can utilize different 
internalization and trafficking pathways which allowed specific localization within the 
cells upon entry for a successful infection.  For enveloped viruses, the entry process can 
occur either via the fusion of virus envelope glycoproteins at the plasma membrane at 
neutral pH to promote the internalization of viral nucleocapsids or by endocytosis.  For 
the latter, conformational change of the virus fusion protein to expose the hydrophobic 
fusion peptide is induced by an acidic pH for the release of the virus nucleocapsids into 
the cytoplasm (Chazal and Gerlier, 2003). 
Generally, flavivirus are believed to enter cells by receptor-mediated endocytosis, 
although studies have also reported a less documented mode of entry by direct fusion at 
the plasma membrane (Se-Thoe et al., 2000; Hase et al., 1989a).  A variety of 
experimental approaches was designed to study the entry pathway taken by flavivirus 
WN during the early events of infection.  The engagement of WNV with αVβ3 integrin 
(Section 4 and Figure 87) triggered the activation of FAK (integrin - linked kinases), 
which is the central paradigm of outside-in signaling by integrin.  The auto-
phosphorylation of FAK in response to virus - integrin engagement leads to formation of 
phosphotyrosine docking sites for several classes of signaling molecules.  This is 
necessary for the recruitment and activation of the downstream signaling molecules and  
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 Engagement of WNV and αVβ3 integrin triggered outside-in signaling pathway for WNV 
endocytosis.  The figure is not drawn to scale. 
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signaling complexes that eventually lead to the triggering of actin assembly and followed 
by the process of endocytosis (Parsons, 2003; Greber, 2002). 
Similarly, signaling pathways other than that of the FAK are also activated 
through virus - integrin engagement.  Protein kinase C (PKC) is activated through an 
unknown signaling pathway by the β subunit of the integrin [(Figure 87) (Greber, 2002)].  
Protein kinase C and its isoforms have been recently shown to be involved in the process 
of endocytosis (Ivaska et al., 2003; Sieczkarski et al., 2003).  The inhibition of PKC and 
its isoforms activities by specific antibodies and bisindolymaleimides I prevented the 
trafficking of WNV from endosomes to late endosomes (Section 5.5).  Therefore, these 
results implied a distinct effect of PKC in trafficking machinery of endosomes to late 
endosomes for WNV entry (Figure 88). 
Upon the activation of internalization signal by the interaction of WNV and αVβ3 
integrin, WNV particles were internalized within 2 to 3 min across the plasma membrane 
in a clathrin coated pit (Section 5 and Figure 88).  Vero cells when exposed to 
chloropromazine and sucrose (Figures 45b & c) significantly inhibited virus 
internalization. In contrast, filipin (inhibits caveolae - dependent endocytosis) did not 
significantly affect WNV infection (Figure 45d). These results were further supported by 
the finding that WNV co-localized with clathrin but not caveolin by using 
immunofluorescence assay (Figure 46).  
The formation of clathrin - coated pits at the plasma membrane during the process 
of receptor - mediated endocytosis required the interaction of clathrin along with its 
accessory factors (Watson et al., 2001).  These accessory factors served important roles 
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in the regulatory and catalytic mechanism at specific stages in clathrin - mediated 
endocytosis.  One of the newly discovered accessory factors, Eps15 is ubiquitously and 
constitutively associated with AP-2 for the formation of clathrin - coated pits at the 
plasma membrane. Studies by Carbone and colleagues (1997) and Benmerah and group 
(1998) showed that the overexpression or microinjection of dominant negative mutants of 
Eps15 strongly inhibited clathrin - dependent endocytosis.  Expression of dominant 
negative Eps15 in Vero cells demonstrated strong inhibition of WNV uptake (Figure 
47c). However, the inhibition of clathrin - coated pits formation at the plasma membrane 
did not affect the binding of WNV particles to the cell surface as revealed by 
immunofluorescence assay (Figure 47d).  These data so far provided strong evidence that 
the initial internalization of WNV proceeds by clathrin - mediated endocytosis. 
As previously mentioned that the activation of FAK signaling will lead to actin 
assembly for the process of endocytosis, actin filaments was shown to be involved in the 
initial penetration of WNV across plasma membrane (Figure 88).  This was revealed by 
percoll sub-cellular fractionation studies where the internalization of WNV was affected 
in Vero cells that were pre-treated with cytochalasin D (Figure 56).  WNV are 
predominantly detected in the plasma membrane fraction instead of the endosomal 
fraction, suggesting the early involvement of actin filaments in clathrin - mediated 
endocytosis (Figure 57).  It can be proposed that actin filaments may provide a scaffold 
for the assembly of components during clathrin-coated pit formation.  The polymerization 
of actin may also provide a force for the constriction of clathrin - coated pit during 
endocytosis and propel newly released clathrin vesicles away from the plasma membrane. 
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By 5 min after the start of entry, majority of WNV are observed as single particle 
within endocytic vesicles and these vesicles are identified as early endosomes based on 
its morphological characteristics and immunolabelling with cellular marker, EEA1 
(Figures 39a, 39d and Figure 88).  Co-localization of WNV with LAMP1 positive 
vesicles was observed by 15 min after the start of the entry process (Figures 39c & 39e). 
The trafficking process of WNV along the endocytic pathway seemed to occur rapidly 
(within 15 min after the start of virus entry process) and was consistent with the speed of 
typical trafficking of cellular ligands such as transferrin or epidermal growth factor that 
utilized clathrin - mediated endocytosis (Kornilova et al., 1996; Michaely et al., 1999). 
The trafficking/maturation model of endosomes has proposed that endosomes acts as 
transient independent carriers that progressively change in size and shapes by 
homologous fusion and eventually matured into late endosomes and lysosomes (Courtoy, 
1991).  This was also observed in the trafficking of WNV, endosomes containing single 
WNV particles were observed to fuse with each other, resulting in the formation of large 
endocytic vesicles (late endosomes and lysosomes) that contained several virus particles 
(Figures 41b & 41d).  Therefore, the data showed that after the internalization of WNV 
by clathrin - mediated endocytosis, the virus particles were trafficked through the 
endosomes and eventually to the late endosomes and lysosomes (Chu and Ng, 2004).  
It also appeared noteworthy that the endocytic pathway for WNV was closely 
associated with cellular cytoskeleton network (Chu and Ng, 2004).  In the previous 
paragraph, actin filaments were shown to be important for the initial internalization of 
WNV.  Again, by using percoll sub-cellular fractionation of cells treated with 
nocodazole, WNV was observed to accumulate in endosomes and trafficking of the virus 
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particles to lysosomes was deterred (Figure 57).  Furthermore, using of real - time 
imaging with the laser scanning confocal microscope revealed additional information on 
the involvement of microtubules network in mediating the delivery of virus - containing 
endocytic vesicles to the endoplasmic reticula region for replication (Figure 88).  In 
consistent with the speed of movement of the endocytic vesicles, endocytic vesicles 
containing WNV were transported along the microtubules at the speed of 0.3 µm/sec.  
Subsequent to internalization by clathrin - mediated endocytosis, internalized 
virus particles are trafficked along the cellular endocytic pathway. The endocytic 
pathway also serves as a rapid transit system in delivery of viral cargo to specific 
locations within cells for its replication.  The acidification process occurring along the 
endocytic pathway is shown to be essential for the uncoating of many enveloped viruses.  
Viruses such as adeno-associated viruses (Bartlett et al., 2000) and human rhinovirus 
HRV14 (Bayer et al., 2001) have been shown to uncoat in early endosomes while many 
other viruses (poliovirus type 1 and Mouse Elberfeld virus) are trafficked from early 
endosomes to late endosomes and then to lysosomes for uncoating (Ziechhardt et al., 
1985). 
It is also notable that incubation of cells with lysomotropic weak bases 
(chloroquine and amantidine) and vacuolar H+-ATPase (VATPase) inhibitor 
(Bafilomycin) caused a marked reduction in the entry of WNV (Section 5.6).  This 
observation is consistent with a number of enveloped viruses that are currently 
considered to be pH - dependent for the uncoating process along endocytic vesicles 
(Kielian and Jungerwirth, 1990).  For flaviviruses, it is proposed that the structural 
domain II of the E protein is required for the pH-dependent fusion at the endocytic 
  260 
                                                                                       CHAPTER 8 
                                                                                     DISCUSSION &CONCLUSIONS 
 
membranes.  Mutational studies that disrupted the functional biology of this domain 
decreased the virulence of these flaviviruses (Monath et al., 2002).  A highly conserved 
amino acids cluster that is located at the tip of domain II has been proposed to be the 
internal fusion peptide.  At the pH of fusion, the flavivirus E protein on the surface of the 
virus undergo irreversible conformational changes to expose the fusion peptide for 
interaction with the target membrane (Heinz and Allison, 2000).   
Ultrastructural analyses and immuonfluorescence assays indicated that the pH - 
dependent fusion of WNV E protein occur predominantly within late endosomes and 
lysosomes (Figure 88).  The fusion process of WNV E protein with the lysosomal 
membrane was observed using cryo-immuno-electron microscopy (Figure 42a & b) and 
the uncoated nucleocapsid particles were released into the cytoplasm in the vicinity of the 
ER (Figure 42c).  So far, entry studies of flaviviruses have not been able to visualize the 
presence of nucleocapsid particles in the cytoplasm after its release from endocytic 
vesicles.  It was suggested by Gollins and Porterfields (1985) that the uncoated 
nucleocapsids upon exit into cytoplasm underwent spontaneous dissociation due to the 
instability nature of the capsid protein interactions.  In this study, the identity of the intact 
newly realeased WNV nucleocapsids in the cytoplasm was clearly defined by cryo-
immuno-electron microscopy (Figure 42c).  Immunofluorescence assay also clearly 
demonstrated the co-localization of WNV nucleocapsids with ER (Figure 43). 
In situ hybridization coupled with immunoelectron microscopy further confirmed 
that the viral RNA genomes were localized in the proximity of ER region after the 
dissociation of the nucleocapsids (Figure 44d).  It is plausible that cellular proteins may 
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interact with the viral RNA and facilitate its interaction with the ribosomes to initiate 
translation of the viral polyprotein.  Future works are required to solve this aspect. 
In the classical mode of flavivirus maturation (trans - type), mature virions are 
assembled intracellularly. Mature virions were then transported by the host cell secretory 
channel to the plasma membrane and eventually released by exocytosis [(Leary & Blair, 
1980)]. However, for flaviviruses [e.g. WN(S)V and some strains of DV serotype 2, 
strain PR-159] that egress by budding at the plasma membrane (cis - type maturation) 
(Ng et al., 2001; Hase et al., 1987), the exact trafficking mechanism of the structural 
proteins to the plasma membrane has not been well understood. In a previous study (Ng 
et al., 2001), with the use of immunogold labelling and cryo-electron microscopy, it was 
shown that there was co-transportation of the E and C proteins of WNV to the plasma 
membrane for assembly.  Section 6.2 of this study further defined the trafficking 
mechanism of the E and C proteins during the replication cycle of WNV. Both E and C 
proteins were revealed to be strongly associated and transported along the microtubules 
to the plasma membrane (Chu and Ng, 2002a). 
Several studies over the years have documented the involvement of mammalian 
cell cytoskeleton and its associated proteins in the replication of both DNA and RNA 
viruses (Aspasia and Michael, 2001). Microtubules network has been reported to he 
essential for the intracellular transport of virus particles and their proteins at both early 
and late stages of the replication cycle. Intracellular type A retrovirus (Heine et al., 
1985), glycoproteins of herpes simplex virus type 1 (Norrild et al., 1986), UL25 protein 
of pseudorabies virus (Kaelin et al., 2000) and VP4 (spike protein) of rotavirus 
(Nejmeddine et al., 2000) were dependent on intact microtubules for the transportation of 
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the respective proteins to the site of assembly, which was necessary for the formation of 
infectious particles. It is not such an unusual phenomenon that the microtubules network 
should he involved in flavivirus replication. It has been documented that virus-induced 
microtubule paracrystals were observed during the replication of KUN virus (subtype of 
WNV) by Hong and Ng (1987). The association of the virus NS3 protein with the 
microtubules was also shown to be necessary for the intracellular replication of KUN 
virus and JEV (Ng and Hong, 1989; Chiou et al., 2003) 
In addition, by using microtubule disrupting drug, it clearly illustrated that intact 
microtubule network has an essential role during the early phase of KUN virus 
replication (Hong and Ng 1987). As such, the roles of microtubules in KUN virus 
(mature intracellularly) replication cycle, might serve as scaffold for virus - specific 
proteins involved in the early phase of the virus replication cycle. Whereas in this study, 
the host microtubules network served as a transport highway for the movement of the 
WNV (mature by budding at the plasma membrane) structural proteins towards the 
plasma membrane for assembly. 
Triton X-100 extraction coupled with immuno-electron microscopy and time - 
based indirect immunofluorescence revealed co-localization of the virus E and C proteins 
with the microtubules at various times p.i. (Figure 63 and 64). This observation is 
consistent to the previous observation that both the E and C proteins were co-transported 
during the virus replication cycle (Ng et al., 2001). 
The association of E protein and microtubules was found to be sensitive to high 
salt extraction but resistant to Triton X-100 and OG extraction (Figure 65). Therefore, it 
was concluded that the virus E protein and possibly also C protein associate effectively 
  263 
                                                                                       CHAPTER 8 
                                                                                     DISCUSSION &CONCLUSIONS 
 
with the microtubules through an ionic interaction.  The exact mechanism as to how the 
membrane associated E protein become associated with the microtubule warrants further 
investigation. 
The disruption of microtubules with vinblastine sulphate had inhibitory effect on 
the trafficking of WNV E and C proteins along the microtubules. Morphological studies 
using indirect immunofluorescent staining showed the retention of the E (Figures 66a-c) 
and C (Figures 66d-f) proteins with in the vinblastine sulphate - induced microtubulin 
paracrystals. Due to the perturbation of the microtubule network by vinblastine sulphate., 
both E and C proteins failed to be transported to the plasma membrane (in contrast to 
Figure 63). This observation was confirmed by the significant decrease in the 
extracellular virus production in the presence of vinblastine sulphate in the culture 
medium at a non – cytotoxic concentration (Figure 67). These further supported the 
postulation that intact microtubules are essential for the trafficking of the virus E and C 
proteins during the replication cycle of WNV. 
It was also of interest to explore the involvement of microtubule-based motor 
protein that could be responsible for generating directional movement of the WNV 
structural proteins along the microtubules.  Several microtubules-based proteins (e.g. 
dynein and kinesin) have been implicated for transporting cellular proteins and vesicles 
along the microtubules (Suomalainen et al., 1999). Dynein motor proteins mediate minus 
end - directed movement (towards the cell nucleus from cell peripheral), whereas kinesin 
superfamily motor typically transport cargo towards the plasma membrane. The cargo 
loading domain of kinesin heavy chain has been reported to generate functions in vesicle 
and organelle transport.  
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Tang and colleagues (1999) has recently reported that the C - terminus (cargo 
loading domain) of KIF4, a member of kinesin superfamily of motor proteins is 
associated with retroviral Gag proteins and is responsible for anterograde movements of 
retroviral proteins to the plasma membrane. For this reason, kinesin was selected in this 
study to validate its involvement in transporting the viral structural proteins along the 
microtubules. The virus E protein was observed to be strongly associated with kinesin 
and more specifically the cargo loading domain of kinesin heavy chain (Figure 68). This 
suggested that kinesin could serve as a transport vehicle (generating force and movement) 
for the trafficking of the virus structural (E and C) proteins along the microtubules 
highway. 
Polarized release of viruses from polarized epithelial cells was first observed in 
enveloped RNA viruses. Influenza virions were observed to bud from the apical 
membrane, while vesicular stomatitis virus was released basolaterally (Rodriguez- 
Boulan et al., 1983). The polarized fashion of virus release was subsequently found to be 
attributed to the polarized expression and intracellular sorting of the respective virus 
proteins to either the apical or the basolateral surface for release (Boulan & Pendergast, 
1980; Matlin & Simons, 1984; Misek et al., 1984; Rindler et al., 1985; Gottlieb et al., 
1986; Fuller et al., 1985).  
In this part of the study, it was revealed that sorting of WNV E protein to the 
apical domain of Vero C1008 cells was highly dependent on the presence of intact 
microtubules (Chu and Ng, 2002b).  A drastic decrease in the apical release of WNV was 
observed upon disruption of the microtubule network by vinblastine sulphate (Figure 72).  
The reduction in the apical release of WNV was probably caused by the entrapment of 
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the viral structural proteins with the depolymerized microtubules, which failed to deliver 
the virus structural proteins to the apical surface for virion assembly (Figure 73a).  
Similarly, Eilers and group (1989) have proposed the possible involvement of 
microtubules on the intracellular sorting mechanism of cellular membrane proteins and 
secreting proteins in Caco-2 cell line (intestinal epithelial cells). 
As for KUN virus, the disruption of microtubules during late infection did not 
affect the direction of release and the titres of progeny virus (Figure 72).  Bi-directional 
release of KUN virus by exocytosis was observed in Vero C1008 cells (Figures 71c-e), in 
contrast to WNV.  One possible explanation for the difference in the release of these 
closely related viruses could be due to the different modes of maturation of the two 
viruses. The maturation of KUN virus has been well documented to be intracellularly 
(Mackenzie & Westaway, 2001).  The apical egression of WNV from polarized epithelial 
Vero C1008 cells could be due to the microtubule - dependent polarized sorting of the 
structural proteins to the apical membrane. 
Different models have been proposed for the budding of enveloped viruses.  One 
of the earliest and attractive models by Garoff and Simons (1974) suggested that the 
budding mechanism of Semliki Forest virus required the specific interaction between 
nucleocapsid and spike proteins.  The nucleocapsid - spike protein association 
subsequently induced the membrane to curve outward and eventually enwrap the 
nucleocapsid completely.  Other budding strategies include the lateral interaction 
between the core or matrix protein with the lipid bilayer, viral proteins, and viral RNA.  
Host cytoskeleton interaction with virus proteins was also observed to mediate or 
drive virus budding (Garoff et al., 1998).  There have been several reports that the host 
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cytoskeleton (actin filaments) is directly involved in the budding of both enveloped DNA 
and RNA viruses.  For example, measles virus has been convincingly shown to interact 
with actin filaments during budding (Bohn et al., 1986).  Actin filaments were observed 
to protrude into virus particles with their barbed ends and are in close association with the 
virus nucleocapsids.  Bohn and colleagues (1986) also suggested that the forces resulting 
from the vectorial growth of actin filaments contributed to the formation of virus buds.  
Other viruses, such as the frog virus 3 (Murti et al., 1985), retrovirus (Perotti et al., 
1996), black creek canal virus (Lanier and Volkman, 1998), Autographa california 
nuclear polyhedrosis virus (Ravkov et al., 1997), and fowlpox virus (Boulanger et al., 
2000), have also been documented to be associated with actin filaments at the site of 
release.  These filaments contributed to the budding mechanism of the viruses.  
From this study, the use of both biochemical and microscopy techniques provided 
evidence, for the first time, that actin filaments directly participated in the budding of 
WNV at the plasma membrane (Chu et al., 2003).  At the ultrastructural level, budding of 
WNV was shown to interact specifically with actin filaments by immunogold labelling of 
cryo-sections prepared from WNV-infected cells at late infection (Figure 77).  This 
association was further supported by the results from the immunogold - labelled, Triton 
X-100 - extracted cytoskeleton (Figure 75).  Proliferation of the actin filaments was also 
observed using atomic force microscopy (Figure 74). The results using 
immunoprecipitation (Figure 76a, Lanes 5 and 6) confirmed the specific association of 
the virus precursors (envelope and core proteins) with the actin filament at late infection.  
No affiliation was observed during early infection (Figure 76a, Lanes 3 and 4).  
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This observation correlated well with our earlier study [Section 6 or Chu and Ng 
(2002a)], showing that newly synthesized WNV structural proteins were transported from 
the site of synthesis (perinuclear region) to the plasma membrane for assembly via the 
microtubules.  It could be postulated that virus structural proteins at the cell periphery 
were then transferred from the microtubules to the actin filaments for assembly and 
budding at the plasma membrane.  This type of protein trafficking has also been 
documented for a number of cellular vesicles and for organelle transport in cells (Tabb et 
al., 1998).  The microtubules function as tracks for long distance transport, while the 
actin filaments function as tracks for local movement and kinetic forces for budding at 
the plasma membrane. 
Apparently, the growing barbed ends of the actin filaments are essential for 
generating the vectorial force for membrane bending and virus budding (Bohn et al., 
1986; Garoff et al., 1998).  Thus, inhibition of the barbed ends by cytochalasin B 
(MacLean-Fletcher and Pollard, 1980) directly prevented the budding of WNV. 
Boulanger and group (2000) have also postulated that the disruption of actin filaments by 
cytochalasin could also disengage the interaction between actin and its membrane linker, 
destabilizing the interaction between the fowlpox virus precursors and the plasma 
membrane.  This, too, could explain the cytoplasmic accumulation of WNV 
nucleocapsids and envelope proteins and their failure to bud at the plasma membrane 
(Figure 79).  Therefore, the intact actin filaments are essential in providing the essential 
force needed to expel the WNV successfully from the plasma membrane. 
The factors that influenced the cell death pathways of WNV - infected cells at the 
late stages of infection were found to be dependent on the infectious virus load (Chu and 
  268 
                                                                                       CHAPTER 8 
                                                                                     DISCUSSION &CONCLUSIONS 
 
Ng, 2003b). West Nile virus - infected Vero cells underwent necrosis with high infectious 
doses (M.O.I. ≥ 10) of WNV.  Apoptosis was observed when the infectious dose was at a 
low M.O.I. of ≤ 1. It appears noteworthy that the virus load can also determine the 
kinetics of infection.  Vero cells that were infected with a high virus load (M.O.I. ≥ 10) 
can accelerate infection and produce a much higher load of infectious progeny (Figures 
80c & d) within a shorter period, whereas a lower virus load (M.O.I. ≤ 1) results in a 
delay in kinetics, with a lower load of infectious progeny (Figures 80a & b).  
Infections exhibiting necrosis often are accompanied by inflammatory responses. 
During WNV infection in humans, inflammation was observed in several locations of the 
body (Senne et al., 2000; Deubel et al., 2001; Sampson & Armbrustmacher, 2001).  The 
characteristic features observed in the necrotic process include swelling of cells (Figure 
81c), vacuolation of cells (Figure 81d), a burst of LDH release (Figure 82a) and liberation 
of HMGB1 protein (Figure 83).  Recent studies have demonstrated that HMGB1 protein 
is a critical factor that links necrotic cell death to inflammation (Degryse et al., 2001; 
Muller et al., 2001; Anderson et al., 2002; Scaffidi et al., 2002).  This protein is a potent 
macrophage - activating factor and a pro-inflammatory mediator cytokine that is released 
exclusively by necrotic cells but not by apoptotic cells (Scaffidi et al., 2002).  The release 
of HMGB1 protein contributes to the pathogenesis of systemic inflammation (Anderson 
et al., 2002). 
A previous study by Despres and Colleagues (1998) also reported that dengue 
virus infection in Vero cells at a high infectious dose (M.O.I. ≥ 10) resulted in the 
activation of necrosis in these cells.  The possible explanation provided for the activation 
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of necrosis in these cells was due to the cytotoxic effect resulting from the accumulating 
dengue virus particles.
However, in WNV infection, the loss of plasma membrane integrity was largely 
responsible for the necrotic process.  This was caused by the profuse budding of the 
progeny virus particles at the cell surface (Ng et al., 2001), eventually resulting in cells 
undergoing necrosis.  This was confirmed when Vero cells infected with WNV at an 
M.O.I. of ≥10 were subjected to cytochalasin B treatment.  This treatment reduced 
dramatically the actin - dependent virus egression (Section 6.5.2) and there was a marked 
reduction in released LDH activity (Figure 82b) - the marker to indicate that the process 
of necrosis. 
Consistent with Yang et al. (2002), this study also showed that WNV - induced 
apoptosis but only when a low titre inoculum was used [(M.O.I. ≤ 1) (Figures 84 and 
85)]. During WNV infection (at low infectious doses), cytochrome c was first detected in 
the cytosolic fraction by 14 hr p.i. and increased substantially by 18 hr p.i. (Figure 86a). 
Cytochrome c is one of the universal factors that are released from the mitochondria in 
response to the disruption of mitochondrial permeability.  In the mitochondrial-mediated 
apoptotic pathway, the pro-apoptotic Bcl-2 family members Bak and Bax have direct 
effects on the endoplasmic reticular Ca2+ pool with subsequent sensitization of 
mitochondria to calcium-mediated fluxes and cytochrome c release (Nutt et al., 2002).  In 
addition, Parquet and coworkers (2001) have documented the up-regulation of bax in WN 
virus-induced apoptosis.  Up-regulation of pro-apoptotic bax in WNV - infected cells by 
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acting on the upstream of the pathway would therefore activate the mitochondrial - 
mediated apoptosis pathway observed in this study. 
The release of cytochrome c and other proteins then activates pro-caspase-9 in the 
apoptosome complex. Caspase-9 activity was substantially up-regulated within 2 hr after 
the release of cytochrome c in WNV - infected cells (Figure 86c). The activation of pro-
caspase-9 led to activation of effector caspases, such as caspase-3 (Figure 86d) at 6 hr 
later. This in turn results in the cleavage of a number of cellular proteins (eg. PARP) that 
contribute to the irreversible events in cell death (Kroemer et al., 1997; Zamzami & 
Kroemer, 1999).  
In conclusion, this study revealed the following: 
• αVβ3 integrin was identified to be the cellular receptor for WNV.  The binding of 
WNV to αVβ3 integrin triggered the activation of FAK, therefore mediating the 
endocytosis of WNV. Actin filaments in respond to integrin - mediated signaling 
were required for the initial internalization of WNV. 
• Infectious entry of WNV occurred by clathrin - mediated endocytosis.  Internalized 
WNV particles were trafficked along the endosomal - lysosomal pathway with the aid 
of microtubule network.  Uncoating of WNV took place in low pH environment of 
the late endosomes/lysosomes and the virus nucleocapsids were expelled into the 
cytoplasm in the perinuclear region.  Spontaneous dissociation of the nucleocapsids 
released the virus RNA for replication in the endoplasmic reticulum. 
• During the process of WNV morphogenesis, the intracellular trafficking of WNV 
structural (E and C) proteins from the site of synthesized (endoplasmic reticulum) to 
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the site of assembly (plasma membrane) was highly dependent on the intact 
microtubule network for transportation.  The E and C proteins of WNV were 
associated with the microtubule network via ionic interaction although the exact 
process to initiate this interaction has not been deciphered.  Furthermore, kinesin is 
responsible for transporting the virus proteins along the microtubule tracks towards 
the plasma membrane. 
• Actin filaments were essential for the budding process of WNV across the plasma 
membrane.  WNV E and C proteins associated strongly with actin and the growing 
barbed ends of F-actins to provide the kinetic energy for virus budding. 
• High infectious doses of WNV induced necrosis in infected cells while low infectious 
doses induced mitochondrial - mediated apoptotsis. 
Ultimately, the detail understanding of the interactions between WNV and cellular 
components during the entry, morphogenesis and cell death processes, can serve as 
important target sites for anti-viral strategies as well as the platform for cell - base 
screening of anti-viral agents.  Molecular inhibitors and drug derivatives can be designed 
to block the specific interactions between virus and host cells hence eradicating the 
pathogenic virus infection. 
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APPENDIX 1  
 
MATERIALS FOR CELL CULTURE 
 
All materials prepared for cell culture were either sterile or sterilised.  Double glass 
distilled water [(dgd) (Corning, USA)] was used for all dilutions. 
(a) Growth Medium, M199 for Vero cells (pH 7.2 - pH 7.4), filter sterilised. 
 
Items Amount  Source 
Medium M199   1 packet (commerical) CSL, Australia 
NaHCO3 2.2 g Merck, Germany 
Foetal calf serum 100.0 ml GIBCO BRL, New Zealand 
Dgd 900.0 ml Corning, USA 
 
(b) Growth Medium, RPMI for Hela cell, CS-1 cell, CS-1β3 cells (pH 7.2 - pH 
7.4), filter sterilised. 
 
Items Amount  Source 
RPMI   1 packet (commerical) CSL, Australia 
NaHCO3 2.0 g Merck, Germany 
Foetal calf serum 100.0 ml GIBCO BRL, New Zealand 
Dgd 900.0 ml Corning, USA 
 
(c) Growth Medium, L15 for C6/36 cells (pH 7.2 - pH 7.4), filter sterilised. 
 
Items Amount  Source 
L15   1 packet (commerical) CSL, Australia 
Foetal calf serum 100.0 ml GIBCO BRL, New Zealand 
Dgd 900.0 ml Corning, USA 
 
The solution was then sterilised by filtration through 0.22 µm filter unit (Sterivex G-S, 
Millipore, USA). All cell culture media were screened for microbial contamination 
before the addition of serum.  The serum supplemented media were kept at 4 °C.  The 
cell culture media were warmed up in water bath to the temperature suitable for cell 
culture before use. 
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(d) Phosphate Buffered Saline (PBS) 
 
Items Amount (g) Source 
NaCl 8.0 Merck, Germany 
KCl 0.2 Merck, Germany 
Na2HPO4 1.15 Merck, Germany 
KH2PO4 0.2 Merck, Germany 
 
The above materials were dissolved in 1 litre of dgd water.  The pH was adjusted to 
7.2 using either 1 M HCl or 1 M NaOH.  The solution was aliquoted and sterilised at 
15 ib/in2 (1 kg/cm2) pressure for 20 min.  Storage was at room temperature. 
(e) Trypsin-Versene (ATV) Solution (10x concentrate) 
 
Items Amount  Source 
NaCl 80.0 g Merck, Germany 
KCl 4.0 g Merck, Germany 
D-glucose 10.0 g Analar, UK 
NaHCO3 5.8 g Merck, Germany 
Trypsin 5.0 g Difco, New Zealand 
Versene (EDTA) 2.0 g Sigma, USA 
dgd 1000.0 ml Corning, USA 
 
The mixture was heated to 37 °C with occasional shaking for 3 to 4 hr to dissolve the 
trypsin.  The solution was then sterilised by filtration through 0.22 µm filter unit 
(Sterivex G-S, Millipore, USA).  To use, 10.0 ml of this solution was added to 90.0 
ml of sterile dgd to give 1x ATV solution. 
(f)  Preservation Medium 
 
Items Amount (ml) Source 
Dimethylsulphoxide 
(DMSO) 
1.0 Sigma, USA 
Foetal calf serum 1.0 GIBCO BRL, New Zealand 
Growth medium  7.0 Appendix 1(a-c) 
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(g) 0.4% Phenol Red Solution 
 
0.8 g of phenol red powder (Merck, Germany) was dissolved in a mortar using 1 M 
NaOH.  The NaOH was also used to adjust the pH of the solution.  The solution was 
made up to 200.0 ml with dgd.  Working concentration of 0.1 % was made by 
diluting in dgd and sterilising at 15 Ib/in2 pressure for 15 min. 
(h) 0.04 % L-Glutamine Solution 
 
Items Amount  Source 
L-glutamine 5.85 g Merck, Germany 
NaCl 1.70 g Merck, Germany 
Dgd 200.0 ml Corning, USA 
 
 
(i) 3 % Sodium Bicarbonate - 0.01 % Phenol Red Solution 
 
Items Amount  Source 
NaHCO3 30.0 g  Merck, Germany 
0.4 % phenol red solution 250.0 ml Appendix 1(g) 
Dgd 975.0 ml Corning, USA 
 
(j) 0.5 % Trypan Blue Solution 
 
Items Amount  Source 
Trypan blue 0.5 g Merck, Germany 
PBS 100.0 ml Appendix 1(d) 
 
The solution was autoclaved at 121 ºC for 15 min (Hirayama, Japan).  The solution 
was filtered before use. 
(k) 1 % SDS Cell Lysis Buffer 
Items Amount  Source 
SDS 1.0 g Sigma, USA 
PBS 100.0 ml Appendix 1(d) 
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APPENDIX 2 
MATERIALS FOR VIRUS INFECTION, GROWTH OF VIRUS AND 
PLAQUE ASSAY 
 
(a) Maintenance Medium (MEM) - pH 7.2-7.4 
 
9.57 g of MEM (Minimal Essential Medium) powder was dissolved in 995.0 ml of 
dgd with 5.0 ml of 0.4 % Phenol Red solution [Appendix 1(g)].  Ninety mls of the 
solution was aliquoted into 100.0 ml glass bottles and sterilised at 15 Ib/in2 pressure 
for 20 min.  Storage was at 4 °C.  MEM was warmed to the required temperature 
before adding to cells. 
The complete MEM was prepared as follow: 
 
Items Amount (ml) Source 
MEM 90.0 From above 
10% BSA 1.0 CSL, Australia 
L-glutamine 1.0 Appendix 1(h) 
3% Sodium bicarbonate 2.0 Appendix 1(i) 
 
 
(b) Virus Diluent (pH 7.2 - 7.4) 
 
Items Amount (ml) Source 
Hank's BSS (10x 
concentrate) 
10.0 CSL, Australia 
10% Bovine serum albumin 1.0 CSL, Australia 
Dgd 87.0 Corning, USA 
3% Sodium bicarbonate 1.0 Appendix 1(i) 
 
The solution was then sterilised by filtration through 0.22 µm filter unit (Sterivex G-S, 
Millipore, USA).  Storage was at 4 °C.  Virus diluent was warmed to room 
temperature before use. 
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(c) Overlay Medium (pH 7.2 - 7.4) 
 
Items Amount  Source 
Medium M199   1 packet (commerical) CSL, Australia 
NaHCO3 2.2 g Merck, Germany 
Foetal calf serum 20.0 ml GIBCO, New Zealand 
Dgd 500.0 ml Corning, USA 
2 % w/v 
Carboxymethylcellulose 
(CMC) 
500.0 ml Behring Diagnostic, USA 
 
The solution was then sterilised by filtration through 0.22 µm filter unit (Sterivex G-S, 
Millipore, USA) before mixing with CMC (sterilising at 15 Ib/in2 pressure for 15 
min).  Storage was at 4 °C. Overlay medium is warmed to the required temperature 
before adding to cells. 
(d) 0.5 % Crystal Violet / 25 % Formaldehyde Solution 
 
Items Amount  Source 
Crystal violet 5.0 g Sigma, USA 
37 % Formaldehyde 
solution 
300.0 ml Merck, Germany 
PBS 200.0 ml See Appendix 1(d) 
 
(e) 0.02 M Tris (hydroxymethyl)-aminoethane buffer, pH 7.4 
 
Items Amount  Source 
Tris-base 0.24 g Merck, Germany 
NaCl 0.87 g Merck, Germany 
 
The solution was then sterilised by filtration through 0.22 µm filter unit (Sterivex G-S, 
Millipore, USA). 
(f) Sucrose Gradient 
 
Items Amount (g) Source 
10 % Sucrose 10.0 Merck, Germany 
20 % Sucrose 20.0 Merck, Germany 
30 % Sucrose 30.0 Merck, Germany 
40 % Sucrose 40.0 Merck, Germany 
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Sucrose (ultracentrifugation type) was dissolved in Tris buffer, pH 7.4 (Appendix 2) 
and made up to 100.0 ml by stirring constantly at 40 ºC.  Storage was at 4 °C. 
 
(g) PBS with 5 mM EDTA 
 
Items Amount (g) Source 
EDTA 0.146  Merck, Germany 
 
The EDTA is dissolved in PBS [Appendix 1(d)] with continuously stirring at 40 ºC to 
a final volume of 100.0 ml. The solution was then sterilised by filtration through 0.22 
µm filter unit (Sterivex G-S, Millipore, USA). The solution is stored at 4 °C until use. 
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APPENDIX 3  
 
MEDIUM FOR RADIO-LABELLING OF VIRUS PROTEINS 
 
All the media for labelling experiment were prepared under sterile conditions and 
stored at 4 °C. 
(a) Starvation Medium (for [35S]-Methionine) 
 
Items Amount (ml) Source 
Earle's salt for MEM (10x 
concentrate) 
10.0 CSL, Australia 
Vitamins (100x concentrate) 1.0 CSL, Australia 
L-glutamine solution (100x 
concentrate) 
1.0 Appendix 1(h) 
0.1 % phenol red solution 1.0 Appendix 1(g) 
Amino acid A (100x 
concentrate) 
0.1 CSL, Australia 
Amino acid A (100x 
concentrate, methionine 
deficient) 
1.0 Appendix 3(c) 
 
Amino acid B (100x 
concentrate) 
1.0 CSL, Australia 
10 % BSA 1.0 CSL, Australia 
Actinomycin D solution  
,300 mg/ml (ACD) 
1.0 Appendix 3 (d) 
Double glass distilled water 82.0 Corning, USA 
 
(b) Labelling Medium (for [35S]-Methionine) 
 
The labelling medium was prepared from the starvation medium. [35S]-methionine 
was added to the starvation medium at the concentration of 10.0 µCi/ml. 
(c) Amino Acid Solution A, Methionine Deficient (100x concentrate) 
 
Items Amount (mg) Source 
L-arginine.HCl 1050.0 Merck, Germany 
L-histidine.HCl.H2O 310.0 Merck, Germany 
L-isoleucine (allo free) 520.0 Merck, Germany 
L-leucine 520.0 Merck, Germany 
L-lysine.HCl 580.0 Merck, Germany 
L-phenylalanine 320.0 Merck, Germany 
L-threonine (allo free) 480.0 Merck, Germany 
L-tryptophan 100.0 Merck, Germany 
L-valine 460.0 Merck, Germany 
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The above was dissolved in 100.0 ml of dgd.  The solution was dissolved on a heater 
with stirring to dissolve the compounds completely and sterilised by filtration through 
0.22 µm filter (Sterivex G-S, Millipore, USA). 
(d) Actinomycin D Solution (ACD) 
 
Fifty mg of Actinomycin D (Sigma, USA) was dissolved in 1 ml of absolute ethanol 
and the solution made up to 167.0 ml using diluted (1x) Hank's BSS to give a 
concentration of 300 mg/ml.  The drug was sterilised by filtering through 0.22 µm 
filter (Sterivex G-S, Millipore, USA).  Aliquots of 5.0 ml each were made and stored 
at -20 °C.  Actinomycin D was added to media just before use and stored in dark.  
(e) 0.2% SDS Virus Lysis Buffer  
0.2 grams of SDS (Sigma, USA) were dissolved in 100.0 ml of dgd.  The solution 
was stored at room temperature. 
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APPENDIX 4 
MATERIALS FOR MOLECULAR CLONING 
Materials Required for DNA Agarose Gel Electrophoresis 
(a) 1 x Tris-Borate-EDTA Buffer (TBE) 
The stock solution of 10 x TBE buffer was purchased from the National University 
Medical Institute (NUMI) Store.  Ten ml of the 10 x TBE buffer was added to 90.0 
ml of deionized water to obtain the 1 x TBE buffer. 
(b) 1.5 % Agarose Gel 
Items Amount Source 
Agarose 20.0 g Seakem, USA 
10 x TBE 25.0 ml Prepared by NUMI Store 
Ethidium Bromide (10 
mg/ml) 
12.5 µl Sigma, USA 
 
The above mixture was topped up to 250.0 ml (excluding ethidium bromide) with 
dgd and the mixture was boiled for 3 min in a microwave oven.  The solution was 
allowed to cool to 60 °C followed by the addition of ethidium bromide.  The solution 
was mixed well before pouring into the agarose gel apparatus in the fume cardboard. 
 
Materials Required for Bacterial Culture 
(c) Luria-Bertani (LB) Broth, pH 7.0 
Items Amount Source 
Bacto-tryptone 10.0 g BD Biosciences, USA 
Bacto-yeast extract 5.0 g BD Biosciences, USA 
NaCl 10.0 g Merck, Germany 
 
The above components were dissolved in 1.0 liter of dgd.  The solution was 
autoclaved at 121 ºC for 15 min (Hirayama, Japan).  Storage was at 4 °C. 
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(d) Luria-Bertani (LB) Agar 
Items Amount Source 
Bacto-tryptone 10.0 g BD Biosciences, USA 
Bacto-yeast extract 5.0 g BD Biosciences, USA 
NaCl 10.0 g Merck, Germany 
Agarose 10.0 g Oxoid, UK 
 
The above components were dissolved in 1.0 liter of deionised water.  The solution 
was autoclaved at 121 ºC for 15 min (Hirayama, Japan) and cooled to 60 °C before 
pouring plates.  Storage was at 4 °C. 
(e) Antibiotics 
Ampicillin was prepared as stock solution of 100 mg/ml in dgd while kanamycin was 
prepared as stock solution of 50 mg/ml in deionised water.  All the antibiotic 
solutions were filtered through a 0.22 µm filter and stored at -20 °C prior to use.  
Working concentrations of ampicillin and kanamycin are 100 µg/ml and 50 µg/ml, 
respectively. 
(f) SOC media 
Items Amount  Source 
Bacto-Tryptone 2.0 g BD Biosciences, USA 
Bacto -Yeast extract 0.5 g BD Biosciences, USA 
NaCl 0.58 g Merck, Germany 
KCl 0.25 g Merck, Germany 
MgCl2 2.03 g Merck, Germany 
MgSO4 2.46 g Merck, Germany 
Glucose 1.8 g Merck, Germany 
 
The above components were dissolved in 1.0 liter of dgd.  The solution was 
autoclaved at 121 ºC for 15 min (Hirayama, Japan).  Storage was at 4 °C. 
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Materials for Recombinant Fusion Protein Extraction 
 
(f) GST Purification buffer 
Items Amount Source 
Tris-HCl 7.88 g Sigma, USA 
Magnesium chloride 0.1 g Sigma, USA 
Triton X-100 (v/v) 0.1 ml Sigma, USA 
PMSF 5.0 ml Appendix 5 (e) 
DTT 0.78 g Sigma, USA 
 
The above materials were dissolved in 1.0 litre of dgd water.  The pH was adjusted to 
7.2 using either 1 M HCl or 1 M NaOH. Storage was at room temperature. 
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APPENDIX 5 
MATERIAL FOR SODIUM DODECYL SULPHATE - POLYACRYLAMIDE 
GEL ELECTROPHORESIS (SDS-PAGE) 
 
(a) Stacking Gel 
 
Items Amount  Source 
30 % Acrylamide & 0.8 % 
bis-acrylamide 
1.67 ml Merck, Germany 
0.5 M Tris buffer pH 6.8 2.5 ml Merck, Germany 
10 % SDS 0.1 ml Merck, Germany 




20.0 µl Merck, Germany 
10 % Ammonium 
persulphate 
50.0 µl Merck, Germany 
 
The chemicals were added in the above order. 
 
(b) Separation Gel (12% SDS-PAGE) 
 
Items Amount  Source 
30 % Acrylamide & 0.8 % 
bis acrylamide 
12.0 ml Merck, Germany 
1 M Tris buffer pH 8.8 11.25 ml Merck, Germany 
10 % SDS 0.3 ml Merck, Germany 




40.0 µl Merck, Germany 
10 % Ammonium 
persulphate 
80.0 µl Merck, Germany 
 
The chemicals were added in the above order. 
 
(c) Dye Mixture (Stock Solution) 
 
Items Amount  Source 
Bromophenol blue 0.1g Sigma, USA 
Glycerol 1.0 ml Analar, UK 
0.5 M Tris buffer, pH 6.8 10.0 ml Merck, Germany 
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(d) SDS-Sample Buffer 
 
A 1ml cocktail of dye mixture [see Appendix 5 (c)] stock solution were mixed with 
100 mg of dithioerythritol (Biorad, USA).  To every 25.0 µl of sample, 5.0 µl of these 
cocktail were added.  After mixing the sample with cocktail, the mixture was boiled 
for 1 min in a water bath before loading onto the gel. 
(e) Running Buffer (pH 8.9) 
 
Items Amount  Source 
Tris 6.0 g Merck, Germany 
Glycine 28.7 g Merck, Germany 
SDS 2.0 g BioRad, USA 
 
The above was dissolved in 1 litre of dgd to make a 2x concentrated solution.  From 
this concentrated solution, 250.0 ml were diluted to 500.0 ml and used as the top 
chamber buffer.  The remaining stock solution were diluted to 4 litres and used as the 
bottom chamber buffer. 
(f) Gel Fixing Solution 
 
Items Amount (ml) Source 
Glycerol 25.0 Merck, Germany 
Glacial acetic acid  25.0 Merck, Germany 
Deionised water 450.0 Elga, UK 
 
This solution was prepared fresh before usage. 
 
(g) X-Ray Film Developer  
 
Items Amount (ml) Source 
X-ray Film Developer 100.0 Kodak, USA 
Deionised water 900.0 Elga, UK 
 
(h) X-Ray Film Fixer  
 
Items Amount (ml) Source 
X-ray Film Fixer 100.0 Kodak, USA 
Deionised water 900.0 Elga, UK 
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APPENDIX 6 
 
MATERIAL FOR IMMUNOBLOTTING 
 
(a) Transfer Buffer 
 
Items Amount  Source 
Tris (hydroxymethyl)-
aminoethane 
3.0 g Merck, Germany 
Glycine 14.40 g Merck, Germany 
Methanol 200.0 ml Merck, Germany 
Dgd 800.0 ml Elga, UK 
 
 
(b) 5% Skim Milk Blocking Solution 
 
Items Amount  Source 
Skim milk powder 5.0 g Diploma, Singapore 
PBS 100.0 ml  Appendix 1 (d) 
 
(c) 0.1 % Bovine Serum Albumin (BSA)/PBS 
 
0.1 ml of BSA (CSL, Australia) was added into 100.0 ml of PBS [see Appendix 1 (d)].  
The solution was prepared fresh. 
(d) 10% Bovine Serum Albumin (BSA)/PBS 
 
1.0 ml of BSA (CSL, Australia) was added into 100.0 ml of PBS [see Appendix 1 (d)].  
The solution was prepared fresh. 
(e) 20 mM Phenylmethylsulfonyl Fluoride (PMSF) 
Items Amount  Source 
Phenylmethylsulfonyl 
fluoride 
0.35 g Sigma, USA 
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(f) RIP Buffer for Immuno-precipitation 
Items Amount  Source 
NaCl 0.88 g Merck, Germany 
SDS 0.1 ml Merck, Germany 
Triton X-100 1.0 ml Sigma, USA 
Phenylmethylsulfonyl 
fluoride 
2.0 ml Sigma, USA 
Sodium deoxycholate (w/v) 0.8 g Merck, Germany 
Tris-HCl 0.16 g Merck, Germany 
 
A final 100.0 ml solution of the buffer was prepared.  Storage was at 4 °C. 
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APPENDIX 7 
 
MATERIAL FOR CELL EXTRACTION 
 
(a)  2% Sodium Dodecyl Sulphate (SDS) 
 
Two g of SDS (Sigma, USA) were dissolved in 100.0 ml of dgd.  The solution was 
stored at room temperature. 
(b) Stabilisation Buffer (pH 6.9) 
 
Items Amount  Source 
PIPES [Pierazine-N,N'-bis 
(2-ethane sulfonic acid) 
sodium salt] 




0.038 g Sigma, USA 
PEG 6000 (Polyethylene 
glycol) 
4.0 g Sigma, USA 
PMSF (Phenyl methyl 
sulfonyl flouride) 
0.15 g Sigma, USA 
Dgd 100.0 ml Corning, USA 
 
(c) Stabilisation Buffer (pH 6.9) with 0.2 % Triton X-100 
 
Items Amount (ml) Source 
Stabilisation buffer, pH 6.9 99.8  Appendix 7 (b) 
Triton X-100 0.2 Merck, Germany 
 
(d) Stabilisation Buffer (pH 6.9) with 0.05 % Tween-20 
 
Items Amount (ml) Source 
Stabilisation buffer, pH 6.9 99.95 See Appendix 7 (b) 
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APPENDIX 8 
 
MATERIALS FOR BIO-IMAGING  
 
Materials for Indirect Immunofluorescence Microscopy 
 
(a) Ammonium Chloride - PBS Solution 
 
Ammonium chloride (Merck, Germany) was prepared fresh by dissolving in PBS [see 
Appendix 1 (d)] to give a final concentration of 0.265 g/100.0 ml. 
(b) 0.1 % Bovine Serum Albumin (BSA) 
 
0.1 ml of BSA (CSL, Australia) was added into 100.0 ml of PBS [Appendix 1 (d)].  
The solution was prepared fresh. 
(c) DABCO Mountant 
 
4.5 g of DABCO (Sigma, USA) was dissolved in 180.0 ml of glycerol (Merck, 
Germany) and stirred gently while heating.  This was made up to 200.0 ml with PBS 
[see Appendix 1 (d)]. 
 
Materials for Processing of Samples for Tranmission Electron Microscopy 
(d) 0.4 M Sodium Cacodylate Stock 
 
Items Amount  Source 
Sodim cacodylate 8.56 g Merck, Germany 
Dgd 100.0 ml Elga, UK 
 
(e) 0.2 M Sodium Cacodylate Stock (pH 7.4) 
 
Items Amount (ml) Source 
0.4 M Sodim cacodylate 50.0 Appendix 8 (d) 
0.1 M HCl 25.2 Merck, Germany 
0.1 M CaCl2 (1.1 g in 100 
ml of dgd 
2.0 Merck, Germnay 
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(f) 10 % Paraformaldehyde in 0.1 M Cacodylate buffer, pH 7.4 
 
Items Amount  Source 
Paraformaldehyde powder 10.0 Merck, Germany 
0.2 M Sodium cacodylate 
buffer (pH 7.4) 
50.0 ml Appendix 8 (e) 
 
Paraformaldehyde powder was first dissolved in the buffer by heating to 65 ºC.  A 
few drops of 1 M NaOH solution were added to clear the solution.  The solution was 
cooled before making up to 100.0 ml with the buffer. 
(g) 2.5 % Glutaradehyde and 2.0 % Paraformaldehyde in 0.1 M Cacodylate 
Buffer, pH 7.4 
Items Amount  Source 
0.2 M Cacodylate buffer 50.0 ml Appendix 8 (e) 
10 % Paraformaldehyde 
solution 
20.0 ml Appendix 8 (f) 
25 % Glutaraldehyde 10.0 ml Merck, Germany 
CaCl2 0.01 g Merck, Germany 
Dgd 20.0 ml Elga, UK 
 
(h) 1 % Osmium Tetroxide in 0.1 M Cacodylate Buffer, pH 7.4 
Items Amount  Source 
Osmium tetroxide (packed 
in ampoule) 
1.0g Taab, UK 
0.2 M Sodium cacodylate 
buffer (pH 7.4) 
100.0 ml Appendix 8 (e) 
 
To prepare the solution, the ampoule was opened in a brown glass bottle with the 
buffer inside.  The mixture was swirled to ensure that the osmium tetroxide is 
dissolved totally.  The solution was aliquoted into 5.0 ml bottle and stored at -20 °C. 
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(i) Low Viscosity Epoxy Resin (LVER) 
Items Amount (g) Source 
ERL 4206 (Epoxy resin) 10.0 Agar Aids, UK 
DER 736 (reactive 
flexibiliser 
6.0 Agar Aids, UK 
NSA (harder) 26.0 Agar Aids, UK 
S-1 accelerator  0.1 Agar Aids, UK 
 
All bottles used for preparation of LVER must be clean and preheated at 60 ºC before 
use.  All containers used in making of LVER were first de-toxified at 65 °C for 24 hr 
before disposal.  The prepared resin was stored at 0 ºC for not more than a month. 
(j) Ryter Kellenburger Buffer Stock Solution 
Items Amount  Source 
Sodium veronal 2.9 g Analar, UK 
Sodium acetate (hydrated) 1.9 g Analar, UK 
NaCl 3.4 g Merck, Germany 
Dgd  100 ml Elge, UK 
 
(k) Saturated Uranyl Acetate Solution 
Items Amount  Source 
Ryter kellenburger buffer 5.0 ml Appendix 8 (j) 
0.1 M CaCl2 5.0 ml Merck, Germany 
0.1 M HCl 6.5 ml Merck, Germany 
Uranyl acetate 1.3 g Merck, Germany 
Dgd 13.0 ml Elga, UK 
 
The saturated solution was stored in bottle covered with aluminium foil at room 
temperature and centrifuged at 2000 x g before use. 
(l) Reynold’s Lead Citrate Solution 
Items Amount  Source 
Lead citrate  1.3 g BDH, UK 
Sodium citrate 1.8 g Merck, Germany 
Dgd 30.0 ml Elga, UK 
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The solution was stirred continuously for about 45 min to ensure the complete 
conversion of lead nitrate (impurity) to lead citrate.  To this, 8.0 ml of 1 M NaOH was 
added, followed by dgd to make up to the 50.0 ml mark.  The solution was stored at 4 
°C. 
 
Materials for Fluorescence Labelling of Virus 
(m) 0.1 M Sodium Carbonate Buffer, pH 9.5 
 
Items Amount  Source 
Sodium carbonate 0.8 g Merck, Germany 
 
Sodium carbonate was dissolved in dgd to a final volume of 100 ml. 
(n) 50 mM Hepes Buffer 
 
Items Amount  Source 
1M Hepes buffer 5.0 ml Irvine Scientific, USA 
 
Hepes buffer was diluted in dgd to a final volume of 100.0 ml. 
 
Materials for Cryo-Immuno Electron Microscopy 
(o) 4 % Paraformaldehyde and 0.2 % Glutaldehyde in PBS 
 
Items Amount  Source 
Paraformaldehyde 2.0 g Merck, Germany 
25 % Glutaraldehyde 0.5 ml Merck, Germany 
 
Paraformaldehyde powder was first dissolved in the buffer by heating to 65 ºC.  A 
few drops of 1 M NaOH solution were added to clear the solution.  The solution was 
cooled before making up to 50.0 ml with PBS [Appendix 1 (d)]. 
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(p) 2.3 M Sucrose 
 
Items Amount  Source 
Sucrose 78.7 g Merck, Germany 
 
Sucrose was added to PBS [Appendix 1 (d)] in small amount with continuously 
mixing to a final volume of 100.0 ml. 
(q) 0.05 M Glycine in PBS 
 
Items Amount  Source 
Glycine 0.3 g Sigma, USA 
 
Glycine was added to PBS [Appendix 1(d)] in small amount with continuously 
mixing to a final volume of 100.0 ml PBS. 
(r) 2 % Glutaldehyde in PBS 
 
Items Amount  Source 
25 % Glutaraldehyde 8.0 ml Merck, Germany 
PBS 92.0 ml Appendix 1 (d) 
 
(s) 2 % Uranyl Acetate and 2 % Methylcellulose  
 
Items Amount  Source 
Saturated uranyl acetate 
solution 
2.0 ml Appendix 8 (k) 
Methylcellulose 2.0 g Sigma, USA 
 
Methylcellulose was first dissolved in 100.0 ml of dgd by heating to 65 °C with 
continuous stirring and followed by the addition of saturated uranyl acetate.  The 
solution was then clarified by centrifugation for 30 min at 30,000 x g at 4 ºC.  The 
solution can be kept for 6 months at 4 ºC in the dark. 
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Materials for DNA probe hybridization 
(t) 100 mM EDTA 
Items Amount  Source 
Ethylenediaminetetraacetic 
acid (EDTA) 
2.92 g Merck, Germany 
Dgd 100.0 ml Elga, UK 
 
(u) Hybridization buffer, pH 7.4 
 
Items Amount  Source 
Dextran Sulphate (MW 
500,000) 
10.0 g Sigma, USA 
Formamide  50.0 ml Merck, Germany 
Polyvinylpyrrolidone 0.5 g Sigma, USA 
Herring sperm DNA (w/v) 0.05 ml Invitrogen, USA 
SDS 0.05 ml Merck, Germany 
Tris-HCl 0.8 g Merck, Germany 
NaCl 1.75 g Merck, Germany 
EDTA 2.0 ml Appendix 7 (t) 
 
The buffer was prepared in a final volume of 100.0 ml. 
(v) Wash buffer 
 
Items Amount  Source 
20 X Wash Buffer  0.25 ml Genelab Diagnostic, 
Singapore 
Dgd 5.0 ml Elga, UK 
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APPENDIX 9 
MATERIALS FOR CELL FRACTIONATION 
(a) 100 mM Sucrose 
 
3.4 g of sucrose (Merck, Germany) was dissolved in deionized water to make up the 
final volume of 100.0 ml. 
(b) Homogenization Buffer 
Items Amount  Source 
Tris-HCl 0.15 g Merck, Germany 
100 mM Sucrose 0.2 ml Appendix 9 (a) 
EDTA 0.1 g Merck, Germany 
Cocktail proteases inhibitor 
tablet 
1 tablet Roche, UK 
 
The buffer was prepared in a final volume of 100.0 ml. 
(c) 0.15 M NaCl 
Items Amount  Source 
NaCl 0.88 g Merck, Germany 
Dgd 100.0 ml Elga, UK 
 
(d) 20 % Percoll Gradient  
Two ml of percoll (Amersham Biosciences, USA) was added to 8.0 ml of 0.15 M 
NaCl to make a 20 % Percoll gradient. 
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APPENDIX 10 
MATERIALS FOR PEPTIDE SEQUENCING AND MASS SPECTROMETRY 
(a) 50 mM Ammonium Bicarbonate in 50 % Methanol 
Items Amount  Source 
Ammonium bicarbonate 0.40 g Merck, Germany 
Methanol 50.0 ml Merck, Germany 
Dgd 50.0 ml Elga, UK 
 
Ammonium bicarbonate was completely dissolved in dgd with continuous stirring 
before adding methanol. 
(b) 50 % Acetonitrile 
Items Amount  (ml) Source 
Acetonitrile 5.0 Sigma, USA 
 
Acetonitrile was added to 5.0 ml of dgd with continuous stirring. 
(c) 5 % (v/v) of TFA in 50 % Acetonitrile 
Items Amount (ml) Source 
TFA 0.5 Sigma, USA 
50 % Acetonitrile 10.0 Appendix 10 (b) 
 
TFA was added to the 50 % Acetonitrile with continuous stirring. 
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APPENDIX 11 
MATERIALS FOR VIRUS INACTIVATION BUFFER 
(a) Sodium Citrate Buffer, pH 2.8 
Items Amount  Source 
Sodium citrate 0.29 g Sigma, USA 
Dgd 100.0 ml Elga, UK 
 
Sodium citrate was first completely dissolved in dgd and the pH was adjusted by 
adding 1 M HCl. 
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APPENDIX 12 
MATERIALS FOR VIRUS RECEPTOR ANALYSES 
Materials for Plasma Membrane Protein Extraction 
(a) 100 mM EDTA 
Items Amount  Source 
EDTA 2.9 g Merck, Germany 
Dgd 100.0 ml Elga, UK 
 
(b) Buffer M   
 
Items Amount  Source 
NaCl 5.8 g Merck, Germnay 
Tris-base 0.3 g Merck, Germany 
MgCl2 0.1 g Merck, Germany 
EDTA 1.0 ml Appendix 12 (a) 
β-mecaptoethanol 8 µl Sigma, USA 
 
The final volume of the buffer was made up to 100.0 ml. 
 
(c) Buffer M without β-mercaptoethanol 
 
Items Amount  Source 
NaCl 5.84 g Merck, Germnay 
Tris-base 0.3 g Merck, Germany 
MgCl2 0.1 g Merck, Germany 
EDTA 1.0 ml Appendix 12 (a) 
 
The final volume of the buffer was made up to 100.0 ml. 
 
 
Materials for Virus Overlay Protein Blot Assay (VOPBA) 
 
(d)      200 mM High Salt Wash buffer  
 
Items Amount  Source 
NaCl 1.16 g Merck, Germnay 
PBS 100.0 ml Appendix 1(d) 
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APPENDIX 13 
 
MATERIALS FOR ASSAYING CELL DEATH MECHANISM 
 
Materials for Lactate Dehydrogenase (LDH) Assay  
(a) TNT Buffer, pH 7.5
Items Amount  Source 
Tris-HCl 0.32 g Merck, Germany 
NaCl 2.92 g Merck, Germnay 
Triton X-100 1.0 ml Sigma, USA 
Cocktail proteases inhibitor 
tablet 
1 tablet Roche, UK 
 
The final volume of the buffer was made up to 100.0 ml. 
 
(b) Tris-EDTA (TE) Buffer, pH 8 
 
Items Amount  Source 
Tris-HCl 0.16 g Merck, Germany 
EDTA 1.0 ml Appendix 10 (a) 
  
The final volume of the buffer was made up to 100.0 ml. 
 
(c) Cell Lysis Buffer, pH 7.6 
 
Items Amount  Source 
Tris-HCl 0.79 g Merck, Germany 
NaCl 0.88 g Merck, Germany 
EDTA 0.5 ml Appendix 12 (a) 
Na2HPO4 0.36 g Merck, Germany 
Nonidet P-40 1.0 ml Sigma, USA 
 
The final volume of the buffer was made up to 100.0 ml. 
 
 
Materials for Lactate Dehydrogenase Assay (CytoTox 96, Promega) 
 
(d) The reagents were provided in the kit and were added in the following 
order: 
Step  Items Amount  Temperature/Time 
1 10 X Lysis 
Solution (9 % v/v 
Triton X-100) 
15.0 µl 37 ºC / 45-60 min 
2 Substrate mix 50.0 µl 25 ºC / 30 min 
3 Stop Solution 50.0 µl Procced for analysis 
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Materials for Fluorometric Caspase Assay (ClonTech) 
 
(e) The reagents were provided in the kit and were added in the following 
order: 
 
Step  Items Amount  Temperature/Time 
1 1 x Cell Lysis 
Buffer 
50.0 µl On ice / 10 min 
2 2 x Reaction buffer 50.0 µl 37 ºC / 2 hr 
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APPENDIX 14 
 
DATA FOR FIGURES IN CHAPTER 3 
 
(a) Effects of enzymes, sodium periodate and lectins treatment on WNV-
binding molecules present on the surface of intact Vero cells 
Enzyme Concentration Exp 1 (log 
unit 
inhibition) 
Exp 2 (log 
unit 
inhibition) 









PLA 1U/ml 0.6 0.5 0.6 0.5667 0.057735 95 
  0.1U/ml 0.5 0.45 0.5 0.4833 0.0288675 98 
PLC 10 U/ml 0.4 0.6 0.5 0.5 0.1 95 
  1 U/ml 0.6 0.7 0.5 0.6 0.1 98 
PLD 100 U/ml 0.3 0.2 0.3 0.2667 0.057735 96 
  10 U/ml 0.2 0.2 0.3 0.2333 0.057735 98 
Trypsin 10 µg/ml 3.7 3.8 3.6 3.7 0.1 94 
  1 µg/ml 0.35 0.4 0.35 0.3667 0.0288675 96 
  0.1 µg/ml 0.1 0.15 0.15 0.1333 0.0288675 96 
Proteinase K 10 µg/ml 2.8 2.5 2.4 2.5667 0.2081666 95 
  1 µg/ml 1.45 1.5 1.6 1.5167 0.0763763 96 
  0.1 µg/ml 0.3 0.2 0.3 0.2667 0.057735 98 
Bromelian 20 mU/ml 4.5 4.3 4.1 4.3 0.2 89 
  2 mU/ml 1.6 1.4 1.6 1.5333 0.1154701 90 
  0.2 mU/ml 0.4 0.4 0.5 0.4333 0.057735 93 
Papain 50 mU/ml 6 5.8 5.7 5.8333 0.1527525 98 
  10 mU/ml 2.5 2.7 2.3 2.5 0.2 98 
α-
chymotrypsin 
10 µg/ml 3 3.8 3.5 3.4333 0.4041452 98 
  1 µg/ml 1.7 1.65 1.6 1.65 0.05 98 
EH 100 mU/ml 3.8 3.9 3.8 3.8333 0.057735 97 
  10 mU/ml 1.6 1.3 1.5 1.4667 0.1527525 98 
OG 1 mU/ml 0.7 0.65 0.9 0.75 0.1322876 99 
  0.1 mU/ml 0.3 0.3 0.3 0.3 5.268E-09 98 
ΜΑ 1000 µg/ml 4.5 4.3 4.6 4.4667 0.1527525 98 
  100 µg/ml 3.65 3.2 3.4 3.4167 0.2254625 98 
  10 µg/ml 1.25 1.5 1.1 1.2833 0.2020726 98 
FU 100 mU/ml 0.8 0.9 0.9 0.8667 0.057735 97 
  10 mU/ml 0.55 0.65 0.5 0.5667 0.0763763 98 
Hep I 1 U/ml 0.8 0.8 0.8 0.8 0 97 
  0.1 U/ml 0.65 0.55 0.7 0.6333 0.0763763 95 
Hep III 1 U/ml 0.5 0.5 0.6 0.5333 0.057735 98 
  0.1 U/ml 0.85 0.8 0.9 0.85 0.05 98 
SP 1 mM/ml 4.8 4 4.5 4.4333 0.4041452 99 
  0.1 mM/ml 2.5 1.8 2 2.1 0.3605551 98 
WGA 1000 µg/ml 0.65 0.8 0.85 0.7667 0.1040833 99 
  100 µg/ml 0.35 0.4 0.4 0.3833 0.0288675 98 
PHA 1000 µg/ml 0.25 0.4 0.5 0.3833 0.1258306 98 
  100 µg/ml 0.3 0.25 0.3 0.2833 0.0288675 98 
ConA 1000 µg/ml 4 4.5 4.2 4.2333 0.2516611 97 
  100 µg/ml 2.7 2.6 2.7 2.6667 0.057735 98 
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(b) Polarized entry of WNV into Vero C1008 cells 
Apical Inoculation 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  8.50E+05 8.30E+05 8.40E+05 8.40E+05 10000 
8 hr 9.00E+07 8.90E+07 9.10E+07 9.00E+07 1000000 
12 hr 8.00E+08 8.20E+08 8.20E+08 8.13E+08 11547005 
14 hr 8.00E+09 7.60E+09 7.90E+09 7.83E+09 208166600 
Basolateral Inoculation 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  8.00E+02 7.80E+02 8.05E+02 7.95E+02 13.228757 
8 hr 1.00E+03 1.50E+03 1.80E+03 1.43E+03 404.14519 
12 hr 3.00E+03 3.50E+03 3.20E+03 3.23E+03 251.66115 
14 hr 8.50E+03 8.20E+03 8.50E+03 8.40E+03 173.20508 
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APPENDIX 15 
 
DATA FOR FIGURES IN CHAPTER 4 
 
(a) Virus entry blockage by using antibodies against putative receptor 
molecules. 
Antibodies  Exp 1 Exp 2 Exp 3 Avg  SD  
spectrin β1         
100 µg/ml 28721.89 28113.56 28876.78 -3.9274358 403.43547 
50 µg/ml 25113.42 26000.89 25037.06 7.6652583 535.78636 
20 µg/ml 25436.12 25511.93 24998.23 7.9139332 277.30323 
PC           
100 µg/ml 29563.23 28188.45 28794.22 -4.062607 689.00335 
50 µg/ml 25547.98 26664.12 22667.80 10.082603 2062.0289 
10 µg/ml 29818.21 25536.22 24559.17 3.9791617 2797.2477 
MPTP           
100 µg/ml 27140.12 27731.78 27682.11 -0.295769 234.42727 
50 µg/ml 25612.21 25562.98 25891.04 6.5559761 176.91482 
20 µg/ml 27123.72 27778.34 27891.23 -0.3881748 414.39576 
VAP           
100 µg/ml 23417.91 24112.61 22239.89 15.402273 946.69772 
50 µg/ml 24516.34 22198.77 24590.51 13.540807 1359.9664 
20 µg/ml 26891.23 25123.93 25562.05 5.9364048 920.32765 
Integrin β3           
100 µg/ml 7124.56 7551.64 7095.49 73.601481 255.3805 
50 µg/ml 11066.54 12071.33 11529.75 57.964962 502.90412 
20 µg/ml 18392.06 17013.73 17981.60 35.266944 707.70089 
Control 27654.12 2749.05 2750.67     
 




anti-INTA1                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2325 26 1.1059124 2341 10 0.4253509 2333 18 0.7656316 2351 
Exp 2 2356 0 0 2333 23 0.9762309 2245 111 4.7113752 2356 
Exp 3 2333 17 0.7234043 2341 9 0.3829787 2214 136 5.787234 2350 
Avg     0.6097722     0.5948535     3.754747   
SD     0.5616447     0.3309613     2.6439508   
WNV 
inhibition by 
anti-INTA2                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 1922 73 3.6591479 1987 8 0.4010025 1734 261 13.082707 1995 
Exp 2 1945 54 2.7013507 1994 5 0.2501251 1802 197 9.8549275 1999 
Exp 3 1561 30 1.8856065 1589 2 0.1257071 1499 92 5.7825267 1591 
Avg     2.7487017     0.2589449     9.573387   
SD     0.8877183     0.1378595     3.6582244   
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WNV inhibition by 
anti-INTA3                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 856 1503 63.713438 1589 770 32.64095 2090 269 11.403137 2359 
Exp 2 745 1511 66.97695 1256 ## 44.326241 1989 267 11.835106 2256 
Exp 3 985 1576 61.538462 1865 696 27.176884 2111 450 17.571261 2561 
Avg     64.076283     43.12451     13.603168   
SD     2.7373404     8.7607315     3.4432501   
WNV inhibition by 
anti-INTA4                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 784 1441 64.764045 1325 900 40.449438 1826 399 17.932584 2225 
Exp 2 652 1493 69.60373 1256 889 41.445221 1785 360 16.783217 2145 
Exp 3 845 1486 63.749464 1210 ## 48.090948 1741 590 25.311025 2331 
Avg     66.039079     43.328536     20.008942   
SD     3.1284808     4.1543138     4.6275616   
WNV inhibition by 
anti-INTA5                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2256 77 3.3004715 2155 178 7.6296614 2303 30 1.285898 2333 
Exp 2 2156 32 1.4625229 2045 143 6.535649 2156 32 1.4625229 2188 
Exp 3 2445 11 0.4478827 2399 57 2.3208469 2401 55 2.2394137 2456 
Avg     1.736959     5.4953858     1.6626115   
SD     1.4459606     2.8031212     0.5072718   
WNV inhibition by 
anti-INTA6                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2333 2 0.0856531 2313 22 0.9421842 2308 27 1.1563169 2335 
Exp 2 2312 19 0.8151008 2229 102 4.3758044 2308 23 0.986701 2331 
Exp 3 2333 2 0.0856531 2313 22 0.9421842 2323 12 0.5139186 2335 
Avg     0.3288023     2.0867242     0.8856455   
SD     0.4211468     1.9824016     0.3329085   
WNV inhibition by 
anti-INTAV                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 800 1555 66.029724 1569 786 33.375796 2014 341 14.47983 2355 
Exp 2 825 1464 63.95806 1506 783 34.207077 2000 289 12.625601 2289 
Exp 3 884 1451 62.141328 1456 879 37.64454 1998 337 14.432548 2335 
Avg     64.043037     35.075804     13.845993   
SD     1.9455905     2.2630859     1.0571551   
WNV inhibition by 
anti-INTA2                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 562 1894 77.117264 1489 967 39.372964 2020 436 17.752443 2456 
Exp 2 604 1734 74.165954 1356 982 42.001711 1999 339 14.499572 2338 
Exp 3 800 1456 64.539007 1489 767 33.998227 2000 256 11.347518 2256 
Avg     71.940742     38.457634     14.533178   
SD     6.5777513     4.0794988     3.2025949   
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WNV inhibition by 
anti-INTB1                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2325 8 0.3429061 2259 74 3.1718817 2333 0 0 2333 
Exp 2 2784 72 2.5210084 2798 58 2.0308123 2659 197 6.8977591 2856 
Exp 3 2410 150 5.859375 2451 109 4.2578125 2324 236 9.21875 2560 
Avg     2.9077632     3.1535022     5.3721697   
SD     2.7784963     1.1136138     4.7949875   
WNV inhibition by 
anti-INTB2                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2554 10 0.3900156 2356 208 8.1123245 2412 152 5.9282371 2564 
Exp 2 1990 9 0.4502251 1789 210 10.505253 1885 114 5.7028514 1999 
Exp 3 1982 22 1.0978044 1785 219 10.928144 1875 129 6.4371257 2004 
Avg     0.646015     9.8485736     6.0227381   
SD     0.3924175     1.5184301     0.3761483   
WNV inhibition by 
anti-INTB3                     
      25ug/ml     0.55895     0.25ug/ml   
Exp 1 2200 147 6.2633149 2300 47 2.0025565 2256 91 3.8772902 2347 
Exp 2 2410 159 6.1891787 2498 71 2.7637213 2471 98 3.8147139 2569 
Exp 3 2456 85 3.3451397 2500 41 1.613538 2347 194 7.6347895 2541 
Avg     5.2658777     2.1266052     5.1089312   
SD     1.6638209     0.5850397     2.1876812   
WNV inhibition by 
anti-INTB4                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2201 44 1.9599109 2199 46 2.0489978 2005 240 10.690423 2245 
Exp 2 1895 106 5.2973513 1874 127 6.3468266 1871 130 6.4967516 2001 
Exp 3 2569 89 3.3483822 2479 179 6.7343868 2478 180 6.772009 2658 
Avg     3.5352148     5.0434037     7.9863946   
SD     1.6765461     2.6004617     2.3457983   
WNV inhibition by 
anti-INTB5                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2256 77 3.3004715 2155 178 7.6296614 2303 30 1.285898 2333 
Exp 2 2156 32 1.4625229 2045 143 6.535649 2156 32 1.4625229 2188 
Exp 3 2445 11 0.4478827 2399 57 2.3208469 2401 55 2.2394137 2456 
Avg     1.736959     5.4953858     1.6626115   
SD     1.4459606     2.8031212     0.5072718   
WNV inhibition by 
anti-INTB6                     
      25ug/ml     2.5ug/ml     0.25ug/ml   
Exp 1 2001 144 6.7132867 2078 67 3.1235431 1978 167 7.7855478 2145 
Exp 2 2189 36 1.6179775 2200 25 1.1235955 2156 69 3.1011236 2225 
Exp 3 2000 188 8.5923218 2084 104 4.7531993 2100 88 4.0219378 2188 
Avg     5.6411953     3.0001126     4.9695364   
SD     3.6086569     1.8179472     2.4818168   
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(c) Antibody to αVβ3 integrin inhibit WNV and JEV entry into Vero cells 
WNV inhibition 
by anti-αVβ3 
integrin                     
      25 µg/ml     2.5 µg/ml     0.25 µg/ml   
Exp 1 562 1894 77.117264 1489 967 39.372964 2020 436 17.752443 2456 
Exp 2 604 1734 74.165954 1356 982 42.001711 1999 339 14.499572 2338 
Exp 3 800 1456 64.539007 1489 767 33.998227 2000 256 11.347518 2256 
Avg     71.940742     38.457634     14.533178   
SD     6.5777513     4.0794988     3.2025949   
                      
WNV inhibition 
by anti-αVβ5 
integrin                     
      25 µg/ml     2.5 µg/ml     0.25 µg/ml   
Exp 1 1254 1002 44.414894 1847 409 18.129433 2011 245 10.859929 2256 
Exp 2 1333 812 37.855478 1841 304 14.172494 2000 145 6.7599068 2145 
Exp 3 1227 777 38.772455 1658 346 17.265469 1978 26 1.2974052 2004 
Avg     25.2314     16.522465     6.305747   
SD     3.5520861     2.0804763     4.797412   
                      
JEV inhibition 
by anti-αVβ3 
integrin                     
      25 µg/ml     2.5 µg/ml     0.25 µg/ml   
Exp 1 1204 2494 67.44186 2003 1695 45.835587 2658 1040 28.12331 3698 
Exp 2 986 2347 70.417042 1987 1346 40.384038 2784 549 16.471647 3333 
Exp 3 1156 2302 66.570272 1999 1459 42.192019 2884 574 16.59919 3458 
Avg     68.143058     42.803881     20.398049   
SD     2.01697     2.7768016     6.690576   
                      
JEV inhibition 
by anti-αVβ5 
integrin                     
      25 µg/ml     2.5 µg/ml     0.25 µg/ml   
Exp 1 2451 663 21.290944 2441 673 21.612075 3002 112 3.5966602 3114 
Exp 2 2365 1197 33.604716 2698 864 24.256036 3254 308 8.6468276 3562 
Exp 3 2214 1327 37.475289 2987 554 15.645298 3231 310 8.7545891 3541 
Avg     25.2314     20.504469     6.999359   
SD     8.4512658     4.4109289     2.9473161   
                      
DV inhibition 
by anti-αVβ3 
integrin                     
      25 µg/ml     2.5 µg/ml     0.25 µg/ml   
Exp 1 4781 631 11.659276 4978 434 8.0192166 4987 425 7.8529194 5412 
Exp 2 4001 1622 28.845812 4895 728 12.946826 4999 624 11.097279 5623 
Exp 3 4456 1085 19.581303 4987 554 9.9981953 4987 554 9.9981953 5541 
Avg     20.028797     10.321412     9.6494646   
SD     8.6020023     2.4796541     1.6500537   
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integrin                     
      25 µg/ml     2.5 µg/ml     0.25 µg/ml   
Exp 1 4589 632 12.104961 4689 532 10.189619 5114 107 2.0494158 5221 
Exp 2 4875 666 12.019491 4985 556 10.03429 5369 172 3.1041328 5541 
Exp 3 4997 248 4.7283127 4859 386 7.3593899 5180 65 1.2392755 5245 
Avg     9.6175882     9.1944329     2.1309414   
SD     4.2344524     1.5910904     0.9350979   
 
(d) RGD – independent WNV interactions with host cells 
  Exp1 Exp 2 Exp 3 Avg SD 
FN           
50 µg/ml 35 26.5 34 31.833 4.6458 
100 µg/ml 38 41 36 38.333 2.5166 
VN           
50 µg/ml 30 25 23 26 3.6056 
100 µg/ml 34 31 31.5 32.167 1.6073 
LM           
50 µg/ml 11 10.5 11 10.833 0.2887 
100 µg/ml 10 12.5 11 11.167 1.2583 
CS           
50 µg/ml 8.5 9 12.5 10 2.1794 
100 µg/ml 5.5 8 9 7.5 1.8028 
HP           
50 µg/ml 5 9 3.5 5.8333 2.8431 
100 µg/ml 5 6 5.5 5.5 0.5 
CL           
50 µg/ml 7 10.5 10 9.1667 1.893 
100 µg/ml 11 4 5 6.6667 3.7859 
BSA           
50 µg/ml 9 12.5 13.5 11.667 2.3629 
100 µg/ml 18 18.5 19 18.5 0.5 
RGE           
50 µg/ml 25 22 19 22 3 
100 µg/ml 24 23.3 23 23.433 0.5132 
RGD           
50 µg/ml 27.5 27 26.5 27 0.5 
100 µg/ml 30 33 26 29.667 3.5119 
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(e) The effects of EDTA on WNV and JEV binding to Vero cells 
EDTA Exp 1 Exp 2 Exp 3 Avg SD 
WNV           
3 mM 5.34 5.68 5.12 5.38 1.3631874 
5 mM 6.75 8.33 7.9 7.66 1.5188603 
7mM 4.68 5.01 5.66 5.1166667 0.4717379 
10 mM 5.11 5.98 5.43 5.5066667 0.3489842 
12 mM 5.81 5.94 5.9 5.8833333 0.0665833 
            
JEV Exp 1 Exp 2 Exp 3 Avg SD 
3 mM 3.11 3.24 3.56 3.3033333 1.3573946 
5 mM 5.9 5.12 6.07 5.6966667 0.818022 
7mM 7.34 5.12 6.09 6.1833333 1.3129014 
10 mM 3.83 4.98 4.05 4.2866667 1.6854317 
12 mM 7.11 7.81 6.72 7.2133333 0.5522982 
 
(f) Gene silencing of human β3 integrin reduced WNV entry 
% inhibition of virus entry 
 Exp 1 Exp 2 Exp 3 Avg SD 
pSilencer-INTB3 63 60 56 59 3.5118846 
pSilencer-GADPH 5 4 5 4 0.5773503 
pSilencer 11 3.8 5.5 6 3.7634204 
 
(g) Specific interactions between soluble αVβ3 integrin and WNV prevent 
virus infection 
INTAVB3 Exp 1 Exp 2 Exp 3 AVG SD 
10 µg/ml 85.6 83.2 87 85.266667 1.9218047 
7.5 µg/ml 77.23 72.49 74.08 74.6 2.4124054 
5 µg/ml 68.56 61.08 63.34 64.326667 3.8363698 
2.5 µg/ml 35.28 38.45 41.87 38.533333 3.2957902 
1 µg/ml 26 30.12 28.48 28.2 2.0742227 
INTAVB5 Exp 1 Exp 2 Exp 3 AVG SD 
10 µg/ml 23.33 26.12 25.07 24.84 1.4091487 
7.5 µg/ml 9.87 9.17 11.48 10.173333 1.1844971 
5 µg/ml 7.98 5.88 6.98 6.9466667 1.0503968 
2.5 µg/ml 8.37 8.44 8.11 8.3066667 0.1738774 
1 µg/ml 5.56 6.68 4.1 5.4466667 1.2937285 
(h) Expression of αVβ3 integrin in CS-1 cells increased its permissiveness for 
WNV 
CS-1 cells Exp 1 Exp 2 Exp 3 Avg SD Background 
  542 487 410     101 
substraction of background 441 386 309 378.66667 66.304852   
CS-1β3 cells             
  3325 2911 2874     123 
substraction of background 3202 2788 2751 2913.6667 250.38837   
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(i) Competitive inhibition of flaviviruses entry into Vero / C6/36 cells with 
soluble WNV E DIII protein 
Vero cell          
WNV+DIII Exp 1 Exp 2 Exp 3 Avg SD 
100ug/ml 66.82 68.51 67.02 67.45 0.9234176 
50ug/ml 53.95 55.73 55.4 55.0267 0.9469072 
25ug/ml 45.62 32.42 40.62 39.5533 6.6643329 
10ug/ml 36.73 37.45 36.09 36.7567 0.680392 
5ug/ml 23.99 19.87 22.09 21.9833 2.0620702 
WNV+BSA          
100ug/ml 9.543 9.776 9.642 9.65367 0.1169373 
50ug/ml 3.982 2.476 3.479 3.31233 0.7667088 
25ug/ml 5.321 5.99 5.802 5.70433 0.345028 
10ug/ml 9.11 10.12 9.892 9.70733 0.5297182 
5ug/ml 5.765 6.112 6.027 5.968 0.1808674 
DV2 + DIII          
100ug/ml 32.1 33.67 32.45 32.74 0.8241966 
50ug/ml 22.99 21.95 22.82 22.5867 0.5578829 
25ug/ml 11.34 11.76 11.56 11.5533 0.2100794 
10ug/ml 2.19 2.76 2.052 2.334 0.3753239 
5ug/ml 2.67 1.12 1.924 1.90467 0.7751808 
DV2+BSA          
100ug/ml 1.67 2.89 2.24 2.26667 0.610437 
50ug/ml 3.36 3.11 3.239 3.23633 0.1250213 
25ug/ml 5.31 5.88 5.954 5.71467 0.3523994 
10ug/ml 1.053 2.08 1.603 1.57867 0.5139322 
5ug/ml 0.665 0.599 0.645 0.63633 0.0338428 
C6/36          
WNV+DIII Exp 1 Exp 2 Exp 3 Avg SD 
100ug/ml 70.32 63.43 69.15 67.6333 3.6869002 
50ug/ml 58.88 59.04 59.58 59.1667 0.3667879 
25ug/ml 53.92 45.96 50.03 49.97 3.9803392 
10ug/ml 44.62 43.12 43.25 43.6633 0.8310435 
5ug/ml 24.3 25.09 25.86 25.0833 0.7800214 
WNV+BSA        
100ug/ml 2.55 3.97 2.16 2.89333 0.952593 
50ug/ml 2.71 2.9 2.94 2.85 0.1228821 
25ug/ml 5.33 6.17 5.28 5.59333 0.5000333 
10ug/ml 1.34 -2.44 -3.18 -1.4267 2.4244037 
5ug/ml 3.65 4.04 4.16 3.95 0.2666458 
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DV2 + DIII        
100ug/ml 65.34 64.39 63.58 64.4367 0.8809275 
50ug/ml 53.63 56.77 55.33 55.2433 1.571793 
25ug/ml 47.52 50.87 48.48 48.9567 1.7251184 
10ug/ml 40.65 42.25 41.2 41.3667 0.8129166 
5ug/ml 35.19 30.65 31.18 32.34 2.4823578 
DV2+BSA        
100ug/ml 3.98 2.34 3.56 3.29333 0.8518998 
50ug/ml 2.89 2.61 2.7 2.73333 0.1429452 
25ug/ml 0.32 0.83 0.55 0.56667 0.2554082 
10ug/ml 1.93 2.54 1.98 2.15 0.3386739 
5ug/ml 1.54 2.77 2.09 2.13333 0.6161439 
 
(j) Plaque neutralization of WNV with murine polyclonal antibody against 
WNV E DIII protein 
West Nile virus 












2 1.20E+02 99.63 1.25 100.00 3.21E+04 3.20E+04 
  1.22E+02 99.62     3.30E+04   
  1.25E+02 99.61     3.09E+04   
4 2.95E+02 99.07 2.36 99.07 3.12E+04 3.19E+04 
  2.98E+02 99.06     3.20E+04   
  3.00E+02 99.06     3.24E+04   
8 5.72E+02 98.23 1.25 98.21 3.16E+04 3.23E+04 
  5.80E+02 98.20     3.22E+04   
  5.79E+02 98.21     3.31E+04   
16 1.23E+03 96.07 5.26 96.09 3.23E+04 3.12E+04 
  1.22E+03 96.09     3.14E+04   
  1.22E+03 96.09     2.99E+04   
32 1.05E+03 96.69 2.32 95.65 3.17E+04 3.17E+04 
  1.20E+03 96.21     3.06E+04   
  1.25E+03 96.06     3.28E+04   
64 2.19E+03 93.16 1.23 93.10 3.20E+04 3.20E+04 
  2.22E+03 93.06     3.30E+04   
  2.21E+03 93.09     3.10E+04   
128 5.32E+03 83.36 0.13 80.25 3.28E+04 3.20E+04 
  5.34E+03 83.30     3.25E+04   
  5.35E+03 83.26     3.06E+04   
256 8.00E+03 75.86 0.90 77.26 3.29E+04 3.31E+04 
  7.98E+03 75.92     3.38E+04   
  7.99E+03 75.88     3.27E+04   
512 1.32E+04 58.27 0.15 60.25 3.00E+04 3.16E+04 
  1.31E+04 58.59     3.23E+04   
  1.30E+04 58.94     3.26E+04   
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1024 1.94E+04 37.98 0.80 38.03 3.02E+04 3.12E+04 
  1.96E+04 37.25     3.23E+04   
  1.91E+04 38.85     3.12E+04   
2048 2.50E+04 21.30 0.66 21.09 3.16E+04 3.18E+04 
  2.49E+04 21.62     3.29E+04   
  2.53E+04 20.36     3.08E+04   
4096 2.98E+04 9.61 1.00 12.03 3.40E+04 3.30E+04 
  2.97E+04 9.91     3.28E+04   
  3.00E+04 9.00     3.21E+04   
8192 3.09E+04 1.24 3.26 2.40 3.15E+04 3.13E+04 
  3.02E+04 3.45     3.11E+04   













2 1.77E+04 51.81 51.54 0.27 100.00 3.54E+04 3.67E+04 
  1.78E+04 51.54       3.67E+04   
  1.79E+04 51.27       3.81E+04   
4 1.81E+04 48.29 47.43 1.03 47.43 3.51E+04 3.50E+04 
  1.88E+04 46.29       3.34E+04   
  1.83E+04 47.71       3.65E+04   
8 1.89E+04 46.05 46.43 1.74 46.43 3.51E+04 3.50E+04 
  1.81E+04 48.33       3.45E+04   
  1.93E+04 44.91       3.55E+04   
16 2.00E+04 41.46 43.02 1.38 43.02 3.44E+04 3.42E+04 
  1.93E+04 43.51       3.12E+04   
  1.91E+04 44.10       3.69E+04   
32 2.10E+04 37.75 30.93 6.67 95.65 3.01E+04 3.37E+04 
  2.55E+04 24.41       3.44E+04   
  2.34E+04 30.63       3.67E+04   
64 2.55E+04 27.69 26.65 4.49 26.65 3.65E+04 3.53E+04 
  2.76E+04 21.74       3.59E+04   
  2.45E+04 30.53       3.34E+04   
128 3.01E+04 15.21 14.37 1.97 80.25 3.45E+04 3.55E+04 
  2.99E+04 15.77       3.59E+04   
  3.12E+04 12.11       3.61E+04   
256 3.23E+04 3.96 5.55 1.82 77.26 3.55E+04 3.36E+04 
  3.11E+04 7.53       3.27E+04   
  3.19E+04 5.15       3.27E+04   
512 3.29E+04 6.71 6.81 0.71 60.25 3.60E+04 3.53E+04 
  3.26E+04 7.56       3.51E+04   
  3.31E+04 6.14       3.47E+04   
1024 3.42E+04 5.26 4.16 1.27 4.16 3.71E+04 3.61E+04 
  3.45E+04 4.43       3.57E+04   
  3.51E+04 2.77       3.55E+04   
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2048 3.41E+04 0.29 1.17 0.88 1.17 3.34E+04 3.42E+04 
  3.38E+04 1.17       3.41E+04   
  3.35E+04 2.05       3.51E+04   
4096 3.44E+04 0.86 2.02 1.75 12.03 3.47E+04 3.47E+04 
  3.33E+04 4.03       3.33E+04   
  3.43E+04 1.15       3.61E+04   
8192 3.49E+04 1.51 2.63 2.72 2.63 3.44E+04 3.54E+04 
  3.34E+04 5.74       3.57E+04   
  3.52E+04 0.66       3.62E+04   
 
(k) Specific binding of WNV E DIII protein to αVβ3 integrin 
WNV+DIII Exp 1 Exp 2 Exp 3 Avg SD 
100 µg/ml 3224.98 3312.34 3200.77 75.797569 0.437579 
50 µg/ml 5563.12 5009.77 5398.1 60.306715 2.1181455 
25 µg/ml 7773.9 7688.9 7745.08 42.320608 0.3223059 
            
WNV+BSA Exp 1 Exp 2 Exp 3 Avg SD 
100 µg/ml 1886.54 1802.56 1844.6 7.6543877 2.1021703 
50 µg/ml 1900.34 1899.67 1895.34 4.9567951 0.1358772 
25 µg/ml 1944.3 1906.3 1913.5 3.8095047 1.0105075 
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APPENDIX 16 
 
DATA FOR FIGURES IN CHAPTER 5 
 
(a) Effects of clathrin-mediated endocytosis-disrupting drugs on WNV entry 
into Vero cells 
Monodansly-
cadervine                 
  Exp 1 Exp 2 Exp 3 
Avg No. Virus 
Infected Cells Avg   
% 
Reduction SD 
Pre-1hr 200 189 178 986 189 797 80.831643 5.2 
10 min 210 189 232 986 210.333 775.667 78.668019 10 
30 min 678 753 699 986 710 276 27.991886 8.6 
1 hr  910 930 896 986 912 74 7.505071 2.5 
2 hr  943 935 912 986 930 56 5.6795132 1.5 
Chlorpromazine                 
  Exp 1 Exp 2 Exp 3 
Avg No. Virus 
Infected Cells Avg   
% 
Reduction SD 
Pre-1hr 289 302 311 986 300.67 685.33 69.50642 12 
10 min 356 325 386 986 355.67 630.33 63.92833 5.5 
30 min 745 702 714 986 720.33 265.67 26.94388 1.5 
1 hr  980 945 925 986 950 36 3.651116 0.25 
2 hr  943 968 945 986 952 34 3.448276 0.8 
Sucrose                 
 Exp 1 Exp 2 Exp 3 
Avg No. Virus 
Infected Cells Avg  
% 
Reduction SD 
Pre-1hr 168 189 178 986 178.333 807.667 81.913455 9 
10 min 300 358 389 986 349 637 64.604462 4.5 
30 min 758 753 789 986 766.667 219.333 22.24476 5.5 
1 hr 856 930 896 986 894 92 9.3306288 0.25 
2 hr 943 902 912 986 919 67 6.7951318 0.6 
Filipin                 
  Exp 1 Exp 2 Exp 3 
Avg No. Virus 
Infected Cells Avg   
% 
Reduction SD 
Pre-1hr 856 823 845 986 841.333 144.667 14.672076 1.5 
10 min 924 922 902 986 916 70 7.0993915 2.5 
30 min 914 956 922 986 930.667 55.3333 5.6118999 0.5 
1 hr  910 930 931 986 923.667 62.3333 6.3218391 0.89 
2 hr  943 953 904 986 933.333 52.6667 5.3414469 1.8 
 
(b) Inhibition of WNV entry into Vero cells expressing Eps15-dominant 
negative mutant protein 
  % of fluorescent unit     
Cell Samples Exp 1 Exp 2 Exp 3 Avg SD 
Vero cell (Control) 93 94 80 7.81 89 
Vero cell (EGFP-C2) 85 92 78 85 7 
Vero cell (GFP-
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(c) Effects of PKC inhibitor (BIS I) on WNV entry into Vero cells 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
1 hr Pre 7.00E+03 6.80E+03 7.20E+03 7.00E+03 200 
2 hr Pre 6.50E+03 6.80E+03 6.40E+03 6.57E+03 208.1666 
0.5 hr 6.80E+03 6.30E+03 6.40E+03 6.50E+03 264.57513 
1 hr 3.00E+04 3.80E+04 3.30E+04 3.37E+04 4041.4519 
2 hr 4.00E+05 4.20E+05 4.00E+05 4.07E+05 11547.005 
3 hr 1.00E+08 1.50E+08 1.30E+08 1.27E+08 25166115 
4 hr  3.00E+09 3.40E+09 2.80E+09 3.07E+09 305505046 
5 hr 2.00E+09 2.30E+09 2.50E+09 2.27E+09 251661148 
 
(d) Effect of BIS I on WNV infectivity for cells – transfected with virus RNA 
Concentration PFU/ml 
0 µM 5.00E+05 
10 µM 8.50E+05 
20 µM 5.60E+05 
30 µM 7.20E+05 
40 µM 8.30E+05 
50 µM 7.80E+05 
60 µM 9.80E+04 
 
(e) Effect of BIS I on WNV binding to cell surface of Vero cells 
Radioactivity (CPM) 
  Exp 1 Exp 2 Exp 3 Avg SD 
No treatment 25000 24987 24956 24981 22.605309 
BIS 1 - treated 25100 25002 24996 25032.667 58.389497 
 
(f) Sub-cellular fractionations of cellular homogenates from WNV-infected 







No. CPM 1 CPM2 CPM3 
1 505 1490 456 
2 512 1465 461 
3 509 1491 458 
4 518 1477 477 
5 511 1601 476 
6 516 1444 455 
7 517 1510 469 
8 536 3004 572 
9 1000 3997 645 
10 608 3452 678 
11 534 2647 455 
12 509 1566 432 
13 506 1573 433 
14 508 1400 451 
15 511 700 623 
16 588 523 711 
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17 1123 132 877 
18 913 56 745 
19 503 59 433 
20 109 64 209 
21 23 60 33 
22 22 61 32 
23 27 54 21 
24 21 55 20 
 
(g) Enzymatic activites of PKC and its isoforms 
PKC 
enzymatic 
assay         
  10µg (Exp 1) 10µg (Exp 2) Avg SD 
PKC α 1891.22 1832.67 253.895 41.401102 
PKC ζ 1732.43 1771.07 143.7 27.322606 
PKCβI 1800.59 1812.98 198.735 8.761053 
PKCβII 1888.21 1809.48 240.795 55.670517 
PKC 1727.15 1732.76 121.905 3.966869 
Control 3382.47 3614.66 1890.515 8.2345 
PKC 
enzymatic 
assay         
  1 µg (Exp 1) 1 µg (Exp 2) Avg SD 
PKC α 2413.2 2011.26 604.18 284.2145 
PKC ζ 2588.38 2431.03 901.655 111.26325 
PKCβI 2391.83 2400.19 787.96 5.9114127 
PKCβII 2098.41 2001.56 441.935 68.483292 
PKC 2309.47 2335.77 714.57 18.596908 
Control 3413.08 3491.29 1844.135 55.302821 
 
(h) Inhibition of WNV infectivity in cells transfected with antibodies against 
PKC and its isoforms 
  Exp 1 Exp 2 Exp 3 Avg SD 
PKC α 6.00E+03 7.00E+03 1.00E+03 3.5410831 0.46978576 
PKC ζ 1.00E+04 3.00E+04 2.00E+04 4.25938375 0.24127159 
PKCβI 3.00E+04 5.00E+04 8.00E+04 4.69306042 0.21304585 
PKCβII 3.00E+04 1.00E+04 9.00E+03 4.14378792 0.28958033 
PKC 1.00E+03 5.00E+02 9.00E+02 2.88440417 0.16221224 
FITC 2.00E+06 5.00E+06 8.00E+06 6.63436333 0.30618552 










  356  
                                                                                                             APPENDICES 
(i) Low pH-dependent of WNV into Vero cells 
Bafilomycin A                 




Cells Avg  
% 
reduction SD 
1.5 µm 225 200 189 986 204.67 781.333 79.2427 5.6 
1 µm 356 333 389 986 359.33 626.667 63.5565 5.5 
0.5 µm 456 478 411 986 448.33 537.667 54.5301 2.5 
0.1 µm 789 777 747 986 771 215 21.8053 1.2 
0.05 µm 895 888 874 986 885.67 100.333 10.1758 1.3 
Chloroquine         




Cells Avg  
% 
reduction SD 
30 µm 111 125 156 995 130.67 864.333 86.8677 2.3 
25 µm 145 155 156 995 152 843 84.7236 2 
20 µm 200 214 235 995 216.33 778.667 78.258 1.5 
15 µm 256 289 299 995 281.33 713.667 71.7253 1.9 
10 µm 789 777 745 995 770.33 224.667 22.5796 0.5 
Amantidine         




Cells Avg  
% 
reduction SD 
2 µm 256 300 304 995 286.67 708.333 71.1893 4.2 
1.5 µm 356 389 400 995 381.67 613.333 61.6415 2.3 
1 µm 562 555 589 995 568.67 426.333 42.8476 5.6 
0.5 µm 845 878 881 995 868 127 12.7638 2 
0.1 µm 856 898 911 995 888.33 106.667 10.7203 1.5 
 
(j) Cytochalasin D and nacodazole pre-treated Vero cells inhibit entry of 
WNV 
Cytochalasin 
D                 
Concentration Exp 1 Exp 2 Exp 3 
Avg No. Virus 
Infected Cells Avg   
% 
reduction SD 
2.0 µg/ml 89 58 52 995 66.3333 928.667 93.333333 2.3 
1.5 µg/ml 152 155 180 995 162.333 832.667 83.685092 1.5 
1.0 µg/ml 189 193 195 995 192.333 802.667 80.670017 0.56 
0.5 µg/ml 356 389 400 995 381.667 613.333 61.641541 4.8 
0.1 µg/ml 758 777 745 995 760 235 23.61809 1.2 
Nacodazole                 
Concentration Exp 1 Exp 2 Exp 3 
Avg No. Virus 
Infected Cells Avg  
% 
reduction SD 
40 µm 156 189 200 995 181.67 813.33 81.74204 5.5 
30 µm 256 289 245 995 263.33 731.67 73.53434 5.6 
20 µm 356 389 399 995 381.33 613.67 61.67504 4.5 
10 µm 589 510 571 995 556.67 438.33 44.0536 1.2 
5 µm 689 666 689 995 681.33 313.67 31.52429 4 
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(k) Sub-cellular fractionations of cellular homogenates from WNV-infected 
cells in 20 % percoll gradients 
Markers   Untreated   Nacodazole   
Cytochalasin 
D   







1   1 10 1 11 1 8 
2   2 12 2 15 2 5 
3   3 9 3 8 3 6 
4   4 15 4 9 4 3 
5   5 14 5 10 5 10 
6   6 10 6 10 6 11 
7   7 15 7 8 7 12 
8 1.03 g/ml 8 14 8 14 8 10 
9   9 45 9 89 9 5 
10   10 25 10 68 10 8 
11   11 18 11 55 11 10 
12 
1.042 
g/ml 12 10 12 10 12 95 
13   13 9 13 6 13 56 
14   14 8 14 8 14 20 
15 
1.056 
g/ml 15 11 15 10 15 8 
16   16 11 16 11 16 15 
17 
1.063 
g/ml 17 26 17 8 17 9 
18 
1.079 
g/ml 18 59 18 4 18 10 
19   19 45 19 5 19 11 
20 1.1 g/ml 20 22 20 4 20 5 
21   21 10 21 6 21 6 
22 1.15 g/ml 22 6 22 6 22 2 
23   23 5 23 5 23 8 
24   24 8 24 8 24 5 
 
(l) Infectivity of WNV with Cy5 labelling at different D/P ratio.   
(R/D) Exp 1 Exp 2 Exp 3 Avg SD 
0.5 6.00E+08 5.00E+08 1.00E+08 4.00E+08 208166600 
1.5 2.40E+08 3.10E+08 4.00E+08 3.17E+08 50147929 
2 3.30E+08 4.50E+08 2.33E+08 3.38E+08 108522570 
3 9.00E+07 3.00E+07 2.00E+07 4.67E+07 13471506 
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APPENDIX 17 
 
DATA FOR FIGURES IN CHAPTER 6 
 
(a) Extracellular virus production of WNV-infected Vero cells treated with 
10 µg/ml of vinblastine sulphate 
Extracellular virus yield (PFU/ml) / vinblastine sulphate treated 
    Log   Log   Log Avg SD 
4 4.00E+03 3.6021 3.00E+03 3.47712 9.00E+02 2.95424 3.34E+00 0.34368 
6 6.00E+04 4.7782 4.00E+05 5.60206 2.00E+05 5.30103 5.23E+00 0.4169 
8 2.00E+05 5.301 3.00E+05 5.47712 5.00E+05 5.69897 5.49E+00 0.19941 
10 5.00E+05 5.699 1.80E+06 6.25527 6.00E+05 5.77815 5.91E+00 0.30094 
12 2.00E+06 6.301 3.00E+06 6.47712 4.00E+06 6.60206 6.46E+00 0.15124 
Extracellular virus yield / untreated 
    Log   Log   Log Avg SD 
4 4.00E+04 4.6021 4.00E+04 4.60206 2.00E+05 5.30103 4.84E+00 0.40355 
6 8.00E+05 5.9031 3.00E+06 6.47712 4.00E+06 6.60206 6.33E+00 0.37276 
8 4.00E+07 7.6021 2.00E+07 7.30103 5.00E+07 7.69897 7.53E+00 0.20751 
10 3.00E+08 8.4771 2.00E+08 8.30103 5.00E+08 8.69897 8.49E+00 0.19941 
12 1.00E+09 9 1.20E+09 9.07918 3.00E+09 9.47712 9.19E+00 0.25569 
Viability of Infected Vero cells 
    Log   Log   Log Avg SD 
4 7.90E+05 5.8976 7.80E+05 5.89209 7.80E+05 5.89209 5.893939 0.00319 
6 7.60E+05 5.8808 7.00E+05 5.8451 7.80E+05 5.89209 5.872669 0.02453 
8 7.00E+05 5.8451 6.60E+05 5.81954 6.30E+05 5.79934 5.821328 0.02293 
10 6.30E+05 5.7993 6.50E+05 5.81291 7.00E+05 5.8451 5.819117 0.0235 
12 6.30E+05 5.7993 5.90E+05 5.77085 5.40E+05 5.73239 5.767529 0.0336 
 
(b) Release of WNV occurs predominantly at the apical domain, while KUN 
virus release occurs bi-directionally in Vero C1008 cells. 
WNV apical release (Vero C1008 cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  5.00E+05 4.80E+05 5.00E+05 4.93E+05 11547.005 
8 hr 6.00E+07 6.20E+07 6.40E+07 6.20E+07 2000000 
12 hr 4.50E+08 4.50E+08 5.00E+08 4.67E+08 28867513 
14 hr 8.00E+09 8.40E+09 8.30E+09 8.23E+09 208166600 
WNV basolateral release (Vero C1008 cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  6.00E+03 6.30E+03 6.10E+03 6.13E+03 152.75252 
8 hr 6.00E+03 6.00E+03 6.20E+03 6.07E+03 115.47005 
12 hr 7.00E+03 7.50E+03 7.20E+03 7.23E+03 251.66115 
14 hr 1.00E+04 1.50E+04 1.00E+04 1.17E+04 2886.7513 
KUN virus apical release (Vero C1008 cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
6 hr  2.00E+04 2.50E+04 2.40E+04 2.30E+04 2645.7513 
12 hr 6.00E+04 6.70E+04 6.30E+04 6.33E+04 3511.8846 
18 hr 8.90E+05 8.80E+05 8.60E+05 8.77E+05 15275.252 
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24 hr 2.30E+07 2.50E+07 2.40E+07 2.40E+07 1000000 
KUN virus basolateral release (Vero C1008 cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
6 hr  8.60E+03 8.60E+03 8.30E+03 8.50E+03 173.20508 
12 hr 9.60E+03 9.10E+03 9.50E+03 9.40E+03 264.57513 
18 hr 7.60E+05 7.70E+05 7.60E+05 7.63E+05 5773.5027 
24 hr 9.30E+06 9.00E+06 9.00E+06 9.10E+06 173205.08 
WNV apical release (Vero cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  8.00E+04 8.50E+04 7.80E+04 8.10E+04 3605.5513 
8 hr 3.50E+06 2.90E+06 3.90E+06 3.43E+06 503322.3 
12 hr 8.30E+08 8.00E+08 8.50E+08 8.27E+08 25166115 
14 hr 8.90E+09 8.70E+09 8.90E+09 8.83E+09 115470054 
WNV basolateral release (Vero cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  8.20E+04 8.40E+04 8.60E+04 8.40E+04 2000 
8 hr 3.70E+06 3.75E+06 3.60E+06 3.68E+06 76376.262 
12 hr 8.20E+08 8.00E+08 8.00E+08 8.07E+08 11547005 
14 hr 8.40E+09 8.50E+09 7.90E+09 8.27E+09 321455025 
KUN virus apical release (Vero cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
6 hr  9.50E+03 9.50E+03 9.30E+03 9.43E+03 115.47005 
12 hr 4.10E+04 4.00E+04 4.50E+04 4.20E+04 2645.7513 
18 hr 9.60E+05 9.90E+05 9.50E+05 9.67E+05 20816.66 
24 hr 9.80E+06 9.80E+06 9.50E+06 9.70E+06 173205.08 
KUN virus basolateral release (Vero cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
6 hr  9.40E+03 9.80E+03 9.80E+03 9.67E+03 230.94011 
12 hr 1.10E+04 9.80E+03 9.55E+03 1.01E+04 775.1344 
18 hr 8.60E+05 8.00E+05 8.50E+05 8.37E+05 32145.503 
24 hr 8.00E+06 8.00E+06 8.10E+06 8.03E+06 57735.027 
Poliovirus apical release (Vero C1008 cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  6.70E+02 6.00E+02 6.50E+02 6.40E+02 36.055513 
8 hr 6.40E+04 6.50E+04 6.60E+04 6.50E+04 1000 
12 hr 5.60E+05 5.70E+05 5.80E+05 5.70E+05 10000 
14 hr 9.70E+06 9.00E+06 9.50E+06 9.40E+06 360555.13 
Poliovirus basolateral release (Vero C1008 cells) 
Virus yield (Log PFU/ml) 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr  5.50E+02 5.50E+02 5.40E+02 5.47E+02 5.7735027 
8 hr 1.00E+04 9.80E+03 9.80E+03 9.87E+03 115.47005 
12 hr 1.00E+05 9.70E+04 1.30E+05 1.09E+05 18248.288 
14 hr 8.10E+06 7.50E+06 7.90E+06 7.83E+06 305505.05 
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(c) Role of microtubules in the polarized release of WNV and KUN virus in 
polarized epithelial cells 
Productive yields (PFU/ml) of WNV  
  Exp 1 Exp 2 Exp 3 Avg  SD 
Apical 2.00E+04 2.50E+04 2.20E+04 2.23E+04 2516.611 
Basolateral 4.00E+03 3.80E+03 4.40E+03 4.07E+03 305.505 
Productive yields (PFU/ml) of KUN virus 
  Exp 1 Exp 2 Exp 3 Avg  SD 
Apical 5.00E+07 5.50E+07 6.00E+07 5.50E+07 5000000 
Basolateral 2.00E+07 2.50E+07 2.80E+07 2.43E+07 4041452 
 
(d) Effect of cytochalasin B on WNV egression from Vero cells 
Virus yield (Log PFU/ml) w/o treatment 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr 4.50E+03 3.90E+03 4.70E+03 4.37E+03 416.3332 
6 hr 2.00E+04 2.00E+04 2.50E+04 2.17E+04 2886.7513 
8 hr 6.00E+05 5.80E+05 6.30E+05 6.03E+05 25166.115 
10 hr 7.00E+07 6.80E+07 7.20E+07 7.00E+07 2000000 
12 hr 3.00E+09 2.50E+09 3.00E+09 2.83E+09 288675135 
Virus yield (Log PFU/ml) after Cytochalasin treatment 
Time Exp 1 Exp 2 Exp 3 Avg SD 
4 hr 2.00E+02 2.50E+02 2.30E+02 2.27E+02 25.166115 
6 hr 6.00E+03 5.30E+03 5.50E+03 5.60E+03 360.55513 
8 hr 7.00E+03 7.50E+03 6.90E+03 7.13E+03 321.45503 
10 hr 6.00E+03 5.80E+03 5.90E+03 5.90E+03 100 
12 hr 2.00E+04 2.00E+04 1.00E+04 1.67E+04 5773.5027 
Virus yield (Log PFU/ml) after removal of cytochalasin treatment 
Time Exp 1 Exp 2 Exp 3 Avg SD 
1 hr 5.00E+03 5.20E+03 5.00E+03 5.07E+03 115.47005 
2 hr 9.00E+04 8.50E+04 8.70E+04 8.73E+04 2516.6115 
3 hr 8.00E+07 7.50E+07 8.45E+07 7.98E+07 4752192.5 
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APPENDIX 18 
 
DATA FOR FIGURES IN CHAPTER 7 
 
(a) The effect of different infectious doses of WNV-infected Vero cells. 
Extracellular virus production (PFU/ml) at different M.O.I. 
M.O.I. 
= 100 Exp 1 Log Exp 2 Log Exp 3 Log Avg SD 
4 h 2.00E+03 3.30103 4.00E+03 3.60206 5.80E+03 3.763428 3.555506 0.2346879 
8 h 4.00E+07 7.60206 6.00E+07 7.7781513 2.50E+07 7.39794 7.5927171 0.1902777 
12 h 8.00E+08 8.90309 3.00E+09 9.4771213 5.00E+09 9.69897 9.3597271 0.4107217 
14 h 2.00E+09 9.30103 5.50E+09 9.7403627 6.00E+09 9.7781513 9.6065146 0.2652313 
                  
M.O.I. 
= 10                 
4 h 1.00E+03 3 5.50E+03 3.7403627 2.00E+03 3.30103 3.3471309 0.3723281 
8 h 3.00E+07 7.4771213 4.00E+07 7.60206 1.00E+07 7 7.3597271 0.3177343 
12 h 1.00E+09 9 8.00E+08 8.90309 9.00E+08 8.9542425 8.9524442 0.04848 
14 h 3.00E+09 9.4771213 1.00E+09 9 8.00E+08 8.90309 9.1267371 0.307286 
                  
M.O.I. 
= 1                 
8 h 1.00E+04 4 9.00E+03 3.9542425 8.70E+03 3.9395193 3.9645873 0.0315395 
16 h 2.00E+05 5.30103 3.00E+05 5.4771213 1.80E+05 5.2552725 5.3444746 0.1171315 
24 h 4.00E+06 6.60206 8.00E+06 6.90309 7.00E+06 6.845098 6.783416 0.1597131 
32 h 2.00E+07 7.30103 8.00E+06 6.90309 1.00E+07 7 7.06804 0.2075118 
                  
M.O.I. 
= 0.1                 
8 h 2.00E+04 4.30103 1.00E+04 4 1.80E+04 4.2552725 4.1854342 0.1622122 
16 h 1.00E+05 5 1.50E+05 5.1760913 8.70E+04 4.9395193 5.0385368 0.122904 
24 h 5.00E+06 6.69897 6.00E+06 6.7781513 1.20E+06 6.0791812 6.5187675 0.382746 
32 h 6.00E+06 6.7781513 9.00E+06 6.9542425 8.00E+06 6.90309 6.8784946 0.0905855 
Cell viability (cells/ml) after infection with WNV  
M.O.I. 
= 100 Exp 1 Log Exp 2 Log Exp 3 Log Avg SD 
4 h 5.00E+06 6.69897 4.80E+06 6.6812412 5.50E+06 6.7403627 6.706858 0.0303398 
8 h 3.00E+05 5.4771213 8.00E+05 5.90309 4.00E+05 5.60206 5.6607571 0.2189666 
12 h 2.00E+05 5.30103 3.50E+05 5.544068 1.00E+05 5 5.2816993 0.2725486 
14 h 2.00E+02 2.30103 1.00E+02 2 4.50E+02 2.6532125 2.3180808 0.3269399 
                  
M.O.I. 
= 10                 
4 h 5.00E+06 6.69897 4.00E+06 6.60206 4.50E+06 6.6532125 6.6514142 0.04848 
8 h 4.00E+05 5.60206 3.00E+05 5.4771213 1.00E+05 5 5.3597271 0.3177343 
12 h 1.00E+05 5 9.00E+04 4.9542425 8.00E+04 4.90309 4.9524442 0.04848 
14 h 1.00E+02 2 4.00E+02 2.60206 8.00E+02 2.90309 2.5017167 0.4598309 
                  
M.O.I. 
= 1                 
8 h 5.00E+06 6.69897 8.00E+06 6.90309 3.00E+06 6.4771213 6.6930604 0.2130458 
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16 h 6.00E+06 6.7781513 4.00E+06 6.60206 1.00E+06 6 6.4600704 0.4080449 
24 h 1.00E+05 5 2.00E+05 5.30103 3.00E+05 5.4771213 5.2593838 0.2412716 
32 h 8.00E+03 3.90309 7.00E+03 3.845098 1.00E+04 4 3.9160627 0.0782616 
 
M.O.I. 
= 0.1                 
8 h 5.50E+06 6.7403627 6.00E+06 6.7781513 5.00E+06 6.69897 6.7391613 0.0396043 
16 h 6.00E+06 6.7781513 3.00E+06 6.4771213 4.00E+06 6.60206 6.6191108 0.1512376 
24 h 2.00E+05 5.30103 9.00E+04 4.9542425 3.00E+05 5.4771213 5.2441313 0.2660426 
32 h 2.00E+04 4.30103 7.00E+03 3.845098 9.50E+03 3.9777236 4.0412839 0.2345174 
 
(b) Measurement of LDH activity in WNV-infected Vero cell supernatants 
LDH assay  Exp 1 Exp 2 Exp 3 Avg SD 
M.O.I. = 10           
6 hr 1 0.5 0.6 0.7 0.264575 
8 hr 5.6 6.5 6.6 6.233333 0.550757 
12 hr 8.5 8.8 8 8.433333 0.404145 
14 hr 8 9 8.5 8.5 0.5 
M.O.I. = 1           
8 hr 1 0.8 0.5 0.766667 0.251661 
16 hr 1.2 0.5 1 0.9 0.360555 
24 hr 2.2 1.6 1.8 1.866667 0.305505 
32 hr 5 6.5 5.8 5.766667 0.750555 
            
Cytochalasin B 
treatment           
  Exp 1 Exp 2 Exp 3 Avg SD 
6 hr 0.8 0.5 0.6 0.633333 0.152753 
8 hr 1 0.5 0.5 0.666667 0.288675 
12 hr 2.5 3.2 3 2.9 0.360555 
14 hr 2.8 3.5 3.3 3.2 0.360555 
 
(d) Activation of caspases activities by WNV-infected cells 
Caspase - 8 Activation  
Time Exp 1 Exp 2 Exp 3 Avg SD 
12 hr 1.2 1.4 1.5 1.3666667 0.1527525 
18 hr 2.1 1.8 2 1.9666667 0.1527525 
 20 hr 7.8 8 7.5 7.7666667 0.2516611 
26 hr 8.9 8.8 8.7 8.8 0.1 
 Caspase – 9 Activation  
12 hr 1 1.2 1.1 1.1 0.1 
18 hr 1.2 1.5 1.6 1.4333333 0.2081666 
20 hr 2 2.5 2.8 2.4333333 0.4041452 
26 hr 3.3 2.8 2.9 3 0.2645751 
 Caspase – 3 Activation  
12 hr 0.3 0.5 0.2 0.3333333 0.1527525 
18 hr 0.5 0.8 1.2 0.8333333 0.3511885 
20 hr 1.5 1.2 0.8 1.1666667 0.3511885 
26 hr 6.3 6.9 5.8 6.3333333 0.5507571 
32 hr 7.5 7.9 6.8 7.4 0.5567764 
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